0001964738-24-000044.txt : 20241108 0001964738-24-000044.hdr.sgml : 20241108 20241108155745 ACCESSION NUMBER: 0001964738-24-000044 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 241440314 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 10-Q 1 solv-20240930.htm 10-Q solv-20240930
FALSE2024Q3000196473812/31P18MP3YP3YP5YP7YP10YP30YP40YP18Mxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puresolv:operatingSegmentsolv:seriessolv:plansolv:countrysolv:lawsuitsolv:classActionsolv:casesolv:quiTamActionsolv:employee00019647382024-01-012024-09-3000019647382024-09-300001964738us-gaap:ProductMember2024-07-012024-09-300001964738us-gaap:ProductMember2023-07-012023-09-300001964738us-gaap:ProductMember2024-01-012024-09-300001964738us-gaap:ProductMember2023-01-012023-09-300001964738solv:SalesOfSoftwareAndRentalsMember2024-07-012024-09-300001964738solv:SalesOfSoftwareAndRentalsMember2023-07-012023-09-300001964738solv:SalesOfSoftwareAndRentalsMember2024-01-012024-09-300001964738solv:SalesOfSoftwareAndRentalsMember2023-01-012023-09-3000019647382024-07-012024-09-3000019647382023-07-012023-09-3000019647382023-01-012023-09-3000019647382023-12-310001964738us-gaap:CommonStockMember2024-06-300001964738us-gaap:AdditionalPaidInCapitalMember2024-06-300001964738us-gaap:RetainedEarningsMember2024-06-300001964738solv:NetParentInvestmentMember2024-06-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000019647382024-06-300001964738us-gaap:RetainedEarningsMember2024-07-012024-09-300001964738solv:NetParentInvestmentMember2024-07-012024-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001964738us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001964738us-gaap:CommonStockMember2024-09-300001964738us-gaap:AdditionalPaidInCapitalMember2024-09-300001964738us-gaap:RetainedEarningsMember2024-09-300001964738solv:NetParentInvestmentMember2024-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001964738us-gaap:CommonStockMember2023-06-300001964738us-gaap:AdditionalPaidInCapitalMember2023-06-300001964738us-gaap:RetainedEarningsMember2023-06-300001964738solv:NetParentInvestmentMember2023-06-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000019647382023-06-300001964738solv:NetParentInvestmentMember2023-07-012023-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001964738us-gaap:CommonStockMember2023-09-300001964738us-gaap:AdditionalPaidInCapitalMember2023-09-300001964738us-gaap:RetainedEarningsMember2023-09-300001964738solv:NetParentInvestmentMember2023-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000019647382023-09-300001964738us-gaap:CommonStockMember2023-12-310001964738us-gaap:AdditionalPaidInCapitalMember2023-12-310001964738us-gaap:RetainedEarningsMember2023-12-310001964738solv:NetParentInvestmentMember2023-12-310001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001964738us-gaap:RetainedEarningsMember2024-01-012024-09-300001964738solv:NetParentInvestmentMember2024-01-012024-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001964738us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001964738us-gaap:CommonStockMember2024-01-012024-09-300001964738us-gaap:CommonStockMember2022-12-310001964738us-gaap:AdditionalPaidInCapitalMember2022-12-310001964738us-gaap:RetainedEarningsMember2022-12-310001964738solv:NetParentInvestmentMember2022-12-310001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100019647382022-12-310001964738solv:NetParentInvestmentMember2023-01-012023-09-300001964738us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-3000019647382024-04-0100019647382024-04-012024-04-010001964738solv:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-01-012023-12-310001964738solv:MedSurgSegmentMember2023-12-310001964738solv:DentalSolutionsSegmentMember2023-12-310001964738solv:HealthInformationSystemsSegmentMember2023-12-310001964738solv:PurificationAndFiltrationSegmentMember2023-12-310001964738solv:MedSurgSegmentMember2024-01-012024-09-300001964738solv:DentalSolutionsSegmentMember2024-01-012024-09-300001964738solv:HealthInformationSystemsSegmentMember2024-01-012024-09-300001964738solv:PurificationAndFiltrationSegmentMember2024-01-012024-09-300001964738solv:MedSurgSegmentMember2024-09-300001964738solv:DentalSolutionsSegmentMember2024-09-300001964738solv:HealthInformationSystemsSegmentMember2024-09-300001964738solv:PurificationAndFiltrationSegmentMember2024-09-300001964738us-gaap:CustomerRelatedIntangibleAssetsMember2024-09-300001964738us-gaap:CustomerRelatedIntangibleAssetsMember2023-12-310001964738us-gaap:IntellectualPropertyMember2024-09-300001964738us-gaap:IntellectualPropertyMember2023-12-310001964738us-gaap:TradeNamesMember2024-09-300001964738us-gaap:TradeNamesMember2023-12-310001964738us-gaap:BuildingAndBuildingImprovementsMember2024-09-300001964738us-gaap:BuildingAndBuildingImprovementsMember2023-12-310001964738us-gaap:MachineryAndEquipmentMember2024-09-300001964738us-gaap:MachineryAndEquipmentMember2023-12-310001964738us-gaap:ConstructionInProgressMember2024-09-300001964738us-gaap:ConstructionInProgressMember2023-12-310001964738us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300001964738us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-09-300001964738us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-07-012024-09-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001964738us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001964738us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001964738us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001964738us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-09-300001964738us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001964738us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001964738us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300001964738solv:CreditFacilitiesMembersolv:A18MonthSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-162024-02-160001964738solv:CreditFacilitiesMembersolv:A18MonthSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001964738solv:CreditFacilitiesMembersolv:A3YearSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-162024-02-160001964738solv:CreditFacilitiesMembersolv:A3YearSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001964738solv:A5.450SeniorNotesDue2027Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A5.450SeniorNotesDue2027Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A5.450SeniorNotesDue2027Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:A5.400SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A5.400SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A5.400SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:A5.450SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A5.450SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A5.450SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:A5.600SeniorNotesDue2034Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A5.600SeniorNotesDue2034Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A5.600SeniorNotesDue2034Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:A5.900SeniorNotesDue2054Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A5.900SeniorNotesDue2054Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A5.900SeniorNotesDue2054Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:A6.000SeniorNotesDue2064Memberus-gaap:SeniorNotesMember2024-02-270001964738solv:A6.000SeniorNotesDue2064Memberus-gaap:SeniorNotesMember2024-02-272024-02-270001964738solv:A6.000SeniorNotesDue2064Memberus-gaap:SeniorNotesMember2024-09-300001964738solv:OtherBorrowingsMember2024-09-300001964738us-gaap:SeniorNotesMember2024-02-270001964738solv:CreditFacilitiesMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-162024-02-160001964738solv:CreditFacilitiesMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-160001964738solv:CreditFacilitiesMembersolv:A18MonthSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-160001964738solv:CreditFacilitiesMembersolv:A3YearSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-160001964738solv:CreditFacilitiesMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001964738solv:CreditFacilitiesMembersolv:TermLoanCreditFacilitiesMemberus-gaap:LineOfCreditMember2024-03-072024-03-070001964738solv:CreditFacilitiesMembersolv:A18MonthSeniorTermLoanCreditFacilityMemberus-gaap:LineOfCreditMember2024-08-012024-08-310001964738us-gaap:CommercialPaperMember2024-03-040001964738us-gaap:CommercialPaperMember2024-03-042024-03-040001964738us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001964738us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-09-300001964738us-gaap:ForeignPlanMember2024-03-310001964738country:USus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001964738country:USus-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001964738us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001964738us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001964738us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300001964738us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300001964738country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001964738country:USus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300001964738us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001964738us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300001964738us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300001964738us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300001964738us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001964738us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-12-310001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2023-12-310001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-12-310001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001964738us-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001964738us-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001964738us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-12-310001964738us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2024-09-300001964738us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-12-310001964738us-gaap:NondesignatedMember2024-09-300001964738us-gaap:NondesignatedMember2023-12-310001964738solv:BairHuggerPatientWarmingSystemsLitigationMembersolv:A3MMember2024-09-300001964738solv:A3MMember2024-09-300001964738stpr:MOsolv:A3MMembersolv:BairHuggerPatientWarmingSystemsLitigationMember2024-09-300001964738solv:BairHuggerPatientWarmingSystemsLitigationMembersolv:A3MMember2022-01-012022-12-310001964738stpr:ALsolv:A3MMembersolv:BairHuggerPatientWarmingSystemsLitigationMember2024-09-300001964738solv:BairHuggerPatientWarmingSystemsLitigationMembersolv:A3MMember2019-01-012019-12-310001964738solv:FederalFalseClaimsActQuiTamLitigationMembersolv:A3MMember2011-12-310001964738solv:FederalFalseClaimsActQuiTamLitigationMembersolv:A3MMember2008-12-310001964738solv:FederalFalseClaimsActQuiTamLitigationMembersolv:A3MMember2022-01-012022-01-3100019647382024-03-310001964738solv:A2024LongTermIncentivePlanMemberus-gaap:SpinoffMember2024-03-310001964738solv:A2024LongTermIncentivePlanMemberus-gaap:SpinoffMember2024-01-012024-09-300001964738us-gaap:CostOfSalesMember2024-07-012024-09-300001964738us-gaap:CostOfSalesMember2023-07-012023-09-300001964738us-gaap:CostOfSalesMember2024-01-012024-09-300001964738us-gaap:CostOfSalesMember2023-01-012023-09-300001964738us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001964738us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001964738us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300001964738us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001964738solv:ResearchDevelopmentAndRelatedExpensesMemberMember2024-07-012024-09-300001964738solv:ResearchDevelopmentAndRelatedExpensesMemberMember2023-07-012023-09-300001964738solv:ResearchDevelopmentAndRelatedExpensesMemberMember2024-01-012024-09-300001964738solv:ResearchDevelopmentAndRelatedExpensesMemberMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:PriorToSpinOffMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:PriorToSpinOffMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:PriorToSpinOffMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMembersolv:SalesOfSoftwareAndRentalsMembersolv:PriorToSpinOffMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMembersolv:SalesOfSoftwareAndRentalsMembersolv:PriorToSpinOffMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersolv:SalesOfSoftwareAndRentalsMembersolv:PriorToSpinOffMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMembersolv:PriorToSpinOffMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMembersolv:PriorToSpinOffMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersolv:PriorToSpinOffMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMember2024-04-012024-09-300001964738us-gaap:RelatedPartyMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersrt:MinimumMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersrt:MaximumMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersolv:TransitionAgreementServicesMember2024-07-012024-09-300001964738us-gaap:RelatedPartyMembersolv:TransitionAgreementServicesMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersolv:MasterSupplyAgreementsMember2024-07-012024-09-300001964738us-gaap:RelatedPartyMembersolv:MasterSupplyAgreementsMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:AfterSpinOffMember2024-07-012024-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:AfterSpinOffMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:AfterSpinOffMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMemberus-gaap:ProductMembersolv:AfterSpinOffMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMembersolv:AfterSpinOffMember2024-07-012024-09-300001964738us-gaap:RelatedPartyMembersolv:AfterSpinOffMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMembersolv:AfterSpinOffMember2024-01-012024-09-300001964738us-gaap:RelatedPartyMembersolv:AfterSpinOffMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMember2024-09-300001964738solv:NetParentInvestmentMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001964738solv:NetParentInvestmentMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001964738solv:NetParentInvestmentMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001964738solv:NetParentInvestmentMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001964738us-gaap:RelatedPartyMember2024-07-012024-09-300001964738us-gaap:RelatedPartyMember2023-07-012023-09-300001964738us-gaap:RelatedPartyMember2023-01-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:MedSurgSegmentMember2024-07-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:MedSurgSegmentMember2023-07-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:MedSurgSegmentMember2024-01-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:MedSurgSegmentMember2023-01-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:DentalSolutionsSegmentMember2024-07-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:DentalSolutionsSegmentMember2023-07-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:DentalSolutionsSegmentMember2024-01-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:DentalSolutionsSegmentMember2023-01-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:HealthInformationSystemsSegmentMember2024-07-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:HealthInformationSystemsSegmentMember2023-07-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:HealthInformationSystemsSegmentMember2024-01-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:HealthInformationSystemsSegmentMember2023-01-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:PurificationAndFiltrationSegmentMember2024-07-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:PurificationAndFiltrationSegmentMember2023-07-012023-09-300001964738us-gaap:OperatingSegmentsMembersolv:PurificationAndFiltrationSegmentMember2024-01-012024-09-300001964738us-gaap:OperatingSegmentsMembersolv:PurificationAndFiltrationSegmentMember2023-01-012023-09-300001964738solv:CorporateAndReconcilingItemsMember2024-07-012024-09-300001964738solv:CorporateAndReconcilingItemsMember2023-07-012023-09-300001964738solv:CorporateAndReconcilingItemsMember2024-01-012024-09-300001964738solv:CorporateAndReconcilingItemsMember2023-01-012023-09-300001964738us-gaap:OperatingSegmentsMember2024-07-012024-09-300001964738us-gaap:OperatingSegmentsMember2023-07-012023-09-300001964738us-gaap:OperatingSegmentsMember2024-01-012024-09-300001964738us-gaap:OperatingSegmentsMember2023-01-012023-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number: 001-41968
SOLVENTUM CORPORATION
(Exact name of registrant as specified in its charter)
Delaware92-2008841
(State or other jurisdiction of incorporation)(IRS Employer Identification No.)
3M Center, Building 275-6W 2510 Conway Avenue East, Maplewood, Minnesota
55144
(Address of Principal Executive Offices)(Zip Code)
(Registrant’s Telephone Number, Including Area Code) (651) 733-1110
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Par Value $.01 Per ShareSOLVNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”" “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer☐Accelerated filer☐
Non-accelerated filer☒Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class
Outstanding at September 30, 2024
Common Stock, $0.01 par value per share
172,754,070 shares
1
SOLVENTUM CORPORATION
Form 10-Q for the Quarterly Period Ended September 30, 2024
TABLE OF CONTENTS
PAGE
2
SOLVENTUM CORPORATION
FORM 10-Q
For the Quarterly Period Ended September 30, 2024
PART I. Financial Information
Item 1. Financial Statements
Solventum Corporation
Condensed Consolidated and Combined Statements of Income
(Unaudited)
Three months ended September 30,Nine months ended September 30,
(Millions, except per share data)2024202320242023
Net sales of product$1,608 $1,593 $4,766 $4,750 
Net sales of software and rentals474 481 1,413 1,411 
Total net sales2,082 2,074 6,179 6,161 
Cost of product793 748 2,341 2,262 
Cost of software and rentals124 117 364 364 
Gross profit1,165 1,209 3,474 3,535 
Selling, general and administrative expenses701 525 1,998 1,681 
Research and development expenses 189 180 576 568 
Total operating expenses 1,807 1,570 5,279 4,875 
Operating income275 504 900 1,286 
Interest expense, net107 — 260 — 
Other expense (income), net1 4 48 10 
Income before income taxes 167 500 592 1,276 
Provision for income taxes 45 40 144 202 
Net income$122 $460 $448 $1,074 
Earnings per share:
Basic earnings per share $0.70 $2.66 $2.59 $6.22 
Diluted earnings per share0.70 2.66 2.58 6.22 
Weighted-average number of shares outstanding:
Basic173.4 172.7 173.1 172.7 
Diluted173.9 172.7 173.4 172.7 
The accompanying Notes to the Condensed Consolidated and Combined Financial Statements are an integral part of these statements.













3
Solventum Corporation
Condensed Consolidated and Combined Statements of Comprehensive Income
(Unaudited)
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Net income$122 $460 $448 $1,074 
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment179 (134)94 (44)
Defined benefit pension
10 — 20 — 
Cash flow hedging instruments(11)— (10)— 
Total other comprehensive income (loss), net of tax178 (134)104 (44)
Comprehensive income$300 $326 $552 $1,030 
The accompanying Notes to the Condensed Consolidated and Combined Financial Statements are an integral part of these statements.
4
Solventum Corporation
Condensed Consolidated and Combined Balance Sheets
(Unaudited)
September 30,December 31,
(Millions)20242023
Assets
Current assets
Cash and cash equivalents$772 $194 
Accounts receivable — net of allowances of $86 and $82
1,105 1,313 
Due from related parties222 — 
Inventories
Finished goods 529 453 
Work in process 181 171 
Raw materials and supplies 243 233 
Total inventories 953 857 
Other current assets 302 155 
Total current assets 3,354 2,519 
Property, plant and equipment — net1,599 1,457 
Goodwill 6,592 6,535 
Intangible assets — net 2,651 2,902 
Other assets 549 530 
Total assets $14,745 $13,943 
Liabilities
Current liabilities
Short-term borrowings and current portion of long-term debt$300 $— 
Accounts payable 560 477 
Due to related parties450 — 
Unearned revenue563 574 
Other current liabilities1,031 677 
Total current liabilities 2,904 1,728 
Long-term debt 7,809 — 
Pension and postretirement benefits321 166 
Deferred income taxes214 231 
Other liabilities 305 152 
Total liabilities $11,553 $2,277 
Commitments and contingencies (Note 11)
Equity
Common stock, par value $0.01 per share, 750,000,000 shares authorized
$2 $— 
Shares issued and outstanding - September 30, 2024: 172,754,070
Shares issued and outstanding - December 31, 2023: 0
Additional paid-in-capital3,744 — 
Retained earnings211 — 
Net parent investment— 12,003 
Accumulated other comprehensive income (loss)
(765)(337)
Total equity 3,192 11,666 
Total liabilities and equity $14,745 $13,943 
The accompanying Notes to the Condensed Consolidated and Combined Financial Statements are an integral part of these statements.


5
Solventum Corporation
Condensed Consolidated and Combined Statements of Changes in Equity
(Unaudited)

Three Months Ended September 30, 2024 and September 30, 2023
Common Stock
(Millions)Shares OutstandingPar ValueAdditional Paid-In-CapitalRetained EarningsNet Parent InvestmentAccumulated Other Comprehensive Income (Loss)Total
Balance at June 30, 2024173 $2 $3,719 $89 $— $(943)$2,867 
Net income— — — 122 — — 122 
Other comprehensive income (loss), net of tax
Cumulative translation adjustment— — — — — 179 179 
Defined benefit pension— — — — — 10 10 
Cash flow hedging— — — — — (11)(11)
Total other comprehensive income (loss), net of tax— — — — — 178 178 
Net transfers to 3M
— — — — — — — 
Stock-based compensation— — 27 — — — 27 
Common stock for tax withholding obligations
— — (2)— — — (2)
Balance at September 30, 2024173 $2 $3,744 $211 $— $(765)$3,192 
Balance at June 30, 2023— $— $— $— $12,136 $(407)$11,729 
Net income— — — — 460 — 460 
Other comprehensive income (loss), net of tax
Cumulative translation adjustment— — — — — (134)(134)
Defined benefit pension— — — — — — — 
Total other comprehensive income (loss), net of tax— — — — — (134)(134)
Net transfers to 3M— — — — (473)— (473)
Balance at September 30, 2023— $— $— $— $12,123 $(541)$11,582 




















6
Solventum Corporation
Condensed Consolidated and Combined Statements of Changes in Equity, Continued
(Unaudited)
Nine Months Ended September 30, 2024 and September 30, 2023

Common Stock
(Millions)Shares OutstandingPar ValueAdditional Paid-In-CapitalRetained EarningsNet Parent InvestmentAccumulated Other Comprehensive Income (Loss)Total
Balance at December 31, 2023— $— $— $— $12,003 $(337)$11,666 
Net income— — — 211 237 — 448 
Other comprehensive income (loss), net of tax
Cumulative translation adjustment— — — — — 94 94 
Defined benefit pension— — — — — 20 20 
Cash flow hedging— — — — — (10)(10)
Total other comprehensive income (loss), net of tax— — — — — 104 104 
Net transfers to 3M
— — — — (8,575)(532)(9,107)
Stock-based compensation— — 83 — — — 83 
Common stock for tax withholding obligations
— — (2)— — — (2)
Issuance of common stock in connection with Spin-Off and reclassification of net parent investment
173 2 3,663 — (3,665)— — 
Balance at September 30, 2024173 $2 $3,744 $211 $— $(765)$3,192 
Balance at December 31, 2022— $— $— $— $12,239 $(497)$11,742 
Net income— — — — 1,074 — 1,074 
Other comprehensive income (loss), net of tax
Cumulative translation adjustment— — — — — (44)(44)
Defined benefit pension
— — — — — — — 
Total other comprehensive income (loss), net of tax— — — — — (44)(44)
Net transfers to 3M— — — — (1,190)— (1,190)
Balance at September 30, 2023— $— $— $— $12,123 $(541)$11,582 
The accompanying Notes to the Condensed Consolidated and Combined Financial Statements are an integral part of these statements.
7
Solventum Corporation
Condensed Consolidated and Combined Statements of Cash Flows
(Unaudited)
Nine months ended September 30,
(Millions)20242023
Cash Flows from Operating Activities
Net income$448 $1,074 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 405 422 
Pension and postretirement benefit expense
30 31 
Stock-based compensation expense 87 32 
Gain on business divestitures— (56)
Deferred income taxes (93)(99)
Changes in assets and liabilities
Accounts receivable 14 (24)
Due from related parties200 — 
Inventories (99)(7)
Accounts payable 200 48 
Due to related parties
(393)— 
All other operating activities167 (53)
Net cash provided by operating activities 966 1,368 
Cash Flows from Investing Activities
Purchases of property, plant and equipment(253)(202)
Proceeds from sale of business— 60 
Net cash used in investing activities
(253)(142)
Cash Flows from Financing Activities
Repayment of debt(200)— 
Net transfers to 3M(8,247)(1,248)
Proceeds from long-term debt, net of issuance costs8,303 — 
Other — net 8 2 
Net cash used in financing activities
(136)(1,246)
Effect of exchange rate changes on cash and cash equivalents 1 1 
Net increase (decrease) in cash and cash equivalents 578 (19)
Cash and cash equivalents at beginning of year 194 61 
Cash and cash equivalents at end of period$772 $42 
The accompanying Notes to the Condensed Consolidated and Combined Financial Statements are an integral part of these statements.
8
Solventum Corporation
Notes to the Condensed Consolidated and Combined Financial Statements
(Unaudited)
NOTE 1. Significant Accounting Policies
Organization and Description of Business
Solventum Corporation (“Solventum” or the “Company”) was a carve-out business of 3M Company (“3M”). On April 1, 2024 (the “Distribution Date”), 3M completed the previously announced spin-off of Solventum Corporation (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1% of the Company’s outstanding common stock to holders of record of 3M’s common stock as of the close of business on March 18, 2024 (the “Distribution”), which resulted in the issuance of 172,709,505 shares of common stock. As a result of the Distribution, the Company became an independent public company. Solventum’s common stock is listed under the symbol “SOLV” on the New York Stock Exchange (“NYSE”).
Solventum is a leading global healthcare company with a broad portfolio of trusted solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. Solventum is organized into four operating business segments that are aligned with the end markets that we serve: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Basis of Presentation
The unaudited condensed consolidated and combined financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and present the historical results of operations, and comprehensive income for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, and the financial position as of September 30, 2024 and December 31, 2023. The interim condensed consolidated and combined financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of the Company’s consolidated and combined financial position, results of operations and cash flows for the periods presented. These adjustments consist of normal, recurring items. The results of operations for any interim periods are not necessarily indicative of results for the full year.
Effective April 1, 2024, the Company’s financial statements are presented on a consolidated basis, as the Spin-Off was completed on such date. The unaudited financial statements for all periods following the Spin-Off are referred to as the “Condensed Consolidated Financial Statements.” Prior to April 1, 2024, Solventum was a carve-out business of 3M. The Company's financial statements prior to April 1, 2024 were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of 3M, including the historical cost basis of assets and liabilities comprising the Company, as well as the historical revenues, direct costs, and allocations of indirect costs attributable to the operations of the Company, using the historical accounting policies applied by 3M. The historical financial statements of the Company prior to April 1, 2024, are referred to as the “Condensed Combined Financial Statements”.
All intercompany transactions and balances within Solventum have been eliminated. These unaudited condensed consolidated and combined financial statements include certain transactions with 3M, which are disclosed as related party transactions in Note 14 “Related Parties”.
The unaudited condensed consolidated and combined financial statements and related footnotes as of and for the three and nine months ended September 30, 2024 should be read in conjunction with the audited combined financial statements as of and for the year ended December 31, 2023 contained in Exhibit 99.1 to Amendment No. 2 to the Company’s Registration Statement on Form 10 as filed with the SEC on March 11, 2024, which became effective on March 13, 2024 (the “Information Statement”).
9
New Accounting Pronouncements
The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.
StandardRelevant DescriptionEffective Date for SolventumImpact of Adoption
ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.Year-end December 31, 2024
The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.
ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.Year-end December 31, 2025The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.

NOTE 2. Revenue Recognition
Contract Balances
Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $110 million and $500 million of the December 31, 2023 balance were recognized as revenue during the three and nine months ended September 30, 2024, respectively, while approximately $115 million and $475 million of the December 31, 2022 balance were recognized as revenue during the three and nine months ended September 30, 2023, respectively.
Operating Lease Revenue
Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $148 million and $442 million for the three and nine months ended September 30, 2024, and $160 million and $458 million for the three and nine months ended September 30, 2023, respectively.
Customer Concentration
No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2024 or 2023. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2024 and one customer accounted for approximately 10% of accounts receivable at December 31, 2023.

NOTE 3. Goodwill and Intangible Assets
Goodwill
There was no goodwill recorded from acquisitions during the nine months ended September 30, 2024.
The goodwill balance by business segment follows:
(Millions)MedSurgDental SolutionsHealth Information SystemsPurification and FiltrationTotal
Balance as of December 31, 2023$3,685$458$873$1,519$6,535
Translation impact4631757
Balance as of September 30, 2024$3,731$461$874$1,526$6,592
10
Acquired Intangible Assets: The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:
September 30,December 31,
(Millions)20242023
Customer related intangible assets
$2,748 $2,734 
Patents and other technology-based intangible assets
1,901 1,897 
Tradenames and other amortizable intangible assets
732 705 
Total gross carrying amount5,381 5,336 
Accumulated amortization — customer related(1,188)(1,081)
Accumulated amortization — patents and other technology-based(1,185)(1,055)
Accumulated amortization — tradenames and other(357)(323)
Total accumulated amortization (2,730)(2,459)
Total finite-lived intangible assets — net 2,651 2,877 
Indefinite lived intangible assets— 25 
Total intangible assets — net$2,651 $2,902 
In June 2024, the Company made the decision to start phasing out the use of a tradename within its Dental Solutions business. This tradename, which was categorized as indefinite-lived as of December 31, 2023, has been reclassified to finite-lived and is being amortized over the expected phase-out period.

Amortization expense was as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Amortization expense $88 $92 $261 $276 
Expected amortization expense for acquired amortizable intangible assets recorded as of September 30, 2024 is as follows:
(Millions)Remainder of 202420252026202720282029After 2029
Amortization expense$88 $326 $321 $316 $312 $274 $1,014 

NOTE 4. Other Current Liabilities
Other current liabilities included in the condensed consolidated and combined balance sheets consist of the following:
September 30,December 31,
(Millions)20242023
Other current liabilities
Accrued compensation$251 $209 
Accrued taxes
202 106 
Accrued rebates
166 206 
Accrued interest91 — 
Other321 156 
Total other current liabilities$1,031 $677 



11
NOTE 5. Property, Plant, and Equipment - Net
Property, plant and equipment, net consisted of the following:
September 30,December 31,
(Millions)20242023
Property, plant and equipment - at cost
Buildings and leasehold improvements
$952 $937 
Machinery and equipment
2,180 2,081 
Construction in progress465 320 
Gross property, plant and equipment3,597 3,338 
Accumulated depreciation(1,998)(1,881)
Property, plant and equipment - net$1,599 $1,457 
Depreciation expense consisted of the following:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Depreciation expense$37 $45 $121 $124 

NOTE 6. Comprehensive Income Information
Changes in Accumulated Other Comprehensive Income (Loss) by Component
The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”), including the reclassifications out of AOCI by component:
Three months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2024, net of tax:$(432)$(512)$1 $(943)
Other comprehensive income (loss), before tax:
Amounts before reclassifications179 — (15)164 
Amounts reclassified out— 13 — 13 
Total other comprehensive income (loss), before tax179 13 (15)177 
Tax effect— (3)4 1 
Total other comprehensive income (loss), net of tax179 10 (11)178 
Transfers from 3M, net of tax— — — — 
Balance at September 30, 2024, net of tax:
$(253)$(502)$(10)$(765)
12
Three months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023, net of tax:$(414)$7 $(407)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(134)— (134)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(134)— (134)
Tax effect— — — 
Total other comprehensive income (loss), net of tax(134)— (134)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
Nine months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023, net of tax:$(347)$10 $— $(337)
Other comprehensive income (loss), before tax:
Amounts before reclassifications56 — (13)43 
Amounts reclassified out38 26 — 64 
Total other comprehensive income (loss), before tax94 26 (13)107 
Tax effect— (6)3 (3)
Total other comprehensive income (loss), net of tax94 20 (10)104 
Transfers from 3M, net of tax— (532)— (532)
Balance at September 30, 2024, net of tax:$(253)$(502)$(10)$(765)
Nine months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022, net of tax:$(504)$7 $(497)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(44)— (44)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(44)— (44)
Tax effect—— — 
Total other comprehensive income (loss), net of tax(44)— (44)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
Additional details on the amounts reclassified from accumulated other comprehensive income (loss) into consolidated income include:
•Cumulative translation adjustment: amounts were reclassified into other expense (income), net and were related to charges associated with the substantial liquidation of foreign operations completed as part of our separation from 3M.
•Defined benefit pension plans adjustment: amounts were reclassified into other expense (income), net (see Note 9).
13
•The tax effects, if applicable, associated with these reclassifications were reflected in provision for income taxes.

NOTE 7. Income Taxes

The Company’s income tax provision through March 31, 2024 was prepared on a separate return basis. The income tax provision post Spin-Off is prepared based on a stand-alone basis.

The effective tax rates for the three months ended September 30, 2024 and 2023 were 26.9% and 8.0%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions.

The effective tax rates for the nine months ended September 30, 2024 and 2023 were 24.3% and 15.8%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions.

In 2021, the Organisation for Economic Co-operation and Development (“OECD”) announced Pillar Two Model Rules which call for the taxation of large multinational corporations at a global minimum tax rate of 15%. Many non-U.S. tax jurisdictions, including Ireland, have either recently enacted legislation to adopt certain components of the Pillar Two Model Rules beginning in fiscal year 2024 or announced their plans to enact legislation in future years. The Company’s income tax provision for the nine months ended September 30, 2024, reflects currently enacted legislation and guidance related to the OECD model rules.

The Company’s income tax provision or benefit for the interim periods is determined based on an estimated annual effective tax rate, adjusted for discrete items. Because significant foreign earnings are generated by the Company’s subsidiaries organized in jurisdictions with lower statutory tax rates, the Company’s estimated annual effective tax rate may be materially impacted if earnings in these lower-tax jurisdictions fluctuate.

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized based on evaluation of all available positive and negative evidence. On the basis of this evaluation, the Company continues to maintain a valuation allowance to reduce its deferred tax assets to the amount realizable. As of September 30, 2024 and December 31, 2023, valuation allowances were $22 million and $56 million, respectively. The decrease is primarily due to separation-related adjustments in connection with the Spin-Off on April 1, 2024, which is reflected in the condensed consolidated and combined statements of changes in equity.

NOTE 8. Long-Term Debt and Short-Term Borrowings
Carrying value includes the impact of debt issuance costs. Long-term debt and short-term borrowings as of September 30, 2024 consisted of the following:
(Millions)Currency/ Fixed vs. FloatingFinal Maturity DateCarrying Value
DescriptionSeptember 30, 2024
Eighteen month senior term loan credit facility
USD Floating2025$300 
Three year senior term loan credit facility
USD Floating2027979 
$1 billion 5.45 percent three year senior notes
USD Fixed2027994 
$1.5 billion 5.40 percent five year senior notes
USD Fixed20291,487 
$1 billion 5.45 percent seven year senior notes
USD Fixed2031990 
$1.65 billion 5.60 percent ten year senior notes
USD Fixed20341,636 
$1.25 billion 5.90 percent thirty year senior notes
USD Fixed20541,231 
$500 million 6.00 percent forty year senior notes
USD Fixed2064492 
Other borrowings— 
Total long-term debt8,109 
Less: current portion of long-term debt300 
Long-term debt (excluding current portion)$7,809 

14
Senior Notes
On February 27, 2024, the Company issued six series of senior notes with a combined aggregate principal amount of $6.9 billion: $1 billion aggregate principal amount of 5.45% senior notes due 2027, $1.5 billion aggregate principal amount of 5.40% senior notes due 2029, $1 billion aggregate principal amount of 5.45% senior notes due 2031, $1.65 billion aggregate principal amount of 5.60% senior notes due 2034, $1.25 aggregate principal amount of 5.90% senior notes due 2054, and $0.5 billion aggregate principal amount of 6.00% senior notes due 2064 (collectively, the “Senior Notes”). Interest payments on the Senior Notes are due semi-annually until maturity, with the first payment due in August 2024. The Company recorded $62 million of debt issuance costs related to the Senior Notes. Debt issuance costs are presented as a reduction of debt in the condensed consolidated and combined balance sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method.
In connection with the issuance of the senior notes, the Company entered into a registration rights agreement with the initial purchasers, pursuant to which the Company is obligated to use commercially reasonable efforts to file with the SEC and cause to become effective a registration statement with respect to an offer to exchange each series of Senior Notes for registered notes with terms that are substantially identical in all material respects to the notes of such series.
The Senior Notes were offered as part of the financing for the Spin-Off. In connection with the consummation of the Spin-Off, Solventum made direct and indirect cash payments to 3M as partial consideration for 3M’s transfer of its health care business to Solventum. All of the net proceeds from the offering of the notes were paid to 3M, other than amounts retained in order to achieve the $600 million retained cash target.
The Senior Notes are governed by an indenture and supplemental indenture between the Company and a trustee (collectively, the “Indenture”). The Indenture contains certain customary affirmative and negative covenants, including restrictions on the Company’s ability to consolidate, merge, convey, transfer or lease substantially all of its assets. In addition, the Indenture contains other customary terms, including certain events of default, upon the occurrence of which, the Senior Notes may be declared immediately due and payable.
Credit Facilities
On February 16, 2024, the Company entered into credit agreements providing for:
•a five year senior unsecured revolving credit facility in an aggregate committed amount of $2.0 billion expiring in 2029 (the “5-year Revolving Credit Facility”); and
•an eighteen month senior unsecured term loan credit facility in an aggregate principal amount of $500 million and a three year senior unsecured term credit loan facility in an aggregate principal amount of $1.0 billion (together, the “Term Loan Credit Facilities”, and together with the 5-Year Revolving Credit Facility, the “Credit Facilities”).
The Company intends to use the Credit Facilities for general corporate purposes. At September 30, 2024, there are no amounts outstanding under the 5-year Revolving Credit Facility. On March 7, 2024, the Company drew on the Term Loan Credit Facilities in the amount of $1.48 billion. These Term Loan Credit Facilities have a floating interest rate based on a Secured Overnight Financing Rate (“SOFR”) index.
In August 2024, the Company repaid $200 million of the aggregate principal amount outstanding under the eighteen month senior unsecured term loan credit facility.
Commercial Paper
On March 4, 2024, the Company entered into a commercial paper program that allows it to issue up to $2.0 billion aggregate principal amount of short-term notes to finance short-term liabilities. Any such issuance will mature within 364 days from date of issue. There was no commercial paper outstanding as of September 30, 2024.
Future Maturities of Long-term Debt: Maturities of long-term debt in the table below reflect the impact of repayment such that total maturities equal the contractual value of long-term debt net of amounts repaid as of September 30, 2024. The maturities of long-term debt for the periods subsequent to September 30, 2024 are as follows (in millions):
Remainder of
2024		20252026202720282029After 2029Total
$—$300$—$1,980$—$1,500$4,400$8,180


15
Financial Instruments Not Measured at Fair Value
The fair values of cash equivalents, accounts receivable, and accounts payable approximated carrying values because of the short-term nature of these instruments. At September 30, 2024, the estimated fair value of the Company’s long-term debt obligations, comprised of both Senior Notes and Term Loan Credit Facilities with current portions excluded, was $8.1 billion compared to a carrying value of $7.8 billion. The Company did not have any outstanding debt obligations at December 31, 2023. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts. Because there is no active market for trading outstanding term loans, the fair values of the Term Loan Credit Facilities are estimated to be equal to their respective carrying values.

NOTE 9. Pension and Postretirement Benefit Plans
Transfer of Solventum Sponsored Pension and Postretirement Benefit Plans
Historically, certain employees of Solventum participated in U.S. and non-U.S. retirement plans sponsored by 3M. The primary U.S. defined-benefit pension plan was closed to new participants effective January 1, 2009. In December 2023, 3M committed to the future freeze of U.S. defined benefit pension benefits for non-union U.S. employees, effective December 31, 2028. During March 2024, in advance of the Spin-Off, all U.S. and most remaining 3M sponsored non-U.S. pension and postretirement plan obligations and assets were legally transferred to Solventum from 3M, except for certain assets held back within the 3M sponsored pension plans for regulatory purposes. Assets not yet delivered from 3M sponsored pension plans are already recognized within the Company's pension assets. These plans included the U.S. defined benefit pension plans as well as postretirement health care and life insurance benefits for U.S. employees who reach a retirement age while employed by the Company and were employed prior to January 1, 2016. Additionally, seven international plans covering employees in four countries were transferred to Solventum from 3M in March 2024.
As these plans are sponsored by Solventum, they are accounted for as single employer plans. Therefore, the funded status is reflected in the condensed consolidated and combined balance sheets, and the net periodic benefit costs are included in the condensed consolidated and combined statements of income.
The Company has made deposits for its defined benefit plans with independent trustees. In certain non-U.S. jurisdictions, trust funds and deposits with insurance companies are maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan assets in the non-qualified plan due to its nature. For the U.S. postretirement health care benefit plan, the Company has set aside amounts at least equal to annual benefit payments with an independent trustee.

Components of net periodic cost and other amounts recognized in other comprehensive (income) loss
The service cost component of defined benefit net periodic benefit cost is recorded in costs of product; costs of software and rentals; selling, general and administrative; and research and development. Components of net periodic benefit cost and other supplemental information for the three and nine months ended September 30, 2024 and 2023 follow:
Three months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$7 $— $5 $— $1 $— 
Non-operating expense
Interest cost23 — 5 — 3 — 
Expected return on plan assets(34)— (5)— (2)— 
Amortization of prior service benefit(1)— — — (1)— 
Amortization of net actuarial loss14 — — — 1 — 
Total non-operating expense (benefit)2 — — — 1 — 
Total net periodic benefit cost (benefit)$9 $— $5 $— $2 $— 
16
Nine months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$14 $— $14 $— $2 $— 
Non-operating expense
Interest cost46 — 15 — 6 — 
Expected return on plan assets(68)— (15)— (4)— 
Amortization of prior service benefit(2)— — — (2)— 
Amortization of net actuarial loss28 — — — 2 — 
Total non-operating expense (benefit)4 — — — 2 — 
Total net periodic benefit cost (benefit)$18 $— $14 $— $4 $— 

NOTE 10. Derivatives
Prior to April 1, 2024, Solventum indirectly participated in 3M’s centrally managed hedging program, which utilizes a number of tools to manage currency risk including natural hedges such as pricing, productivity, hard currency, hard currency-indexed billings, and localizing source of supply. 3M also used financial hedges to mitigate currency risk. After Spin-Off, the Company established its own hedging program.

Cash Flow Hedges - For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized in current earnings.
Cash Flow Hedging - Foreign Currency Forward Contracts: The Company enters into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as cash flow hedges. The settlement or extension of these derivatives will result in reclassifications (from accumulated other comprehensive income) to earnings in the period during which the hedged transactions affect earnings. Solventum may de-designate these cash flow hedge relationships in advance of the occurrence of the forecasted transaction. The portion of gains or losses on the derivative instrument previously included in accumulated other comprehensive income for de-designated hedges remains in accumulated other comprehensive income until the forecasted transaction occurs or becomes probable of not occurring. Changes in the value of derivative instruments after de-designation are recorded in earnings. The maximum length of time over which Solventum hedges its exposure to the variability in future cash flows of the forecasted transactions is 36 months.
As of September 30, 2024, the Company had a balance of $10 million associated with the after-tax net unrealized loss associated with cash flow hedging instruments recorded in accumulated other comprehensive income. Of the total after-tax net unrealized balance as of September 30, 2024, Solventum expects to reclassify to earnings approximately $7 million after-tax net unrealized loss over the next 12 months based on exchange rates as of September 30, 2024.
The amount of pretax gain (loss) recognized in other comprehensive income (loss) related to derivative instruments designated as cash flow hedges is provided in the following table.
Pretax Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Foreign currency forward contracts $(15)$— $(13)$— 
17
Derivatives Not Designated as Hedging Instruments - Derivatives not designated as hedging instruments include foreign currency contracts to offset, in part, the impacts of changes in value of various non-functional currency denominated items including certain intercompany financing balances. These derivative instruments are not designated in a hedging relationship; therefore, fair value gains and losses on these contracts are recorded in earnings. The Company does not hold or issue derivative financial instruments for trading purposes.
Statement of Income Location and Impact of Cash Flow Derivative Instruments
There was an immaterial impact to income related to both derivative instruments designated in cash flow hedging relationships and those not designated as hedging instruments in the three and nine months ended September 30, 2024.
Location, Fair Value, and Gross Notional Amounts of Derivative Instruments
The following tables summarize the fair value of Solventum’s derivative instruments and their location in the condensed consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates.
Gross Notional AmountAssetsLiabilities
 (Millions)LocationFair Value AmountLocationFair Value Amount
September 30,December 31,September 30,December 31,September 30,December 31,
202420232024202320242023
Derivatives designated as hedging instruments
Foreign currency forward contracts$297 $— Other current assets$— $— Other current liabilities$9 $— 
Foreign currency forward contracts92 — Other assets— — Other liabilities2 — 
Total derivatives designated as hedging instruments $389 $— $— $— $11 $— 
Derivatives not designated as hedging instruments
Foreign currency forward contracts$18 $— Other current assets$— $— Other current liabilities$1 $— 
Total derivatives not designated as hedging instruments
$18 $— $— $— $1 $— 
Total derivative instruments
$407 $— $— $— $12 $— 
The Company’s derivative assets and liabilities within the scope of ASC 815, Derivatives and Hedging, are required to be recorded at fair value. The Company’s derivatives that are recorded at fair value include foreign currency forward contracts. Solventum has determined that foreign currency forward contracts will be considered level 2 fair value measurements. Solventum determines fair value using observable inputs including foreign currency exchange rates.

Credit Risk and Offsetting of Assets and Liabilities of Derivative Instruments: The Company is exposed to credit loss in the event of nonperformance by counterparties in forward contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as counterparties. Solventum enters into master netting arrangements with counterparties, which may allow each counterparty to net settle amounts owed between a Solventum entity and the counterparty as a result of multiple, separate derivative transactions. The Company does not anticipate nonperformance by any of these counterparties.
18
Solventum has elected to present the fair value of derivative assets and liabilities within the Company’s condensed consolidated balance sheet on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. Solventum determined that the impact of the amount of eligible offsetting derivative assets and liabilities was not material if it had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties. For each counterparty, if netted, the Company would offset the asset and liability balances of all derivatives at the end of the reporting period based on the Solventum entity that is a party to the transactions. Derivatives not subject to master netting agreements are not eligible for net presentation. For the periods presented, Solventum has not received cash collateral from derivative counterparties.

NOTE 11. Commitments and Contingencies
Legal Proceedings
Solventum is involved in numerous claims and lawsuits, principally in the United States, and regulatory proceedings worldwide. These claims, lawsuits and proceedings relate to matters including, but not limited to, product liability (involving products that the Company now or formerly manufactured and sold, including products made by the Health Care Business Group at 3M), intellectual property, commercial, antitrust, federal healthcare program related laws and regulations, such as the False Claims Act and anti-kickback laws in the United States and other jurisdictions. Unless otherwise stated, Solventum is vigorously defending all such litigation and proceedings. From time to time, Solventum also receives subpoenas, investigative demands or requests for information from various government agencies in the United States and foreign countries. Solventum generally responds in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such requests can also lead to the assertion of claims or the commencement of administrative, civil, or criminal legal proceedings against Solventum and others, as well as to settlements. The outcomes of legal proceedings and regulatory matters are often difficult to predict. Any determination that the Company’s operations or activities are not, or were not, in compliance with applicable laws or regulations could result in the imposition of fines, civil or criminal penalties, and equitable remedies, including disgorgement, suspension or debarment or injunctive relief.
Process for Disclosure and Recording of Liabilities Related to Legal Proceedings
Many lawsuits and claims involve highly complex issues relating to causation, scientific evidence, and alleged actual damages, all of which are otherwise subject to substantial uncertainties. Assessments of lawsuits and claims can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The categories of legal proceedings in which the Company is involved may include multiple lawsuits and claims, may be spread across multiple jurisdictions and courts that may handle the lawsuits and claims differently, may involve numerous and different types of plaintiffs, raising claims and legal theories based on specific allegations that may not apply to other matters, and may seek substantial compensatory and, in some cases, punitive, damages. These and other factors contribute to the complexity of these lawsuits and claims and make it difficult for the Company to predict outcomes and make reasonable estimates of any resulting losses. The Company's ability to predict outcomes and make reasonable estimates of potential losses is further influenced by the fact that a resolution of one or more matters within a category of legal proceedings may impact the resolution of other matters in that category in terms of timing, amount of liability, or both.
When making determinations about recording liabilities related to legal proceedings, the Company complies with the requirements of ASC 450, Contingencies, and related guidance, and records liabilities in those instances where it can reasonably estimate the amount of the loss and when the loss is probable. Where the reasonable estimate of the probable loss is a range, the Company records as an accrual in its financial statements the most likely estimate of the loss, or the low end of the range if there is no one best estimate. The Company either discloses the amount of a possible loss or range of loss in excess of established accruals if estimable, or states that such an estimate cannot be made. The Company discloses significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a loss may be incurred. Based on experience and developments, the Company reexamines its estimates of probable liabilities and associated expenses and receivables each period, and whether a loss previously determined to not be reasonably estimable and/or not probable is now able to be reasonably estimated or has become probable. Where appropriate, the Company makes additions to or adjustments of its reasonably estimated losses and/or accruals. As a result, the current accruals and/or estimates of loss and the estimates of the potential impact on the Company’s consolidated financial position, results of operations and cash flows for the legal proceedings and claims pending against the Company will likely change over time. During the third quarter of 2024 and 2023, the Company recognized $3 million and no legal charges, respectively. During the first nine months of 2024 and 2023, the Company recognized $8 million and $1 million in legal charges, respectively. During the third quarter of 2024, the Company made a payment of $6 million related to a legal settlement, which reduced the accrued litigation balance. At September 30, 2024 and December 31, 2023, accrued litigation charges were $25 million and $23 million, respectively.
19
Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, the Company may ultimately incur charges substantially in excess of presently recorded liabilities, including with respect to matters for which no accruals are currently recorded because losses are not currently probable and reasonably estimable. Many of the matters described herein are at varying stages, seek an indeterminate amount of damages or seek damages in amounts that the Company believes are not indicative of the ultimate losses that may be incurred. It is not uncommon for claims to be resolved over many years. As a matter progresses, the Company may receive information, through plaintiff demands, through discovery, in the form of reports of purported experts, or in the context of settlement or mediation discussions that purport to quantify an amount of alleged damages, but with which the Company may not agree. Such information may or may not lead the Company to determine that it is able to make a reasonable estimate as to a probable loss or range of loss in connection with a matter. However, even when a loss or range of loss is not probable and reasonably estimable, developments in, or the ultimate resolution of, a matter could be material to the Company and could have a material adverse effect on the Company, its consolidated financial position, results of operations and cash flows. In addition, future adverse rulings or developments, or settlements in, one or more matters could result in future changes to determinations of probable and reasonably estimable losses in other matters.
Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings
The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal proceedings for which the Company has recorded an accrued liability in its financial statements, the Company also records receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those insured matters for which the Company has not recorded an accrued liability because the liability is not probable or the amount of the liability is not estimable, or both, but for which the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it concludes as recognizable for the expense incurred.
Product Liability Litigation
The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the liabilities, if any, the Company has accrued relating to its significant legal proceedings.
3M is a named defendant in over 7,500 lawsuits in the United States and one Canadian putative class action with a single named plaintiff, alleging that they underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections due to the use of the Bair Hugger patient warming system. Under the terms of the Separation and Distribution Agreement, dated as of March 31, 2024, by and between Solventum and 3M (the “Separation and Distribution Agreement”), Solventum has agreed to indemnify 3M for uninsured liabilities related to the Bair Hugger patient warming system, to manage the litigation, and pay for legal expenses.
The plaintiffs seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and/or negligent misrepresentation/concealment, unjust enrichment, and violations of various state consumer fraud, deceptive or unlawful trade practices and/or false advertising acts.
The U.S. Judicial Panel on Multidistrict Litigation (“JPML”) consolidated all cases pending in federal courts to the U.S. District Court for the District of Minnesota to be managed in a multi-district litigation (“MDL”) proceeding. In July 2019, the court excluded several of the plaintiffs’ causation experts, and granted summary judgment for 3M in all cases pending at that time in the MDL. Plaintiffs appealed that decision to the U.S. Court of Appeals for the Eighth Circuit. Plaintiffs also appealed a 2018 jury verdict in favor of 3M in the first bellwether trial in the MDL and appealed the dismissal of another bellwether case. In August 2021, a panel of the appellate court reversed the district court’s exclusion of the plaintiffs’ causation experts and the grant of summary judgment for 3M. 3M sought further appellate en banc review by the full Eighth Circuit court. In November 2021, the Eighth Circuit court denied 3M’s petition for rehearing en banc. In May 2022, the U.S. Supreme Court declined 3M's February 2022 request to review the Eighth Circuit court's decision. Separately, in August 2021, the Eighth Circuit court affirmed the 2018 jury verdict in 3M’s favor in the only bellwether trial in the MDL.
In February 2022, the MDL court ordered the parties to engage in any mediation sessions that a court-appointed mediator deems appropriate. Mediation sessions took place in May and August 2022 without success in resolving the litigation. In 2023, the MDL assigned a new mediator to facilitate discussions of the litigation and possible resolution. The MDL court denied plaintiffs’ April 2023 motion to disqualify the judge and magistrate judge overseeing the MDL. The parties, working with the new mediator, agreed on a bellwether process, selecting 34 cases. The MDL court transferred the non-Minnesota bellwether cases during April 2024. Bellwether cases are set for trial beginning in April 2025. Fifteen of the bellwether cases have now been voluntarily dismissed by plaintiffs.
20
In addition to the federal MDL cases, there are eight state court cases relating to the Bair Hugger patient warming systems. Two are pending in Missouri state court and combine Bair Hugger product liability claims with medical malpractice claims. One of the Missouri cases was tried in 2022; the jury returned a verdict in 3M’s favor on all the claims. The trial court denied plaintiff’s motion for a new trial, and the verdict was affirmed on appeal in June 2024. The plaintiff has filed a request for further review by the Missouri Supreme Court. The other Missouri case is scheduled for trial in September 2025. There is one case in Etowah County, Alabama that combines Bair Hugger product liability claims with medical malpractice claims that has been settled in principle. A Texas case that 3M removed to federal court was remanded to state court in January 2024, a Pennsylvania case was remanded to state court in April 2024 with a trial date in April 2026, and two Montana cases were remanded to state court in June 2024. Finally, a putative class action has been filed in Ramsey County, Minnesota, seeking economic damages for the use of the Bair Hugger system in knee and hip replacement surgeries involving medically obese people in Minnesota from May 2017 to the present. Discovery is underway and the case is scheduled to be ready for trial in the fourth quarter of 2025.
3M had been named a defendant in 61 cases in Minnesota state court. In January 2018, the Minnesota state court excluded plaintiffs’ experts and granted 3M’s motion for summary judgment on general causation. The Minnesota Court of Appeals affirmed the state court orders in their entirety and the Minnesota Supreme Court denied plaintiffs’ petition for review and entered the final dismissal in 2019, effectively ending the Minnesota state court cases.
In June 2016, 3M was served with a putative class action filed in the Ontario Superior Court of Justice for all Canadian residents who underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections that the representative plaintiff claims were due to the use of the Bair Hugger patient warming system. The representative plaintiff seeks relief (including punitive damages) under Canadian law based on theories similar to those asserted in the MDL.
For product liability litigation matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “Process for Disclosure and Recording of Liabilities Related to Legal Proceedings” section and are not material to the Company’s results of operations or financial condition. In addition, the Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.
Federal False Claims Act/Qui Tam Litigation
In October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries, including Kinetic Concepts, Inc. and KCI USA, Inc. As previously disclosed in the SEC filings by the KCI entities, in 2009, Kinetic Concepts, Inc. received a subpoena from the U.S. Department of Health and Human Services Office of Inspector General. In 2011, following the completion of the government’s review and its decision declining to intervene in two qui tam actions described further below, the qui tam relator-plaintiffs’ pleadings were unsealed.
The government inquiry followed two qui tam actions filed in 2008 by two former employees against Kinetic Concepts, Inc. and KCI USA, Inc. (collectively, the “KCI Defendants”) under seal in the U.S. District Court for the Central District of California. One qui tam action (the Godecke case) was dismissed in January 2022. In the remaining action (the Hartpence case), the complaint contains allegations that the KCI Defendants violated the federal False Claims Act by submitting false or fraudulent claims to federal healthcare programs by billing for 3M V.A.C. Therapy in a manner that was not consistent with the Local Coverage Determinations issued by the Durable Medical Equipment Medicare Administrative Contractors and seeks monetary damages.
In June 2019, the district court entered summary judgment in the KCI Defendants’ favor on all of the relator-plaintiff’s claims. The relator-plaintiff then filed an appeal in the U.S. Court of Appeals for the Ninth Circuit. Oral argument in the Hartpence case was held in July 2020. The appellate court issued an opinion in August 2022 reversing the decision of the district court and remanding the case for further proceedings. The district court held a status conference in January 2023 during which no case deadlines were set; the litigation remains in a pre-trial stage. The KCI Defendants filed a renewed motion for summary judgment in March 2023. In July 2023, the parties filed a joint status report notifying the court of the parties’ agreement to mediate the matter in November 2023.
As a result of a mediation held in November 2023, the relator-plaintiff and KCI reached an agreement in principle to settle the case and resolve all the remaining claims in this action, including the dismissal of the relator-plaintiff’s complaint with prejudice, subject to the agreement of the government and the parties’ negotiation and agreement of all remaining terms of the settlement. The KCI Defendants and relator-plaintiff have jointly requested that the court continue to hold in abeyance any hearing on the KCI Defendants’ pending Renewed Motion for Summary Judgment and any further proceedings in this case, to allow the parties to confer with counsel for the government and negotiate the remaining terms of the settlement agreement. The KCI Defendants and the relator-plaintiff submitted an updated status report to the court during January 2024 and further status reports in July and September 2024. Under the terms of the Separation and Distribution Agreement, Solventum has agreed to indemnify 3M for liabilities related to this matter, to manage the litigation, and pay for related legal expenses.
21
For the matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “Process for Disclosure and Recording of Liabilities Related to Legal Proceedings” section and are not material to the Company’s consolidated results of operations or financial condition. The Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.
Warranties/Guarantees
The Company has not issued any material financial guarantees of loans with third parties or other guarantee arrangements. Furthermore, the Company does not disclose information on its product warranties, as management considers the balance immaterial to its consolidated results of operations and financial condition.
NOTE 12. Earnings Per Share
Earnings Per Share
Prior to the completion of the Spin-Off, the Company had no common shares issued and outstanding. On April 1, 2024, there were 172,709,505 shares of Solventum common stock issued and outstanding as part of the Distribution. This share amount is utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off. For the three and nine months ended September 30, 2023, these shares are treated as issued and outstanding for purposes of calculating historical earnings per share. For periods prior to the Spin-Off, it is assumed that there are no dilutive equity instruments as there were no equity awards of Solventum outstanding prior to the Spin-Off.
The computations for basic and diluted earnings per share follow:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions, except per share amounts)2024202320242023
Numerator:
Net income$122 $460 $448 $1,074 
Denominator:
Weighted average common shares outstanding – basic
173.4 172.7 173.1 172.7 
Dilution associated with stock-based compensation plans0.5 — 0.3 — 
Weighted average common shares outstanding – diluted173.9172.7173.4172.7
Basic earnings per share$0.70 $2.66 $2.59 $6.22 
Diluted earnings per share $0.70 $2.66 $2.58 $6.22 

NOTE 13. Stock-Based Compensation
Prior to the Spin-Off, certain eligible employees were awarded incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units (RSUs), performance share units (PSUs) and other stock awards under 3M's Amended and Restated 2016 Long-Term Incentive Plan (3M Company Plan). Stock-based compensation granted pursuant to the 3M Company Plan was based on 3M’s common stock.
In March 2024, 3M's Board of Directors approved the 2024 Long-Term Incentive Plan (Solventum 2024 Plan) providing for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, RSUs, PSUs, and other stock or cash-based awards to eligible employees and non-employee directors. Stock-based compensation granted pursuant to the 2024 Long-Term Incentive Plan is based on Solventum's stock. The maximum shares that can be issued under the Solventum 2024 Plan is 13,000,000 shares.
In connection with the Spin-Off, all awards granted under the 3M Company Plan for Solventum employees were converted into equivalent awards under the Solventum 2024 Plan subsequent to the Spin-Off in April 2024. This stock award modification at Spin-Off resulted in expense of $20 million in the nine months ended September 30, 2024.
22
Stock-Based Compensation Expense
Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, RSUs, and PSUs, are provided in the following table. Capitalized stock-based compensation amounts were not material.
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Cost of sales$3 $1 $12 $7 
Selling, general and administrative expenses22 4 61 18 
Research, development and related expenses2 1 14 7 
Stock-based compensation expenses27 6 87 32 
Income tax benefits(5)(2)(13)(8)
Stock-based compensation expenses, net of tax
$22 $4 $74 $24 

NOTE 14. Related Parties
Related Party Transactions Prior to Spin-Off
Prior to the Spin-Off, the Company participated in centralized 3M treasury programs. This arrangement was not reflective of the manner in which the Company would have financed its operations had it been a standalone business separate from 3M during the periods presented prior to April 1, 2024. All adjustments relating to certain transactions among the Company and 3M, which include the transfer of the balance of cash to and from 3M, transfer of the balance of cash held in centralized cash management arrangements to and from 3M, and pushdown of all costs of doing business that were paid on behalf of the Company by 3M, are excluded from the asset and liability balances in the condensed combined balance sheets and have instead been reported within Net parent investment as a component of equity.
Corporate Allocations
The condensed combined statements of income for periods prior to April 1, 2024 include general corporate expenses of 3M for services provided by 3M for certain corporate and shared service functions that were provided on a centralized basis, including the use of shared assets. Expenses had been included on a direct usage basis where costs were specifically identifiable to Solventum or allocated based on the Company’s pro rata proportion of 3M's revenue.
Management believes that the expense allocations were determined on a basis that was a reasonable reflection of the utilization of services provided for or the benefit received by the Company during each of the periods presented prior to April 1, 2024. The amounts that would have been incurred on a standalone basis could materially differ from the amounts allocated. Management does not believe, however, that it is practicable to estimate what these expenses would have been had the Company operated as an independent entity, including any expenses associated with obtaining any of these services from unaffiliated entities. There was no expense allocation activity after April 1, 2024.
3M expense allocations were recorded in the condensed combined statements of income within the following captions:
Three months ended September 30,Nine months ended September 30,
(Millions)202320242023
Costs of product$25 $15 $60 
Costs of software and rentals— — — 
Selling, general and administrative186 177 551 
Research and development29 28 84 
Total$240 $220 $695 
Related Party Transactions After Spin-Off
Separation and Distribution Agreement and Other Related Party Transactions with 3M
In connection with the Spin-Off on April 1, 2024, the Company entered into or adopted several agreements that provide a framework for Solventum's relationship with 3M after the separation and distribution. These include, but are not limited to, the following:
23
•Separation and Distribution Agreement - The separation and distribution agreement contains key provisions related to the separation of Solventum from 3M, including the transfer of assets and assumptions of liabilities. In connection with this agreement, certain assets and liabilities included in the Company's condensed combined balance sheet as of March 31, 2024 were retained by 3M and certain assets and liabilities not included in the Company’s condensed combined balance sheet as of March 31, 2024 were transferred to Solventum as of the date of separation. Separation related adjustments resulted in a decrease to net assets and total equity of $1.1 billion and are reflected in the “Net transfers to 3M” line item of the condensed consolidated and combined statements of changes in equity. The impact on net assets primarily represent liabilities payable to 3M for services received prior to Spin-Off as well as cash and accounts receivable retained by 3M.
•Transition Agreements - Transition services agreements include services that 3M will provide to Solventum and its affiliates, and Solventum and its affiliates will provide to 3M and its affiliates, on an interim, transitional basis.
1) Transition services agreement. Includes various services, including, but not limited to, information technology support and access, logistics services, certain finance support functions, compliance reporting, human resources and toxicology laboratory support services. The transition services agreement has an overall term of two years.
2) Transition distribution services agreement. Provides that 3M and its affiliates will retain inventories of and purchase certain Solventum products from Solventum and its subsidiaries and distribute those products to Solventum’s customers. The transition distribution services agreement has an overall term of two years, with shorter terms for individual countries.
3) Transition contract manufacturing agreement. Solventum and 3M will manufacture certain products of the other party at specified manufacturing sites and will supply such products to the other party, in each case on a transitional basis to allow for the orderly exit of production at the supplier site and relocation. The transition contract manufacturing agreement has an overall term of three years, with the terms of individual services ranging from eighteen to thirty-six months.
For the three and nine months ended September 30, 2024, Solventum recognized operating expense of $144 million and $231 million, respectively, related to services received under the above transition agreements between the Company and 3M and its affiliates.
•Tax Matters Agreement - The agreement governs the parties’ respective rights, responsibilities and obligations with respect to taxes (including responsibility for taxes, entitlement to refunds, allocation of tax attributes, preparation of tax returns, control of tax contests and other tax matters). In addition, the tax matters agreement imposes certain restrictions on Solventum and its subsidiaries (including restrictions on share issuances, business combinations, sales of assets and similar transactions) that are designed to preserve the tax-free status of the distribution and certain related transactions.
•Employee Matters Agreement - The agreement allocates liabilities and responsibilities relating to employment matters, employee compensation and benefits plans and programs, and other related matters. The employee matters agreement provides that, unless otherwise specified, each party will be responsible for liabilities associated with current and former employees of such party and its subsidiaries. For the U.S. qualified and non-qualified defined benefit pension plans, Solventum established plans that mirror the corresponding 3M plans and assumed all obligations under 3M’s plans for the accrued benefits of current and former Solventum employees. The employee matters agreement also governs the terms of equity-based awards granted by 3M prior to separation.
•Real Estate License Agreements - Solventum or one of its affiliates, as licensee, has entered into certain real estate license agreements with 3M or one of its affiliates, as licensor, pursuant to which Solventum will be able to continue to use certain premises owned or leased by 3M for a limited period of time following the distribution date. Pursuant to the real estate license agreements, 3M will provide customary building services to the licensee consistent with the property’s use prior to the separation, including, without limitation, basic utilities, janitorial and trash removal services, maintenance services and employee amenities. The terms of the real estate license agreements are generally two years or less.
•Master Supply Agreements - 3M and Solventum entered into master supply agreements in connection with the separation under which each agrees to supply the other with certain products. The term of the master supply agreements will initially be three years, which will extend automatically, with the length of the term extension subject to the parties' ability to identify a third-party supplier, and the ability for such third-party supplier to provide validated production samples. The Company recognized revenue and cost of sales associated with products sold to 3M of $17 million and $12 million, respectively, for the three months ended September 30, 2024. The Company recognized
24
revenue and cost of sales associated with products sold to 3M of $27 million and $20 million, respectively, for the nine months ended September 30, 2024. Cost of sales related to purchases from 3M under the master supply agreements was $68 million for the three and nine months ended September 30, 2024.
Related Party Transactions
The Company had the following transactions with 3M and its affiliates, primarily in connection with the Transition Services Agreement, Transition Distribution Services Agreement, Transition Contract Manufacturing Agreements and Master Supply Agreements, reported on the Company’s condensed consolidated and combined financial statements:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions)2024202320242023
Net sales of product$17 $— $27 $— 
Cost of product171 — 201 — 
Selling, general and administrative expenses63 — 135 — 
Research and development expenses
2 — 5 — 
Current amounts due from and due to 3M under various agreements described above are recognized within the “Due from related parties” and “Due to related parties”, as applicable, in the condensed consolidated and combined financial statements. Non-current amounts due to 3M in connection with the transition distribution services agreement were approximately $72 million at September 30, 2024 and were recognized in “Other liabilities” in the consolidated balance sheet.
Net Parent Investment
Net transfers to 3M are included within Net parent investment in the condensed consolidated and combined statements of changes in equity and within financing activities in the condensed consolidated and combined statements of cash flows and represent the net effect of transactions between the Company and 3M.
The reconciliation of net transfers to 3M between the condensed consolidated and combined changes in equity and the condensed consolidated and combined statements of cash flows are as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Net transfers to 3M on the condensed consolidated and combined changes in equity
$— $(473)$(8,575)$(1,190)
Stock compensation expense— (6)(4)(32)
Multiemployer pension expense— (8)(5)(26)
Net balances transferred from 3M$— $— $337 $— 
Net transfers to 3M on the condensed consolidated and combined statements of cash flows
$— $(487)$(8,247)$(1,248)

NOTE 15. Business Segments

Operating segments include components of an enterprise where separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) for the purpose of assessing performance and allocating resources. The Company’s CODM is its Chief Executive Officer. The Company’s operating activities are managed through four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. There have been no changes to the composition of the segments or to financial information reported within each of the business segments. These segments have been identified based on the nature of the products sold and how the Company manages its operations. Transactions among reportable segments are recorded at cost. No operating segments have been aggregated to form reportable segments.
Corporate and Unallocated includes amortization of acquired intangible assets, restructuring and related charges, benefits or costs related to capitalized manufacturing variances, Spin-Off and separation related costs and other net costs that the Company chose not to allocate directly to its business segments. Spin-Off and separation related costs include any costs incurred as part of our separation from 3M and costs to setup operations as a standalone company, including system implementations, manufacturing relocation, legal entity separation, certain equity awards granted as part of the Spin-Off, profit mark-ups on transition service arrangements with 3M and other one-time costs.
25
Corporate and Unallocated also includes sales and cost of sales related to products supplied to 3M and other supply agreements related to legacy 3M business and assumed by the Company at Spin-Off. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. Business segment operating income is reconciled to total operating income and pre-tax income below.
Consistent accounting policies have been applied by all segments for all reporting periods. A description of our reportable segments has been provided in Note 1 to the audited combined financial statements within the Company’s Information Statement dated March 11, 2024.
Business Segment Information
Three months ended September 30,Nine months ended September 30,
Net Sales (Millions)
2024202320242023
MedSurg$1,182 $1,180 $3,463 $3,464 
Dental Solutions313 331 979 1,023 
Health Information Systems326 321 971 953 
Purification and Filtration238 242 721 721 
Corporate and Unallocated23 — $45 $— 
Total Company$2,082 $2,074 $6,179 $6,161 
Three months ended September 30,Nine months ended September 30,
Operating Performance (Millions)
2024202320242023
MedSurg$243 $307 $678 $829 
Dental Solutions72 114 272 349 
Health Information Systems105 114 317 304 
Purification and Filtration20 48 78 134 
Total business segment operating income440 583 1,345 1,616 
Corporate and Unallocated:
Amortization expense(88)(92)(261)(276)
Other corporate and unallocated(77)13 (184)(54)
Total Corporate and Unallocated(165)(79)(445)(330)
Total Company operating income275 504 900 1,286 
Interest expense, net107 — 260 — 
Other expense/(income), net1 4 48 10 
Income before income taxes$167 $500 $592 $1,276 

26
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Company’s unaudited condensed consolidated and combined financial statements and corresponding notes elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Solventum Corporation (“Solventum,” or the “Company”) for the nine months ended September 30, 2024 and 2023. For a full understanding of our financial condition and results of operations, the below discussion should be read alongside the Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Registration Statement on Form 10 as filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2024, which became effective on March 13, 2024 (the “Information Statement”). This discussion contains forward-looking statements that are based upon current expectations and are subject to uncertainty and changes in circumstances. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed below and elsewhere in this Quarterly Report on Form 10-Q, particularly in “Risk Factors.” Actual results may differ materially from these expectations. See “Cautionary Note Regarding Forward-Looking Statements.”
All amounts discussed are in millions of U.S. dollars, unless otherwise indicated. Certain columns and rows within tables may not add up due to the use of rounded numbers.
Unless the context otherwise requires, references to “Solventum” and the “Company” refer to (i) 3M’s Health Care Business prior to the Spin-Off as a carve-out business of 3M with related condensed combined financial statements and (ii) Solventum Corporation and its subsidiaries following the Spin-Off with related condensed consolidated and combined financial statements.
Transition to Standalone Company
Solventum utilized allocations and carve-out methodologies through the date of the Spin-Off to prepare historical combined financial statements and condensed combined financial statements. The condensed combined financial statements herein for periods prior to the Spin-Off may not be indicative of the Company’s future performance, do not necessarily include the actual expenses that would have been incurred by Solventum, and may not reflect our results of operations, financial position, and cash flows had we been a separate, standalone company during the historical periods presented.
In particular, Solventum benefited from 3M’s long operating history, reputation and well-known brand. Following the separation, Solventum is operating under its own brand, and accordingly may be negatively impacted due to the loss of benefits conferred by 3M’s brand recognition and reputation. In addition, the debt obligations incurred by Solventum in connection with the separation will adversely affect its profitability and could affect its ability to use its cash flow for investing in the business, strategic transactions, including mergers and acquisitions, and returning capital. See Note 1, “Organization and Basis of Presentation” to the condensed consolidated and combined financial statements and Item II, Part 1A “Risk Factors” for additional information.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of Solventum’s financial statements with a narrative from the perspective of management. Solventum’s MD&A is presented in the following sections:
•Overview
•Results of Operations
•Performance by Business Segment
•Financial Condition and Liquidity





27
Overview
Our Business
Solventum is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. Our 70+ year history of discovering and innovating advanced solutions has helped us solve our customers’ toughest challenges and become a trusted partner.
Operating Segments and Sales Change Information
Solventum manages its operations in four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
References are made to organic sales change, which is defined as the change in net sales, absent the separate impacts on sales from foreign currency translation and acquisitions, net of divestitures. Other, as comprised in the tables below, includes acquisition and divestiture-related activities. Acquisitions include non-health care related supply agreements that conveyed from 3M to the Company at Spin-Off and sales from new supply agreements with 3M that commenced at Spin-Off. Divestiture impacts include lost sales from the Company’s dental anesthetics business that was sold in August 2023 as well as lost sales of certain health care businesses retained by 3M India in connection with the Spin-Off. Solventum believes this information is useful to investors and management in understanding ongoing operations and in analysis of ongoing operating trends.
Sales and operating income by business segment:
The following tables contain sales and operating results by business segment for all periods presented. The Company’s use of the term “NM” reflects results considered not material due to not having material activity in comparable prior years. Refer to the section entitled “—Performance by Business Segment” below for discussion of sales change and operating performance. Refer to Note 15 to the condensed consolidated and combined financial statements for additional information on business segments.
Segment and Total Company Net Sales
Three months ended September 30,
Increase/(Decrease)
(Dollars in millions)20242023
Total
Currency Impact
Other
Organic
Segment Sales
MedSurg$1,182 $1,180 0.1 %(0.1)%(0.7)%1.0 %
Dental Solutions313 331 (5.2)— (1.2)(3.9)
Health Information Systems326 321 1.5 0.1 — 1.5 
Purification and Filtration238 242 (1.5)— (1.1)(0.3)
Corporate and Unallocated23 — NMNMNMNM
Total Company$2,082 $2,074 0.4 %(0.1)%0.2%0.3 %
Nine months ended September 30,
Increase/(Decrease)
(Dollars in millions)20242023
Total
Currency Impact
Other
Organic
Segment Sales
MedSurg$3,463 $3,464 — %(0.6)%(0.5)%1.1 %
Dental Solutions979 1,023 (4.3)(0.6)(1.9)(1.8)
Health Information Systems971 953 1.8 — — 1.8 
Purification and Filtration721 721 0.1 (0.7)(0.9)1.7 
Corporate and Unallocated45 — NMNMNMNM
Total Company$6,179 $6,161 0.3 %(0.5)%— %0.8 %
28
Segment and Total Company Operating Income

Three months ended September 30,
(Dollars in millions)202420232024 vs 2023 change
Segment Operating Income
MedSurg$243 $307 (20.8)%
Dental Solutions72 114 (36.8)
Health Information Systems105 114 (7.9)
Purification and Filtration20 48 (58.3)
Corporate and Unallocated(165)(79)108.9 
Total Company$275 $504 (45.4)%
Nine months ended September 30,
(Dollars in millions)202420232024 vs 2023 change
Segment Operating Income
MedSurg$678 $829 (18.2)%
Dental Solutions272 349 (22.1)
Health Information Systems317 304 4.3 
Purification and Filtration78 134 (41.8)
Corporate and Unallocated(445)(330)34.8 
Total Company$900 $1,286 (30.0)%
Net Sales by Geographic Area
Percent change information compares the three and nine months ended September 30, 2024 with the same period for the prior year, unless otherwise indicated.
Three months ended September 30, 2024
United StatesInternationalWorldwide
Net sales (millions)$1,217 $865 $2,082 
% of worldwide sales58.5  %41.5  %100.0  %
Increase/(decrease)
Total
4.1  %(4.5) %0.4  %
Currency impact
— (0.1)(0.1)
Other1.9 (1.9)0.2 
Organic
2.2 %(2.5)%0.3 %
Nine months ended September 30, 2024
United StatesInternationalWorldwide
Net sales (millions)$3,532 $2,647 $6,179 
% of worldwide sales57.2 %42.8 %100.0 %
Increase/(decrease)
Total
3.4 %(3.6)%0.3 %
Currency impact
— (1.2)(0.5)
Other1.4 (1.8)— 
Organic
2.0 %(0.6)%0.8 %
Additional information beyond what is included in the preceding table is as follows:
Third quarter 2024 results
•In the United States both total sales and organic sales increased. Organic growth was led by MedSurg and Health Information Systems.
•In International, both total sales and organic sales decreased. Organic growth decline was led by MedSurg and Dental Solutions.
29
First nine months 2024 results
•In the United States both total sales and organic sales increased. Organic growth was led by MedSurg and Health Information Systems.
•In International, both total sales and organic sales decreased. Foreign currency translation negatively impacted total growth. Organic growth decline was led by MedSurg, partially offset by growth in Purification and Filtration.
Managing currency risks
Prior to April 1, 2024, Solventum indirectly participated in 3M’s centrally managed hedging program, which utilizes a number of tools to manage currency risk including natural hedges such as pricing, productivity, hard currency, hard currency-indexed billings, and localizing source of supply. 3M also used financial hedges to mitigate currency risk. Starting in the second quarter of 2024, Solventum established its own hedging program. Refer to Note 10 for additional details.
The stronger U.S. dollar had an immaterial worldwide impact on sales for the third quarter of 2024 compared to the same period last year. The stronger U.S. dollar had a negative worldwide impact on sales of less than 1 percent in the first nine months of 2024 compared to the first nine months of 2023. Net of the Company’s hedging strategy, foreign currency negatively impacted earnings for the third quarter and first nine months of 2024 compared to the same periods last year.
Financial condition
Refer to the section entitled “—Financial Condition and Liquidity” below for a discussion of items impacting cash flows.

Results of Operations
Net Sales
Refer to the preceding “—Overview” section and the “—Performance by Business Segment” section later in MD&A for discussion of sales change.
Operating Expenses
Three months ended September 30,Nine months ended September 30,
(Percent of corresponding net sales)20242023Change20242023Change
Cost of product49.3 %47.0 %2.3 %49.1 %47.6 %1.5 %
Cost of software and rentals26.2 24.3 1.9 25.8 25.8 — 
Costs of Product
Costs of product includes manufacturing, engineering and freight costs.
Costs of product, measured as a percent of sales of product, increased in the third quarter of 2024 when compared to the third quarter of 2023. The increase was driven by increased costs due to the impact of higher costs on inventory sourced under the master supply and transition manufacturing agreements with 3M and due to the cost of other transition support provided by 3M.
Costs of product, measured as a percent of sales of product, increased in the first nine months of 2024 when compared to the first nine months of 2023. The increase was driven by increased costs due to the impact of higher costs on inventory sourced under the master supply and transition manufacturing agreements with 3M and due to the cost of other transition support provided by 3M. These costs were partially offset by a sales price benefit.
Costs of Software and Rentals
Costs of software and rentals includes compensation-related costs associated with installation, training and maintenance for our software products, and depreciation, maintenance and refurbishment cost and freight costs related to our hardware rental units.
Costs of software and rentals, measured as a percent of sales of software and rentals, increased during the third quarter of 2024 as compared to the same period last year due to the impact of lower rental equipment revenue. Costs of software and rentals, measured as a percent of sales of software and rentals, were flat for the first nine months of 2024 as compared to the same period last year driven by higher software sales offset by higher compensation costs and lower rental revenue.
30

Three months ended September 30,Nine months ended September 30,
(Percent of total net sales)20242023Change20242023Change
Selling, general and administrative (SG&A)33.7 %25.3 %8.4 %32.3 %27.3 %5.0 %
Research and development (R&D)9.1 8.7 0.4 9.3 9.2 0.1 
Operating Income13.2 24.3 (11.1)14.6 20.9 (6.3)
Selling, General and Administrative
SG&A, measured as a percent of total net sales, increased in both the third quarter and first nine months of 2024 when compared to the same periods last year. The increase in both periods was driven by higher compensation, including equity- based awards, and higher costs associated with both initial stand-up and ongoing operations to support a standalone company.
Research and Development
R&D, measured as a percent of total net sales, increased in both the third quarter and the first nine months of 2024 when compared to the same periods last year due to higher compensation costs.
Interest Expense, Net and Other Expense (Income), Net

Three months ended September 30,Nine months ended September 30,
(Dollars in millions)2024202320242023
Interest expense, net$107 $— $260 $— 
Other expense (income), net 1 4 $48 $10 

Interest expense, net includes interest accrued on debt obligations, offset by interest income from cash and marketable securities. Interest expense, net increased in both the third quarter and first nine months of 2024 as compared to the same periods last year due to interest incurred on the February 2024 issuance of senior notes and March draw on the senior term loan credit facilities. Refer to Note 8 to the financial statements for more information. This increase was partially offset by interest earned from cash and marketable securities held during the period.

Other expense (income), net includes the non-service component of periodic pension cost, investment gains and losses, and currency-related impacts from foreign currency translation. Other expense (income), net decreased slightly for the third quarter of 2024 as compared to the same period last year. Other expense (income), net increased for the first nine months of 2024 as compared to the same period last year resulting from charges associated with the substantial liquidation of foreign operations completed as part of our separation from 3M.
Provision (benefit) for Income Taxes:
Three months ended September 30,Nine months ended September 30,
(Percent of pre-tax income/loss)2024202320242023
Effective tax rate 26.9 %8.0 %24.3 %15.8 %

Refer to Note 7 to the financial statements for further discussion of income taxes.







31
Performance by Business Segment
Note 14 to the audited combined financial statements within the Company’s Information Statement provides an overview of Solventum’s business segments. In addition, disclosures relating to Solventum’s segments are provided in Note 15 to the accompanying condensed consolidated and combined financial statements. We manage our operations in four business segments. The reportable segments are MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Our Chief Operating Decision Maker evaluates segment operating performance using net sales and business segment operating income.
Corporate and Unallocated
In addition to the four business segments, the Company assigns certain costs to “Corporate and Unallocated,” which is presented separately in Note 15 to the condensed consolidated and combined financial statements. Corporate and Unallocated includes amortization of acquired intangible assets, restructuring and related charges, benefits or costs related to capitalized manufacturing variances, Spin-Off and separation related costs and other net costs that the Company chose not to allocate directly to its business segments. Spin-Off and separation related costs include any costs incurred as part of our separation from 3M and costs to setup operations as a standalone Company, including system implementations, manufacturing relocation, legal entity separation, certain equity awards granted as part of the Spin-Off, profit mark-ups on transition service arrangements with 3M and other one-time costs.
Corporate and Unallocated also includes sales and cost of sales related to product supplied to 3M and other supply agreements related to legacy 3M non-health care business that were assumed by the Company at Spin-Off. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis.
Corporate and Unallocated net operating loss increased in both the third quarter and the first nine months of 2024 when compared to the same period last year as the Company had higher Spin-Off and separation related costs.
Operating Business Segments
Information related to the Company’s segments is presented in the tables that follow with additional context in the corresponding narrative below the tables.
Refer to the section entitled “Business” in Solventum’s Information Statement for discussion of products that are included in each business segment.
MedSurg (56.8% and 56.0% of consolidated sales for the three and nine months ended September 30, 2024)
Three months ended September 30,Nine months ended September 30,
2024202320242023
Net sales (millions)
$1,182 $1,180$3,463$3,464
Increase/(decrease)
Organic
1.0  %1.4 %1.1  %1.4 %
Other
(0.7)— (0.5)— %
Currency impact
(0.1)0.6 (0.6)(1.1 %)
Total
0.1  %2.0 %—  %0.3 %
Business segment operating income (millions)
$243 $307$678$829
Percent change(20.8)%16.3 %(18.2)%2.5 %
Percent of sales20.6 %26.0 %19.6 %23.9 %
Third quarter 2024 results
Sales in MedSurg were up 0.1%:
•Organic sales growth was driven by volumes, including a benefit from I.V. site management and medical OEM products, partially offset by traditional negative pressure wound therapy.
•Volume growth continues to benefit from single-use negative pressure wound therapy.
•Other includes lost sales from certain health care businesses in India retained by 3M in connection with the Spin-Off.
•Foreign currency translation negatively impacted sales by (0.1%).
32
Business segment operating income margin decreased when compared to the same period last year. The decrease was driven by higher costs to stand-up and operate our standalone structure after Spin-Off.
First nine months 2024 results
Sales in MedSurg were flat:
•Positive price growth was driven by the impact from actions initiated during the prior year in response to higher material and labor input costs. The favorable impact of prior year price actions has and will continue to decline during the remainder of 2024.
•Organic growth was led by I.V. site management, medical OEM products, and single-use negative pressure wound therapy, partially offset by declines in sterilization assurance products and traditional negative pressure wound therapy.
•Other includes certain health care businesses retained by 3M India in connection with the Spin-Off.
•Foreign currency translation negatively impacted sales by (0.6%).
Business segment operating income margin decreased when compared to the same period last year. The decrease was driven by higher costs to stand-up and operate our standalone structure after Spin-Off.
Dental Solutions (15.0% and 15.8% of consolidated sales for the three and nine months ended September 30, 2024)
Three months ended September 30,Nine months ended September 30,
2024202320242023
Net sales (millions)
$313$331$979$1,023
Increase/(decrease)
Organic
(3.9)%7.7 %(1.8) %3.2 %
Other
(1.2)(2.1)(1.9)(0.6)
Currency impact
— 1.5(0.6)(1.0)
Total
(5.2) %7.1%(4.3) %1.6  %
Business segment operating income (millions) $72 $114 $272 $349 
Percent change (36.8) %31.0  %(22.1) %2.0  %
Percent of sales 23.0  %34.4  %27.8  %34.1  %
Third quarter 2024 results:
Sales in Dental Solutions were down (5.2)%:
•Lower volumes were driven by soft end-market demand.
•Other includes lost sales from the Company’s dental anesthetics business that was sold in August 2023 as well as certain health care businesses retained by 3M India in connection with the Spin-Off.
•Foreign currency translation impact to sales was flat.
Business segment operating income margin decreased when compared to the same period last year as a result of higher costs to stand-up and operate our standalone structure after Spin-Off in addition to the impact of lower sales volumes.
First nine months 2024 results:
Sales in Dental Solutions were down (4.3)%:
•Volume declines were partially offset by positive price growth. The favorable impact of prior year price actions decreased during the period and the impact of such price actions has and will continue to moderate through the remainder of 2024.
•Other is primarily driven by lost sales from the Company’s dental anesthetics business that was sold in August 2023 as well as certain health care businesses retained by 3M India in connection with the Spin-Off.
•Foreign currency translation negatively impacted sales by (0.6%)
33
Business segment operating income margin decreased when compared to the same period last year as a result of higher costs to stand-up and operate our standalone structure after Spin-Off, partially offset by the benefits from both higher price and lower manufacturing inflation.
Health Information Systems (15.7% and 15.7% of consolidated sales for the three and nine months ended September 30, 2024)
Three months ended September 30,Nine months ended September 30,
2024202320242023
Net sales (millions)
$326 $321 $971 $953 
Increase/(decrease)
Organic
1.5  %3.9 %1.8  %5.2 %
Other
—— —— 
Currency impact
0.10.3 —(0.1)
Total
1.5  %4.2 %1.8  %5.1 %
Business segment operating income (millions) $105 $114 $317 $304 
Percent change (7.9) %14.0 %4.3  %21.1 %
Percent of sales 32.2  %35.5  %32.6  %31.9  %
Third quarter 2024 results:
Sales in Health Information Systems were up 1.5%:
•Positive growth was driven by continued adoption of our 3MTM 360 EncompassTM, partially offset by performance management solutions and clinician productivity solutions.
•Clinician productivity solutions declined primarily due to impacts from changing market conditions.
Business segment operating income margin decreased when compared to the same period last year driven by higher compensation costs.
First nine months 2024 results:
Sales in Health Information Systems were up 1.8%:
•Positive growth was driven by continued adoption of our 3MTM 360 EncompassTM and performance management solutions.
•Clinician productivity solutions declined primarily due to impacts from changing market conditions.
Business segment operating income margin increased when compared to the same period last year driven by a product mix benefit due to higher software sales and lower professional services, partially offset by higher compensation costs.
Purification and Filtration (11.4% and 11.7% of consolidated sales for the three and nine months ended September 30, 2024)
Three months ended September 30,Nine months ended September 30,
2024202320242023
Net sales (millions)
$238$242$721$721
Increase/(decrease)
Organic
(0.3) %1.4 %1.7  %(3.8)%
Other
(1.1)— (0.9)— 
Currency impact
— 1.6 (0.7)(1.0)
Total
(1.5) %3.0 %0.1  %(4.8)%
Business segment operating income (millions) $20 $48 $78 $134 
Percent change (58.3)%33.3 %(41.8) %(13.5)%
Percent of sales 8.4  %19.8  %10.8  %18.6  %
34
Third quarter 2024 results:
Sales in Purification and Filtration were down (1.5)%:
•Primarily driven by declines in drinking water filtration and membrane OEM product categories, partially offset by continued strength in bioprocessing filtration product category and added capacity coming online for industrial filtration product category.
•Other includes certain business in India retained by 3M in connection with the Spin-Off.
•Foreign currency translation impact to sales was flat.
Business segment operating income margin decreased due to a negative impact from costs to stand-up and operate our standalone structure after Spin-Off and sales mix.
First nine months 2024 results:
Sales in Purification and Filtration were up 0.1%:
•Primarily driven by higher volume growth in our bioprocessing filtration product category. This growth was partially offset by a decline in our industrial filtration and drinking water filtration product categories.
•Other includes certain health care businesses retained by 3M India in connection with the Spin-Off.
•Foreign currency translation negatively impacted growth by (0.7%).
Business segment operating income margin decreased due to the negative impact from costs to stand-up and operate our standalone structure after Spin-Off and sales mix.

Financial Condition and Liquidity
The strength and stability of Solventum’s operating model and strong free cash flow capability provides financial flexibility and enables the Company to invest through business cycles. Historically, Solventum generated positive operating cash flows and a majority of such cash flows were transferred to 3M as part of 3M’s cash pooling arrangements, the effect of which is presented as Net parent investment in our condensed combined financial statements.
Upon completion of the Spin-Off, Solventum has ceased participation in 3M's cash pooling arrangement and our cash and cash equivalents are held and used solely for our own operations. The Company's capital structure, long-term commitments and sources of liquidity will change significantly from historical practices. For additional detail regarding changes to our capital structure, refer to the section entitled “Description of Material Indebtedness” in Solventum's Information Statement.
Debt and Credit Facilities
On February 16, 2024, the Company entered into a five-year $2.0 billion unsecured revolving credit facility expiring in 2029, an 18-month senior unsecured term loan facility of $500 million and a three-year senior unsecured term loan facility of $1.0 billion (collectively, the “Facilities”). In March 2024, the Company withdrew $1.48 billion under the Facilities. The funds from the Facilities were transferred to 3M as partial consideration for the Spin-Off.
On February 27, 2024, Solventum issued $6.9 billion of Senior Notes in preparation for the payment of partial consideration to 3M Company in connection with the Spin-Off.
In August 2024, the Company repaid $200 million of the outstanding principal amount from the 18-month senior unsecured term loan credit facility.
Refer to Note 8 for more information.
Commercial Paper
On March 4, 2024, the Company entered into a commercial paper program that allows it to issue up to an $2.0 billion aggregate principal amount of short-term notes to finance short-term liabilities. Any such issuance will mature within 364 days from date of issue. There was no commercial paper outstanding as of September 30, 2024.
35
Cash, cash equivalents and marketable securities
As of September 30, 2024, Solventum had $772 million of cash and cash equivalents, of which approximately $570 million was held by the Company’s foreign subsidiaries and approximately $202 million was held in the United States. These balances are invested in bank instruments and other high-quality fixed income securities. As of December 31, 2023, Solventum had $194 million of cash and cash equivalents, of which approximately $150 million was held by the Company’s foreign subsidiaries and $44 million was held in the United States. The increase from December 31, 2023 resulted from both cash retained by the Company at Spin-Off and operating cash generated by the Company subsequent to the Spin-Off.
Cash Flows
Cash flows from operating, investing and financing activities are provided in the tables that follow. Individual amounts in the condensed consolidated and combined statements of cash flows exclude the effect of exchange rate impacts on cash and cash equivalents, which are presented separately in the cash flows. Thus, the amounts presented in the following operating, investing and financing activities tables reflect changes in balances from period to period adjusted for these effects.
Cash Flows from Operating Activities:
Nine months ended September 30,
(Millions)20242023
Cash Flows from Operating Activities
Net income$448 $1,074 
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 405 422 
Postretirement benefit plan expense30 31 
Stock-based compensation expense 87 32 
Gain on business divestitures— (56)
Deferred income taxes (93)(99)
Changes in assets and liabilities
Accounts receivable 14 (24)
Due from related parties
200 — 
Inventories (99)(7)
Accounts payable 200 48 
Due to related parties
(393)— 
All other operating activities167 (53)
Net cash provided by operating activities $966 $1,368 
In the first nine months of 2024, cash flows provided by operating activities decreased compared to the first nine months of 2023 primarily due to lower net income, partially offset by payments from related parties. The benefit in accounts payable is largely offset by amounts due to related parties as the Company reimburses 3M for certain procurement activities managed through 3M's IT systems. In addition to this procurement activity, due to related parties also includes cash paid to 3M for operating transactions with Solventum entities prior to the Spin-Off and the net impact of payables and associated payments related to transition agreements with 3M.
Cash Flows from Investing Activities:
Nine months ended September 30,
(Millions)20242023
Cash Flows from Investing Activities
Purchases of property, plant and equipment $(253)$(202)
Proceeds from sale of business— 60 
Net cash used in investing activities $(253)$(142)

Purchases of property, plant and equipment increased in the first nine months of 2024 as compared to the first nine months of 2023. The increase is primarily driven by the timing of investment spend. The Company is focused on investments to support growth, renewal and maintenance programs, environmental health services, and relocating manufacturing operations currently co-located within 3M facilities.


36
Cash Flows from Financing Activities:
Nine months ended September 30,
(Millions)20242023
Cash Flows from Financing Activities
Repayment of debt$(200)$— 
Net transfers to 3M(8,247)(1,248)
Proceeds from long-term debt, net of issuance costs8,303 — 
Other — net 8 2 
Net cash provided by (used in) financing activities $(136)$(1,246)
Repayment of debt is related to the August 2024 repayment of $200 million outstanding principal from the 18-month senior unsecured term loan credit facility.
Proceeds from debt of $8.3 billion were related to the first quarter issuance of $6.9 billion in senior notes and $1.5 billion in senior term loan credit facilities. The proceeds from these financing transactions were transferred to 3M in connection with the Spin-Off transaction, other than the amounts retained in order to achieve the $600 million retained cash target.


Material Cash Requirements from Known Contractual and Other Obligations:
Solventum’s material cash requirements from known contractual and other obligations primarily relate to the following, for which information on both a short-term and long-term basis is provided in the indicated notes to the condensed consolidated and combined financial statements and the audited combined financial statements included in the Information Statement:
•Tax obligations—Refer to Note 9 to the audited combined financial statements and Note 7 to the unaudited condensed consolidated and combined financial statements.
•Debt—Refer to Note 8 to the unaudited condensed consolidated and combined financial statements.
•Commitments and contingencies—Refer to Note 11 to the audited combined financial statements and Note 11 to the unaudited condensed consolidated and combined financial statements.
•Operating leases—Refer to Note 12 to the audited combined financial statements.
Solventum purchases the majority of its materials and services as needed, with no unconditional commitments. In limited circumstances, in the normal course of business, the Company enters into unconditional purchase obligations with various vendors that may take the form of, for example, take or pay contracts in which the Company guarantees payment to ensure availability of certain materials or services or to ensure ongoing efforts on capital projects. The Company expects to receive underlying materials or services for these purchase obligations. To the extent the limited amount of these purchase obligations fluctuates, it largely trends with normal-course changes in regular operating activities. Additionally, contractual capital commitments represent a small part of the Company’s expected capital spending.
37
Cautionary Note Concerning Forward Looking Statements
This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part I, Item 2, contains or incorporates by reference statements that relate to future events and expectations and, as such, constitute forward-looking statements that involve risk and uncertainties. Forward-looking statements include those containing such words as “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “guidance,” “intends,” “may,” “outlook,” “plans,” “projects,” “seeks,” “sees,” “should,” “targets,” “will,” “would,” or other words of similar meaning.

All statements that reflect Solventum’s expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, forecasts relating to discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth and cash flows) and statements regarding Solventum’s strategy for growth, future product development, regulatory clearances and approvals, competitive position and expenditures. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and changes in circumstances that are difficult to predict. Although Solventum believes that the expectations reflected in any forward-looking statements it makes are based on reasonable assumptions, it can give no assurance that these expectations will be attained and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks and uncertainties. Such risks and uncertainties include, but are not limited to:

•the effects of, and changes in, worldwide economic, political, regulatory, international, trade and geopolitical conditions, natural disasters, war, public health crises, and other events beyond Solventum’s control;
•unexpected events, such as those related to the COVID-19 public health crisis;
•operational execution risks;
•damage to our reputation or our brands;
•risks from acquisitions, strategic alliances, divestitures and other strategic events;
•Solventum’s business dealings involving third-party partners in various markets;
•Solventum’s ability to access the capital and credit markets and changes in Solventum’s credit ratings;
•exposure to interest rate and currency risks;
•the highly competitive environment in which Solventum operates and consolidation in the healthcare industry;
•reduction in customers’ research budgets or government funding;
•the timing and market acceptance of Solventum’s new product and service offerings;
•ongoing working relationships with certain key healthcare professionals;
•changes in reimbursement practices of governments or private payers or other cost containment measures;
•Solventum’s ability to obtain components or raw materials supplied by third parties and other manufacturing and related supply chain difficulties, interruptions, and disruptive factors;
•legal and regulatory proceedings and legal compliance risks (including third-party risks) with regards to antitrust, Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws, environmental laws, anti-kickback and false claims laws, privacy laws, tax laws, and other laws and regulations in the United States and other countries in which Solventum operates;
•potential liabilities related to a broad group of perfluoroalkyl and polyfluoroalkyl substances, collectively known as “PFAS”;
•risks related to the highly regulated environment in which Solventum operates;
•risks associated with product liability claims;
•climate change and measures to address climate change;
•security breaches and other disruptions to information technology infrastructure;
•Solventum’s failure to obtain, maintain, protect, or effectively enforce its intellectual property rights;
•pension and postretirement obligation liabilities;
•any failure by 3M to perform any of its obligations under the various separation agreements in connection with the separation and distribution;
•any failure to realize the expected benefits of the separation, and/or that the separation will not be completed within the expected time frame, on the expected terms or at all;
•a determination by the IRS or other tax authorities that the distribution or certain related transactions should be treated as taxable transactions;
•expected financing transactions undertaken in connection with the separation and risks associated with additional indebtedness;
•the risk that incremental costs of operating on a standalone basis (including the loss of synergies), costs of restructuring transactions and other costs incurred in connection with the separation will exceed Solventum’s estimates; and
•the impact of the separation on its businesses and the risk that the separation may be more difficult, time-consuming or costly than expected, including the impact on its resources, systems, procedures and controls, diversion of
38
management’s attention and the impact on relationships with customers, suppliers, employees and other business counterparties.
The above list is not exhaustive or necessarily set forth in the order of importance. Forward-looking statements are based on certain assumptions and expectations of future events and trends, and actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Solventum assumes no obligation to update or revise such statement, whether as a result of new information, future events or otherwise, except as required by applicable law.
Important information as to these factors can be found in this document, including, among others, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the headings of “Overview,” “Financial Condition and Liquidity” and annually in “Critical Accounting Estimates.” Discussion of these factors is incorporated by reference from Part II, Item 1A, “Risk Factors,” of this document, and should be considered an integral part of Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” For additional information concerning factors that may cause actual results to vary materially from those stated in the forward-looking statements, see our reports on Form 8-K filed with the SEC from time to time and the Company's Registration Statement on Form 10, including the amendments thereto, as filed with the SEC.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Foreign Currency Exchange Rate Risks:
Solventum faces transactional exchange rate risk from transactions with customers in countries outside the United States and from intercompany transactions between affiliated entities. Foreign currency exchange rates and fluctuations in those rates may cause fluctuations in cash flows related to foreign denominated transactions. The Company is also exposed to the translation of foreign currency earnings to the U.S. dollar.
3M enters into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. While part of 3M, Solventum indirectly benefited from 3M’s hedging activities and was allocated a proportion of the realized gains or losses on these contracts. However, the benefits and costs realized from these contracts may not reflect the benefits and costs Solventum would have incurred as a standalone company for the periods presented.
Concentration of Credit Risk:
Solventum’s sales are not materially dependent on any single customer. For the three and nine months ended September 30, 2024 and September 30, 2023, no one individual customer or group of affiliated customers represented more than 10 percent of the Company's total sales. At September 30, 2024 no customers represented more than 10 percent of the Company's total accounts receivable balance and at December 31, 2023, one customer accounted for approximately 10 percent of Solventum’s total accounts receivable balance. Credit risk associated with the Company’s accounts receivable is representative of the geographic, industry, and customer diversity associated with the global businesses.
Commodity Prices Risk:
Solventum manages commodity price risks through negotiated supply contracts and price protection agreements. The Company does not participate in material commodity hedging activity.
Item 4. Controls and Procedures
a. The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.
b. There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

39
SOLVENTUM CORPORATION
FORM 10-Q
For the Quarterly Period Ended September 30, 2024
PART II. Other Information
Item 1. Legal Proceedings
Discussion of legal matters is incorporated by reference from Part I, Item 1, Note 11, “Commitments and Contingencies,” of this document, and should be considered an integral part of Part II, Item 1, “Legal Proceedings.”
Item 1A. Risk Factors
There have been no material changes to the risk factors as disclosed in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2024.
Discussion of these factors is incorporated by reference into and considered an integral part of Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
There were no unregistered sales of equity securities during the period covered by this report.
Item 3. Defaults Upon Senior Securities
No matters require disclosure.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Insider Trading Arrangements and Policies
During the three months ended September 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Disclosure Under Iran Threat Reduction and Syria Human Rights Act of 2012

As part of its intellectual property (“IP”) protection efforts, 3M has obtained and maintains patents and trademarks in Iran. Certain of these patents and trademarks are now owned by Solventum’s affiliate Solventum Intellectual Properties Company, but registered title has not yet been assigned to Solventum Intellectual Properties Company. As authorized under 3M’s specific license granted by the Office of Foreign Assets Control, during the three months ended September 30, 2024, a third-party IP service provider/counsel paid on behalf of 3M a renewal fee of $130 to the Iran Intellectual Property Office’s account with Bank Melli, which was designated pursuant to Executive Order 13224, to maintain a trademark owned by Solventum that has registered title held by 3M. Solventum did not direct this activity and understands that 3M plans to continue these IP rights protection activities as authorized under its specific license.

Availability of Information
Solventum's website address is www.solventum.com. Investors and others should note that the Company announces material information to its investors using SEC filings, press releases, its investor relations website, public conference calls and webcasts. The Company uses these channels to communicate with investors, customers and the public about the Company, its products and other issues. The information on, or that may be accessed through, Solventum's website is not incorporated by reference into this Quarterly Report on Form 10-Q and should not be considered a part of this Quarterly Report on Form 10-Q.




40
Item 6. Exhibits
2.1
3.1
3.2
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
10.18
31.1
31.2
41
32.1
32.2
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
__________________
+Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
*Schedules and exhibits omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish a supplemental copy of any omitted schedule to the Securities and Exchange Commission (the “SEC”) upon request.

42
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SOLVENTUM CORPORATION
(Registrant)
Date: November 8, 2024
By/s/ Wayde McMillan
Wayde McMillan,
Executive Vice President and Chief Financial Officer (Mr. McMillan is a Principal Financial Officer and has been duly authorized to sign on behalf of the Registrant.)
43
 EX-31.1 2 a2024q3exhibit311.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Bryan Hanson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Solventum Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(c)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 8, 2024By: /s/ Bryan Hanson
Name: Bryan Hanson
Title: Chief Executive Officer
          (Principal Executive Officer)

 EX-31.2 3 a2024q3exhibit312.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION PURSUANT TO
SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Wayde McMillan, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Solventum Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(c)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 8, 2024By: /s/ Wayde McMillan
Name: Wayde McMillan
Title: Chief Financial Officer
          (Principal Financial Officer)

 EX-32.1 4 a2024q3exhibit321.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Bryan Hanson, Chief Executive Officer of Solventum Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
November 8, 2024/s/ Bryan Hanson
Bryan Hanson
Chief Executive Officer
(Principal Financial Officer)

 EX-32.2 5 a2024q3exhibit322.htm EX-32.2 Document

EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Wayde McMillan, Chief Financial Officer of Solventum Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
November 8, 2024/s/ Wayde McMillan
Wayde McMillan
Chief Financial Officer
(Principal Financial Officer)

 EX-101.SCH 6 solv-20240930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Condensed Consolidated and Combined Statements of Income link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Condensed Consolidated and Combined Statements of Income link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Condensed Consolidated and Combined Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Condensed Consolidated and Combined Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Condensed Consolidated and Combined Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Condensed Consolidated and Combined Statements of Changes in Equity link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Condensed Consolidated and Combined Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Property, Plant, and Equipment - Net link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Comprehensive Income Information link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Long-Term Debt and Short-Term Borrowings link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Pension and Postretirement Benefit Plans link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 9952171 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Property, Plant, and Equipment - Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Comprehensive Income Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Long-Term Debt and Short-Term Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Pension and Postretirement Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Related Parties (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Long-Term Debt and Short-Term Borrowings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Pension and Postretirement Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Derivatives - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Derivatives - Cash Flow Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Commitment and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Earnings Per Share - Schedule of Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Related Parties - Schedule of Parent's Expense Allocations (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Related Parties - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Related Parties - Condensed Consolidated Statements of Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Business Segments - Schedule of Business Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 solv-20240930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 solv-20240930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 solv-20240930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Proceeds from long-term lines of credit Proceeds from Long-Term Lines of Credit Adjustments to reconcile net income to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill, acquired during period Goodwill, Acquired During Period Statistical Measurement [Domain] Statistical Measurement [Domain] Related Parties Related Party Transactions Disclosure [Text Block] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Cover [Abstract] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect International Foreign Plan [Member] Other current liabilities Total other current liabilities Other Liabilities, Current Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Assets Fair Value Amount Derivative Asset, Subject to Master Netting Arrangement, before Offset Non-NEOs Non-NEOs [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Income tax benefits Share-Based Payment Arrangement, Expense, Tax Benefit Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Allowance Accounts Receivable, Allowance for Credit Loss, Current Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Accumulated other comprehensive income (loss), unrealized gain (loss) on cash flow hedges AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Net parent investment Net Parent Investment Net Parent Investment Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] 3M 3M [Member] 3M Hedging Relationship [Domain] Hedging Relationship [Domain] Schedule of Location and Fair Value of Derivative Instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Award Timing Disclosures [Line Items] Stock-based compensation expenses, net of tax Share-Based Payment Arrangement, Expense, after Tax Other Performance Measure, Amount Other Performance Measure, Amount 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Goodwill [Line Items] Goodwill [Line Items] Common stock outstanding (in shares) Common Stock, Shares, Outstanding Due from related parties Other Receivables, Net, Current Maximum shares issued Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of pending/ongoing cases Loss Contingency, Pending Claims, Number Cash Flow Hedging Cash Flow Hedging [Member] Revenue from Contract with Customer [Abstract] Allocation of Expenses [Table] Allocation of Expenses [Table] Allocation of Expenses [Table] Unearned revenue Contract with Customer, Liability, Current Plan Name [Domain] Plan Name [Domain] United States UNITED STATES Inventories Inventory, Net [Abstract] Service cost Defined Benefit Plan, Service Cost Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Total gross carrying amount Finite-Lived Intangible Assets, Gross Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Payments for legal settlements Payments for Legal Settlements Retirement Plan Type [Axis] Retirement Plan Type [Axis] Operating Segments Operating Segments [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Accrued taxes Taxes Payable, Current Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Plan Name [Axis] Plan Name [Axis] Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Award Timing Method Award Timing Method [Text Block] Total net periodic benefit cost (benefit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Restructuring Type [Axis] Restructuring Type [Axis] Tradenames and other amortizable intangible assets Trade Names [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Proceeds from sale of business Proceeds from Divestiture of Businesses Corporate and Unallocated Corporate and Reconciling Items [Member] Corporate and Reconciling Items Total operating expenses Total Corporate and Unallocated Costs and Expenses Amounts reclassified out Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Adjustment to Compensation, Amount Adjustment to Compensation Amount Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Prior To Spin-Off Prior To Spin-Off [Member] Prior To Spin-Off Company Selected Measure Amount Company Selected Measure Amount Geographical [Axis] Geographical [Axis] Tabular List, Table Tabular List [Table Text Block] Gain on business divestitures Gain (Loss) on Disposition of Business Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Loss contingency accrual Loss Contingency Accrual Due to related parties Accrued Liabilities, Current Credit Facility [Domain] Credit Facility [Domain] Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Current assets Assets, Current [Abstract] Goodwill Beginning balance Ending balance Goodwill Consolidation Items [Axis] Consolidation Items [Axis] Operating expense Net Periodic Benefit Cost (Benefit), Operating Expense [Abstract] Net Periodic Benefit Cost (Benefit), Operating Expense Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Depreciation expense Depreciation Goodwill [Roll Forward] Goodwill [Roll Forward] Other — net Proceeds from (Payments for) Other Financing Activities Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net balances transferred from 3M Net Transfers From Parent Net Transfers From Parent Qualified and Non-qualified Pension Benefits Pension Plan [Member] Repayment of debt Debt Instrument, Repaid, Principal Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Security Exchange Name Security Exchange Name Award Type Award Type [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Translation impact Goodwill, Foreign Currency Translation Gain (Loss) Property, plant and equipment — net Property, plant and equipment - net Property, Plant and Equipment, Net Work in process Inventory, Work in Process, Net of Reserves Repayment of debt Repayments of Debt Total liabilities Liabilities Other comprehensive income (loss), before tax: Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Common stock par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development expenses Research and development Research and Development Expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revolving Credit Facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Tax effect Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Total Shareholder Return Amount Total Shareholder Return Amount Common stock issued (in shares) Common Stock, Shares, Issued Entity [Domain] Entity [Domain] Retained cash target Stockholders' Equity Note, Spinoff Transaction, Retained Cash Target Stockholders' Equity Note, Spinoff Transaction, Retained Cash Target Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Concentration risk, percentage Concentration Risk, Percentage Number of employees who filed qui tam actions Loss Contingency, Employees Who Filed Claims, Number Loss Contingency, Employees Who Filed Claims, Number Cost of sales Accounts Payable and Accrued Liabilities, Noncurrent Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Gross property, plant and equipment Property, Plant and Equipment, Gross Foreign currency forward contracts Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Net transfers to 3M Net transfers to 3M on the condensed consolidated and combined statements of cash flows Payments For (Proceeds From) Parent Payments For (Proceeds From) Parent Separation and distribution agreement, individual services, terms Separation And Distribution Agreement, Individual Services, Terms Separation And Distribution Agreement, Individual Services, Terms Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Common stock authorized (in shares) Common Stock, Shares Authorized Number of plans transferred from parent Defined Benefit Plan, Number Of Plans Transferred From Parent Defined Benefit Plan, Number Of Plans Transferred From Parent Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Diluted (in shares) Weighted average common shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Remainder of 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total equity Beginning balance Ending balance Equity, Attributable to Parent Related Party Related Party [Member] Amortization of net actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Litigation Case [Axis] Litigation Case [Axis] Statement of Financial Position Location, Balance [Axis] Statement of Financial Position Location, Balance [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Deferred income taxes Deferred Income Tax Expense (Benefit) Schedule of Goodwill Segment Schedule of Goodwill [Table Text Block] Property, Plant, and Equipment - Net Property, Plant and Equipment Disclosure [Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Selling, general and administrative expenses Selling, general and administrative Selling, General and Administrative Expense Short-term borrowings and current portion of long-term debt Debt, Current Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Accounts receivable — net of allowances of $86 and $82 Accounts Receivable, after Allowance for Credit Loss, Current Cost of sales Cost of Sales [Member] Cost of product Product [Member] Total Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus 2028 Long-Term Debt, Maturity, Year Four All Executive Categories All Executive Categories [Member] Dilution associated with stock-based compensation plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements After 2029 Long-Term Debt, Maturity, after Year Five Statement of Financial Position Location, Balance [Domain] Statement of Financial Position Location, Balance [Domain] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Assets Assets [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Commercial Paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan [Table] MedSurg MedSurg MedSurg Segment [Member] MedSurg Segment Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Indefinite lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Separation and distribution agreement, real estate license terms Separation And Distribution Agreement, Real Estate License Agreements, Term Separation And Distribution Agreement, Real Estate License Agreements, Term Maximum Maximum [Member] Amortization expense Amortization of Intangible Assets Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Total finite-lived intangible assets — net Finite-Lived Intangible Assets, Net Accounts payable Accounts Payable, Current Accounting Policies [Abstract] Liabilities Liabilities [Abstract] Commitments and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount All Award Types Award Type [Domain] Name Outstanding Recovery, Individual Name Number of cases settled Loss Contingency, Claims Settled, Number Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Pension and postretirement benefits Liability, Defined Benefit Plan, Noncurrent Non-PEO NEO Non-PEO NEO [Member] Additional Paid-In-Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Award Timing Predetermined Award Timing Predetermined [Flag] Pension and Postretirement Benefit Plans Retirement Benefits [Text Block] Series of notes issued Debt Instrument, Series Of Notes Issued Debt Instrument, Series Of Notes Issued New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Amortization of prior service benefit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Schedule of Finite-Lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Type of Restructuring [Domain] Type of Restructuring [Domain] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Number of operating segments Number of Operating Segments Retirement Benefits [Abstract] Customer [Axis] Customer [Axis] Statement of Financial Position [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Liabilities Fair Value Amount Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement Defined Benefit Pension Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Provision for income taxes Income Tax Expense (Benefit) Interest cost Defined Benefit Plan, Interest Cost Solventum 2024 Plan 2024 Long-Term Incentive Plan [Member] 2024 Long-Term Incentive Plan Interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Gross Notional Amount Derivative, Notional Amount Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating income Operating Income Operating Income (Loss) Total liabilities and equity Liabilities and Equity All other operating activities Other Operating Activities, Cash Flow Statement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Accrued compensation Employee-related Liabilities, Current Additional paid-in-capital Additional Paid in Capital Short-Term Debt, Type [Domain] Short-Term Debt, Type [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Legal Entity [Axis] Legal Entity [Axis] Interest expense, net Interest expense, net Interest Income (Expense), Nonoperating Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Operating lease, lease income Operating Lease, Lease Income Individual: Individual [Axis] Related Party Transaction [Axis] Related Party Transaction [Axis] Buildings and leasehold improvements Building and Building Improvements [Member] Common stock for tax withholding obligations Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Accumulated Other Comprehensive Income (Loss) Total Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Transferred plans, number of countries included in coverage Defined Benefit Plan, Transferred Plans, Number Of Countries Included In Coverage Defined Benefit Plan, Transferred Plans, Number Of Countries Included In Coverage Number of putative class actions Loss Contingency, Putative Class Action, Number Loss Contingency, Putative Class Action, Number Cash Flow Hedging Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Total inventories Inventory, Net Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Total non-operating expense (benefit) Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Credit Facilities Credit Facilities [Member] Credit Facilities Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Related Party Transactions [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Axis] Segments [Axis] Segments [Axis] One Customer One Customer [Member] One Customer Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Maximum length of time hedged in cash flow hedge Maximum Length of Time Hedged in Cash Flow Hedge Derivative Instrument [Axis] Derivative Instrument [Axis] Property, Plant and Equipment [Abstract] Total long-term debt Long-Term Debt, Gross Exercise Price Award Exercise Price Earnings Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Total lawsuits to date Loss Contingency, Total Claims To Date, Number Loss Contingency, Total Claims To Date, Number Equity Equity, Attributable to Parent [Abstract] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Federal False Claims Act/Qui Tam Litigation Federal False Claims Act/Qui Tam Litigation [Member] Federal False Claims Act/Qui Tam Litigation Debt instrument, term Debt Instrument, Term Number of cases removed to federal court Loss Contingency, Claims Remanded To Federal Court, Number Loss Contingency, Claims Remanded To Federal Court, Number 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Schedule of Accounting Standards Update and Change in Accounting Principle Accounting Standards Update and Change in Accounting Principle [Table Text Block] All Individuals All Individuals [Member] PEO PEO [Member] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other expense (income), net Other expense/(income), net Other Nonoperating Income (Expense) Postretirement Benefits Other Postretirement Benefits Plan [Member] Allocation of Expenses [Line Items] Allocation of Expenses [Line Items] Allocation of Expenses [Line Items] Statement of Stockholders' Equity [Abstract] Intangible assets — net Intangible assets — net Intangible Assets, Net (Excluding Goodwill) Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Master Supply Agreements Master Supply Agreements [Member] Master Supply Agreements Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] ALABAMA ALABAMA Remainder of 2024 Long-Term Debt, Maturity, Remainder of Fiscal Year Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Local Phone Number Local Phone Number Deferred tax assets, valuation allowance Deferred Tax Assets, Valuation Allowance Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Deferred income taxes Deferred Income Tax Liabilities, Net Separation and distribution agreement, transition manufacturing contract Separation And Distribution Agreement, Transition Manufacturing Contract, Terms Separation And Distribution Agreement, Transition Manufacturing Contract, Terms Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Changes in assets and liabilities Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Total other comprehensive income (loss), before tax Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Accrued interest Interest Payable, Current Purification and Filtration Purification and Filtration Purification and Filtration Segment [Member] Purification and Filtration Segment Bair Hugger Patient Warming Systems Litigation Bair Hugger Patient Warming Systems Litigation [Member] Bair Hugger Patient Warming Systems Litigation Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] After 2029 Finite-Lived Intangible Asset, Expected Amortization, after Year Five Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Number of cases voluntarily dismissed by plaintiffs Loss Contingency, Bellwether Cases, Voluntarily Dismissed By Plaintiffs Loss Contingency, Bellwether Cases, Voluntarily Dismissed By Plaintiffs Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares) Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares) Stock Issued During Period, Shares, New Issues Line of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company 5.450% Senior Notes Due 2031 5.450% Senior Notes Due 2031 [Member] 5.450% Senior Notes Due 2031 Segment Reporting [Abstract] Cost of software and rentals Sales Of Software And Rentals [Member] Sales Of Software And Rentals Entity Central Index Key Entity Central Index Key 2029 Long-Term Debt, Maturity, Year Five Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Other borrowings Other Borrowings [Member] Other Borrowings Comprehensive Income Information Equity [Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Less: current portion of long-term debt Long-Term Debt, Current Maturities Business Segments Segment Reporting Disclosure [Text Block] Accrued rebates Accrued Rebates, Current Accrued Rebates, Current Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Entity Shell Company Entity Shell Company Measurement Basis [Axis] Measurement Basis [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Legal charges (recoveries) in period Loss Contingency, Loss in Period Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Significant Accounting Policies Significant Accounting Policies [Text Block] 18-Month Senior Term Loan Credit Facility 18-Month Senior Term Loan Credit Facility [Member] 18-Month Senior Term Loan Credit Facility Pension and postretirement benefit expense Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code Current liabilities Liabilities, Current [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] 5.450% Senior Notes Due 2027 5.450% Senior Notes Due 2027 [Member] 5.450% Senior Notes Due 2027 Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Total current assets Assets, Current Statement of Cash Flows [Abstract] Senior Notes Senior Notes [Member] 2027 Long-Term Debt, Maturity, Year Three Number of cases selected for bellwether process Loss Contingency, Claims Selected For Bellwether Process, Number Loss Contingency, Claims Selected For Bellwether Process, Number Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-term debt Long-term debt (excluding current portion) Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Income Taxes Income Tax Disclosure [Text Block] Earnings per share: Earnings Per Share [Abstract] Equity [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) After-tax net unrealized gain (loss) anticipated to be reclassified from AOCI to the income statement within next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Related Party Transaction [Line Items] Related Party Transaction [Line Items] Domestic Plan Domestic Plan [Member] Inventories Increase (Decrease) in Inventories Debt issuance costs Debt Issuance Costs, Gross Schedule of Long -Term Debt and Short-Term Debt Schedule of Debt [Table Text Block] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] 2026 Long-Term Debt, Maturity, Year Two Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Long-term debt, fair value Long-Term Debt, Fair Value Commercial paper Commercial Paper Reported Value Measurement Reported Value Measurement [Member] Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Depreciation and amortization Depreciation, Depletion and Amortization Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Gross profit Gross Profit Cumulative translation adjustment Cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Machinery and equipment Machinery and Equipment [Member] Fair Value as of Grant Date Award Grant Date Fair Value Customer Concentration Risk Customer Concentration Risk [Member] Long-Term Debt and Short-Term Borrowings Debt Disclosure [Text Block] Geographical [Domain] Geographical [Domain] Customer related intangible assets Customer-Related Intangible Assets [Member] 5.400% Senior Notes Due 2029 5.400% Senior Notes Due 2029 [Member] 5.400% Senior Notes Due 2029 Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Issuance of common stock in connection with Spin-Off and reclassification of net parent investment Stock Issued During Period, Value, New Issues Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, par value $0.01 per share, 750,000,000 shares authorized Shares issued and outstanding - June 30, 2024: 172,710,593 Shares issued and outstanding - December 31, 2023: 0 Common Stock, Value, Issued Separation and distribution agreement, transition services Separation And Distribution Agreement, Transition Distribution Services, Terms Separation And Distribution Agreement, Transition Distribution Services Share-Based Payment Arrangement [Abstract] Non-operating expense Net Periodic Benefit Cost (Benefit), Non-Operating Expense [Abstract] Net Periodic Benefit Cost (Benefit), Non-Operating Expense Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Revenue Recognition Lessor, Operating Leases [Text Block] Other Noncurrent Assets Other Noncurrent Assets [Member] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Other Current Liabilities Other Current Liabilities [Member] Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Basic earnings per share (in dollars per share) Earnings Per Share, Basic Accounts payable Increase (Decrease) in Accounts Payable Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Separation and distribution agreement, master supply, terms Separation And Distribution Agreement, Master Supply Agreements, Term Separation And Distribution Agreement, Master Supply Agreements, Term Other Liabilities Disclosure [Abstract] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Amortization expense Amortization Schedule of Goodwill [Table] Goodwill [Table] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Proceeds from long-term debt, net of issuance costs Proceeds from Debt, Net of Issuance Costs Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Number of cases dismissed Loss Contingency, Claims Dismissed, Number Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total assets Assets 3-Year Senior Term Loan Credit Facility 3-Year Senior Term Loan Credit Facility [Member] 3-Year Senior Term Loan Credit Facility 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Cost of sales Cost of product Cost of Goods and Services Sold Long-term line of credit Long-Term Line of Credit Spinoff transaction, percent of shares outstanding distributed Stockholders' Equity Note, Spinoff Transaction, Percent Of Shares Outstanding Distributed Stockholders' Equity Note, Spinoff Transaction, Percent Of Shares Outstanding Distributed 5.600% Senior Notes Due 2034 5.600% Senior Notes Due 2034 [Member] 5.600% Senior Notes Due 2034 Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Other liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Commitments and contingencies (Note 11) Commitments and Contingencies Termination Date Trading Arrangement Termination Date Related Party Transaction [Table] Related Party Transaction [Table] 5.900% Senior Notes Due 2054 5.900% Senior Notes Due 2054 [Member] 5.900% Senior Notes Due 2054 Net Parent Investment Net Parent Investment [Member] Net Parent Investment Total net sales Net sales of product Revenues 2025 Long-Term Debt, Maturity, Year One Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Entity Address, City or Town Entity Address, City or Town Debt Instrument [Axis] Debt Instrument [Axis] Other corporate and unallocated Other Operating Income (Expense), Net Stock-based compensation expenses Stock compensation expense Share-Based Payment Arrangement, Expense Net income Net income Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Multiemployer pension expense Multiemployer Plan, Employer Contribution, Cost Revenue Recognition Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Amounts before reclassifications OCI, before Reclassifications, before Tax, Attributable to Parent Weighted-average number of shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Due to related parties Increase (Decrease) in Due to Related Parties Entity Address, Address Line Two Entity Address, Address Line Two Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Other Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Period End Date Document Period End Date Finished goods Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Arrangements [Line Items] Due from related parties Increase (Decrease) in Due from Related Parties Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount 6.000% Senior Notes Due 2064 6.000% Senior Notes Due 2064 [Member] 6.000% Senior Notes Due 2064 Other Current Assets Other Current Assets [Member] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Dental Solutions Dental Solutions Dental Solutions Segment [Member] Dental Solutions Segment Patents and other technology-based intangible assets Intellectual Property [Member] Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Adjustment to Compensation: Adjustment to Compensation [Axis] Accounts Receivable Accounts Receivable [Member] Foreign Exchange Contract Foreign Exchange Contract [Member] Spinoff Spinoff [Member] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report MISSOURI MISSOURI Litigation Case [Domain] Litigation Case [Domain] Defined benefit pension Defined benefit pension Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Customer [Domain] Customer [Domain] Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Basic (in shares) Weighted average common shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Transition Agreement Services Transition Agreement Services [Member] Transition Agreement Services Transfers from 3M, net of tax Transfers From Parent, Net Of Tax Transfers From Parent, Net Of Tax Research, development and related expenses Research Development And Related Expenses Member [Member] Research Development And Related Expenses Member Term Loan Credit Facilities Term Loan Credit Facilities [Member] Term Loan Credit Facilities Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Health Information Systems Health Information Systems Health Information Systems Segment [Member] Health Information Systems Segment Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Net transfers to 3M Net transfers to 3M Net transfers to 3M on the condensed consolidated and combined changes in equity Net Transfers To Parent Net Transfers To Parent Construction in progress Construction in Progress [Member] Entity Filer Category Entity Filer Category Schedule of Other Current Liabilities Other Current Liabilities [Table Text Block] After Spin-Off After Spin-Off [Member] After Spin-Off Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cash flow hedging instruments Cash flow hedging Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Company Selected Measure Name Company Selected Measure Name EX-101.PRE 10 solv-20240930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover
 9 Months Ended
Sep. 30, 2024
shares
Cover [Abstract]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Sep. 30, 2024
Document Transition Report false
Entity File Number 001-41968
Entity Registrant Name SOLVENTUM CORPORATION
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 92-2008841
Entity Address, Address Line One 3M Center, Building 275-6W
Entity Address, Address Line Two 2510 Conway Avenue East
Entity Address, City or Town Maplewood
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55144
City Area Code 651
Local Phone Number 733-1110
Title of 12(b) Security Common Stock, Par Value $.01 Per Share
Trading Symbol SOLV
Security Exchange Name NYSE
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 172,754,070
Amendment Flag false
Document Fiscal Year Focus 2024
Document Fiscal Period Focus Q3
Entity Central Index Key 0001964738
Current Fiscal Year End Date --12-31
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Total net sales $ 2,082 $ 2,074 $ 6,179 $ 6,161
Gross profit 1,165 1,209 3,474 3,535
Selling, general and administrative expenses 701 525 1,998 1,681
Research and development expenses 189 180 576 568
Total operating expenses 1,807 1,570 5,279 4,875
Operating income 275 504 900 1,286
Interest expense, net 107 0 260 0
Other expense (income), net 1 4 48 10
Income before income taxes 167 500 592 1,276
Provision for income taxes 45 40 144 202
Net income $ 122 $ 460 $ 448 $ 1,074
Earnings per share:        
Basic earnings per share (in dollars per share) $ 0.70 $ 2.66 $ 2.59 $ 6.22
Diluted earnings per share (in dollars per share) $ 0.70 $ 2.66 $ 2.58 $ 6.22
Weighted-average number of shares outstanding:        
Basic (in shares) 173.4 172.7 173.1 172.7
Diluted (in shares) 173.9 172.7 173.4 172.7
Cost of product        
Total net sales $ 1,608 $ 1,593 $ 4,766 $ 4,750
Cost of sales 793 748 2,341 2,262
Cost of software and rentals        
Total net sales 474 481 1,413 1,411
Cost of sales $ 124 $ 117 $ 364 $ 364
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income $ 122 $ 460 $ 448 $ 1,074
Other comprehensive income (loss), net of tax:        
Cumulative translation adjustment 179 (134) 94 (44)
Defined benefit pension 10 0 20 0
Cash flow hedging instruments (11) 0 (10) 0
Total other comprehensive income (loss), net of tax 178 (134) 104 (44)
Comprehensive income $ 300 $ 326 $ 552 $ 1,030
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 772 $ 194
Accounts receivable — net of allowances of $86 and $82 1,105 1,313
Due from related parties 222 0
Inventories    
Finished goods 529 453
Work in process 181 171
Raw materials and supplies 243 233
Total inventories 953 857
Other current assets 302 155
Total current assets 3,354 2,519
Property, plant and equipment — net 1,599 1,457
Goodwill 6,592 6,535
Intangible assets — net 2,651 2,902
Other assets 549 530
Total assets 14,745 13,943
Current liabilities    
Short-term borrowings and current portion of long-term debt 300 0
Accounts payable 560 477
Due to related parties 450 0
Unearned revenue 563 574
Other current liabilities 1,031 677
Total current liabilities 2,904 1,728
Long-term debt 7,809 0
Pension and postretirement benefits 321 166
Deferred income taxes 214 231
Other liabilities 305 152
Total liabilities 11,553 2,277
Commitments and contingencies (Note 11)
Equity    
Common stock, par value $0.01 per share, 750,000,000 shares authorized Shares issued and outstanding - June 30, 2024: 172,710,593 Shares issued and outstanding - December 31, 2023: 0 2 0
Additional paid-in-capital 3,744 0
Retained earnings 211 0
Net parent investment 0 12,003
Accumulated other comprehensive income (loss) (765) (337)
Total equity 3,192 11,666
Total liabilities and equity $ 14,745 $ 13,943
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Balance Sheets (Parentheticals) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowance $ 86 $ 82
Common stock par value (in dollars per share) $ 0.01  
Common stock authorized (in shares) 750,000,000  
Common stock issued (in shares) 172,754,070 0
Common stock outstanding (in shares) 172,754,070 0
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In-Capital
Retained Earnings
Net Parent Investment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 $ 11,742 $ 0 $ 0 $ 0 $ 12,239 $ (497)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,074       1,074  
Other comprehensive income (loss), net of tax:            
Cumulative translation adjustment (44)         (44)
Defined benefit pension 0          
Cash flow hedging 0          
Total other comprehensive income (loss), net of tax (44)         (44)
Net transfers to 3M (1,190)       (1,190)  
Ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 11,582 $ 0 0 0 12,123 (541)
Beginning balance (in shares) at Jun. 30, 2023   0        
Beginning balance at Jun. 30, 2023 11,729 $ 0 0 0 12,136 (407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 460       460  
Other comprehensive income (loss), net of tax:            
Cumulative translation adjustment (134)         (134)
Defined benefit pension 0          
Cash flow hedging 0          
Total other comprehensive income (loss), net of tax (134)         (134)
Net transfers to 3M (473)       (473)  
Ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 11,582 $ 0 0 0 12,123 (541)
Beginning balance (in shares) at Dec. 31, 2023   0        
Beginning balance at Dec. 31, 2023 11,666 $ 0 0 0 12,003 (337)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 448     211 237  
Other comprehensive income (loss), net of tax:            
Cumulative translation adjustment 94         94
Defined benefit pension 20         20
Cash flow hedging (10)         (10)
Total other comprehensive income (loss), net of tax 104         104
Net transfers to 3M (9,107)       (8,575) (532)
Stock-based compensation 83   83   0  
Common stock for tax withholding obligations (2)   (2)      
Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares)   173,000,000        
Issuance of common stock in connection with Spin-Off and reclassification of net parent investment 0 $ 2 3,663   (3,665)  
Ending balance (in shares) at Sep. 30, 2024   173,000,000        
Ending balance at Sep. 30, 2024 3,192 $ 2 3,744 211 0 (765)
Beginning balance (in shares) at Jun. 30, 2024   173,000,000        
Beginning balance at Jun. 30, 2024 2,867 $ 2 3,719 89 0 (943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 122     122 0  
Other comprehensive income (loss), net of tax:            
Cumulative translation adjustment 179         179
Defined benefit pension 10         10
Cash flow hedging (11)         (11)
Total other comprehensive income (loss), net of tax 178         178
Net transfers to 3M 0       0  
Stock-based compensation 27   27      
Common stock for tax withholding obligations (2)   (2)      
Ending balance (in shares) at Sep. 30, 2024   173,000,000        
Ending balance at Sep. 30, 2024 $ 3,192 $ 2 $ 3,744 $ 211 $ 0 $ (765)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated and Combined Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities    
Net income $ 448 $ 1,074
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 405 422
Pension and postretirement benefit expense 30 31
Stock-based compensation expense 87 32
Gain on business divestitures 0 (56)
Deferred income taxes (93) (99)
Changes in assets and liabilities    
Accounts receivable 14 (24)
Due from related parties 200 0
Inventories (99) (7)
Accounts payable 200 48
Due to related parties (393) 0
All other operating activities 167 (53)
Net cash provided by operating activities 966 1,368
Cash Flows from Investing Activities    
Purchases of property, plant and equipment (253) (202)
Proceeds from sale of business 0 60
Net cash used in investing activities (253) (142)
Cash Flows from Financing Activities    
Repayment of debt (200) 0
Net transfers to 3M (8,247) (1,248)
Proceeds from long-term debt, net of issuance costs 8,303 0
Other — net 8 2
Net cash used in financing activities (136) (1,246)
Effect of exchange rate changes on cash and cash equivalents 1 1
Net increase (decrease) in cash and cash equivalents 578 (19)
Cash and cash equivalents at beginning of year 194 61
Cash and cash equivalents at end of period $ 772 $ 42
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Accounting Policies
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
Organization and Description of Business
Solventum Corporation (“Solventum” or the “Company”) was a carve-out business of 3M Company (“3M”). On April 1, 2024 (the “Distribution Date”), 3M completed the previously announced spin-off of Solventum Corporation (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1% of the Company’s outstanding common stock to holders of record of 3M’s common stock as of the close of business on March 18, 2024 (the “Distribution”), which resulted in the issuance of 172,709,505 shares of common stock. As a result of the Distribution, the Company became an independent public company. Solventum’s common stock is listed under the symbol “SOLV” on the New York Stock Exchange (“NYSE”).
Solventum is a leading global healthcare company with a broad portfolio of trusted solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. Solventum is organized into four operating business segments that are aligned with the end markets that we serve: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Basis of Presentation
The unaudited condensed consolidated and combined financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and present the historical results of operations, and comprehensive income for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, and the financial position as of September 30, 2024 and December 31, 2023. The interim condensed consolidated and combined financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of the Company’s consolidated and combined financial position, results of operations and cash flows for the periods presented. These adjustments consist of normal, recurring items. The results of operations for any interim periods are not necessarily indicative of results for the full year.
Effective April 1, 2024, the Company’s financial statements are presented on a consolidated basis, as the Spin-Off was completed on such date. The unaudited financial statements for all periods following the Spin-Off are referred to as the “Condensed Consolidated Financial Statements.” Prior to April 1, 2024, Solventum was a carve-out business of 3M. The Company's financial statements prior to April 1, 2024 were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of 3M, including the historical cost basis of assets and liabilities comprising the Company, as well as the historical revenues, direct costs, and allocations of indirect costs attributable to the operations of the Company, using the historical accounting policies applied by 3M. The historical financial statements of the Company prior to April 1, 2024, are referred to as the “Condensed Combined Financial Statements”.
All intercompany transactions and balances within Solventum have been eliminated. These unaudited condensed consolidated and combined financial statements include certain transactions with 3M, which are disclosed as related party transactions in Note 14 “Related Parties”.
The unaudited condensed consolidated and combined financial statements and related footnotes as of and for the three and nine months ended September 30, 2024 should be read in conjunction with the audited combined financial statements as of and for the year ended December 31, 2023 contained in Exhibit 99.1 to Amendment No. 2 to the Company’s Registration Statement on Form 10 as filed with the SEC on March 11, 2024, which became effective on March 13, 2024 (the “Information Statement”).
New Accounting Pronouncements
The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.
StandardRelevant DescriptionEffective Date for SolventumImpact of Adoption
ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.Year-end December 31, 2024
The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.
ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.Year-end December 31, 2025The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Recognition
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Contract Balances
Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $110 million and $500 million of the December 31, 2023 balance were recognized as revenue during the three and nine months ended September 30, 2024, respectively, while approximately $115 million and $475 million of the December 31, 2022 balance were recognized as revenue during the three and nine months ended September 30, 2023, respectively.
Operating Lease Revenue
Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $148 million and $442 million for the three and nine months ended September 30, 2024, and $160 million and $458 million for the three and nine months ended September 30, 2023, respectively.
Customer Concentration
No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2024 or 2023. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2024 and one customer accounted for approximately 10% of accounts receivable at December 31, 2023.
Revenue Recognition Revenue Recognition
Contract Balances
Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $110 million and $500 million of the December 31, 2023 balance were recognized as revenue during the three and nine months ended September 30, 2024, respectively, while approximately $115 million and $475 million of the December 31, 2022 balance were recognized as revenue during the three and nine months ended September 30, 2023, respectively.
Operating Lease Revenue
Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $148 million and $442 million for the three and nine months ended September 30, 2024, and $160 million and $458 million for the three and nine months ended September 30, 2023, respectively.
Customer Concentration
No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2024 or 2023. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2024 and one customer accounted for approximately 10% of accounts receivable at December 31, 2023.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
There was no goodwill recorded from acquisitions during the nine months ended September 30, 2024.
The goodwill balance by business segment follows:
(Millions)MedSurgDental SolutionsHealth Information SystemsPurification and FiltrationTotal
Balance as of December 31, 2023$3,685$458$873$1,519$6,535
Translation impact4631757
Balance as of September 30, 2024$3,731$461$874$1,526$6,592
Acquired Intangible Assets: The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:
September 30,December 31,
(Millions)20242023
Customer related intangible assets
$2,748 $2,734 
Patents and other technology-based intangible assets
1,901 1,897 
Tradenames and other amortizable intangible assets
732 705 
Total gross carrying amount5,381 5,336 
Accumulated amortization — customer related(1,188)(1,081)
Accumulated amortization — patents and other technology-based(1,185)(1,055)
Accumulated amortization — tradenames and other(357)(323)
Total accumulated amortization (2,730)(2,459)
Total finite-lived intangible assets — net 2,651 2,877 
Indefinite lived intangible assets— 25 
Total intangible assets — net$2,651 $2,902 
In June 2024, the Company made the decision to start phasing out the use of a tradename within its Dental Solutions business. This tradename, which was categorized as indefinite-lived as of December 31, 2023, has been reclassified to finite-lived and is being amortized over the expected phase-out period.
Amortization expense was as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Amortization expense $88 $92 $261 $276 
Expected amortization expense for acquired amortizable intangible assets recorded as of September 30, 2024 is as follows:
(Millions)Remainder of 202420252026202720282029After 2029
Amortization expense$88 $326 $321 $316 $312 $274 $1,014 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Other Current Liabilities
 9 Months Ended
Sep. 30, 2024
Other Liabilities Disclosure [Abstract]  
Other Current Liabilities Other Current Liabilities
Other current liabilities included in the condensed consolidated and combined balance sheets consist of the following:
September 30,December 31,
(Millions)20242023
Other current liabilities
Accrued compensation$251 $209 
Accrued taxes
202 106 
Accrued rebates
166 206 
Accrued interest91 — 
Other321 156 
Total other current liabilities$1,031 $677 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Property, Plant, and Equipment - Net
 9 Months Ended
Sep. 30, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant, and Equipment - Net Property, Plant, and Equipment - Net
Property, plant and equipment, net consisted of the following:
September 30,December 31,
(Millions)20242023
Property, plant and equipment - at cost
Buildings and leasehold improvements
$952 $937 
Machinery and equipment
2,180 2,081 
Construction in progress465 320 
Gross property, plant and equipment3,597 3,338 
Accumulated depreciation(1,998)(1,881)
Property, plant and equipment - net$1,599 $1,457 
Depreciation expense consisted of the following:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Depreciation expense$37 $45 $121 $124 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Comprehensive Income Information
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Comprehensive Income Information Comprehensive Income Information
Changes in Accumulated Other Comprehensive Income (Loss) by Component
The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”), including the reclassifications out of AOCI by component:
Three months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2024, net of tax:$(432)$(512)$1 $(943)
Other comprehensive income (loss), before tax:
Amounts before reclassifications179 — (15)164 
Amounts reclassified out— 13 — 13 
Total other comprehensive income (loss), before tax179 13 (15)177 
Tax effect— (3)4 1 
Total other comprehensive income (loss), net of tax179 10 (11)178 
Transfers from 3M, net of tax— — — — 
Balance at September 30, 2024, net of tax:
$(253)$(502)$(10)$(765)
Three months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023, net of tax:$(414)$7 $(407)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(134)— (134)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(134)— (134)
Tax effect— — — 
Total other comprehensive income (loss), net of tax(134)— (134)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
Nine months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023, net of tax:$(347)$10 $— $(337)
Other comprehensive income (loss), before tax:
Amounts before reclassifications56 — (13)43 
Amounts reclassified out38 26 — 64 
Total other comprehensive income (loss), before tax94 26 (13)107 
Tax effect— (6)3 (3)
Total other comprehensive income (loss), net of tax94 20 (10)104 
Transfers from 3M, net of tax— (532)— (532)
Balance at September 30, 2024, net of tax:$(253)$(502)$(10)$(765)
Nine months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022, net of tax:$(504)$7 $(497)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(44)— (44)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(44)— (44)
Tax effect—— — 
Total other comprehensive income (loss), net of tax(44)— (44)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
Additional details on the amounts reclassified from accumulated other comprehensive income (loss) into consolidated income include:
•Cumulative translation adjustment: amounts were reclassified into other expense (income), net and were related to charges associated with the substantial liquidation of foreign operations completed as part of our separation from 3M.
•Defined benefit pension plans adjustment: amounts were reclassified into other expense (income), net (see Note 9).
•The tax effects, if applicable, associated with these reclassifications were reflected in provision for income taxes.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes
 9 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company’s income tax provision through March 31, 2024 was prepared on a separate return basis. The income tax provision post Spin-Off is prepared based on a stand-alone basis.

The effective tax rates for the three months ended September 30, 2024 and 2023 were 26.9% and 8.0%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions.

The effective tax rates for the nine months ended September 30, 2024 and 2023 were 24.3% and 15.8%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions.

In 2021, the Organisation for Economic Co-operation and Development (“OECD”) announced Pillar Two Model Rules which call for the taxation of large multinational corporations at a global minimum tax rate of 15%. Many non-U.S. tax jurisdictions, including Ireland, have either recently enacted legislation to adopt certain components of the Pillar Two Model Rules beginning in fiscal year 2024 or announced their plans to enact legislation in future years. The Company’s income tax provision for the nine months ended September 30, 2024, reflects currently enacted legislation and guidance related to the OECD model rules.

The Company’s income tax provision or benefit for the interim periods is determined based on an estimated annual effective tax rate, adjusted for discrete items. Because significant foreign earnings are generated by the Company’s subsidiaries organized in jurisdictions with lower statutory tax rates, the Company’s estimated annual effective tax rate may be materially impacted if earnings in these lower-tax jurisdictions fluctuate.

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized based on evaluation of all available positive and negative evidence. On the basis of this evaluation, the Company continues to maintain a valuation allowance to reduce its deferred tax assets to the amount realizable. As of September 30, 2024 and December 31, 2023, valuation allowances were $22 million and $56 million, respectively. The decrease is primarily due to separation-related adjustments in connection with the Spin-Off on April 1, 2024, which is reflected in the condensed consolidated and combined statements of changes in equity.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Long-Term Debt and Short-Term Borrowings
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Long-Term Debt and Short-Term Borrowings Long-Term Debt and Short-Term Borrowings
Carrying value includes the impact of debt issuance costs. Long-term debt and short-term borrowings as of September 30, 2024 consisted of the following:
(Millions)Currency/ Fixed vs. FloatingFinal Maturity DateCarrying Value
DescriptionSeptember 30, 2024
Eighteen month senior term loan credit facility
USD Floating2025$300 
Three year senior term loan credit facility
USD Floating2027979 
$1 billion 5.45 percent three year senior notes
USD Fixed2027994 
$1.5 billion 5.40 percent five year senior notes
USD Fixed20291,487 
$1 billion 5.45 percent seven year senior notes
USD Fixed2031990 
$1.65 billion 5.60 percent ten year senior notes
USD Fixed20341,636 
$1.25 billion 5.90 percent thirty year senior notes
USD Fixed20541,231 
$500 million 6.00 percent forty year senior notes
USD Fixed2064492 
Other borrowings— 
Total long-term debt8,109 
Less: current portion of long-term debt300 
Long-term debt (excluding current portion)$7,809 
Senior Notes
On February 27, 2024, the Company issued six series of senior notes with a combined aggregate principal amount of $6.9 billion: $1 billion aggregate principal amount of 5.45% senior notes due 2027, $1.5 billion aggregate principal amount of 5.40% senior notes due 2029, $1 billion aggregate principal amount of 5.45% senior notes due 2031, $1.65 billion aggregate principal amount of 5.60% senior notes due 2034, $1.25 aggregate principal amount of 5.90% senior notes due 2054, and $0.5 billion aggregate principal amount of 6.00% senior notes due 2064 (collectively, the “Senior Notes”). Interest payments on the Senior Notes are due semi-annually until maturity, with the first payment due in August 2024. The Company recorded $62 million of debt issuance costs related to the Senior Notes. Debt issuance costs are presented as a reduction of debt in the condensed consolidated and combined balance sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method.
In connection with the issuance of the senior notes, the Company entered into a registration rights agreement with the initial purchasers, pursuant to which the Company is obligated to use commercially reasonable efforts to file with the SEC and cause to become effective a registration statement with respect to an offer to exchange each series of Senior Notes for registered notes with terms that are substantially identical in all material respects to the notes of such series.
The Senior Notes were offered as part of the financing for the Spin-Off. In connection with the consummation of the Spin-Off, Solventum made direct and indirect cash payments to 3M as partial consideration for 3M’s transfer of its health care business to Solventum. All of the net proceeds from the offering of the notes were paid to 3M, other than amounts retained in order to achieve the $600 million retained cash target.
The Senior Notes are governed by an indenture and supplemental indenture between the Company and a trustee (collectively, the “Indenture”). The Indenture contains certain customary affirmative and negative covenants, including restrictions on the Company’s ability to consolidate, merge, convey, transfer or lease substantially all of its assets. In addition, the Indenture contains other customary terms, including certain events of default, upon the occurrence of which, the Senior Notes may be declared immediately due and payable.
Credit Facilities
On February 16, 2024, the Company entered into credit agreements providing for:
•a five year senior unsecured revolving credit facility in an aggregate committed amount of $2.0 billion expiring in 2029 (the “5-year Revolving Credit Facility”); and
•an eighteen month senior unsecured term loan credit facility in an aggregate principal amount of $500 million and a three year senior unsecured term credit loan facility in an aggregate principal amount of $1.0 billion (together, the “Term Loan Credit Facilities”, and together with the 5-Year Revolving Credit Facility, the “Credit Facilities”).
The Company intends to use the Credit Facilities for general corporate purposes. At September 30, 2024, there are no amounts outstanding under the 5-year Revolving Credit Facility. On March 7, 2024, the Company drew on the Term Loan Credit Facilities in the amount of $1.48 billion. These Term Loan Credit Facilities have a floating interest rate based on a Secured Overnight Financing Rate (“SOFR”) index.
In August 2024, the Company repaid $200 million of the aggregate principal amount outstanding under the eighteen month senior unsecured term loan credit facility.
Commercial Paper
On March 4, 2024, the Company entered into a commercial paper program that allows it to issue up to $2.0 billion aggregate principal amount of short-term notes to finance short-term liabilities. Any such issuance will mature within 364 days from date of issue. There was no commercial paper outstanding as of September 30, 2024.
Future Maturities of Long-term Debt: Maturities of long-term debt in the table below reflect the impact of repayment such that total maturities equal the contractual value of long-term debt net of amounts repaid as of September 30, 2024. The maturities of long-term debt for the periods subsequent to September 30, 2024 are as follows (in millions):
Remainder of
2024		20252026202720282029After 2029Total
$—$300$—$1,980$—$1,500$4,400$8,180
Financial Instruments Not Measured at Fair Value
The fair values of cash equivalents, accounts receivable, and accounts payable approximated carrying values because of the short-term nature of these instruments. At September 30, 2024, the estimated fair value of the Company’s long-term debt obligations, comprised of both Senior Notes and Term Loan Credit Facilities with current portions excluded, was $8.1 billion compared to a carrying value of $7.8 billion. The Company did not have any outstanding debt obligations at December 31, 2023. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts. Because there is no active market for trading outstanding term loans, the fair values of the Term Loan Credit Facilities are estimated to be equal to their respective carrying values.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Pension and Postretirement Benefit Plans
 9 Months Ended
Sep. 30, 2024
Retirement Benefits [Abstract]  
Pension and Postretirement Benefit Plans Pension and Postretirement Benefit Plans
Transfer of Solventum Sponsored Pension and Postretirement Benefit Plans
Historically, certain employees of Solventum participated in U.S. and non-U.S. retirement plans sponsored by 3M. The primary U.S. defined-benefit pension plan was closed to new participants effective January 1, 2009. In December 2023, 3M committed to the future freeze of U.S. defined benefit pension benefits for non-union U.S. employees, effective December 31, 2028. During March 2024, in advance of the Spin-Off, all U.S. and most remaining 3M sponsored non-U.S. pension and postretirement plan obligations and assets were legally transferred to Solventum from 3M, except for certain assets held back within the 3M sponsored pension plans for regulatory purposes. Assets not yet delivered from 3M sponsored pension plans are already recognized within the Company's pension assets. These plans included the U.S. defined benefit pension plans as well as postretirement health care and life insurance benefits for U.S. employees who reach a retirement age while employed by the Company and were employed prior to January 1, 2016. Additionally, seven international plans covering employees in four countries were transferred to Solventum from 3M in March 2024.
As these plans are sponsored by Solventum, they are accounted for as single employer plans. Therefore, the funded status is reflected in the condensed consolidated and combined balance sheets, and the net periodic benefit costs are included in the condensed consolidated and combined statements of income.
The Company has made deposits for its defined benefit plans with independent trustees. In certain non-U.S. jurisdictions, trust funds and deposits with insurance companies are maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan assets in the non-qualified plan due to its nature. For the U.S. postretirement health care benefit plan, the Company has set aside amounts at least equal to annual benefit payments with an independent trustee.
Components of net periodic cost and other amounts recognized in other comprehensive (income) loss
The service cost component of defined benefit net periodic benefit cost is recorded in costs of product; costs of software and rentals; selling, general and administrative; and research and development. Components of net periodic benefit cost and other supplemental information for the three and nine months ended September 30, 2024 and 2023 follow:
Three months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$7 $— $5 $— $1 $— 
Non-operating expense
Interest cost23 — 5 — 3 — 
Expected return on plan assets(34)— (5)— (2)— 
Amortization of prior service benefit(1)— — — (1)— 
Amortization of net actuarial loss14 — — — 1 — 
Total non-operating expense (benefit)2 — — — 1 — 
Total net periodic benefit cost (benefit)$9 $— $5 $— $2 $— 
Nine months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$14 $— $14 $— $2 $— 
Non-operating expense
Interest cost46 — 15 — 6 — 
Expected return on plan assets(68)— (15)— (4)— 
Amortization of prior service benefit(2)— — — (2)— 
Amortization of net actuarial loss28 — — — 2 — 
Total non-operating expense (benefit)4 — — — 2 — 
Total net periodic benefit cost (benefit)$18 $— $14 $— $4 $— 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives
 9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives Derivatives
Prior to April 1, 2024, Solventum indirectly participated in 3M’s centrally managed hedging program, which utilizes a number of tools to manage currency risk including natural hedges such as pricing, productivity, hard currency, hard currency-indexed billings, and localizing source of supply. 3M also used financial hedges to mitigate currency risk. After Spin-Off, the Company established its own hedging program.
Cash Flow Hedges - For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized in current earnings.
Cash Flow Hedging - Foreign Currency Forward Contracts: The Company enters into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as cash flow hedges. The settlement or extension of these derivatives will result in reclassifications (from accumulated other comprehensive income) to earnings in the period during which the hedged transactions affect earnings. Solventum may de-designate these cash flow hedge relationships in advance of the occurrence of the forecasted transaction. The portion of gains or losses on the derivative instrument previously included in accumulated other comprehensive income for de-designated hedges remains in accumulated other comprehensive income until the forecasted transaction occurs or becomes probable of not occurring. Changes in the value of derivative instruments after de-designation are recorded in earnings. The maximum length of time over which Solventum hedges its exposure to the variability in future cash flows of the forecasted transactions is 36 months.
As of September 30, 2024, the Company had a balance of $10 million associated with the after-tax net unrealized loss associated with cash flow hedging instruments recorded in accumulated other comprehensive income. Of the total after-tax net unrealized balance as of September 30, 2024, Solventum expects to reclassify to earnings approximately $7 million after-tax net unrealized loss over the next 12 months based on exchange rates as of September 30, 2024.
The amount of pretax gain (loss) recognized in other comprehensive income (loss) related to derivative instruments designated as cash flow hedges is provided in the following table.
Pretax Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Foreign currency forward contracts $(15)$— $(13)$— 
Derivatives Not Designated as Hedging Instruments - Derivatives not designated as hedging instruments include foreign currency contracts to offset, in part, the impacts of changes in value of various non-functional currency denominated items including certain intercompany financing balances. These derivative instruments are not designated in a hedging relationship; therefore, fair value gains and losses on these contracts are recorded in earnings. The Company does not hold or issue derivative financial instruments for trading purposes.
Statement of Income Location and Impact of Cash Flow Derivative Instruments
There was an immaterial impact to income related to both derivative instruments designated in cash flow hedging relationships and those not designated as hedging instruments in the three and nine months ended September 30, 2024.
Location, Fair Value, and Gross Notional Amounts of Derivative Instruments
The following tables summarize the fair value of Solventum’s derivative instruments and their location in the condensed consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates.
Gross Notional AmountAssetsLiabilities
 (Millions)LocationFair Value AmountLocationFair Value Amount
September 30,December 31,September 30,December 31,September 30,December 31,
202420232024202320242023
Derivatives designated as hedging instruments
Foreign currency forward contracts$297 $— Other current assets$— $— Other current liabilities$9 $— 
Foreign currency forward contracts92 — Other assets— — Other liabilities2 — 
Total derivatives designated as hedging instruments $389 $— $— $— $11 $— 
Derivatives not designated as hedging instruments
Foreign currency forward contracts$18 $— Other current assets$— $— Other current liabilities$1 $— 
Total derivatives not designated as hedging instruments
$18 $— $— $— $1 $— 
Total derivative instruments
$407 $— $— $— $12 $— 
The Company’s derivative assets and liabilities within the scope of ASC 815, Derivatives and Hedging, are required to be recorded at fair value. The Company’s derivatives that are recorded at fair value include foreign currency forward contracts. Solventum has determined that foreign currency forward contracts will be considered level 2 fair value measurements. Solventum determines fair value using observable inputs including foreign currency exchange rates.
Credit Risk and Offsetting of Assets and Liabilities of Derivative Instruments: The Company is exposed to credit loss in the event of nonperformance by counterparties in forward contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as counterparties. Solventum enters into master netting arrangements with counterparties, which may allow each counterparty to net settle amounts owed between a Solventum entity and the counterparty as a result of multiple, separate derivative transactions. The Company does not anticipate nonperformance by any of these counterparties.
Solventum has elected to present the fair value of derivative assets and liabilities within the Company’s condensed consolidated balance sheet on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. Solventum determined that the impact of the amount of eligible offsetting derivative assets and liabilities was not material if it had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties. For each counterparty, if netted, the Company would offset the asset and liability balances of all derivatives at the end of the reporting period based on the Solventum entity that is a party to the transactions. Derivatives not subject to master netting agreements are not eligible for net presentation. For the periods presented, Solventum has not received cash collateral from derivative counterparties.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Commitment and Contingencies
 9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Proceedings
Solventum is involved in numerous claims and lawsuits, principally in the United States, and regulatory proceedings worldwide. These claims, lawsuits and proceedings relate to matters including, but not limited to, product liability (involving products that the Company now or formerly manufactured and sold, including products made by the Health Care Business Group at 3M), intellectual property, commercial, antitrust, federal healthcare program related laws and regulations, such as the False Claims Act and anti-kickback laws in the United States and other jurisdictions. Unless otherwise stated, Solventum is vigorously defending all such litigation and proceedings. From time to time, Solventum also receives subpoenas, investigative demands or requests for information from various government agencies in the United States and foreign countries. Solventum generally responds in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such requests can also lead to the assertion of claims or the commencement of administrative, civil, or criminal legal proceedings against Solventum and others, as well as to settlements. The outcomes of legal proceedings and regulatory matters are often difficult to predict. Any determination that the Company’s operations or activities are not, or were not, in compliance with applicable laws or regulations could result in the imposition of fines, civil or criminal penalties, and equitable remedies, including disgorgement, suspension or debarment or injunctive relief.
Process for Disclosure and Recording of Liabilities Related to Legal Proceedings
Many lawsuits and claims involve highly complex issues relating to causation, scientific evidence, and alleged actual damages, all of which are otherwise subject to substantial uncertainties. Assessments of lawsuits and claims can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The categories of legal proceedings in which the Company is involved may include multiple lawsuits and claims, may be spread across multiple jurisdictions and courts that may handle the lawsuits and claims differently, may involve numerous and different types of plaintiffs, raising claims and legal theories based on specific allegations that may not apply to other matters, and may seek substantial compensatory and, in some cases, punitive, damages. These and other factors contribute to the complexity of these lawsuits and claims and make it difficult for the Company to predict outcomes and make reasonable estimates of any resulting losses. The Company's ability to predict outcomes and make reasonable estimates of potential losses is further influenced by the fact that a resolution of one or more matters within a category of legal proceedings may impact the resolution of other matters in that category in terms of timing, amount of liability, or both.
When making determinations about recording liabilities related to legal proceedings, the Company complies with the requirements of ASC 450, Contingencies, and related guidance, and records liabilities in those instances where it can reasonably estimate the amount of the loss and when the loss is probable. Where the reasonable estimate of the probable loss is a range, the Company records as an accrual in its financial statements the most likely estimate of the loss, or the low end of the range if there is no one best estimate. The Company either discloses the amount of a possible loss or range of loss in excess of established accruals if estimable, or states that such an estimate cannot be made. The Company discloses significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a loss may be incurred. Based on experience and developments, the Company reexamines its estimates of probable liabilities and associated expenses and receivables each period, and whether a loss previously determined to not be reasonably estimable and/or not probable is now able to be reasonably estimated or has become probable. Where appropriate, the Company makes additions to or adjustments of its reasonably estimated losses and/or accruals. As a result, the current accruals and/or estimates of loss and the estimates of the potential impact on the Company’s consolidated financial position, results of operations and cash flows for the legal proceedings and claims pending against the Company will likely change over time. During the third quarter of 2024 and 2023, the Company recognized $3 million and no legal charges, respectively. During the first nine months of 2024 and 2023, the Company recognized $8 million and $1 million in legal charges, respectively. During the third quarter of 2024, the Company made a payment of $6 million related to a legal settlement, which reduced the accrued litigation balance. At September 30, 2024 and December 31, 2023, accrued litigation charges were $25 million and $23 million, respectively.
Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, the Company may ultimately incur charges substantially in excess of presently recorded liabilities, including with respect to matters for which no accruals are currently recorded because losses are not currently probable and reasonably estimable. Many of the matters described herein are at varying stages, seek an indeterminate amount of damages or seek damages in amounts that the Company believes are not indicative of the ultimate losses that may be incurred. It is not uncommon for claims to be resolved over many years. As a matter progresses, the Company may receive information, through plaintiff demands, through discovery, in the form of reports of purported experts, or in the context of settlement or mediation discussions that purport to quantify an amount of alleged damages, but with which the Company may not agree. Such information may or may not lead the Company to determine that it is able to make a reasonable estimate as to a probable loss or range of loss in connection with a matter. However, even when a loss or range of loss is not probable and reasonably estimable, developments in, or the ultimate resolution of, a matter could be material to the Company and could have a material adverse effect on the Company, its consolidated financial position, results of operations and cash flows. In addition, future adverse rulings or developments, or settlements in, one or more matters could result in future changes to determinations of probable and reasonably estimable losses in other matters.
Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings
The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal proceedings for which the Company has recorded an accrued liability in its financial statements, the Company also records receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those insured matters for which the Company has not recorded an accrued liability because the liability is not probable or the amount of the liability is not estimable, or both, but for which the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it concludes as recognizable for the expense incurred.
Product Liability Litigation
The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the liabilities, if any, the Company has accrued relating to its significant legal proceedings.
3M is a named defendant in over 7,500 lawsuits in the United States and one Canadian putative class action with a single named plaintiff, alleging that they underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections due to the use of the Bair Hugger patient warming system. Under the terms of the Separation and Distribution Agreement, dated as of March 31, 2024, by and between Solventum and 3M (the “Separation and Distribution Agreement”), Solventum has agreed to indemnify 3M for uninsured liabilities related to the Bair Hugger patient warming system, to manage the litigation, and pay for legal expenses.
The plaintiffs seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and/or negligent misrepresentation/concealment, unjust enrichment, and violations of various state consumer fraud, deceptive or unlawful trade practices and/or false advertising acts.
The U.S. Judicial Panel on Multidistrict Litigation (“JPML”) consolidated all cases pending in federal courts to the U.S. District Court for the District of Minnesota to be managed in a multi-district litigation (“MDL”) proceeding. In July 2019, the court excluded several of the plaintiffs’ causation experts, and granted summary judgment for 3M in all cases pending at that time in the MDL. Plaintiffs appealed that decision to the U.S. Court of Appeals for the Eighth Circuit. Plaintiffs also appealed a 2018 jury verdict in favor of 3M in the first bellwether trial in the MDL and appealed the dismissal of another bellwether case. In August 2021, a panel of the appellate court reversed the district court’s exclusion of the plaintiffs’ causation experts and the grant of summary judgment for 3M. 3M sought further appellate en banc review by the full Eighth Circuit court. In November 2021, the Eighth Circuit court denied 3M’s petition for rehearing en banc. In May 2022, the U.S. Supreme Court declined 3M's February 2022 request to review the Eighth Circuit court's decision. Separately, in August 2021, the Eighth Circuit court affirmed the 2018 jury verdict in 3M’s favor in the only bellwether trial in the MDL.
In February 2022, the MDL court ordered the parties to engage in any mediation sessions that a court-appointed mediator deems appropriate. Mediation sessions took place in May and August 2022 without success in resolving the litigation. In 2023, the MDL assigned a new mediator to facilitate discussions of the litigation and possible resolution. The MDL court denied plaintiffs’ April 2023 motion to disqualify the judge and magistrate judge overseeing the MDL. The parties, working with the new mediator, agreed on a bellwether process, selecting 34 cases. The MDL court transferred the non-Minnesota bellwether cases during April 2024. Bellwether cases are set for trial beginning in April 2025. Fifteen of the bellwether cases have now been voluntarily dismissed by plaintiffs.
In addition to the federal MDL cases, there are eight state court cases relating to the Bair Hugger patient warming systems. Two are pending in Missouri state court and combine Bair Hugger product liability claims with medical malpractice claims. One of the Missouri cases was tried in 2022; the jury returned a verdict in 3M’s favor on all the claims. The trial court denied plaintiff’s motion for a new trial, and the verdict was affirmed on appeal in June 2024. The plaintiff has filed a request for further review by the Missouri Supreme Court. The other Missouri case is scheduled for trial in September 2025. There is one case in Etowah County, Alabama that combines Bair Hugger product liability claims with medical malpractice claims that has been settled in principle. A Texas case that 3M removed to federal court was remanded to state court in January 2024, a Pennsylvania case was remanded to state court in April 2024 with a trial date in April 2026, and two Montana cases were remanded to state court in June 2024. Finally, a putative class action has been filed in Ramsey County, Minnesota, seeking economic damages for the use of the Bair Hugger system in knee and hip replacement surgeries involving medically obese people in Minnesota from May 2017 to the present. Discovery is underway and the case is scheduled to be ready for trial in the fourth quarter of 2025.
3M had been named a defendant in 61 cases in Minnesota state court. In January 2018, the Minnesota state court excluded plaintiffs’ experts and granted 3M’s motion for summary judgment on general causation. The Minnesota Court of Appeals affirmed the state court orders in their entirety and the Minnesota Supreme Court denied plaintiffs’ petition for review and entered the final dismissal in 2019, effectively ending the Minnesota state court cases.
In June 2016, 3M was served with a putative class action filed in the Ontario Superior Court of Justice for all Canadian residents who underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections that the representative plaintiff claims were due to the use of the Bair Hugger patient warming system. The representative plaintiff seeks relief (including punitive damages) under Canadian law based on theories similar to those asserted in the MDL.
For product liability litigation matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “Process for Disclosure and Recording of Liabilities Related to Legal Proceedings” section and are not material to the Company’s results of operations or financial condition. In addition, the Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.
Federal False Claims Act/Qui Tam Litigation
In October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries, including Kinetic Concepts, Inc. and KCI USA, Inc. As previously disclosed in the SEC filings by the KCI entities, in 2009, Kinetic Concepts, Inc. received a subpoena from the U.S. Department of Health and Human Services Office of Inspector General. In 2011, following the completion of the government’s review and its decision declining to intervene in two qui tam actions described further below, the qui tam relator-plaintiffs’ pleadings were unsealed.
The government inquiry followed two qui tam actions filed in 2008 by two former employees against Kinetic Concepts, Inc. and KCI USA, Inc. (collectively, the “KCI Defendants”) under seal in the U.S. District Court for the Central District of California. One qui tam action (the Godecke case) was dismissed in January 2022. In the remaining action (the Hartpence case), the complaint contains allegations that the KCI Defendants violated the federal False Claims Act by submitting false or fraudulent claims to federal healthcare programs by billing for 3M V.A.C. Therapy in a manner that was not consistent with the Local Coverage Determinations issued by the Durable Medical Equipment Medicare Administrative Contractors and seeks monetary damages.
In June 2019, the district court entered summary judgment in the KCI Defendants’ favor on all of the relator-plaintiff’s claims. The relator-plaintiff then filed an appeal in the U.S. Court of Appeals for the Ninth Circuit. Oral argument in the Hartpence case was held in July 2020. The appellate court issued an opinion in August 2022 reversing the decision of the district court and remanding the case for further proceedings. The district court held a status conference in January 2023 during which no case deadlines were set; the litigation remains in a pre-trial stage. The KCI Defendants filed a renewed motion for summary judgment in March 2023. In July 2023, the parties filed a joint status report notifying the court of the parties’ agreement to mediate the matter in November 2023.
As a result of a mediation held in November 2023, the relator-plaintiff and KCI reached an agreement in principle to settle the case and resolve all the remaining claims in this action, including the dismissal of the relator-plaintiff’s complaint with prejudice, subject to the agreement of the government and the parties’ negotiation and agreement of all remaining terms of the settlement. The KCI Defendants and relator-plaintiff have jointly requested that the court continue to hold in abeyance any hearing on the KCI Defendants’ pending Renewed Motion for Summary Judgment and any further proceedings in this case, to allow the parties to confer with counsel for the government and negotiate the remaining terms of the settlement agreement. The KCI Defendants and the relator-plaintiff submitted an updated status report to the court during January 2024 and further status reports in July and September 2024. Under the terms of the Separation and Distribution Agreement, Solventum has agreed to indemnify 3M for liabilities related to this matter, to manage the litigation, and pay for related legal expenses.
For the matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “Process for Disclosure and Recording of Liabilities Related to Legal Proceedings” section and are not material to the Company’s consolidated results of operations or financial condition. The Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.
Warranties/Guarantees
The Company has not issued any material financial guarantees of loans with third parties or other guarantee arrangements. Furthermore, the Company does not disclose information on its product warranties, as management considers the balance immaterial to its consolidated results of operations and financial condition.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Earnings Per Share
Prior to the completion of the Spin-Off, the Company had no common shares issued and outstanding. On April 1, 2024, there were 172,709,505 shares of Solventum common stock issued and outstanding as part of the Distribution. This share amount is utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off. For the three and nine months ended September 30, 2023, these shares are treated as issued and outstanding for purposes of calculating historical earnings per share. For periods prior to the Spin-Off, it is assumed that there are no dilutive equity instruments as there were no equity awards of Solventum outstanding prior to the Spin-Off.
The computations for basic and diluted earnings per share follow:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions, except per share amounts)2024202320242023
Numerator:
Net income$122 $460 $448 $1,074 
Denominator:
Weighted average common shares outstanding – basic
173.4 172.7 173.1 172.7 
Dilution associated with stock-based compensation plans0.5 — 0.3 — 
Weighted average common shares outstanding – diluted173.9172.7173.4172.7
Basic earnings per share$0.70 $2.66 $2.59 $6.22 
Diluted earnings per share $0.70 $2.66 $2.58 $6.22 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Prior to the Spin-Off, certain eligible employees were awarded incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units (RSUs), performance share units (PSUs) and other stock awards under 3M's Amended and Restated 2016 Long-Term Incentive Plan (3M Company Plan). Stock-based compensation granted pursuant to the 3M Company Plan was based on 3M’s common stock.
In March 2024, 3M's Board of Directors approved the 2024 Long-Term Incentive Plan (Solventum 2024 Plan) providing for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, RSUs, PSUs, and other stock or cash-based awards to eligible employees and non-employee directors. Stock-based compensation granted pursuant to the 2024 Long-Term Incentive Plan is based on Solventum's stock. The maximum shares that can be issued under the Solventum 2024 Plan is 13,000,000 shares.
In connection with the Spin-Off, all awards granted under the 3M Company Plan for Solventum employees were converted into equivalent awards under the Solventum 2024 Plan subsequent to the Spin-Off in April 2024. This stock award modification at Spin-Off resulted in expense of $20 million in the nine months ended September 30, 2024.
Stock-Based Compensation Expense
Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, RSUs, and PSUs, are provided in the following table. Capitalized stock-based compensation amounts were not material.
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Cost of sales$3 $1 $12 $7 
Selling, general and administrative expenses22 4 61 18 
Research, development and related expenses2 1 14 7 
Stock-based compensation expenses27 6 87 32 
Income tax benefits(5)(2)(13)(8)
Stock-based compensation expenses, net of tax
$22 $4 $74 $24 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Related Parties Related Parties
Related Party Transactions Prior to Spin-Off
Prior to the Spin-Off, the Company participated in centralized 3M treasury programs. This arrangement was not reflective of the manner in which the Company would have financed its operations had it been a standalone business separate from 3M during the periods presented prior to April 1, 2024. All adjustments relating to certain transactions among the Company and 3M, which include the transfer of the balance of cash to and from 3M, transfer of the balance of cash held in centralized cash management arrangements to and from 3M, and pushdown of all costs of doing business that were paid on behalf of the Company by 3M, are excluded from the asset and liability balances in the condensed combined balance sheets and have instead been reported within Net parent investment as a component of equity.
Corporate Allocations
The condensed combined statements of income for periods prior to April 1, 2024 include general corporate expenses of 3M for services provided by 3M for certain corporate and shared service functions that were provided on a centralized basis, including the use of shared assets. Expenses had been included on a direct usage basis where costs were specifically identifiable to Solventum or allocated based on the Company’s pro rata proportion of 3M's revenue.
Management believes that the expense allocations were determined on a basis that was a reasonable reflection of the utilization of services provided for or the benefit received by the Company during each of the periods presented prior to April 1, 2024. The amounts that would have been incurred on a standalone basis could materially differ from the amounts allocated. Management does not believe, however, that it is practicable to estimate what these expenses would have been had the Company operated as an independent entity, including any expenses associated with obtaining any of these services from unaffiliated entities. There was no expense allocation activity after April 1, 2024.
3M expense allocations were recorded in the condensed combined statements of income within the following captions:
Three months ended September 30,Nine months ended September 30,
(Millions)202320242023
Costs of product$25 $15 $60 
Costs of software and rentals— — — 
Selling, general and administrative186 177 551 
Research and development29 28 84 
Total$240 $220 $695 
Related Party Transactions After Spin-Off
Separation and Distribution Agreement and Other Related Party Transactions with 3M
In connection with the Spin-Off on April 1, 2024, the Company entered into or adopted several agreements that provide a framework for Solventum's relationship with 3M after the separation and distribution. These include, but are not limited to, the following:
•Separation and Distribution Agreement - The separation and distribution agreement contains key provisions related to the separation of Solventum from 3M, including the transfer of assets and assumptions of liabilities. In connection with this agreement, certain assets and liabilities included in the Company's condensed combined balance sheet as of March 31, 2024 were retained by 3M and certain assets and liabilities not included in the Company’s condensed combined balance sheet as of March 31, 2024 were transferred to Solventum as of the date of separation. Separation related adjustments resulted in a decrease to net assets and total equity of $1.1 billion and are reflected in the “Net transfers to 3M” line item of the condensed consolidated and combined statements of changes in equity. The impact on net assets primarily represent liabilities payable to 3M for services received prior to Spin-Off as well as cash and accounts receivable retained by 3M.
•Transition Agreements - Transition services agreements include services that 3M will provide to Solventum and its affiliates, and Solventum and its affiliates will provide to 3M and its affiliates, on an interim, transitional basis.
1) Transition services agreement. Includes various services, including, but not limited to, information technology support and access, logistics services, certain finance support functions, compliance reporting, human resources and toxicology laboratory support services. The transition services agreement has an overall term of two years.
2) Transition distribution services agreement. Provides that 3M and its affiliates will retain inventories of and purchase certain Solventum products from Solventum and its subsidiaries and distribute those products to Solventum’s customers. The transition distribution services agreement has an overall term of two years, with shorter terms for individual countries.
3) Transition contract manufacturing agreement. Solventum and 3M will manufacture certain products of the other party at specified manufacturing sites and will supply such products to the other party, in each case on a transitional basis to allow for the orderly exit of production at the supplier site and relocation. The transition contract manufacturing agreement has an overall term of three years, with the terms of individual services ranging from eighteen to thirty-six months.
For the three and nine months ended September 30, 2024, Solventum recognized operating expense of $144 million and $231 million, respectively, related to services received under the above transition agreements between the Company and 3M and its affiliates.
•Tax Matters Agreement - The agreement governs the parties’ respective rights, responsibilities and obligations with respect to taxes (including responsibility for taxes, entitlement to refunds, allocation of tax attributes, preparation of tax returns, control of tax contests and other tax matters). In addition, the tax matters agreement imposes certain restrictions on Solventum and its subsidiaries (including restrictions on share issuances, business combinations, sales of assets and similar transactions) that are designed to preserve the tax-free status of the distribution and certain related transactions.
•Employee Matters Agreement - The agreement allocates liabilities and responsibilities relating to employment matters, employee compensation and benefits plans and programs, and other related matters. The employee matters agreement provides that, unless otherwise specified, each party will be responsible for liabilities associated with current and former employees of such party and its subsidiaries. For the U.S. qualified and non-qualified defined benefit pension plans, Solventum established plans that mirror the corresponding 3M plans and assumed all obligations under 3M’s plans for the accrued benefits of current and former Solventum employees. The employee matters agreement also governs the terms of equity-based awards granted by 3M prior to separation.
•Real Estate License Agreements - Solventum or one of its affiliates, as licensee, has entered into certain real estate license agreements with 3M or one of its affiliates, as licensor, pursuant to which Solventum will be able to continue to use certain premises owned or leased by 3M for a limited period of time following the distribution date. Pursuant to the real estate license agreements, 3M will provide customary building services to the licensee consistent with the property’s use prior to the separation, including, without limitation, basic utilities, janitorial and trash removal services, maintenance services and employee amenities. The terms of the real estate license agreements are generally two years or less.
•Master Supply Agreements - 3M and Solventum entered into master supply agreements in connection with the separation under which each agrees to supply the other with certain products. The term of the master supply agreements will initially be three years, which will extend automatically, with the length of the term extension subject to the parties' ability to identify a third-party supplier, and the ability for such third-party supplier to provide validated production samples. The Company recognized revenue and cost of sales associated with products sold to 3M of $17 million and $12 million, respectively, for the three months ended September 30, 2024. The Company recognized
revenue and cost of sales associated with products sold to 3M of $27 million and $20 million, respectively, for the nine months ended September 30, 2024. Cost of sales related to purchases from 3M under the master supply agreements was $68 million for the three and nine months ended September 30, 2024.
Related Party Transactions
The Company had the following transactions with 3M and its affiliates, primarily in connection with the Transition Services Agreement, Transition Distribution Services Agreement, Transition Contract Manufacturing Agreements and Master Supply Agreements, reported on the Company’s condensed consolidated and combined financial statements:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions)2024202320242023
Net sales of product$17 $— $27 $— 
Cost of product171 — 201 — 
Selling, general and administrative expenses63 — 135 — 
Research and development expenses
2 — 5 — 
Current amounts due from and due to 3M under various agreements described above are recognized within the “Due from related parties” and “Due to related parties”, as applicable, in the condensed consolidated and combined financial statements. Non-current amounts due to 3M in connection with the transition distribution services agreement were approximately $72 million at September 30, 2024 and were recognized in “Other liabilities” in the consolidated balance sheet.
Net Parent Investment
Net transfers to 3M are included within Net parent investment in the condensed consolidated and combined statements of changes in equity and within financing activities in the condensed consolidated and combined statements of cash flows and represent the net effect of transactions between the Company and 3M.
The reconciliation of net transfers to 3M between the condensed consolidated and combined changes in equity and the condensed consolidated and combined statements of cash flows are as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Net transfers to 3M on the condensed consolidated and combined changes in equity
$— $(473)$(8,575)$(1,190)
Stock compensation expense— (6)(4)(32)
Multiemployer pension expense— (8)(5)(26)
Net balances transferred from 3M$— $— $337 $— 
Net transfers to 3M on the condensed consolidated and combined statements of cash flows
$— $(487)$(8,247)$(1,248)
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segments
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Business Segments Business Segments
Operating segments include components of an enterprise where separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) for the purpose of assessing performance and allocating resources. The Company’s CODM is its Chief Executive Officer. The Company’s operating activities are managed through four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. There have been no changes to the composition of the segments or to financial information reported within each of the business segments. These segments have been identified based on the nature of the products sold and how the Company manages its operations. Transactions among reportable segments are recorded at cost. No operating segments have been aggregated to form reportable segments.
Corporate and Unallocated includes amortization of acquired intangible assets, restructuring and related charges, benefits or costs related to capitalized manufacturing variances, Spin-Off and separation related costs and other net costs that the Company chose not to allocate directly to its business segments. Spin-Off and separation related costs include any costs incurred as part of our separation from 3M and costs to setup operations as a standalone company, including system implementations, manufacturing relocation, legal entity separation, certain equity awards granted as part of the Spin-Off, profit mark-ups on transition service arrangements with 3M and other one-time costs.
Corporate and Unallocated also includes sales and cost of sales related to products supplied to 3M and other supply agreements related to legacy 3M business and assumed by the Company at Spin-Off. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. Business segment operating income is reconciled to total operating income and pre-tax income below.
Consistent accounting policies have been applied by all segments for all reporting periods. A description of our reportable segments has been provided in Note 1 to the audited combined financial statements within the Company’s Information Statement dated March 11, 2024.
Business Segment Information
Three months ended September 30,Nine months ended September 30,
Net Sales (Millions)
2024202320242023
MedSurg$1,182 $1,180 $3,463 $3,464 
Dental Solutions313 331 979 1,023 
Health Information Systems326 321 971 953 
Purification and Filtration238 242 721 721 
Corporate and Unallocated23 — $45 $— 
Total Company$2,082 $2,074 $6,179 $6,161 
Three months ended September 30,Nine months ended September 30,
Operating Performance (Millions)
2024202320242023
MedSurg$243 $307 $678 $829 
Dental Solutions72 114 272 349 
Health Information Systems105 114 317 304 
Purification and Filtration20 48 78 134 
Total business segment operating income440 583 1,345 1,616 
Corporate and Unallocated:
Amortization expense(88)(92)(261)(276)
Other corporate and unallocated(77)13 (184)(54)
Total Corporate and Unallocated(165)(79)(445)(330)
Total Company operating income275 504 900 1,286 
Interest expense, net107 — 260 — 
Other expense/(income), net1 4 48 10 
Income before income taxes$167 $500 $592 $1,276 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net income $ 122 $ 460 $ 448 $ 1,074
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited condensed consolidated and combined financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and present the historical results of operations, and comprehensive income for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, and the financial position as of September 30, 2024 and December 31, 2023. The interim condensed consolidated and combined financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of the Company’s consolidated and combined financial position, results of operations and cash flows for the periods presented. These adjustments consist of normal, recurring items. The results of operations for any interim periods are not necessarily indicative of results for the full year.
Effective April 1, 2024, the Company’s financial statements are presented on a consolidated basis, as the Spin-Off was completed on such date. The unaudited financial statements for all periods following the Spin-Off are referred to as the “Condensed Consolidated Financial Statements.” Prior to April 1, 2024, Solventum was a carve-out business of 3M. The Company's financial statements prior to April 1, 2024 were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of 3M, including the historical cost basis of assets and liabilities comprising the Company, as well as the historical revenues, direct costs, and allocations of indirect costs attributable to the operations of the Company, using the historical accounting policies applied by 3M. The historical financial statements of the Company prior to April 1, 2024, are referred to as the “Condensed Combined Financial Statements”.
All intercompany transactions and balances within Solventum have been eliminated. These unaudited condensed consolidated and combined financial statements include certain transactions with 3M, which are disclosed as related party transactions in Note 14 “Related Parties”.
The unaudited condensed consolidated and combined financial statements and related footnotes as of and for the three and nine months ended September 30, 2024 should be read in conjunction with the audited combined financial statements as of and for the year ended December 31, 2023 contained in Exhibit 99.1 to Amendment No. 2 to the Company’s Registration Statement on Form 10 as filed with the SEC on March 11, 2024, which became effective on March 13, 2024 (the “Information Statement”).
New Accounting Pronouncements
New Accounting Pronouncements
The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.
StandardRelevant DescriptionEffective Date for SolventumImpact of Adoption
ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.Year-end December 31, 2024
The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.
ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.Year-end December 31, 2025The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.
Commitments and Contingencies
Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings
The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal proceedings for which the Company has recorded an accrued liability in its financial statements, the Company also records receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those insured matters for which the Company has not recorded an accrued liability because the liability is not probable or the amount of the liability is not estimable, or both, but for which the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it concludes as recognizable for the expense incurred.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Accounting Standards Update and Change in Accounting Principle
The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.
StandardRelevant DescriptionEffective Date for SolventumImpact of Adoption
ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.Year-end December 31, 2024
The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.
ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.Year-end December 31, 2025The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill Segment
The goodwill balance by business segment follows:
(Millions)MedSurgDental SolutionsHealth Information SystemsPurification and FiltrationTotal
Balance as of December 31, 2023$3,685$458$873$1,519$6,535
Translation impact4631757
Balance as of September 30, 2024$3,731$461$874$1,526$6,592
Schedule of Finite-Lived Intangible Assets The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:
September 30,December 31,
(Millions)20242023
Customer related intangible assets
$2,748 $2,734 
Patents and other technology-based intangible assets
1,901 1,897 
Tradenames and other amortizable intangible assets
732 705 
Total gross carrying amount5,381 5,336 
Accumulated amortization — customer related(1,188)(1,081)
Accumulated amortization — patents and other technology-based(1,185)(1,055)
Accumulated amortization — tradenames and other(357)(323)
Total accumulated amortization (2,730)(2,459)
Total finite-lived intangible assets — net 2,651 2,877 
Indefinite lived intangible assets— 25 
Total intangible assets — net$2,651 $2,902 
Schedule of Indefinite-Lived Intangible Assets The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:
September 30,December 31,
(Millions)20242023
Customer related intangible assets
$2,748 $2,734 
Patents and other technology-based intangible assets
1,901 1,897 
Tradenames and other amortizable intangible assets
732 705 
Total gross carrying amount5,381 5,336 
Accumulated amortization — customer related(1,188)(1,081)
Accumulated amortization — patents and other technology-based(1,185)(1,055)
Accumulated amortization — tradenames and other(357)(323)
Total accumulated amortization (2,730)(2,459)
Total finite-lived intangible assets — net 2,651 2,877 
Indefinite lived intangible assets— 25 
Total intangible assets — net$2,651 $2,902 
Schedule of Finite-Lived Intangible Assets Amortization Expense
Amortization expense was as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Amortization expense $88 $92 $261 $276 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Expected amortization expense for acquired amortizable intangible assets recorded as of September 30, 2024 is as follows:
(Millions)Remainder of 202420252026202720282029After 2029
Amortization expense$88 $326 $321 $316 $312 $274 $1,014 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Other Current Liabilities (Tables)
 9 Months Ended
Sep. 30, 2024
Other Liabilities Disclosure [Abstract]  
Schedule of Other Current Liabilities
Other current liabilities included in the condensed consolidated and combined balance sheets consist of the following:
September 30,December 31,
(Millions)20242023
Other current liabilities
Accrued compensation$251 $209 
Accrued taxes
202 106 
Accrued rebates
166 206 
Accrued interest91 — 
Other321 156 
Total other current liabilities$1,031 $677 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Property, Plant, and Equipment - Net (Tables)
 9 Months Ended
Sep. 30, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Property, plant and equipment, net consisted of the following:
September 30,December 31,
(Millions)20242023
Property, plant and equipment - at cost
Buildings and leasehold improvements
$952 $937 
Machinery and equipment
2,180 2,081 
Construction in progress465 320 
Gross property, plant and equipment3,597 3,338 
Accumulated depreciation(1,998)(1,881)
Property, plant and equipment - net$1,599 $1,457 
Depreciation expense consisted of the following:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Depreciation expense$37 $45 $121 $124 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Comprehensive Income Information (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”), including the reclassifications out of AOCI by component:
Three months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2024, net of tax:$(432)$(512)$1 $(943)
Other comprehensive income (loss), before tax:
Amounts before reclassifications179 — (15)164 
Amounts reclassified out— 13 — 13 
Total other comprehensive income (loss), before tax179 13 (15)177 
Tax effect— (3)4 1 
Total other comprehensive income (loss), net of tax179 10 (11)178 
Transfers from 3M, net of tax— — — — 
Balance at September 30, 2024, net of tax:
$(253)$(502)$(10)$(765)
Three months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023, net of tax:$(414)$7 $(407)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(134)— (134)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(134)— (134)
Tax effect— — — 
Total other comprehensive income (loss), net of tax(134)— (134)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
Nine months ended September 30, 2024
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Cash Flow HedgingTotal Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023, net of tax:$(347)$10 $— $(337)
Other comprehensive income (loss), before tax:
Amounts before reclassifications56 — (13)43 
Amounts reclassified out38 26 — 64 
Total other comprehensive income (loss), before tax94 26 (13)107 
Tax effect— (6)3 (3)
Total other comprehensive income (loss), net of tax94 20 (10)104 
Transfers from 3M, net of tax— (532)— (532)
Balance at September 30, 2024, net of tax:$(253)$(502)$(10)$(765)
Nine months ended September 30, 2023
(Millions)Cumulative Translation Adjustment
Defined Benefit Pension
Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022, net of tax:$(504)$7 $(497)
Other comprehensive income (loss), before tax:
Amounts before reclassifications(44)— (44)
Amounts reclassified out— — — 
Total other comprehensive income (loss), before tax(44)— (44)
Tax effect—— — 
Total other comprehensive income (loss), net of tax(44)— (44)
Transfers from 3M, net of tax— — — 
Balance at September 30, 2023, net of tax:
$(548)$7 $(541)
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Long-Term Debt and Short-Term Borrowings (Tables)
 9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Long -Term Debt and Short-Term Debt
Carrying value includes the impact of debt issuance costs. Long-term debt and short-term borrowings as of September 30, 2024 consisted of the following:
(Millions)Currency/ Fixed vs. FloatingFinal Maturity DateCarrying Value
DescriptionSeptember 30, 2024
Eighteen month senior term loan credit facility
USD Floating2025$300 
Three year senior term loan credit facility
USD Floating2027979 
$1 billion 5.45 percent three year senior notes
USD Fixed2027994 
$1.5 billion 5.40 percent five year senior notes
USD Fixed20291,487 
$1 billion 5.45 percent seven year senior notes
USD Fixed2031990 
$1.65 billion 5.60 percent ten year senior notes
USD Fixed20341,636 
$1.25 billion 5.90 percent thirty year senior notes
USD Fixed20541,231 
$500 million 6.00 percent forty year senior notes
USD Fixed2064492 
Other borrowings— 
Total long-term debt8,109 
Less: current portion of long-term debt300 
Long-term debt (excluding current portion)$7,809 
Schedule of Maturities of Long-Term Debt The maturities of long-term debt for the periods subsequent to September 30, 2024 are as follows (in millions):
Remainder of
2024		20252026202720282029After 2029Total
$—$300$—$1,980$—$1,500$4,400$8,180
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Pension and Postretirement Benefit Plans (Tables)
 9 Months Ended
Sep. 30, 2024
Retirement Benefits [Abstract]  
Schedule of Net Benefit Costs Components of net periodic benefit cost and other supplemental information for the three and nine months ended September 30, 2024 and 2023 follow:
Three months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$7 $— $5 $— $1 $— 
Non-operating expense
Interest cost23 — 5 — 3 — 
Expected return on plan assets(34)— (5)— (2)— 
Amortization of prior service benefit(1)— — — (1)— 
Amortization of net actuarial loss14 — — — 1 — 
Total non-operating expense (benefit)2 — — — 1 — 
Total net periodic benefit cost (benefit)$9 $— $5 $— $2 $— 
Nine months ended September 30,
Qualified and Non-qualified Pension Benefits
United StatesInternationalPostretirement Benefits
(Millions)202420232024202320242023
Net periodic benefit cost (benefit)
Operating expense
Service cost$14 $— $14 $— $2 $— 
Non-operating expense
Interest cost46 — 15 — 6 — 
Expected return on plan assets(68)— (15)— (4)— 
Amortization of prior service benefit(2)— — — (2)— 
Amortization of net actuarial loss28 — — — 2 — 
Total non-operating expense (benefit)4 — — — 2 — 
Total net periodic benefit cost (benefit)$18 $— $14 $— $4 $— 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives (Tables)
 9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges
The amount of pretax gain (loss) recognized in other comprehensive income (loss) related to derivative instruments designated as cash flow hedges is provided in the following table.
Pretax Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Foreign currency forward contracts $(15)$— $(13)$— 
Schedule of Location and Fair Value of Derivative Instruments
The following tables summarize the fair value of Solventum’s derivative instruments and their location in the condensed consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates.
Gross Notional AmountAssetsLiabilities
 (Millions)LocationFair Value AmountLocationFair Value Amount
September 30,December 31,September 30,December 31,September 30,December 31,
202420232024202320242023
Derivatives designated as hedging instruments
Foreign currency forward contracts$297 $— Other current assets$— $— Other current liabilities$9 $— 
Foreign currency forward contracts92 — Other assets— — Other liabilities2 — 
Total derivatives designated as hedging instruments $389 $— $— $— $11 $— 
Derivatives not designated as hedging instruments
Foreign currency forward contracts$18 $— Other current assets$— $— Other current liabilities$1 $— 
Total derivatives not designated as hedging instruments
$18 $— $— $— $1 $— 
Total derivative instruments
$407 $— $— $— $12 $— 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The computations for basic and diluted earnings per share follow:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions, except per share amounts)2024202320242023
Numerator:
Net income$122 $460 $448 $1,074 
Denominator:
Weighted average common shares outstanding – basic
173.4 172.7 173.1 172.7 
Dilution associated with stock-based compensation plans0.5 — 0.3 — 
Weighted average common shares outstanding – diluted173.9172.7173.4172.7
Basic earnings per share$0.70 $2.66 $2.59 $6.22 
Diluted earnings per share $0.70 $2.66 $2.58 $6.22 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, RSUs, and PSUs, are provided in the following table. Capitalized stock-based compensation amounts were not material.
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Cost of sales$3 $1 $12 $7 
Selling, general and administrative expenses22 4 61 18 
Research, development and related expenses2 1 14 7 
Stock-based compensation expenses27 6 87 32 
Income tax benefits(5)(2)(13)(8)
Stock-based compensation expenses, net of tax
$22 $4 $74 $24 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties (Tables)
 9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
3M expense allocations were recorded in the condensed combined statements of income within the following captions:
Three months ended September 30,Nine months ended September 30,
(Millions)202320242023
Costs of product$25 $15 $60 
Costs of software and rentals— — — 
Selling, general and administrative186 177 551 
Research and development29 28 84 
Total$240 $220 $695 
The Company had the following transactions with 3M and its affiliates, primarily in connection with the Transition Services Agreement, Transition Distribution Services Agreement, Transition Contract Manufacturing Agreements and Master Supply Agreements, reported on the Company’s condensed consolidated and combined financial statements:
Three months ended September 30,Nine months ended September 30,
(Amounts in millions)2024202320242023
Net sales of product$17 $— $27 $— 
Cost of product171 — 201 — 
Selling, general and administrative expenses63 — 135 — 
Research and development expenses
2 — 5 — 
The reconciliation of net transfers to 3M between the condensed consolidated and combined changes in equity and the condensed consolidated and combined statements of cash flows are as follows:
Three months ended September 30,Nine months ended September 30,
(Millions)2024202320242023
Net transfers to 3M on the condensed consolidated and combined changes in equity
$— $(473)$(8,575)$(1,190)
Stock compensation expense— (6)(4)(32)
Multiemployer pension expense— (8)(5)(26)
Net balances transferred from 3M$— $— $337 $— 
Net transfers to 3M on the condensed consolidated and combined statements of cash flows
$— $(487)$(8,247)$(1,248)
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Three months ended September 30,Nine months ended September 30,
Net Sales (Millions)
2024202320242023
MedSurg$1,182 $1,180 $3,463 $3,464 
Dental Solutions313 331 979 1,023 
Health Information Systems326 321 971 953 
Purification and Filtration238 242 721 721 
Corporate and Unallocated23 — $45 $— 
Total Company$2,082 $2,074 $6,179 $6,161 
Three months ended September 30,Nine months ended September 30,
Operating Performance (Millions)
2024202320242023
MedSurg$243 $307 $678 $829 
Dental Solutions72 114 272 349 
Health Information Systems105 114 317 304 
Purification and Filtration20 48 78 134 
Total business segment operating income440 583 1,345 1,616 
Corporate and Unallocated:
Amortization expense(88)(92)(261)(276)
Other corporate and unallocated(77)13 (184)(54)
Total Corporate and Unallocated(165)(79)(445)(330)
Total Company operating income275 504 900 1,286 
Interest expense, net107 — 260 — 
Other expense/(income), net1 4 48 10 
Income before income taxes$167 $500 $592 $1,276 
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Significant Accounting Policies (Details)
 9 Months Ended
Apr. 01, 2024
shares
Sep. 30, 2024
operatingSegment
Accounting Policies [Abstract]    
Spinoff transaction, percent of shares outstanding distributed 80.10%  
Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares) | shares 172,709,505  
Number of operating segments | operatingSegment   4
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue Recognition (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Contract with customer, liability, revenue recognized $ 110 $ 115 $ 500 $ 475  
Operating lease, lease income $ 148 $ 160 $ 442 $ 458  
One Customer | Accounts Receivable | Customer Concentration Risk          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Concentration risk, percentage         10.00%
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Narrative (Details)
 9 Months Ended
Sep. 30, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill, acquired during period $ 0
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 6,535
Translation impact 57
Ending balance 6,592
MedSurg  
Goodwill [Roll Forward]  
Beginning balance 3,685
Translation impact 46
Ending balance 3,731
Dental Solutions  
Goodwill [Roll Forward]  
Beginning balance 458
Translation impact 3
Ending balance 461
Health Information Systems  
Goodwill [Roll Forward]  
Beginning balance 873
Translation impact 1
Ending balance 874
Purification and Filtration  
Goodwill [Roll Forward]  
Beginning balance 1,519
Translation impact 7
Ending balance $ 1,526
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Total gross carrying amount $ 5,381 $ 5,336
Total accumulated amortization (2,730) (2,459)
Total finite-lived intangible assets — net 2,651 2,877
Indefinite lived intangible assets 0 25
Intangible assets — net 2,651 2,902
Customer related intangible assets    
Finite-Lived Intangible Assets [Line Items]    
Total gross carrying amount 2,748 2,734
Total accumulated amortization (1,188) (1,081)
Patents and other technology-based intangible assets    
Finite-Lived Intangible Assets [Line Items]    
Total gross carrying amount 1,901 1,897
Total accumulated amortization (1,185) (1,055)
Tradenames and other amortizable intangible assets    
Finite-Lived Intangible Assets [Line Items]    
Total gross carrying amount 732 705
Total accumulated amortization $ (357) $ (323)
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 88 $ 92 $ 261 $ 276
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details)
$ in Millions
Sep. 30, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remainder of 2024 $ 88
2025 326
2026 321
2027 316
2028 312
2029 274
After 2029 $ 1,014
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Other Current Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Other Liabilities Disclosure [Abstract]    
Accrued compensation $ 251 $ 209
Accrued taxes 202 106
Accrued rebates 166 206
Accrued interest 91 0
Other 321 156
Total other current liabilities $ 1,031 $ 677
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.3
Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 3,597 $ 3,338
Accumulated depreciation (1,998) (1,881)
Property, plant and equipment - net 1,599 1,457
Buildings and leasehold improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 952 937
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 2,180 2,081
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 465 $ 320
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 37 $ 45 $ 121 $ 124
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance $ 2,867 $ 11,729 $ 11,666 $ 11,742
Other comprehensive income (loss), before tax:        
Total other comprehensive income (loss), net of tax 178 (134) 104 (44)
Ending balance 3,192 11,582 3,192 11,582
Cumulative Translation Adjustment        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (432) (414) (347) (504)
Other comprehensive income (loss), before tax:        
Amounts before reclassifications 179 (134) 56 (44)
Amounts reclassified out 0 0 38 0
Total other comprehensive income (loss), before tax 179 (134) 94 (44)
Tax effect 0 0 0 0
Total other comprehensive income (loss), net of tax 179 (134) 94 (44)
Transfers from 3M, net of tax 0 0 0 0
Ending balance (253) (548) (253) (548)
Defined Benefit Pension        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (512) 7 10 7
Other comprehensive income (loss), before tax:        
Amounts before reclassifications 0 0 0 0
Amounts reclassified out 13 0 26 0
Total other comprehensive income (loss), before tax 13 0 26 0
Tax effect (3) 0 (6) 0
Total other comprehensive income (loss), net of tax 10 0 20 0
Transfers from 3M, net of tax 0 0 (532) 0
Ending balance (502) 7 (502) 7
Cash Flow Hedging        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 1   0  
Other comprehensive income (loss), before tax:        
Amounts before reclassifications (15)   (13)  
Amounts reclassified out 0   0  
Total other comprehensive income (loss), before tax (15)   (13)  
Tax effect 4   3  
Total other comprehensive income (loss), net of tax (11)   (10)  
Transfers from 3M, net of tax 0   0  
Ending balance (10)   (10)  
Total Accumulated Other Comprehensive Income (Loss)        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (943) (407) (337) (497)
Other comprehensive income (loss), before tax:        
Amounts before reclassifications 164 (134) 43 (44)
Amounts reclassified out 13 0 64 0
Total other comprehensive income (loss), before tax 177 (134) 107 (44)
Tax effect 1 0 (3) 0
Total other comprehensive income (loss), net of tax 178 (134) 104 (44)
Transfers from 3M, net of tax 0 0 (532) 0
Ending balance $ (765) $ (541) $ (765) $ (541)
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Income Tax Disclosure [Abstract]          
Effective income tax rate reconciliation, percent 26.90% 8.00% 24.30% 15.80%  
Deferred tax assets, valuation allowance $ 22   $ 22   $ 56
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details) - USD ($)
$ in Millions
Feb. 27, 2024
Feb. 16, 2024
Sep. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]        
Total     $ 8,109  
Less: current portion of long-term debt     300  
Long-term debt (excluding current portion)     7,809 $ 0
Line of Credit | Credit Facilities | 18-Month Senior Term Loan Credit Facility        
Debt Instrument [Line Items]        
Line of credit facility, maximum borrowing capacity   $ 500    
Debt instrument, term   18 months    
Total     300  
Line of Credit | Credit Facilities | 3-Year Senior Term Loan Credit Facility        
Debt Instrument [Line Items]        
Line of credit facility, maximum borrowing capacity   $ 1,000    
Debt instrument, term   3 years    
Total     979  
Senior Notes        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 6,900      
Senior Notes | 5.450% Senior Notes Due 2027        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 1,000      
Interest rate, stated percentage 5.45%      
Debt instrument, term 3 years      
Total     994  
Senior Notes | 5.400% Senior Notes Due 2029        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 1,500      
Interest rate, stated percentage 5.40%      
Debt instrument, term 5 years      
Total     1,487  
Senior Notes | 5.450% Senior Notes Due 2031        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 1,000      
Interest rate, stated percentage 5.45%      
Debt instrument, term 7 years      
Total     990  
Senior Notes | 5.600% Senior Notes Due 2034        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 1,650      
Interest rate, stated percentage 5.60%      
Debt instrument, term 10 years      
Total     1,636  
Senior Notes | 5.900% Senior Notes Due 2054        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 1,250      
Interest rate, stated percentage 5.90%      
Debt instrument, term 30 years      
Total     1,231  
Senior Notes | 6.000% Senior Notes Due 2064        
Debt Instrument [Line Items]        
Debt instrument, face amount $ 500      
Interest rate, stated percentage 6.00%      
Debt instrument, term 40 years      
Total     492  
Other borrowings        
Debt Instrument [Line Items]        
Total     $ 0  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Long-Term Debt and Short-Term Borrowings - Narrative (Details)
 1 Months Ended
Mar. 07, 2024
USD ($)
Mar. 04, 2024
USD ($)
Feb. 27, 2024
USD ($)
series
Feb. 16, 2024
USD ($)
Aug. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Apr. 01, 2024
USD ($)
Debt Instrument [Line Items]              
Retained cash target             $ 600,000,000
Commercial paper           $ 0  
Commercial Paper              
Debt Instrument [Line Items]              
Debt instrument, term   364 days          
Line of credit facility, maximum borrowing capacity   $ 2,000,000,000.0          
Senior Notes              
Debt Instrument [Line Items]              
Series of notes issued | series     6        
Debt instrument, face amount     $ 6,900,000,000        
Debt issuance costs     62,000,000        
Senior Notes | Estimate of Fair Value Measurement              
Debt Instrument [Line Items]              
Long-term debt, fair value           8,100,000,000  
Senior Notes | Reported Value Measurement              
Debt Instrument [Line Items]              
Long-term debt, fair value           7,800,000,000  
5.400% Senior Notes Due 2029 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 1,500,000,000        
Interest rate, stated percentage     5.40%        
Debt instrument, term     5 years        
5.450% Senior Notes Due 2027 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 1,000,000,000        
Interest rate, stated percentage     5.45%        
Debt instrument, term     3 years        
5.450% Senior Notes Due 2031 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 1,000,000,000        
Interest rate, stated percentage     5.45%        
Debt instrument, term     7 years        
5.600% Senior Notes Due 2034 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 1,650,000,000        
Interest rate, stated percentage     5.60%        
Debt instrument, term     10 years        
5.900% Senior Notes Due 2054 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 1,250,000,000        
Interest rate, stated percentage     5.90%        
Debt instrument, term     30 years        
6.000% Senior Notes Due 2064 | Senior Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 500,000,000        
Interest rate, stated percentage     6.00%        
Debt instrument, term     40 years        
Credit Facilities | Line of Credit | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, term       5 years      
Line of credit facility, maximum borrowing capacity       $ 2,000,000,000.0      
Long-term line of credit           $ 0  
Credit Facilities | Line of Credit | Term Loan Credit Facilities              
Debt Instrument [Line Items]              
Proceeds from long-term lines of credit $ 1,480,000,000            
Credit Facilities | Line of Credit | 18-Month Senior Term Loan Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, term       18 months      
Line of credit facility, maximum borrowing capacity       $ 500,000,000      
Repayment of debt         $ 200,000,000    
Credit Facilities | Line of Credit | 3-Year Senior Term Loan Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, term       3 years      
Line of credit facility, maximum borrowing capacity       $ 1,000,000,000.0      
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.3
Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details)
$ in Millions
Sep. 30, 2024
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2024 $ 0
2025 300
2026 0
2027 1,980
2028 0
2029 1,500
After 2029 4,400
Total long-term debt $ 8,180
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.3
Pension and Postretirement Benefit Plans - Narrative (Details) - International
Mar. 31, 2024
country
plan
Defined Benefit Plan Disclosure [Line Items]  
Number of plans transferred from parent | plan 7
Transferred plans, number of countries included in coverage | country 4
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.3
Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Postretirement Benefits        
Operating expense        
Service cost $ 1 $ 0 $ 2 $ 0
Non-operating expense        
Interest cost 3 0 6 0
Expected return on plan assets (2) 0 (4) 0
Amortization of prior service benefit (1) 0 (2) 0
Amortization of net actuarial loss 1 0 2 0
Total non-operating expense (benefit) 1 0 2 0
Total net periodic benefit cost (benefit) 2 0 4 0
United States | Qualified and Non-qualified Pension Benefits        
Operating expense        
Service cost 7 0 14 0
Non-operating expense        
Interest cost 23 0 46 0
Expected return on plan assets (34) 0 (68) 0
Amortization of prior service benefit (1) 0 (2) 0
Amortization of net actuarial loss 14 0 28 0
Total non-operating expense (benefit) 2 0 4 0
Total net periodic benefit cost (benefit) 9 0 18 0
International | Qualified and Non-qualified Pension Benefits        
Operating expense        
Service cost 5 0 14 0
Non-operating expense        
Interest cost 5 0 15 0
Expected return on plan assets (5) 0 (15) 0
Amortization of prior service benefit 0 0 0 0
Amortization of net actuarial loss 0 0 0 0
Total non-operating expense (benefit) 0 0 0 0
Total net periodic benefit cost (benefit) $ 5 $ 0 $ 14 $ 0
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives - Narrative (Details)
 9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Maximum length of time hedged in cash flow hedge 36 months
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives - Cash Flow Hedges (Details) - Cash Flow Hedging - Designated as Hedging Instrument
$ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]  
Accumulated other comprehensive income (loss), unrealized gain (loss) on cash flow hedges $ (10)
After-tax net unrealized gain (loss) anticipated to be reclassified from AOCI to the income statement within next twelve months $ (7)
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Foreign Exchange Contract | Cash Flow Hedging | Designated as Hedging Instrument        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency forward contracts $ (15) $ 0 $ (13) $ 0
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Derivatives, Fair Value [Line Items]    
Gross Notional Amount $ 407 $ 0
Assets Fair Value Amount 0 0
Liabilities Fair Value Amount 12 0
Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Gross Notional Amount 389 0
Assets Fair Value Amount 0 0
Liabilities Fair Value Amount 11 0
Not Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Gross Notional Amount 18 0
Assets Fair Value Amount 0 0
Liabilities Fair Value Amount 1 0
Other Current Assets | Foreign Exchange Contract | Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Gross Notional Amount 297 0
Assets Fair Value Amount 0 0
Other Current Assets | Foreign Exchange Contract | Not Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Gross Notional Amount 18 0
Assets Fair Value Amount 0 0
Other Noncurrent Assets | Foreign Exchange Contract | Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Gross Notional Amount 92 0
Assets Fair Value Amount 0 0
Other Current Liabilities | Foreign Exchange Contract | Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Liabilities Fair Value Amount 9 0
Other Current Liabilities | Foreign Exchange Contract | Not Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Liabilities Fair Value Amount 1 0
Other Noncurrent Liabilities | Foreign Exchange Contract | Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Liabilities Fair Value Amount $ 2 $ 0
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.3
Commitment and Contingencies (Details)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 31, 2022
case
Sep. 30, 2024
USD ($)
classAction
case
lawsuit
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
classAction
case
lawsuit
Sep. 30, 2023
USD ($)
Dec. 31, 2022
case
Dec. 31, 2019
case
Dec. 31, 2023
USD ($)
Dec. 31, 2011
quiTamAction
Dec. 31, 2008
employee
quiTamAction
Loss Contingencies [Line Items]                    
Legal charges (recoveries) in period | $   $ 3,000,000 $ 0 $ 8,000,000 $ 1,000,000          
Payments for legal settlements | $   6,000,000                
Loss contingency accrual | $   $ 25,000,000   $ 25,000,000       $ 23,000,000    
Number of cases voluntarily dismissed by plaintiffs   15   15            
3M                    
Loss Contingencies [Line Items]                    
Number of cases selected for bellwether process   34   34            
3M | Bair Hugger Patient Warming Systems Litigation                    
Loss Contingencies [Line Items]                    
Total lawsuits to date | lawsuit   7,500   7,500            
Number of putative class actions | classAction   1   1            
Number of pending/ongoing cases   8   8            
Number of cases settled           1        
Number of cases removed to federal court   2   2            
Number of cases dismissed             61      
3M | Federal False Claims Act/Qui Tam Litigation                    
Loss Contingencies [Line Items]                    
Number of pending/ongoing cases | quiTamAction                 2 2
Number of cases dismissed 1                  
Number of employees who filed qui tam actions | employee                   2
ALABAMA | 3M | Bair Hugger Patient Warming Systems Litigation                    
Loss Contingencies [Line Items]                    
Number of pending/ongoing cases   1   1            
MISSOURI | 3M | Bair Hugger Patient Warming Systems Litigation                    
Loss Contingencies [Line Items]                    
Number of pending/ongoing cases   2   2            
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share - Narrative (Details) - shares
Sep. 30, 2024
Apr. 01, 2024
Mar. 31, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]        
Common stock issued (in shares) 172,754,070 172,709,505 0 0
Common stock outstanding (in shares) 172,754,070 172,709,505 0 0
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share - Schedule of Computation of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:        
Net income $ 122 $ 460 $ 448 $ 1,074
Denominator:        
Weighted average common shares outstanding – basic (in shares) 173.4 172.7 173.1 172.7
Dilution associated with stock-based compensation plans (in shares) 0.5 0.0 0.3 0.0
Weighted average common shares outstanding – diluted (in shares) 173.9 172.7 173.4 172.7
Basic earnings per share (in dollars per share) $ 0.70 $ 2.66 $ 2.59 $ 6.22
Diluted earnings per share (in dollars per share) $ 0.70 $ 2.66 $ 2.58 $ 6.22
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Stock-based compensation expenses $ 27 $ 6 $ 87 $ 32  
Solventum 2024 Plan | Spinoff          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Maximum shares issued         13,000,000
Stock-based compensation expenses     $ 20    
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expenses $ 27 $ 6 $ 87 $ 32
Income tax benefits (5) (2) (13) (8)
Stock-based compensation expenses, net of tax 22 4 74 24
Cost of sales        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expenses 3 1 12 7
Selling, general and administrative expenses        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expenses 22 4 61 18
Research, development and related expenses        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expenses $ 2 $ 1 $ 14 $ 7
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties - Schedule of Parent's Expense Allocations (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Allocation of Expenses [Line Items]        
Selling, general and administrative $ 701 $ 525 $ 1,998 $ 1,681
Research and development 189 180 576 568
Total operating expenses 1,807 1,570 5,279 4,875
Related Party | Prior To Spin-Off        
Allocation of Expenses [Line Items]        
Selling, general and administrative   186 177 551
Research and development   29 28 84
Total operating expenses   240 220 695
Cost of product        
Allocation of Expenses [Line Items]        
Cost of sales 793 748 2,341 2,262
Cost of product | Related Party | Prior To Spin-Off        
Allocation of Expenses [Line Items]        
Cost of sales   25 15 60
Cost of software and rentals        
Allocation of Expenses [Line Items]        
Cost of sales $ 124 117 364 364
Cost of software and rentals | Related Party | Prior To Spin-Off        
Allocation of Expenses [Line Items]        
Cost of sales   $ 0 $ 0 $ 0
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Related Party Transaction [Line Items]          
Net transfers to 3M $ 0 $ 473   $ 9,107 $ 1,190
Total net sales 2,082 2,074   6,179 6,161
Total Corporate and Unallocated 1,807 $ 1,570   $ 5,279 $ 4,875
Related Party          
Related Party Transaction [Line Items]          
Net transfers to 3M     $ 1,100    
Separation and distribution agreement, transition services       2 years  
Separation and distribution agreement, transition manufacturing contract       3 years  
Cost of sales 72   $ 72 $ 72  
Separation and distribution agreement, real estate license terms       2 years  
Separation and distribution agreement, master supply, terms       3 years  
Related Party | Transition Agreement Services          
Related Party Transaction [Line Items]          
Total Corporate and Unallocated 144     $ 231  
Related Party | Master Supply Agreements          
Related Party Transaction [Line Items]          
Total net sales 17     27  
Cost of sales 12     20  
Total Corporate and Unallocated $ 68     $ 68  
Related Party | Minimum          
Related Party Transaction [Line Items]          
Separation and distribution agreement, individual services, terms       18 months  
Related Party | Maximum          
Related Party Transaction [Line Items]          
Separation and distribution agreement, individual services, terms       36 months  
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties - Condensed Consolidated Statements of Income (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Related Party Transaction [Line Items]        
Net sales of product $ 2,082 $ 2,074 $ 6,179 $ 6,161
Selling, general and administrative expenses 701 525 1,998 1,681
Research and development expenses 189 180 576 568
Related Party | After Spin-Off        
Related Party Transaction [Line Items]        
Selling, general and administrative expenses 63 0 135 0
Research and development expenses 2 0 5 0
Cost of product        
Related Party Transaction [Line Items]        
Net sales of product 1,608 1,593 4,766 4,750
Cost of product 793 748 2,341 2,262
Cost of product | Related Party | After Spin-Off        
Related Party Transaction [Line Items]        
Net sales of product 17 0 27 0
Cost of product $ 171 $ 0 $ 201 $ 0
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.24.3
Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Related Party Transaction [Line Items]          
Net transfers to 3M on the condensed consolidated and combined changes in equity $ 0 $ (473)   $ (9,107) $ (1,190)
Stock compensation expense (27) (6)   (87) (32)
Net transfers to 3M on the condensed consolidated and combined statements of cash flows       (8,247) (1,248)
Related Party          
Related Party Transaction [Line Items]          
Net transfers to 3M on the condensed consolidated and combined changes in equity     $ (1,100)    
Stock compensation expense 0 (6)   (4) (32)
Multiemployer pension expense 0 (8)   (5) (26)
Net balances transferred from 3M 0 0   337 0
Net transfers to 3M on the condensed consolidated and combined statements of cash flows 0 (487)   (8,247) (1,248)
Net Parent Investment          
Related Party Transaction [Line Items]          
Net transfers to 3M on the condensed consolidated and combined changes in equity 0 (473)   (8,575) (1,190)
Net Parent Investment | Related Party          
Related Party Transaction [Line Items]          
Net transfers to 3M on the condensed consolidated and combined changes in equity $ 0 $ (473)   $ (8,575) $ (1,190)
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segments - Narrative (Details)
 9 Months Ended
Sep. 30, 2024
operatingSegment
Segment Reporting [Abstract]  
Number of operating segments 4
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.24.3
Business Segments - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Total net sales $ 2,082 $ 2,074 $ 6,179 $ 6,161
Operating Income 275 504 900 1,286
Interest expense, net 107 0 260 0
Other expense/(income), net 1 4 48 10
Income before income taxes 167 500 592 1,276
Operating Segments        
Segment Reporting Information [Line Items]        
Operating Income 440 583 1,345 1,616
Corporate and Unallocated        
Segment Reporting Information [Line Items]        
Total net sales 23 0 45 0
Operating Income (165) (79) (445) (330)
Amortization expense (88) (92) (261) (276)
Other corporate and unallocated (77) 13 (184) (54)
MedSurg | Operating Segments        
Segment Reporting Information [Line Items]        
Total net sales 1,182 1,180 3,463 3,464
Operating Income 243 307 678 829
Dental Solutions | Operating Segments        
Segment Reporting Information [Line Items]        
Total net sales 313 331 979 1,023
Operating Income 72 114 272 349
Health Information Systems | Operating Segments        
Segment Reporting Information [Line Items]        
Total net sales 326 321 971 953
Operating Income 105 114 317 304
Purification and Filtration | Operating Segments        
Segment Reporting Information [Line Items]        
Total net sales 238 242 721 721
Operating Income $ 20 $ 48 $ 78 $ 134
EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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Ǻ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

-8?20$3;8T.P6BP^0"X99K>] M9!:G6ET74\&XW['#V&<+/>:YRWD/5_8KL7QQ1WW()-!,?(=+J6QKCNB MZY][QIWP!_=;6Z>_R-H),^5.7!N]W4BU:KOQ9S$,3J.+P_-G'\13\W_"J)=+ M68JI+K>-4*Z/HQ%U"ZCL6F[L@"G>B,G@2N^$:<_'_\%-U9^;\U!!I,RI]#O, M3=7A4:*H2B@K*N:_65W+RG-4C*NVH5D$D F 3(X(^4\20*8 ,CTF9!I 9@ R M.R9D%D#F #(_)F0>0!8 LC@F9!% ?@"0'V@AYW*EI#^6*\B9U06\'N1*D];KL_ /L$P#[1@EUK73W*NNX&]<8[2JU: M '9AK1=$>/\>H1OXB);RNUL+PZZVQOCCV*WDG77CT1U#PQ KQJ<+&R_SI_=L M5OL+\7T7SL__;N6F_2$+,9%CQN22:7P:M/9SVB<-?KA+W;0??5]2AYC(,F-B MS?P&N^<_XQ%&4AD36^56J]7)O3 -FXJ%Z\9WOM;&]6V7(2;2RIC8*[-V;+7J M^&;:.B.<-**[""^%$B$F$LN8V"Q38>2.MZEK-,!((V-BC_BYT4C71:H77.<1 MH5Y(9(PL,B;6R&=NE(>R;.9OA_,U-]& (HV,B3TR=[I\.+GD?;+0^)XL?V&Y M!!DD(3;(7=OHV6;-7F?!?&^/Q%[ 42>2,A]@9,3Z-U M78*\D1![ V.&*[L$>2,A]@9.5\,\*T$N28A=\FJ^RM[=\T4=8B*=),0Z@5EK M?&TBMR3$;H%9:UP:08I)B14#,\08$RDGI5ZJH PQQD0"2HD%%&2(_:01]J^0 M#5;!B+VSGX8=1$3:2:FU\TH^]ALTQ$3:28FU\R(M.QA&Y)N4V#=[^=E!0J2: M])CEKZC:F2+5I&]? &/OIL)Q6<>Q1*))CUD,BVZ-&1)-1BP:C!E5X9%H,F+1 M8,SPRLR0:#)BT6#,L!*?(>=DQ,[!F&$M/H//7HB] S+?=K:'F,@[&769#&:^ MT11"^LF(]8,QHRF$')31E\Y @AY%$SDH(W906%8^*)\,R2/H1!S)%\ M\J.N ML&_:Z'F/#1/[%\8LPK;M?L2ZT?V5=1K414Q,J1?/*W>T;C,>>^QVKK M$PZ]9-=1WS5I?]+L0$UFH(+;0 M?J$P&O80$UFH(+;0(\KJ<&=9^ M]&\\97G[;L)R6]=7ONV[NM6\>GXI^?F%ZO/_ %!+ P04 " S?VA9EW=R MY"P" #V* &@ 'AL+U]R96QS+W=O )6ZKT"+,.H)4\0&K%!YB"2.7&X!N^\H#))C]: GR&=DE2U?_Z-/ M5MF/+V7?#KON6+>[4YU]'O;'NFRVPW#ZE5)=;F\W)Z M+65H9J]MORG#LDF?^^OIFBZ'?'>>W,R>WY9-__R6FS1UD$"03!^D$*33!QD$ MV?1!#D$^?5! 4$P?M("@Q?1!]Q!T/WW0 P0]3!^4YRCCG"!IA#6!UAFYS@1> M9P0[$XB=D>Q,8'9&M#.!VAG9S@1N9X0[$\B=D>Y,8'=&O#.!WH)Z"X'>@GH+ M@=XR>MDFT%M0;R'06U!O(=!;4&\AT%M0;R'06U!O(=!;4&\AT%M0;R'06U%O M)=!;46\ET%M1;R706T>;)01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJ MK01Z&^IM!'H;ZFT$>AOJ;01Z&^IM!'K;:+.;0&]#O8U ;T.]C4!O0[V-0&]# MO8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U ;Q]]K"30VU%O)]#; M46\GT-M1;R?0VU%O)] [4.\@T#M0[R#0.U#O(- [4.\@T#M0[R#0.U#O(- [ M1C^;$.@=J'<0Z!VH=Q#H':AW_*3>=?C:EWKM^5[C3T$_2?5POK=<'W]9?I]$ MG!<7G--M17WZ"U!+ P04 " S?VA9UD@C+OLG#]%N@"VPX =,,J51D]BR M72A_CY,"$@@J4)&XFT:M[;D3CW16/;][]A0GVZ[MX[Q8I>3/&(O5BCH;2^>I MSRM+%SJ;\M?PP+RMUO:!F)C-#*M/C4=Y0L"\3AI7O U[/ MW3Q2"$U-DUL;TK7M\BZV;5E,SRW%VJ39>/E-$'LG5<$:6N M+7=%C_8GIWS#M/OD!^>/9?8%YIVWP?F8)Q;H]W%O(QE.3WTN1"$U^U_Q/3&7 M/OC]:)AV3?4/L_/U/KFP'N<1V?@X_(X_SOB]_B_[$"!]2) ^%$@?&J0/ ]+' M,4@?)R!]G(+TP6&UL4$L! A0# M% @ ,W]H6&UL4$L! A0#% @ ,W]H69E&PO=V]R:W-H965T M&UL4$L! A0#% @ ,W]H63PC3.;_!0 G!T !@ M ("!F@T 'AL+W=O&PO=V]R:W-H965T&UL4$L! M A0#% @ ,W]H6:1//LC4 @ 00@ !@ ("!P1X 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H6:^) M:H]P"0 31D !@ ("!*S, 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ ,W]H63F25+_X @ 3@< !D ("!^$@ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H64(S MK6FW"0 "1H !D ("!=%< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H647T-$&J&0 V4P !D M ("!M7, 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ ,W]H6?$4@I&PO=V]R:W-H965T&UL4$L! A0#% M @ ,W]H60!ZCZM# @ B@8 !D ("!O+ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H6;UK[&@# !K"0 &0 @(&WT >&PO=V]R M:W-H965T&UL M4$L! A0#% @ ,W]H67BI^/4G! ( P !D ("!G]@ M 'AL+W=O MA1@# P!P &0 @(']W >&PO=V]R:W-H965T&UL4$L! A0#% @ M,W]H6:$ZU+)V! E L !D ("!S>, 'AL+W=O&UL4$L! A0#% @ ,W]H62AI>*NT P M=1 !D ("!M>\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H6!( !D M ("!__D 'AL+W=OJ<" #\!P &0 @($U_@ >&PO=V]R:W-H M965T&UL4$L! M A0#% @ ,W]H62:=YQ:W @ $ @ !D ("!U0,! 'AL M+W=OG_VP# M #-#@ &0 @('#!@$ >&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H M60:*]&=I" D$ !D ("!0@T! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H61B-"<[K"P #*8 M !D ("!SB$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H6;G8?'GF!0 J2< !D M ("!73,! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ ,W]H62T$D@KX @ WPD !D ("![SX! 'AL+W=O M0@$ >&PO=V]R:W-H965TP@ $)A 9 " @3!' M 0!X;"]W;W)K&UL4$L! A0#% @ ,W]H6;VV MC,%W @ RP< !D ("!XD\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ,W]H62"2QZTH! "1< !D M ("!-UH! 'AL+W=O&PO M=V]R:W-H965TJF*0, 8 M ,8S 9 " @?!C 0!X;"]W;W)K&UL4$L! A0#% @ ,W]H61$GFW^3! *1D !D ("! M5VH! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ,W]H63Y@XH9E!@ #RL !D ("!W78! 'AL+W=O&UL+G)E;'-02P$" M% ,4 " S?VA9UD@C+O XML 82 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 264 258 1 false 71 0 false 13 false false R1.htm 0000001 - Document - Cover Sheet http://www.solventum.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated and Combined Statements of Income Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome Condensed Consolidated and Combined Statements of Income Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated and Combined Statements of Comprehensive Income Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome Condensed Consolidated and Combined Statements of Comprehensive Income Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated and Combined Balance Sheets Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets Condensed Consolidated and Combined Balance Sheets Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated and Combined Balance Sheets (Parentheticals) Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals Condensed Consolidated and Combined Balance Sheets (Parentheticals) Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated and Combined Statements of Changes in Equity Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity Condensed Consolidated and Combined Statements of Changes in Equity Statements 6 false false R7.htm 9952156 - Statement - Condensed Consolidated and Combined Statements of Cash Flows Sheet http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows Condensed Consolidated and Combined Statements of Cash Flows Statements 7 false false R8.htm 9952157 - Disclosure - Significant Accounting Policies Sheet http://www.solventum.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 9952158 - Disclosure - Revenue Recognition Sheet http://www.solventum.com/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 9952159 - Disclosure - Goodwill and Intangible Assets Sheet http://www.solventum.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 10 false false R11.htm 9952160 - Disclosure - Other Current Liabilities Sheet http://www.solventum.com/role/OtherCurrentLiabilities Other Current Liabilities Notes 11 false false R12.htm 9952161 - Disclosure - Property, Plant, and Equipment - Net Sheet http://www.solventum.com/role/PropertyPlantandEquipmentNet Property, Plant, and Equipment - Net Notes 12 false false R13.htm 9952162 - Disclosure - Comprehensive Income Information Sheet http://www.solventum.com/role/ComprehensiveIncomeInformation Comprehensive Income Information Notes 13 false false R14.htm 9952163 - Disclosure - Income Taxes Sheet http://www.solventum.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 9952164 - Disclosure - Long-Term Debt and Short-Term Borrowings Sheet http://www.solventum.com/role/LongTermDebtandShortTermBorrowings Long-Term Debt and Short-Term Borrowings Notes 15 false false R16.htm 9952165 - Disclosure - Pension and Postretirement Benefit Plans Sheet http://www.solventum.com/role/PensionandPostretirementBenefitPlans Pension and Postretirement Benefit Plans Notes 16 false false R17.htm 9952166 - Disclosure - Derivatives Sheet http://www.solventum.com/role/Derivatives Derivatives Notes 17 false false R18.htm 9952167 - Disclosure - Commitment and Contingencies Sheet http://www.solventum.com/role/CommitmentandContingencies Commitment and Contingencies Notes 18 false false R19.htm 9952168 - Disclosure - Earnings Per Share Sheet http://www.solventum.com/role/EarningsPerShare Earnings Per Share Notes 19 false false R20.htm 9952169 - Disclosure - Stock-Based Compensation Sheet http://www.solventum.com/role/StockBasedCompensation Stock-Based Compensation Notes 20 false false R21.htm 9952170 - Disclosure - Related Parties Sheet http://www.solventum.com/role/RelatedParties Related Parties Notes 21 false false R22.htm 9952171 - Disclosure - Business Segments Sheet http://www.solventum.com/role/BusinessSegments Business Segments Notes 22 false false R23.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 23 false false R24.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 24 false false R25.htm 9954471 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.solventum.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.solventum.com/role/SignificantAccountingPolicies 25 false false R26.htm 9954472 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.solventum.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.solventum.com/role/SignificantAccountingPolicies 26 false false R27.htm 9954473 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.solventum.com/role/GoodwillandIntangibleAssets 27 false false R28.htm 9954474 - Disclosure - Other Current Liabilities (Tables) Sheet http://www.solventum.com/role/OtherCurrentLiabilitiesTables Other Current Liabilities (Tables) Tables http://www.solventum.com/role/OtherCurrentLiabilities 28 false false R29.htm 9954475 - Disclosure - Property, Plant, and Equipment - Net (Tables) Sheet http://www.solventum.com/role/PropertyPlantandEquipmentNetTables Property, Plant, and Equipment - Net (Tables) Tables http://www.solventum.com/role/PropertyPlantandEquipmentNet 29 false false R30.htm 9954476 - Disclosure - Comprehensive Income Information (Tables) Sheet http://www.solventum.com/role/ComprehensiveIncomeInformationTables Comprehensive Income Information (Tables) Tables http://www.solventum.com/role/ComprehensiveIncomeInformation 30 false false R31.htm 9954477 - Disclosure - Long-Term Debt and Short-Term Borrowings (Tables) Sheet http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsTables Long-Term Debt and Short-Term Borrowings (Tables) Tables http://www.solventum.com/role/LongTermDebtandShortTermBorrowings 31 false false R32.htm 9954478 - Disclosure - Pension and Postretirement Benefit Plans (Tables) Sheet http://www.solventum.com/role/PensionandPostretirementBenefitPlansTables Pension and Postretirement Benefit Plans (Tables) Tables http://www.solventum.com/role/PensionandPostretirementBenefitPlans 32 false false R33.htm 9954479 - Disclosure - Derivatives (Tables) Sheet http://www.solventum.com/role/DerivativesTables Derivatives (Tables) Tables http://www.solventum.com/role/Derivatives 33 false false R34.htm 9954480 - Disclosure - Earnings Per Share (Tables) Sheet http://www.solventum.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.solventum.com/role/EarningsPerShare 34 false false R35.htm 9954481 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.solventum.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.solventum.com/role/StockBasedCompensation 35 false false R36.htm 9954482 - Disclosure - Related Parties (Tables) Sheet http://www.solventum.com/role/RelatedPartiesTables Related Parties (Tables) Tables http://www.solventum.com/role/RelatedParties 36 false false R37.htm 9954483 - Disclosure - Business Segments (Tables) Sheet http://www.solventum.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.solventum.com/role/BusinessSegments 37 false false R38.htm 9954484 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.solventum.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.solventum.com/role/SignificantAccountingPoliciesTables 38 false false R39.htm 9954485 - Disclosure - Revenue Recognition (Details) Sheet http://www.solventum.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://www.solventum.com/role/RevenueRecognition 39 false false R40.htm 9954486 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 40 false false R41.htm 9954487 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details) Details 41 false false R42.htm 9954488 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details) Details 42 false false R43.htm 9954489 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) Details 43 false false R44.htm 9954490 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details) Sheet http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details) Details 44 false false R45.htm 9954491 - Disclosure - Other Current Liabilities (Details) Sheet http://www.solventum.com/role/OtherCurrentLiabilitiesDetails Other Current Liabilities (Details) Details http://www.solventum.com/role/OtherCurrentLiabilitiesTables 45 false false R46.htm 9954492 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details) Sheet http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details) Details 46 false false R47.htm 9954493 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details) Sheet http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofDepreciationExpensesDetails Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details) Details 47 false false R48.htm 9954494 - Disclosure - Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details) Sheet http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details) Details 48 false false R49.htm 9954495 - Disclosure - Income Taxes (Details) Sheet http://www.solventum.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.solventum.com/role/IncomeTaxes 49 false false R50.htm 9954496 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details) Sheet http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details) Details 50 false false R51.htm 9954497 - Disclosure - Long-Term Debt and Short-Term Borrowings - Narrative (Details) Sheet http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails Long-Term Debt and Short-Term Borrowings - Narrative (Details) Details 51 false false R52.htm 9954498 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details) Sheet http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details) Details 52 false false R53.htm 9954499 - Disclosure - Pension and Postretirement Benefit Plans - Narrative (Details) Sheet http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails Pension and Postretirement Benefit Plans - Narrative (Details) Details 53 false false R54.htm 9954500 - Disclosure - Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details) Sheet http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details) Details 54 false false R55.htm 9954501 - Disclosure - Derivatives - Narrative (Details) Sheet http://www.solventum.com/role/DerivativesNarrativeDetails Derivatives - Narrative (Details) Details 55 false false R56.htm 9954502 - Disclosure - Derivatives - Cash Flow Hedges (Details) Sheet http://www.solventum.com/role/DerivativesCashFlowHedgesDetails Derivatives - Cash Flow Hedges (Details) Details 56 false false R57.htm 9954503 - Disclosure - Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details) Sheet http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details) Details 57 false false R58.htm 9954504 - Disclosure - Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details) Sheet http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details) Details 58 false false R59.htm 9954505 - Disclosure - Commitment and Contingencies (Details) Sheet http://www.solventum.com/role/CommitmentandContingenciesDetails Commitment and Contingencies (Details) Details http://www.solventum.com/role/CommitmentandContingencies 59 false false R60.htm 9954506 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.solventum.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 60 false false R61.htm 9954507 - Disclosure - Earnings Per Share - Schedule of Computation of Earnings Per Share (Details) Sheet http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails Earnings Per Share - Schedule of Computation of Earnings Per Share (Details) Details 61 false false R62.htm 9954508 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.solventum.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 62 false false R63.htm 9954509 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) Details 63 false false R64.htm 9954510 - Disclosure - Related Parties - Schedule of Parent's Expense Allocations (Details) Sheet http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails Related Parties - Schedule of Parent's Expense Allocations (Details) Details 64 false false R65.htm 9954511 - Disclosure - Related Parties - Narrative (Details) Sheet http://www.solventum.com/role/RelatedPartiesNarrativeDetails Related Parties - Narrative (Details) Details 65 false false R66.htm 9954512 - Disclosure - Related Parties - Condensed Consolidated Statements of Income (Details) Sheet http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails Related Parties - Condensed Consolidated Statements of Income (Details) Details 66 false false R67.htm 9954513 - Disclosure - Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details) Sheet http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details) Details 67 false false R68.htm 9954514 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.solventum.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 68 false false R69.htm 9954515 - Disclosure - Business Segments - Schedule of Business Segment Information (Details) Sheet http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails Business Segments - Schedule of Business Segment Information (Details) Details 69 false false All Reports Book All Reports solv-20240930.htm solv-20240930.xsd solv-20240930_cal.xml solv-20240930_def.xml solv-20240930_lab.xml solv-20240930_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "solv-20240930.htm": { "nsprefix": "solv", "nsuri": "http://www.solventum.com/20240930", "dts": { "inline": { "local": [ "solv-20240930.htm" ] }, "schema": { "local": [ "solv-20240930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "solv-20240930_cal.xml" ] }, "definitionLink": { "local": [ "solv-20240930_def.xml" ] }, "labelLink": { "local": [ "solv-20240930_lab.xml" ] }, "presentationLink": { "local": [ "solv-20240930_pre.xml" ] } }, "keyStandard": 236, "keyCustom": 22, "axisStandard": 29, "axisCustom": 0, "memberStandard": 43, "memberCustom": 28, "hidden": { "total": 14, "http://fasb.org/us-gaap/2024": 8, "http://xbrl.sec.gov/dei/2024": 5, "http://www.solventum.com/20240930": 1 }, "contextCount": 264, "entityCount": 1, "segmentCount": 71, "elementCount": 565, "unitCount": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 942, "http://xbrl.sec.gov/dei/2024": 30, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://www.solventum.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "longName": "9952151 - Statement - Condensed Consolidated and Combined Statements of Income", "shortName": "Condensed Consolidated and Combined Statements of Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:GrossProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R3": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome", "longName": "9952152 - Statement - Condensed Consolidated and Combined Statements of Comprehensive Income", "shortName": "Condensed Consolidated and Combined Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:ComprehensiveIncomeNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R4": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "longName": "9952153 - Statement - Condensed Consolidated and Combined Balance Sheets", "shortName": "Condensed Consolidated and Combined Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals", "longName": "9952154 - Statement - Condensed Consolidated and Combined Balance Sheets (Parentheticals)", "shortName": "Condensed Consolidated and Combined Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "longName": "9952155 - Statement - Condensed Consolidated and Combined Statements of Changes in Equity", "shortName": "Condensed Consolidated and Combined Statements of Changes in Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-54", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-54", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows", "longName": "9952156 - Statement - Condensed Consolidated and Combined Statements of Cash Flows", "shortName": "Condensed Consolidated and Combined Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R8": { "role": "http://www.solventum.com/role/SignificantAccountingPolicies", "longName": "9952157 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.solventum.com/role/RevenueRecognition", "longName": "9952158 - Disclosure - Revenue Recognition", "shortName": "Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssets", "longName": "9952159 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.solventum.com/role/OtherCurrentLiabilities", "longName": "9952160 - Disclosure - Other Current Liabilities", "shortName": "Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.solventum.com/role/PropertyPlantandEquipmentNet", "longName": "9952161 - Disclosure - Property, Plant, and Equipment - Net", "shortName": "Property, Plant, and Equipment - Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.solventum.com/role/ComprehensiveIncomeInformation", "longName": "9952162 - Disclosure - Comprehensive Income Information", "shortName": "Comprehensive Income Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.solventum.com/role/IncomeTaxes", "longName": "9952163 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.solventum.com/role/LongTermDebtandShortTermBorrowings", "longName": "9952164 - Disclosure - Long-Term Debt and Short-Term Borrowings", "shortName": "Long-Term Debt and Short-Term Borrowings", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.solventum.com/role/PensionandPostretirementBenefitPlans", "longName": "9952165 - Disclosure - Pension and Postretirement Benefit Plans", "shortName": "Pension and Postretirement Benefit Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.solventum.com/role/Derivatives", "longName": "9952166 - Disclosure - Derivatives", "shortName": "Derivatives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.solventum.com/role/CommitmentandContingencies", "longName": "9952167 - Disclosure - Commitment and Contingencies", "shortName": "Commitment and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.solventum.com/role/EarningsPerShare", "longName": "9952168 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.solventum.com/role/StockBasedCompensation", "longName": "9952169 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.solventum.com/role/RelatedParties", "longName": "9952170 - Disclosure - Related Parties", "shortName": "Related Parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.solventum.com/role/BusinessSegments", "longName": "9952171 - Disclosure - Business Segments", "shortName": "Business Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": null }, "R24": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-11", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.solventum.com/role/SignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.solventum.com/role/SignificantAccountingPoliciesTables", "longName": "9954472 - Disclosure - Significant Accounting Policies (Tables)", "shortName": "Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954473 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.solventum.com/role/OtherCurrentLiabilitiesTables", "longName": "9954474 - Disclosure - Other Current Liabilities (Tables)", "shortName": "Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.solventum.com/role/PropertyPlantandEquipmentNetTables", "longName": "9954475 - Disclosure - Property, Plant, and Equipment - Net (Tables)", "shortName": "Property, Plant, and Equipment - Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.solventum.com/role/ComprehensiveIncomeInformationTables", "longName": "9954476 - Disclosure - Comprehensive Income Information (Tables)", "shortName": "Comprehensive Income Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsTables", "longName": "9954477 - Disclosure - Long-Term Debt and Short-Term Borrowings (Tables)", "shortName": "Long-Term Debt and Short-Term Borrowings (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.solventum.com/role/PensionandPostretirementBenefitPlansTables", "longName": "9954478 - Disclosure - Pension and Postretirement Benefit Plans (Tables)", "shortName": "Pension and Postretirement Benefit Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.solventum.com/role/DerivativesTables", "longName": "9954479 - Disclosure - Derivatives (Tables)", "shortName": "Derivatives (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.solventum.com/role/EarningsPerShareTables", "longName": "9954480 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.solventum.com/role/StockBasedCompensationTables", "longName": "9954481 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.solventum.com/role/RelatedPartiesTables", "longName": "9954482 - Disclosure - Related Parties (Tables)", "shortName": "Related Parties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.solventum.com/role/BusinessSegmentsTables", "longName": "9954483 - Disclosure - Business Segments (Tables)", "shortName": "Business Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.solventum.com/role/SignificantAccountingPoliciesDetails", "longName": "9954484 - Disclosure - Significant Accounting Policies (Details)", "shortName": "Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-62", "name": "solv:StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "solv:StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.solventum.com/role/RevenueRecognitionDetails", "longName": "9954485 - Disclosure - Revenue Recognition (Details)", "shortName": "Revenue Recognition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "longName": "9954486 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)", "shortName": "Goodwill and Intangible Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails", "longName": "9954487 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Goodwill Balance by Business Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R42": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails", "longName": "9954488 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Finite-Lived and Indefinite-Lived intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "longName": "9954489 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails", "longName": "9954490 - Disclosure - Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails", "longName": "9954491 - Disclosure - Other Current Liabilities (Details)", "shortName": "Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails", "longName": "9954492 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details)", "shortName": "Property, Plant, and Equipment - Net - Schedule of Property, Plant and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofDepreciationExpensesDetails", "longName": "9954493 - Disclosure - Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details)", "shortName": "Property, Plant, and Equipment - Net - Schedule of Depreciation Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "longName": "9954494 - Disclosure - Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details)", "shortName": "Comprehensive Income Information - Schedule Changes in Accumulated Other Compressive Income (Loss) by Component (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-89", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R49": { "role": "http://www.solventum.com/role/IncomeTaxesDetails", "longName": "9954495 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails", "longName": "9954496 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details)", "shortName": "Long-Term Debt and Short-Term Borrowings - Schedule of Long-Term and Short-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "longName": "9954497 - Disclosure - Long-Term Debt and Short-Term Borrowings - Narrative (Details)", "shortName": "Long-Term Debt and Short-Term Borrowings - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-62", "name": "solv:StockholdersEquityNoteSpinoffTransactionRetainedCashTarget", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "solv:StockholdersEquityNoteSpinoffTransactionRetainedCashTarget", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails", "longName": "9954498 - Disclosure - Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details)", "shortName": "Long-Term Debt and Short-Term Borrowings - Schedule of Maturities of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "longName": "9954499 - Disclosure - Pension and Postretirement Benefit Plans - Narrative (Details)", "shortName": "Pension and Postretirement Benefit Plans - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-149", "name": "solv:DefinedBenefitPlanNumberOfPlansTransferredFromParent", "unitRef": "plan", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-149", "name": "solv:DefinedBenefitPlanNumberOfPlansTransferredFromParent", "unitRef": "plan", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails", "longName": "9954500 - Disclosure - Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details)", "shortName": "Pension and Postretirement Benefit Plans - Schedule of Components of Net Periodic Cost Recognized in Other Comprehensive Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-154", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-154", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.solventum.com/role/DerivativesNarrativeDetails", "longName": "9954501 - Disclosure - Derivatives - Narrative (Details)", "shortName": "Derivatives - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "longName": "9954502 - Disclosure - Derivatives - Cash Flow Hedges (Details)", "shortName": "Derivatives - Cash Flow Hedges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-162", "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-162", "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "longName": "9954503 - Disclosure - Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details)", "shortName": "Derivatives - Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-164", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-164", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails", "longName": "9954504 - Disclosure - Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details)", "shortName": "Derivatives - Schedule of Location and Fair Value of Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.solventum.com/role/CommitmentandContingenciesDetails", "longName": "9954505 - Disclosure - Commitment and Contingencies (Details)", "shortName": "Commitment and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:LossContingencyLossInPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:LossContingencyLossInPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.solventum.com/role/EarningsPerShareNarrativeDetails", "longName": "9954506 - Disclosure - Earnings Per Share - Narrative (Details)", "shortName": "Earnings Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-2", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R61": { "role": "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails", "longName": "9954507 - Disclosure - Earnings Per Share - Schedule of Computation of Earnings Per Share (Details)", "shortName": "Earnings Per Share - Schedule of Computation of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R62": { "role": "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails", "longName": "9954508 - Disclosure - Stock-Based Compensation - Narrative (Details)", "shortName": "Stock-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-194", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R63": { "role": "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails", "longName": "9954509 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)", "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R64": { "role": "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails", "longName": "9954510 - Disclosure - Related Parties - Schedule of Parent's Expense Allocations (Details)", "shortName": "Related Parties - Schedule of Parent's Expense Allocations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-214", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R65": { "role": "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "longName": "9954511 - Disclosure - Related Parties - Narrative (Details)", "shortName": "Related Parties - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-11", "name": "solv:NetTransfersToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-218", "name": "solv:SeparationAndDistributionAgreementTransitionDistributionServicesTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R66": { "role": "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "longName": "9954512 - Disclosure - Related Parties - Condensed Consolidated Statements of Income (Details)", "shortName": "Related Parties - Condensed Consolidated Statements of Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-229", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R67": { "role": "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails", "longName": "9954513 - Disclosure - Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details)", "shortName": "Related Parties - Schedule of Reconciliation of Net Transfers to Parent (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-11", "name": "solv:NetTransfersToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-238", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } }, "R68": { "role": "http://www.solventum.com/role/BusinessSegmentsNarrativeDetails", "longName": "9954514 - Disclosure - Business Segments - Narrative (Details)", "shortName": "Business Segments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "operatingsegment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "longName": "9954515 - Disclosure - Business Segments - Schedule of Business Segment Information (Details)", "shortName": "Business Segments - Schedule of Business Segment Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-261", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "solv-20240930.htm", "unique": true } } }, "tag": { "solv_A18MonthSeniorTermLoanCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A18MonthSeniorTermLoanCreditFacilityMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "18-Month Senior Term Loan Credit Facility", "label": "18-Month Senior Term Loan Credit Facility [Member]", "documentation": "18-Month Senior Term Loan Credit Facility" } } }, "auth_ref": [] }, "solv_A2024LongTermIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A2024LongTermIncentivePlanMember", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Solventum 2024 Plan", "label": "2024 Long-Term Incentive Plan [Member]", "documentation": "2024 Long-Term Incentive Plan" } } }, "auth_ref": [] }, "solv_A3MMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A3MMember", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "3M", "label": "3M [Member]", "documentation": "3M" } } }, "auth_ref": [] }, "solv_A3YearSeniorTermLoanCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A3YearSeniorTermLoanCreditFacilityMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "3-Year Senior Term Loan Credit Facility", "label": "3-Year Senior Term Loan Credit Facility [Member]", "documentation": "3-Year Senior Term Loan Credit Facility" } } }, "auth_ref": [] }, "solv_A5.400SeniorNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A5.400SeniorNotesDue2029Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.400% Senior Notes Due 2029", "label": "5.400% Senior Notes Due 2029 [Member]", "documentation": "5.400% Senior Notes Due 2029" } } }, "auth_ref": [] }, "solv_A5.450SeniorNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A5.450SeniorNotesDue2027Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.450% Senior Notes Due 2027", "label": "5.450% Senior Notes Due 2027 [Member]", "documentation": "5.450% Senior Notes Due 2027" } } }, "auth_ref": [] }, "solv_A5.450SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A5.450SeniorNotesDue2031Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.450% Senior Notes Due 2031", "label": "5.450% Senior Notes Due 2031 [Member]", "documentation": "5.450% Senior Notes Due 2031" } } }, "auth_ref": [] }, "solv_A5.600SeniorNotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A5.600SeniorNotesDue2034Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.600% Senior Notes Due 2034", "label": "5.600% Senior Notes Due 2034 [Member]", "documentation": "5.600% Senior Notes Due 2034" } } }, "auth_ref": [] }, "solv_A5.900SeniorNotesDue2054Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A5.900SeniorNotesDue2054Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.900% Senior Notes Due 2054", "label": "5.900% Senior Notes Due 2054 [Member]", "documentation": "5.900% Senior Notes Due 2054" } } }, "auth_ref": [] }, "solv_A6.000SeniorNotesDue2064Member": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "A6.000SeniorNotesDue2064Member", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "6.000% Senior Notes Due 2064", "label": "6.000% Senior Notes Due 2064 [Member]", "documentation": "6.000% Senior Notes Due 2064" } } }, "auth_ref": [] }, "stpr_AL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2024", "localname": "AL", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ALABAMA", "label": "ALABAMA" } } }, "auth_ref": [] }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [ "r496" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Accounts Payable and Accrued Liabilities, Noncurrent", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r76" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r68", "r825" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r756" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable \u2014 net of allowances of $86 and $82", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r966" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r71" ] }, "solv_AccruedRebatesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "AccruedRebatesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates", "label": "Accrued Rebates, Current", "documentation": "Accrued Rebates, Current" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Pension", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r3", "r4", "r13", "r21", "r89", "r944", "r945", "r946" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r36", "r150", "r625" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedging", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r166", "r173", "r174", "r525", "r778", "r944" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r172", "r173", "r552", "r553", "r554", "r555", "r556", "r557" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r20", "r21", "r90", "r158", "r621", "r660", "r661" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r172", "r173", "r552", "r553", "r554", "r555", "r556", "r557" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated Other Comprehensive Income (Loss)", "terseLabel": "Total Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r13", "r21", "r535", "r538", "r566", "r656", "r657", "r944", "r945", "r946", "r955", "r956", "r957", "r958" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Translation Adjustment", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r2", "r13", "r21", "r87", "r88", "r173", "r174", "r553", "r554", "r555", "r556", "r557", "r944" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r890" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in-capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r81", "r825", "r1107" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In-Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r672", "r955", "r956", "r957", "r958", "r1043", "r1108" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r903" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r903" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r903" ] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentForAmortization", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r8" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Common stock for tax withholding obligations", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r47", "r48", "r460" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "solv_AfterSpinOffMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "AfterSpinOffMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After Spin-Off", "label": "After Spin-Off [Member]", "documentation": "After Spin-Off" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r936" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r862", "r872", "r882", "r914" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r865", "r875", "r885", "r917" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r937" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r903" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r910" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r866", "r876", "r886", "r910", "r918", "r922", "r930" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r928" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails", "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails", "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expenses", "negatedTerseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r490", "r494" ] }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "crdr": "debit", "calculation": { "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Stock-based compensation expenses, net of tax", "label": "Share-Based Payment Arrangement, Expense, after Tax", "documentation": "Amount, after tax, of expense for award under share-based payment arrangement." } } }, "auth_ref": [] }, "solv_AllocationOfExpensesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "AllocationOfExpensesLineItems", "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocation of Expenses [Line Items]", "label": "Allocation of Expenses [Line Items]", "documentation": "Allocation of Expenses [Line Items]" } } }, "auth_ref": [] }, "solv_AllocationOfExpensesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "AllocationOfExpensesTable", "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocation of Expenses [Table]", "label": "Allocation of Expenses [Table]", "documentation": "Allocation of Expenses [Table]" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r159", "r256", "r260" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r8", "r275", "r281", "r793" ] }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss), unrealized gain (loss) on cash flow hedges", "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax", "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r165" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r124", "r135", "r154", "r184", "r218", "r225", "r243", "r247", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r523", "r527", "r551", "r616", "r700", "r786", "r787", "r825", "r853", "r1006", "r1007", "r1063" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r146", "r162", "r184", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r523", "r527", "r551", "r825", "r1006", "r1007", "r1063" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r925" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r926" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r921" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r924" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r923" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r922" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r922" ] }, "solv_BairHuggerPatientWarmingSystemsLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "BairHuggerPatientWarmingSystemsLitigationMember", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bair Hugger Patient Warming Systems Litigation", "label": "Bair Hugger Patient Warming Systems Litigation [Member]", "documentation": "Bair Hugger Patient Warming Systems Litigation" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position Location, Balance [Axis]", "label": "Statement of Financial Position Location, Balance [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r295", "r1075", "r1076" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position Location, Balance [Domain]", "label": "Statement of Financial Position Location, Balance [Domain]", "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r51", "r54", "r295", "r1075", "r1076" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BuildingAndBuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BuildingAndBuildingImprovementsMember", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and leasehold improvements", "label": "Building and Building Improvements [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reported Value Measurement", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r60", "r61" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r25", "r148", "r773" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r25", "r101", "r180" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r101" ] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After-tax net unrealized gain (loss) anticipated to be reclassified from AOCI to the income statement within next twelve months", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r59" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedging", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r50" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r901" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r898" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r896" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r902" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r902" ] }, "us-gaap_CommercialPaper": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommercialPaper", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial paper", "label": "Commercial Paper", "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days." } } }, "auth_ref": [ "r67", "r125", "r1072" ] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommercialPaperMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial Paper", "label": "Commercial Paper [Member]", "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds." } } }, "auth_ref": [ "r112", "r312", "r847", "r848", "r849", "r850" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 11)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r77", "r128", "r619", "r687" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/CommitmentandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r110", "r303", "r304", "r757", "r993", "r998" ] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r37", "r758" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r843", "r844", "r845", "r847", "r848", "r849", "r850", "r955", "r956", "r958", "r1043", "r1106", "r1108" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r80" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r80", "r688" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals", "http://www.solventum.com/role/EarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r80" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheetsParentheticals", "http://www.solventum.com/role/EarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r80", "r688", "r706", "r1108", "r1109" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value $0.01 per share, 750,000,000 shares authorized Shares issued and outstanding - June 30, 2024: 172,710,593 Shares issued and outstanding - December 31, 2023: 0", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r80", "r620", "r825" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r907" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r906" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r908" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r905" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r22", "r169", "r171", "r176", "r612", "r630", "r631" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r30", "r31", "r62", "r63", "r254", "r756" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r30", "r31", "r62", "r63", "r254", "r663", "r756" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r30", "r31", "r62", "r63", "r254", "r756", "r942" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk, percentage", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r30", "r31", "r62", "r63", "r254" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r30", "r31", "r62", "r63", "r254", "r756" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r133", "r188", "r218", "r227", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r786", "r787", "r1006", "r1007" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r133", "r188", "r218", "r227", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r786", "r787", "r1006", "r1007" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r366", "r367", "r376" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with customer, liability, revenue recognized", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r377" ] }, "solv_CorporateAndReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "CorporateAndReconcilingItemsMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate and Unallocated", "label": "Corporate and Reconciling Items [Member]", "documentation": "Corporate and Reconciling Items" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "verboseLabel": "Cost of product", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r93", "r94", "r578" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome_1": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "verboseLabel": "Total Corporate and Unallocated", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r99" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "solv_CreditFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "CreditFacilitiesMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facilities", "label": "Credit Facilities [Member]", "documentation": "Credit Facilities" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r312", "r1004" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r312", "r1004", "r1005" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r105", "r254" ] }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRelatedIntangibleAssetsMember", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer related intangible assets", "label": "Customer-Related Intangible Assets [Member]", "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships." } } }, "auth_ref": [ "r17", "r981", "r982", "r983", "r984", "r986", "r988", "r991", "r992" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings and current portion of long-term debt", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r156" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowings" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt and Short-Term Borrowings", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r111", "r182", "r290", "r291", "r292", "r293", "r294", "r311", "r312", "r324", "r330", "r331", "r332", "r333", "r334", "r335", "r340", "r347", "r348", "r350", "r558" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r19", "r70", "r71", "r126", "r127", "r188", "r325", "r326", "r327", "r328", "r329", "r331", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r795", "r796", "r797", "r798", "r799", "r824", "r951", "r994", "r995", "r996", "r1060", "r1061" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total long-term debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r19", "r127", "r351" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r325", "r558", "r559", "r796", "r797", "r824" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate, stated percentage", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r73", "r326" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r188", "r325", "r326", "r327", "r328", "r329", "r331", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r349", "r795", "r796", "r797", "r798", "r799", "r824", "r951", "r1060", "r1061" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r19", "r188", "r325", "r326", "r327", "r328", "r329", "r331", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r795", "r796", "r797", "r798", "r799", "r824", "r951", "r994", "r995", "r996", "r1060", "r1061" ] }, "us-gaap_DebtInstrumentRepaidPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRepaidPrincipal", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment of debt", "label": "Debt Instrument, Repaid, Principal", "documentation": "Amount of principal of debt repaid." } } }, "auth_ref": [ "r666" ] }, "solv_DebtInstrumentSeriesOfNotesIssued": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "DebtInstrumentSeriesOfNotesIssued", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series of notes issued", "label": "Debt Instrument, Series Of Notes Issued", "documentation": "Debt Instrument, Series Of Notes Issued" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r19", "r39", "r40", "r66", "r114", "r115", "r188", "r325", "r326", "r327", "r328", "r329", "r331", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r349", "r795", "r796", "r797", "r798", "r799", "r824", "r951", "r1060", "r1061" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Gross", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1060", "r1061" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r8", "r140", "r953" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r499", "r500", "r617" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets, valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r507" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of net actuarial loss", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r382", "r420", "r445", "r805", "r806" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of prior service benefit", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r382", "r421", "r446", "r805", "r806" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r382", "r419", "r444", "r805", "r806" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r382", "r386", "r418", "r443", "r805", "r806" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total net periodic benefit cost (benefit)", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r416", "r441", "r805", "r806" ] }, "solv_DefinedBenefitPlanNumberOfPlansTransferredFromParent": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "DefinedBenefitPlanNumberOfPlansTransferredFromParent", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of plans transferred from parent", "label": "Defined Benefit Plan, Number Of Plans Transferred From Parent", "documentation": "Defined Benefit Plan, Number Of Plans Transferred From Parent" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r384", "r417", "r442", "r805", "r806" ] }, "solv_DefinedBenefitPlanTransferredPlansNumberOfCountriesIncludedInCoverage": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "DefinedBenefitPlanTransferredPlansNumberOfCountriesIncludedInCoverage", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transferred plans, number of countries included in coverage", "label": "Defined Benefit Plan, Transferred Plans, Number Of Countries Included In Coverage", "documentation": "Defined Benefit Plan, Transferred Plans, Number Of Countries Included In Coverage" } } }, "auth_ref": [] }, "solv_DentalSolutionsSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "DentalSolutionsSegmentMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dental Solutions", "verboseLabel": "Dental Solutions", "label": "Dental Solutions Segment [Member]", "documentation": "Dental Solutions Segment" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofDepreciationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r35" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r8", "r218", "r230", "r247", "r786", "r787" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r677", "r679", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r701", "r702", "r703", "r704", "r718", "r719", "r720", "r721", "r724", "r725", "r726", "r727", "r745", "r746", "r747", "r750", "r843", "r845", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Assets Fair Value Amount", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r16", "r86", "r120", "r121", "r163", "r777" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r52", "r55", "r56", "r122", "r677", "r679", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r701", "r702", "r703", "r704", "r718", "r719", "r720", "r721", "r724", "r725", "r726", "r727", "r745", "r746", "r747", "r750", "r777", "r843", "r845", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/Derivatives" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r119", "r532", "r540" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r15", "r52", "r55" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r15", "r52", "r55", "r56", "r57", "r58", "r531" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r531" ] }, "us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities Fair Value Amount", "label": "Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset." } } }, "auth_ref": [ "r163", "r748", "r749", "r777" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1041", "r1042" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives, Fair Value [Line Items]", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.solventum.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r458", "r463", "r491", "r492", "r493", "r814" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r857" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r889" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DomesticPlanMember", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Plan", "label": "Domestic Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1011", "r1012", "r1013" ] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r900" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r194", "r195", "r196", "r197", "r198", "r199", "r204", "r206", "r211", "r212", "r213", "r217", "r519", "r522", "r543", "r544", "r613", "r632", "r779" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r194", "r195", "r196", "r197", "r198", "r199", "r206", "r211", "r212", "r213", "r217", "r519", "r522", "r543", "r544", "r613", "r632", "r779" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.solventum.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r203", "r214", "r215", "r216" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1057" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.solventum.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate reconciliation, percent", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r502", "r815" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r71" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "calculation": { "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax benefits", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r490" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r855" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r855" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r855" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r939" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r855" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r855" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r855" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r855" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r894" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r935" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r935" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r935" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r143", "r172", "r173", "r174", "r189", "r190", "r191", "r193", "r198", "r200", "r202", "r220", "r258", "r259", "r287", "r365", "r509", "r510", "r516", "r517", "r518", "r520", "r521", "r522", "r534", "r535", "r536", "r537", "r538", "r539", "r542", "r552", "r553", "r554", "r555", "r556", "r557", "r560", "r561", "r566", "r629", "r656", "r657", "r658", "r672", "r730" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r904" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r862", "r872", "r882", "r914" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of Fair Value Measurement", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r338", "r550", "r796", "r797" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r910" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r338", "r796", "r797" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r338", "r796", "r797" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Disclosure of information about location and fair value of derivative instrument and nonderivative instrument designated as hedging instrument." } } }, "auth_ref": [ "r51", "r53", "r57" ] }, "solv_FederalFalseClaimsActQuiTamLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "FederalFalseClaimsActQuiTamLitigationMember", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal False Claims Act/Qui Tam Litigation", "label": "Federal False Claims Act/Qui Tam Litigation [Member]", "documentation": "Federal False Claims Act/Qui Tam Litigation" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Total accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r152", "r261", "r280", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After 2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r989", "r1110" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r282", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [ "r1110" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r282", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r282", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r282", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r282", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r274", "r276", "r277", "r278", "r279", "r280", "r284", "r285", "r579", "r580", "r770" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total gross carrying amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r261", "r280", "r580", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274", "r280", "r284", "r285", "r286", "r579", "r770", "r793" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r274", "r276", "r277", "r278", "r279", "r280", "r284", "r285", "r770" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total finite-lived intangible assets \u2014 net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r579", "r988" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Contract", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r777", "r804", "r816", "r817" ] }, "us-gaap_ForeignPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignPlanMember", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International", "label": "Foreign Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1011", "r1012", "r1013" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r866", "r876", "r886", "r918" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r866", "r876", "r886", "r918" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r866", "r876", "r886", "r918" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r866", "r876", "r886", "r918" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r866", "r876", "r886", "r918" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on business divestitures", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r526", "r950" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r151", "r262", "r611", "r787", "r792", "r818", "r825", "r970", "r977" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, acquired during period", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r265", "r792" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r968", "r980" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Translation impact", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r269" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillLineItems", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r792" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillRollForward", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r91", "r95", "r134", "r184", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r551", "r781", "r786", "r960", "r962", "r963", "r964", "r965", "r1006" ] }, "solv_HealthInformationSystemsSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "HealthInformationSystemsSegmentMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health Information Systems", "verboseLabel": "Health Information Systems", "label": "Health Information Systems Segment [Member]", "documentation": "Health Information Systems Segment" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r15", "r531" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r15" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.solventum.com/role/DerivativesCashFlowHedgesDetails", "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r92", "r130", "r134", "r614", "r627", "r781", "r786", "r960", "r962", "r963", "r964", "r965" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r288", "r295", "r298", "r546", "r547", "r548", "r653", "r655", "r715", "r770", "r819", "r1077" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r295", "r298", "r546", "r547", "r548", "r653", "r655", "r715", "r770", "r819", "r1077" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r185", "r498", "r502", "r503", "r504", "r505", "r506", "r508", "r511", "r513", "r514", "r515", "r668", "r815" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r136", "r141", "r201", "r202", "r218", "r233", "r247", "r501", "r502", "r512", "r633", "r815" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueFromRelatedParties", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Due from related parties", "label": "Increase (Decrease) in Due from Related Parties", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilution associated with stock-based compensation plans (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r207", "r208", "r209", "r213", "r462" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r261", "r283", "r793" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r866", "r876", "r886", "r910", "r918", "r922", "r930" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r928" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r858", "r934" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r858", "r934" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r858", "r934" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets \u2014 net", "totalLabel": "Intangible assets \u2014 net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r274", "r988", "r990" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntellectualPropertyMember", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents and other technology-based intangible assets", "label": "Intellectual Property [Member]", "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights." } } }, "auth_ref": [ "r18", "r981", "r982", "r983", "r984", "r986", "r988", "r991", "r992" ] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense, net", "negatedLabel": "Interest expense, net", "label": "Interest Income (Expense), Nonoperating", "documentation": "Amount of interest income (expense) classified as nonoperating." } } }, "auth_ref": [ "r786", "r947", "r962" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest Payable, Current", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r71" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r107", "r775" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r160", "r774", "r825" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNetAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and supplies", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments." } } }, "auth_ref": [ "r107", "r943" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r107", "r776" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r19", "r70", "r71", "r72", "r75", "r76", "r77", "r78", "r184", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r524", "r527", "r528", "r551", "r686", "r780", "r853", "r1006", "r1063", "r1064" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r85", "r129", "r623", "r825", "r952", "r967", "r1056" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r72", "r147", "r184", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r524", "r527", "r528", "r551", "r825", "r1006", "r1063", "r1064" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term line of credit", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r19", "r127", "r1073" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r69", "r74" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseAxis", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]" } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r19", "r127", "r337", "r352", "r796", "r797", "r824", "r1073" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r155" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r1044", "r1045", "r1046", "r1047" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After 2029", "label": "Long-Term Debt, Maturity, after Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r1009" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r342" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2029", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r342" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r342" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r342" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r10", "r188", "r342" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofMaturitiesofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2024", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r954" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt (excluding current portion)", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r157" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r19", "r994", "r995", "r996" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r19", "r38", "r994", "r995", "r996" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r305", "r306", "r307", "r310", "r495", "r794", "r1000", "r1001" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r305", "r306", "r307", "r310", "r495", "r794", "r1000", "r1001" ] }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyAccrualAtCarryingValue", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency accrual", "label": "Loss Contingency Accrual", "documentation": "Amount of loss contingency liability." } } }, "auth_ref": [ "r305", "r940" ] }, "solv_LossContingencyBellwetherCasesVoluntarilyDismissedByPlaintiffs": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyBellwetherCasesVoluntarilyDismissedByPlaintiffs", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases voluntarily dismissed by plaintiffs", "label": "Loss Contingency, Bellwether Cases, Voluntarily Dismissed By Plaintiffs", "documentation": "Loss Contingency, Bellwether Cases, Voluntarily Dismissed By Plaintiffs" } } }, "auth_ref": [] }, "us-gaap_LossContingencyClaimsDismissedNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyClaimsDismissedNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases dismissed", "label": "Loss Contingency, Claims Dismissed, Number", "documentation": "Number of claims dismissed." } } }, "auth_ref": [ "r1000", "r1001" ] }, "solv_LossContingencyClaimsRemandedToFederalCourtNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyClaimsRemandedToFederalCourtNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases removed to federal court", "label": "Loss Contingency, Claims Remanded To Federal Court, Number", "documentation": "Loss Contingency, Claims Remanded To Federal Court, Number" } } }, "auth_ref": [] }, "solv_LossContingencyClaimsSelectedForBellwetherProcessNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyClaimsSelectedForBellwetherProcessNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases selected for bellwether process", "label": "Loss Contingency, Claims Selected For Bellwether Process, Number", "documentation": "Loss Contingency, Claims Selected For Bellwether Process, Number" } } }, "auth_ref": [] }, "us-gaap_LossContingencyClaimsSettledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyClaimsSettledNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of cases settled", "label": "Loss Contingency, Claims Settled, Number", "documentation": "Number of claims settled." } } }, "auth_ref": [ "r1000", "r1001" ] }, "solv_LossContingencyEmployeesWhoFiledClaimsNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyEmployeesWhoFiledClaimsNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees who filed qui tam actions", "label": "Loss Contingency, Employees Who Filed Claims, Number", "documentation": "Loss Contingency, Employees Who Filed Claims, Number" } } }, "auth_ref": [] }, "us-gaap_LossContingencyLossInPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyLossInPeriod", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal charges (recoveries) in period", "label": "Loss Contingency, Loss in Period", "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates." } } }, "auth_ref": [ "r999" ] }, "us-gaap_LossContingencyPendingClaimsNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyPendingClaimsNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of pending/ongoing cases", "label": "Loss Contingency, Pending Claims, Number", "documentation": "Number of pending claims pertaining to a loss contingency." } } }, "auth_ref": [ "r1000", "r1001" ] }, "solv_LossContingencyPutativeClassActionNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyPutativeClassActionNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of putative class actions", "label": "Loss Contingency, Putative Class Action, Number", "documentation": "Loss Contingency, Putative Class Action, Number" } } }, "auth_ref": [] }, "solv_LossContingencyTotalClaimsToDateNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "LossContingencyTotalClaimsToDateNumber", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total lawsuits to date", "label": "Loss Contingency, Total Claims To Date, Number", "documentation": "Loss Contingency, Total Claims To Date, Number" } } }, "auth_ref": [] }, "stpr_MO": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2024", "localname": "MO", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MISSOURI", "label": "MISSOURI" } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r254", "r803", "r835", "r840", "r1010", "r1074", "r1078", "r1079", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "solv_MasterSupplyAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "MasterSupplyAgreementsMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Master Supply Agreements", "label": "Master Supply Agreements [Member]", "documentation": "Master Supply Agreements" } } }, "auth_ref": [] }, "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1", "presentation": [ "http://www.solventum.com/role/DerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum length of time hedged in cash flow hedge", "label": "Maximum Length of Time Hedged in Cash Flow Hedge", "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r12" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r456", "r495", "r545", "r577", "r652", "r654", "r662", "r678", "r679", "r738", "r740", "r742", "r743", "r751", "r768", "r769", "r791", "r800", "r813", "r820", "r821", "r822", "r823", "r836", "r1008", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r902" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r902" ] }, "solv_MedSurgSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "MedSurgSegmentMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MedSurg", "verboseLabel": "MedSurg", "label": "MedSurg Segment [Member]", "documentation": "MedSurg Segment" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r456", "r495", "r545", "r577", "r652", "r654", "r662", "r678", "r679", "r738", "r740", "r742", "r743", "r751", "r768", "r769", "r791", "r800", "r813", "r820", "r821", "r822", "r836", "r1008", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r921" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r929" ] }, "us-gaap_MultiemployerPlanEmployerContributionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MultiemployerPlanEmployerContributionCost", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Multiemployer pension expense", "label": "Multiemployer Plan, Employer Contribution, Cost", "documentation": "Amount of cost for employer contribution to multiemployer plan. Multiemployer plan includes, but is not limited to, pension plan determined to be individually significant and insignificant and other postretirement benefit plan." } } }, "auth_ref": [ "r454", "r455", "r457", "r813" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r254", "r803", "r835", "r840", "r1010", "r1074", "r1078", "r1079", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r903" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r179" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows from Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r179" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows from Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r101", "r102", "r103" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows from Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 }, "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r96", "r103", "r131", "r145", "r167", "r170", "r174", "r184", "r192", "r194", "r195", "r196", "r197", "r198", "r201", "r202", "r210", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r519", "r522", "r544", "r551", "r628", "r708", "r728", "r729", "r851", "r1006" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]" } } }, "auth_ref": [] }, "solv_NetParentInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetParentInvestment", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Net parent investment", "label": "Net Parent Investment", "documentation": "Net Parent Investment" } } }, "auth_ref": [] }, "solv_NetParentInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetParentInvestmentMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Parent Investment", "label": "Net Parent Investment [Member]", "documentation": "Net Parent Investment" } } }, "auth_ref": [] }, "solv_NetPeriodicBenefitCostBenefitNonOperatingExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetPeriodicBenefitCostBenefitNonOperatingExpenseAbstract", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating expense", "label": "Net Periodic Benefit Cost (Benefit), Non-Operating Expense [Abstract]", "documentation": "Net Periodic Benefit Cost (Benefit), Non-Operating Expense" } } }, "auth_ref": [] }, "solv_NetPeriodicBenefitCostBenefitOperatingExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetPeriodicBenefitCostBenefitOperatingExpenseAbstract", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expense", "label": "Net Periodic Benefit Cost (Benefit), Operating Expense [Abstract]", "documentation": "Net Periodic Benefit Cost (Benefit), Operating Expense" } } }, "auth_ref": [] }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-operating expense (benefit)", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits." } } }, "auth_ref": [ "r382" ] }, "solv_NetTransfersFromParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetTransfersFromParent", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net balances transferred from 3M", "label": "Net Transfers From Parent", "documentation": "Net Transfers From Parent" } } }, "auth_ref": [] }, "solv_NetTransfersToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "NetTransfersToParent", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net transfers to 3M", "terseLabel": "Net transfers to 3M", "negatedLabel": "Net transfers to 3M on the condensed consolidated and combined changes in equity", "label": "Net Transfers To Parent", "documentation": "Net Transfers To Parent" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r902" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r866", "r876", "r886", "r910", "r918" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r893" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r892" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r910" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r929" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r929" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NondesignatedMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsNarrativeDetails", "http://www.solventum.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r787", "r961" ] }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts before reclassifications", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r21" ] }, "solv_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "OneCustomerMember", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Customer", "label": "One Customer [Member]", "documentation": "One Customer" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "terseLabel": "Operating Income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r134", "r781", "r960", "r962", "r963", "r964", "r965" ] }, "us-gaap_OperatingLeaseLeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLeaseIncome", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, lease income", "label": "Operating Lease, Lease Income", "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable." } } }, "auth_ref": [ "r219", "r564", "r565" ] }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/RevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Lessor, Operating Leases [Text Block]", "documentation": "The entire disclosure for lessor's operating leases." } } }, "auth_ref": [ "r563" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r245", "r248", "r786", "r787" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r71" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r161", "r825" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r153" ] }, "solv_OtherBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "OtherBorrowingsMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other borrowings", "label": "Other Borrowings [Member]", "documentation": "Other Borrowings" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Defined benefit pension", "negatedNetLabel": "Defined benefit pension", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent." } } }, "auth_ref": [ "r3", "r4", "r13", "r89", "r90", "r118" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative translation adjustment", "terseLabel": "Cumulative translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r5", "r13", "r118" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), before tax", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent", "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r5", "r13", "r118" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), before tax:", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedging instruments", "verboseLabel": "Cash flow hedging", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r165" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofGainsLossonDerivativeInstrumentsDesignatedasHedgesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward contracts", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r164", "r165", "r529", "r530", "r533" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r5", "r13", "r118", "r168", "r171", "r198" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax effect", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r5", "r13", "r118" ] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Assets", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r51", "r57" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Total other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r71", "r825" ] }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r76" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Noncurrent Assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.solventum.com/role/DerivativesScheduleofLocationandFairValueofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Noncurrent Liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other expense (income), net", "negatedLabel": "Other expense/(income), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r98" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "All other operating activities", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other corporate and unallocated", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r902" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postretirement Benefits", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r380", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r428", "r429", "r431", "r434", "r437", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r453", "r454", "r455", "r805", "r806", "r807", "r808", "r809" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related parties", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r864", "r874", "r884", "r916" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r867", "r877", "r887", "r919" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r867", "r877", "r887", "r919" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r891" ] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for legal settlements", "label": "Payments for Legal Settlements", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r6" ] }, "solv_PaymentsForProceedsFromParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "PaymentsForProceedsFromParent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net transfers to 3M", "negatedTerseLabel": "Net transfers to 3M on the condensed consolidated and combined statements of cash flows", "label": "Payments For (Proceeds From) Parent", "documentation": "Payments For (Proceeds From) Parent" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r100" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r901" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r901" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Postretirement Benefit Plans", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r379", "r404", "r406", "r412", "r430", "r432", "r433", "r434", "r435", "r436", "r451", "r452", "r453", "r805" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefit expense", "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash", "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefits", "label": "Liability, Defined Benefit Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r76", "r380", "r381", "r403", "r805" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Qualified\u00a0and\u00a0Non-qualified Pension\u00a0Benefits", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r380", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r428", "r429", "r431", "r434", "r437", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r453", "r454", "r457", "r805", "r806", "r810", "r811", "r812" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r893" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r910" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r903" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r892" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r894" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r938" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r893" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r549" ] }, "solv_PriorToSpinOffMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "PriorToSpinOffMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior To Spin-Off", "label": "Prior To Spin-Off [Member]", "documentation": "Prior To Spin-Off" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt, net of issuance costs", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r178" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of business", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term lines of credit", "label": "Proceeds from Long-Term Lines of Credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r24" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other \u2014 net", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r941", "r948" ] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of product", "label": "Product [Member]", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r801" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r250", "r578", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r771", "r801", "r834", "r836", "r837", "r841", "r842", "r1002", "r1003", "r1010", "r1074", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r250", "r578", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r771", "r801", "r834", "r836", "r837", "r841", "r842", "r1002", "r1003", "r1010", "r1074", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9", "r562" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNet" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant, and Equipment - Net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r108", "r137", "r138", "r139" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross property, plant and equipment", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r109", "r149", "r626" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r562" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment \u2014 net", "totalLabel": "Property, plant and equipment - net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r562", "r615", "r626", "r825" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property, Plant and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r109", "r562" ] }, "solv_PurificationAndFiltrationSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "PurificationAndFiltrationSegmentMember", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purification and Filtration", "verboseLabel": "Purification and Filtration", "label": "Purification and Filtration Segment [Member]", "documentation": "Purification and Filtration Segment" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r891" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r891" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r404", "r456", "r486", "r487", "r488", "r495", "r545", "r575", "r576", "r577", "r652", "r654", "r662", "r678", "r679", "r738", "r740", "r742", "r743", "r751", "r768", "r769", "r791", "r800", "r813", "r820", "r821", "r822", "r823", "r836", "r845", "r997", "r1008", "r1046", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r404", "r456", "r486", "r487", "r488", "r495", "r545", "r575", "r576", "r577", "r652", "r654", "r662", "r678", "r679", "r738", "r740", "r742", "r743", "r751", "r768", "r769", "r791", "r800", "r813", "r820", "r821", "r822", "r823", "r836", "r845", "r997", "r1008", "r1046", "r1066", "r1067", "r1068", "r1069", "r1070" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "crdr": "debit", "calculation": { "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified out", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r21" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related and Nonrelated Parties [Domain]", "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r255", "r431", "r570", "r571", "r618", "r624", "r681", "r682", "r683", "r684", "r685", "r705", "r707", "r737" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r186", "r187", "r570", "r571", "r572", "r573", "r618", "r624", "r681", "r682", "r683", "r684", "r685", "r705", "r707", "r737" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r570", "r571", "r1062" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r255", "r711", "r712", "r715" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related and Nonrelated Parties [Axis]", "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r255", "r431", "r570", "r571", "r618", "r624", "r681", "r682", "r683", "r684", "r685", "r705", "r707", "r737", "r1062" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "terseLabel": "Related Parties", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r567", "r568", "r569", "r571", "r574", "r669", "r670", "r671", "r713", "r714", "r715", "r734", "r736" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebt", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayment of debt", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r949" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "verboseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r497", "r770", "r786", "r1071" ] }, "solv_ResearchDevelopmentAndRelatedExpensesMemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "ResearchDevelopmentAndRelatedExpensesMemberMember", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research, development and related expenses", "label": "Research Development And Related Expenses Member [Member]", "documentation": "Research Development And Related Expenses Member" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r860", "r870", "r880", "r912" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r861", "r871", "r881", "r913" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r868", "r878", "r888", "r920" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r296", "r297", "r300", "r301" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r82", "r116", "r622", "r659", "r661", "r667", "r689", "r825" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r143", "r189", "r190", "r191", "r193", "r198", "r200", "r202", "r258", "r259", "r287", "r509", "r510", "r516", "r517", "r518", "r520", "r521", "r522", "r534", "r536", "r537", "r539", "r542", "r560", "r561", "r656", "r658", "r672", "r1108" ] }, "us-gaap_RetirementPlanSponsorLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanSponsorLocationAxis", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Axis]", "label": "Retirement Plan Sponsor Location [Axis]", "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r431", "r434", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r1011", "r1012", "r1013" ] }, "us-gaap_RetirementPlanSponsorLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanSponsorLocationDomain", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Domain]", "label": "Retirement Plan Sponsor Location [Domain]", "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r431", "r434", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r1011", "r1012", "r1013" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r380", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r428", "r429", "r431", "r434", "r437", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r453", "r454", "r455", "r457", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r380", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r428", "r429", "r431", "r434", "r437", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r453", "r454", "r455", "r457", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.solventum.com/role/RevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r142", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r378" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "presentation": [ "http://www.solventum.com/role/RevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 }, "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome_1": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total net sales", "verboseLabel": "Net sales of product", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r132", "r133", "r175", "r184", "r218", "r226", "r227", "r241", "r247", "r250", "r252", "r254", "r257", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r322", "r323", "r551", "r614", "r786", "r1006" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r929" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r929" ] }, "solv_SalesOfSoftwareAndRentalsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SalesOfSoftwareAndRentalsMember", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of software and rentals", "label": "Sales Of Software And Rentals [Member]", "documentation": "Sales Of Software And Rentals" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r21", "r1058", "r1059" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.solventum.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Gains (Loss) on Derivative Instruments Designated as Hedges", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r123" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long -Term Debt and Short-Term Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansNarrativeDetails", "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan [Table]", "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r11", "r41", "r42", "r43", "r44" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.solventum.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Location and Fair Value of Derivative Instruments", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.solventum.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r959" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r46" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset." } } }, "auth_ref": [ "r274", "r280", "r284", "r285", "r286", "r579", "r770", "r793" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r793", "r987" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Goodwill [Table]", "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason." } } }, "auth_ref": [ "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r792" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill Segment", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r792", "r969", "r970", "r971", "r972", "r973", "r974", "r975", "r976", "r977", "r978", "r979" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r793", "r990" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturities of Long-Term Debt", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Benefit Costs", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r117" ] }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounting Standards Update and Change in Accounting Principle", "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]", "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items." } } }, "auth_ref": [ "r26", "r27", "r28", "r29", "r1040" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.solventum.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9", "r562" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesNarrativeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Table]", "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r64", "r65", "r711", "r712", "r715" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.solventum.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r32", "r33", "r34" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r32", "r33", "r34" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails", "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r459", "r461", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r793", "r989" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r854" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r856" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r132", "r133", "r134", "r135", "r218", "r222", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r254", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r286", "r299", "r302", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r783", "r786", "r787", "r792", "r839", "r1074", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r252", "r253", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r674", "r675", "r676", "r739", "r741", "r744", "r752", "r755", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r772", "r802", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r838", "r845", "r1010", "r1074", "r1078", "r1079", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/BusinessSegments" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segments", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r135", "r218", "r221", "r222", "r223", "r224", "r225", "r237", "r239", "r240", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r254", "r782", "r784", "r785", "r786", "r788", "r789", "r790" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/RelatedPartiesCondensedConsolidatedStatementsofIncomeDetails", "http://www.solventum.com/role/RelatedPartiesScheduleofParentsExpenseAllocationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "verboseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r97" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails", "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsScheduleofLongTermandShortTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "solv_SeparationAndDistributionAgreementIndividualServicesTerms": { "xbrltype": "durationItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SeparationAndDistributionAgreementIndividualServicesTerms", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation and distribution agreement, individual services, terms", "label": "Separation And Distribution Agreement, Individual Services, Terms", "documentation": "Separation And Distribution Agreement, Individual Services, Terms" } } }, "auth_ref": [] }, "solv_SeparationAndDistributionAgreementMasterSupplyAgreementsTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SeparationAndDistributionAgreementMasterSupplyAgreementsTerm", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation and distribution agreement, master supply, terms", "label": "Separation And Distribution Agreement, Master Supply Agreements, Term", "documentation": "Separation And Distribution Agreement, Master Supply Agreements, Term" } } }, "auth_ref": [] }, "solv_SeparationAndDistributionAgreementRealEstateLicenseAgreementsTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SeparationAndDistributionAgreementRealEstateLicenseAgreementsTerm", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation and distribution agreement, real estate license terms", "label": "Separation And Distribution Agreement, Real Estate License Agreements, Term", "documentation": "Separation And Distribution Agreement, Real Estate License Agreements, Term" } } }, "auth_ref": [] }, "solv_SeparationAndDistributionAgreementTransitionDistributionServicesTerms": { "xbrltype": "durationItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SeparationAndDistributionAgreementTransitionDistributionServicesTerms", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation and distribution agreement, transition services", "label": "Separation And Distribution Agreement, Transition Distribution Services, Terms", "documentation": "Separation And Distribution Agreement, Transition Distribution Services" } } }, "auth_ref": [] }, "solv_SeparationAndDistributionAgreementTransitionManufacturingContractTerms": { "xbrltype": "durationItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "SeparationAndDistributionAgreementTransitionManufacturingContractTerms", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation and distribution agreement, transition manufacturing contract", "label": "Separation And Distribution Agreement, Transition Manufacturing Contract, Terms", "documentation": "Separation And Distribution Agreement, Transition Manufacturing Contract, Terms" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails", "http://www.solventum.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r459", "r461", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum shares issued", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r45" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r70", "r994", "r995", "r996" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r68", "r994", "r995", "r996" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r104", "r181" ] }, "us-gaap_SpinoffMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SpinoffMember", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Spinoff", "label": "Spinoff [Member]", "documentation": "Creation of an independent entity from an existing entity through divestiture, for example, but not limited to, sale or distribution of new shares." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.solventum.com/role/BusinessSegmentsScheduleofBusinessSegmentInformationDetails", "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillBalancebyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r132", "r133", "r134", "r135", "r144", "r218", "r222", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r254", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r286", "r289", "r299", "r302", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r783", "r786", "r787", "r792", "r839", "r1074", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/RelatedPartiesScheduleofReconciliationofNetTransferstoParentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r80", "r83", "r84", "r143", "r172", "r173", "r174", "r189", "r190", "r191", "r193", "r198", "r200", "r202", "r220", "r258", "r259", "r287", "r365", "r509", "r510", "r516", "r517", "r518", "r520", "r521", "r522", "r534", "r535", "r536", "r537", "r538", "r539", "r542", "r552", "r553", "r554", "r555", "r556", "r557", "r560", "r561", "r566", "r629", "r656", "r657", "r658", "r672", "r730" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.solventum.com/role/CommitmentandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r252", "r253", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r674", "r675", "r676", "r739", "r741", "r744", "r752", "r755", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r772", "r802", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r838", "r845", "r1010", "r1074", "r1078", "r1079", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189", "r190", "r191", "r220", "r561", "r578", "r664", "r673", "r680", "r681", "r682", "r683", "r684", "r685", "r688", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r701", "r702", "r703", "r704", "r705", "r707", "r709", "r710", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r730", "r846" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r189", "r190", "r191", "r220", "r255", "r561", "r578", "r664", "r673", "r680", "r681", "r682", "r683", "r684", "r685", "r688", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r701", "r702", "r703", "r704", "r705", "r707", "r709", "r710", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r730", "r846" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r863", "r873", "r883", "r915" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity", "http://www.solventum.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares)", "terseLabel": "Issuance of common stock in connection with Spin-Off and reclassification of net parent investment (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r14", "r79", "r80", "r116", "r665", "r730", "r753" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock in connection with Spin-Off and reclassification of net parent investment", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r14", "r79", "r80", "r116", "r672", "r730", "r753", "r852" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails", "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets", "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r80", "r83", "r84", "r106", "r690", "r706", "r731", "r732", "r825", "r853", "r952", "r967", "r1056", "r1108" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive Income Information", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r113", "r183", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r541", "r733", "r735", "r754" ] }, "solv_StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed": { "xbrltype": "percentItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed", "presentation": [ "http://www.solventum.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Spinoff transaction, percent of shares outstanding distributed", "label": "Stockholders' Equity Note, Spinoff Transaction, Percent Of Shares Outstanding Distributed", "documentation": "Stockholders' Equity Note, Spinoff Transaction, Percent Of Shares Outstanding Distributed" } } }, "auth_ref": [] }, "solv_StockholdersEquityNoteSpinoffTransactionRetainedCashTarget": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "StockholdersEquityNoteSpinoffTransactionRetainedCashTarget", "crdr": "debit", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retained cash target", "label": "Stockholders' Equity Note, Spinoff Transaction, Retained Cash Target", "documentation": "Stockholders' Equity Note, Spinoff Transaction, Retained Cash Target" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.solventum.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued taxes", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r70", "r71" ] }, "solv_TermLoanCreditFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "TermLoanCreditFacilitiesMember", "presentation": [ "http://www.solventum.com/role/LongTermDebtandShortTermBorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Credit Facilities", "label": "Term Loan Credit Facilities [Member]", "documentation": "Term Loan Credit Facilities" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r901" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r908" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TradeNamesMember", "presentation": [ "http://www.solventum.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedandIndefiniteLivedintangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tradenames and other amortizable intangible assets", "label": "Trade Names [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r49", "r981", "r982", "r983", "r984", "r985", "r986", "r988", "r990", "r991", "r992" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r928" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r930" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.solventum.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "solv_TransfersFromParentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "TransfersFromParentNetOfTax", "crdr": "credit", "presentation": [ "http://www.solventum.com/role/ComprehensiveIncomeInformationScheduleChangesinAccumulatedOtherCompressiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers from 3M, net of tax", "label": "Transfers From Parent, Net Of Tax", "documentation": "Transfers From Parent, Net Of Tax" } } }, "auth_ref": [] }, "solv_TransitionAgreementServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.solventum.com/20240930", "localname": "TransitionAgreementServicesMember", "presentation": [ "http://www.solventum.com/role/RelatedPartiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transition Agreement Services", "label": "Transition Agreement Services [Member]", "documentation": "Transition Agreement Services" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r931" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r932" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r932" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r930" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r930" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r933" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r931" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.solventum.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r296", "r297", "r300", "r301" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "US", "presentation": [ "http://www.solventum.com/role/PensionandPostretirementBenefitPlansScheduleofComponentsofNetPeriodicCostRecognizedinOtherComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United\u00a0States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r927" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r897" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding \u2013 diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r205", "r213" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome", "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding \u2013 basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r204", "r213" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "presentation": [ "http://www.solventum.com/role/EarningsPerShareScheduleofComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.solventum.com/role/CondensedConsolidatedandCombinedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average number of shares outstanding:", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r895" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "44", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-44" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-12" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-13" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715/tableOfContent" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-30/tableOfContent" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479016/842-30-45-3" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r849": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r850": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r851": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r852": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r853": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r940": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } } ZIP 89 0001964738-24-000044-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001964738-24-000044-xbrl.zip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

HREZ?+YPO"57H]!IE@=-K,0.N3@(1,QO M\1:AZ)0-H+[_9P0L.[5IEG#F2_%/ML!YEG*@-/$Z?.5S,;\]?@C%7V"\^_WY M[\%/#?3F4*HO3E,37AWY_3?\7@Q)D2.(Z15BY B--C6Z3_\>&!_FHH>Y&$J) M@XKA'YU6>V#\S7-?[K]S?VY\B0_US0&,O.L^Q8.<\(.?FL;SIBJK%YHV9^%D MEB!B;CPW>64)XPV'@]+C\%#W*3V_.QZ&4V@&X?DHYTMJ.'VO(:#[BP?PQ@DO MGVQ ;>CY 6'9>^5B]#1-BMX,Z&0N#/V0@(W#]EYM2@".IV0CD/$ME5,?4EG# M^$;_7:4E>+G)@IG$NJ0LG$:YSB(T^ >VH#XQ+ 6./4AG.\SL%!W%X -," JB M*9IS]L.> TQE2C4-\S'AT0E7LX6B> AW#@;P%:7G@_5VC*%*1'Y:2*=R^G]9 MKF?\(\BS=:L?7IGMH +PV?/_BO K.\)J@'EJW09P"OYOT\"J^G,BP-^5\UGE M.,RT-,<95I)@%94E*%\5333V/B:#%;D/[T%]C"1_*"8[O0)(.LN'? M2K5Y&_>W]WG[X( VPE3RXQKA_BK>6[8!W*"#_=PWZ-IRZH2:_;QED)CXO9PF MUM.CZ,N,HN]L'D5?1BD3T\ M<__5-OF&:UT(3_CKZQ0'P;^X.)GQ&TT@) ,PQ]SK%ARR=[Y;5PT(\N,3*5&= M3&LF^T),1:1K&>ZJ!5S3>/EM;M3@>W!)ST$#?9O9H%Z#DNM$UIJ*^WNLI$IU M%6YGH2JG-D+#_%!U)B])T_C(%C10_%]**\[;@)QII,8W)E/>2ZA!IYW -QXU MQ\/!'@/XVMV= _AR?+IJV\ P6SR_-_JK37!<^;P[SD?*'A/OAOUR2^E-U6Q3 MPT,&%M:"Z"_X5]7,@SS_.2[K5UO!>J&#(O7\S%RPW.C\S"-C<=3P[K&J 1?'8ZA;&*7XS!WX M\*5AO'"7^\RA3 =FS6W7#D*?\M-4MI^VR$]AD=]DN_/2HJG3:AU+-(U$MF(M M>I9KHJF6:'8,5-^?:,9WCW69+JUIIEJ:Z1R)9H:MN\?!P7:Z)II:$DWW6$2# M=315E>G79*)&K?7CWWG L?JN ?A\Y8ZWF%,1#BC)OJBLU=IQ3>)5A>3/%8ZI MS)4_O6/)'ZRDJDD//DTSU=),1:5YZS33K2X>H6FF7C1SK*#PL X7R?1 M'"OP.>Q7YU76ON,"ON--E6U:);X\AW$JC-)J]DL&]RY;(K6/Y18<#D!;/E@B ME430!;A_;IG6CN9.'-X]5MPO59/:99/:L2AM=/DN'=5JO&%>NA\9S]^$;3] MV??FQ834J'7WV%^346L%N=I-=5GDM$-3/QXYM?-B+)J<+IRR\J?!H M&TOWJZMCT!RM.5IS]"EB=-L8>G#W.-0'RNP_O%P06)!,&U\=(C$;K@_A&H_6I@7)M Q>W,3^TFF&!W=9PU[! ML9N*8)@/M-,D32&*'G%K%DBEF-.U6S1/#]86!X"RYFW03P)7YD3#AW#1R\PUR+.9[+ MC4D4P%F#P @X[!^V;DQ];X[[M2*?1H' BQ8T>R6 G?. BZES"AQB"%=;SI(R M/N#H,.L?41"*,29B.!0NX\5#(L,T';"Y)U^B3H-%B=VGU7$F^ MZ< I0D#"9 M,(O@,?E@=H[/S]C#MKB*(O -A,8B2%G6#M!?B/113,+._-Q55Q M<)J)$VKP'Y:'YX[A2W/T:$;*@MDT?V_"9\R9JLVIXT^68FD?&Y;0V>4+\4<(C9G75PL>,0:+"0+@>2"9<*Q !P2 98D2,0]\I09,L@!1/LQDM]: Q MC5PI@E*2R8K@G M/ PB1JP+HDX,2PS4&"4<^T3C"QUG"5<_3O"%(BG)4I/3R9ZYF2 M)O&@6#B9 9!@^ >R.:H4!,Q_1QD-RT4<%*S]R&VC5GXJ.GQ*Q/6$.S8<1R(5 M(:%F/+*$K02,+1YR?TX42W@1J!#$0%(.[VO/):BK^UA C7 ?@O3]%U,?K9,C M$J(<0"NS#''T%[=?!:FF1;Z\:3F#^TXN7_S&1294([C$YA-M0%%?Y/OJE.FK MGPYLTL_5S"X@-\N>XIV9W#ER\9C2FD8*X);'ACC"5]YQAC=!,:%^)B /.XEQ22"(7#"& ->B20*^ #1^ CO0D-#7 M9T77]07/0&U4URVO4V_5$ ME8D*A0[8[C6[X^USP2H]8+%-M9OM4643U*K;U*"S?8IA-2.^SC )[*)F9NCQ M5[E@T>.O#D/[D5+#KG1.S4$ OAZ@Z%E'>M;1 ;..2*\&P]>*S+ ()>V5+%^= M*JG;PNNV\-3 9\>@!23MK]._>IX5?' M68$0/'N.E1/.'K= -*Q7S]6M%WP% M'*FY2'-1FHMV#%:B6^.B]HXY .6XJ'/W.&C5GHMNH;=JG0"Z#;HG5TE2-N8<^KYZ1P;>=]3?JBG[COT-53T8ZJEVJHJ*>IZ+JI:$=>=C54U*\; M%=U"7ZH",\SJ[%TKQ*67V]:B')?N&%P@4?U7@6A@U \9-&]N6S'&&9ZC@QMD MZF8HM:2:':,+]J>:(5#-L"X]Q3755$LU.X87[$\UH[O'?K\N(R]NP5N@IC31 MS9\:U*0=!1?"BCNN?85?8,)/"7:W<.#X[K$SKHD*K@VYDU[V)6EEW,( 9%U& MZFE:.>D57YI6VG>/H[H,>CTP?Z;:%GCG((7O7LB<0RS[THTBSI!4L[,T_V:C MG =!YIJ$W [EB4)I(.%4?5V>7,.QCKV*(Y^'X.<$YG%U76(TPVJ&K5*#+<*P M7>R]J!E6,ZQFV/.;$448MG?W.!A7G*%W:H;=NVE3P38^[5:!-CZ=W#8^W0MK MX_.!JIOKT\.'5BS>=>-9-+VA@FW7,CZA5]R>1/3!AQ>?RQXP\-77< 8'W0() MJBCO/IT?!%M+J;]@5PS7E;T,:,_IAD;8(R!3JI[M<$3%.%1K'7K4?,+R%B'U MU'@5 6L%,MF*0#9#,)@Q]4'2O'G^']07(>Y@\>^J0Q! <&8O%!!ET3R^.LAB MR$IAB(KP Z[::S0,^)CZYF [ L>>V[BUT&MDB[Q7:KNW=F>3H.MA;?;""VS\ MP8/8\"M/2K+_G&5:*KP("%S06(+![@ M\N(^_@JVPVJS%V/FX]W^I]V7$MS]C]08 I-1/Z)>X.+8,_:8A^#-MU8W]];J M;:=F>5_?HT+YT!TH^K:I:KKDGM!8I<^M=5&W%XJM6)JB:3;DYUI MQ?3OP<[.;-C1!O;S1"'@KFJ+)=NI!$\DA%KOL0.?@C,U'^P^T3?M]P:RFP$* MSEP!.XU*EVPE 5QW8R,<)BF:#V[[Q=IR4C*OKD.LCD83''$@,%Y!<'A1$/\H=4D+DVW57+-=(6QQY9";,Q?.]+(T@FB! MG0N5E. !K 1?@#YAF^G5U;TH6^'&S\4-'QO4OQ20@]^*KJ>TEUD$8,$KR(M\ M.@S=,S]L4[S?81-4P#T_V8IZJ9"S5 ME-R>&.E/:5(Q8R9(27^MR@"^PTN#S%T&^#L>3, M7^MO?7GDVLF0:T8'S:/=;X*E$[FQB??%S43]<5V@#%NT*!5M@4%G0MU%D6,B M2&2G#-E?<%W !-$DL"V;T7(9G1G;('L!3U9(B[!$JP-UR@-,K9/ECH-?&HT. MM]!H0^CNP0Q[&OMTE( 4$[CZ;4!N1 UF0=/P2>V_.(KN9B@:48(Z)G:NCJ;P MA^@HFB+I+)FIJS#Y>4*H,7%)S=(CS^>"/)[ #;(U+;=6W@4[D>1**Z.(=%!2 M@N60)M>5%1ND?F+C4Q.9A5J4KM^/U'@;_7>$05H"8P,.]O:TPU3W&=*J1=]7 MVH -[\&-R:I;U3MRC3%VP>_DG/&4WL='N;L2K#$"UJ &<]N8@TQD8@SJBQGS M1:*[@X6 <"!!E2%S?/&]_>-^9EN@23_@*\=WCT2@G+N2FQ!MVR'4:96$T)=X ME^7E!89EP)8'J@-.^R&;S%5TMW4'9Y,$GR5+"'PCH;N;>^@) [3;4M[]1"Q@ M(]47EYI=R[D!V))8METM;6%W"I1,9T.-10SL) [9QD8AO4TIC/.4@5URWP6* M='>$2-N8A-1=M_T-N:L&JI@+,=W!63;2+JYUHYER="0_? ML%7R^AB%',WE K7QG-IXYG],)Y8&*(#ITY>V>1F>\$[C;K@ISXO5 M>A"%$H(?SP5^?B+G+R(Q)"XEF9I\G0*9/5]XV$]<:4QP)-B/C -[[BZ5/@N, MS),T2L"P@R"BD1Z-9'R(<.(Q:< &('."%:]V ":TP_S,>)6?A 7#J-U]8+^X M0LZ0"\]_Y>J,]U.\.M ]&"7>VXRC/N5OCN55ZCU:IIQ0IOPZ7SC>$A!6;\&B MY@4$&4^Q4,17A$AZ2A"GT]$*DO,:\C/.C%Q*CE8(C(7#7+&Z&J_42+&Y MHEFYHM#_XU77.7R1=@ TX!9VD =IK3<[X(D1U!#&B[".R/"9\.1\CIA[DCG_ MR@P"FLT@,&D:2OW[>_.Y:?P3%&-AG)$>Z+GWR2<6 M (J+,Y(0 RTC@3[% MUO#] (KTO2 4&1' $!-)Z!%ESS'3]".>PB<&*-9!D]JD M).7((FYV5NN=CD M$6&/>S$XA;TQ,!<,(!T:MR'B;'',(AW#TK+N=++N=P[VZ*\4N#+^!JHQ&B-) M%.+,\BXSB )SFT8NO=&$')!BG/@D&;/$8J^] MF%9#FH,]3P_46%,D,"K9-+ZE-H@_V7[\QEKD1G@XF;\$__MEM:S=1]8^L8"2>87G MMC925CHQ4E=_6H+.Q::ENSD3 \[-=$UE$ F51 A(TN+H:9(@<*6R93.#;LA\64C-Q-#@@"NF"<%\@3N]F''WBZ',8&)C@';Y*CI12B#0S&D M+N51=KC[$L:#S @Z] 0IFZ"[_D-Y!A*'P[\;:I@E?"['W2TQ$C"S?>M>:+_* MGR_4>N$12UP(I";G_5R8N^+: /DKTV)2X8* @;A5(E8YSU+.4#D=3V;2!!1M M$.;WJBH?ASD 999,!RCO.-W1W^UWL9WR#E/,2-K4 >@ ?VE%[>@*' [7W6V M'V#5M3K-N,8W3Y5)C=++H0"=,%XBT-[3">,Z83R5,-[+31COETP8/Q,UGUKV M[VP?I&3_NG0< N^MBW?C ,E>H!R_:$?R,:@SCSEEOIM"8DIN;PEDIL3VQPQF M4N$TE8,3Q#/-DW#:9DT-3.GJ(;4K9C@N6,S2Z252_R M3-';D^37[RPR/*R^>+"SOGB<6U\\IOKBS9=U/_>R'FRDV\'EC,#M]9N#T?:Y MI^<9QHIE_'I3%[NISO:E3C!+]T('O>KYM[E@N='YMQ_FHNH+M(=Y]:-PKV?T MJ)[4JJ?]GH*&;@XH>J9OZ@[B89)A>*2YOM5 \KK[EMU0:[+.SF[8&UV?G?:6 MR%9]IAUJGM$\4S'/[.P*GAWZ9% M:24 M KV\#YT#/(:7U&P.L*:BDVJ\Y>0-YJ"UM+RY3DK9H>=5(V]&=9,W5SYWG/)H M"LP=5XU@@JK# (58[$8&^7;&QQGD.X:%'P?=FLSQU413*=%T6]4036$9#2^L MV#K7%%4OBMK1NFMO,=3%0%VWJME!FFKJ134[&J=5+X&H:Y5EEV."XQU'>264 [K6/K[4?57E+4W5L1%H3QI[I&::"-JYM44EU2E MO,4#T[A4/*,^9Q.Y#H<%U53QI(A)N:R(N9#SR+ M? "9Q*08G)MJ@:JPG2 M055F^EQS5Q%U"=[%Q-:=O+N92T_1@B2_&0'68H@9 M=,87]Y6+07GG;ZFP5;#DS*TCX1"/(Y2B 7^W$&>SX[.58>8= ^WD-!)ZE^1[ M'.J!;4;4J,9]7X4M':>.]Z8:&JNA>-2U!([%IU-L>$+ZYBP1R/T 8.T+(7NQN#AVD(5 $[OE(/1QK*(\#V>EBM5V#;G:0_OSJ M2_CUIHIN2C<[T,T.=+.#@YL=/.D.![K#@>YPH&FH)N"J:^^#<\2PXP8(JX:+ M=X#-Y]*O(\??_WU\^>J*_&.0Z0%LPJ*5^*5._Q.!_-93UW.1;BA#2DU MD >*_JX(^KLG'$IE8@'5)6:7PD_Q0(#$4XE E=R(YJQ;Y*QWY5AK0UG>%M9: M9Z'QW6-ON)Z%O68$U)]S])VD.:T>"]%KW3V.&OWA>@[%!3*6 MOI(T8Q5EK V5F]4Q%F;K-]KC]:[]-6*L6VB_\!QZYA]&9O*I3*6^O$X,%V1- M[:AW_2"GVUK/.++Y%QR-^#&%HO+I5KWJZAD.JGTM?VO=+D65%-D[DNN+DM0Z MZ73O'@<'B&E-+[6DEW9%(FB=7GI@BFIZN39ZZ>THG=B?7OIWC]WUW,"3$\R5 M-V,@;>\I@X*A[.;^T:H??P2;3!8<. M\HY8;YE0B3J[%A_X#*15.A^D7UT3J/HX$S0W7"\W;%##*^*&MN8&S0V7PPWK M%D8 !X"_"K'%.OEW[AZ[W8.'7VC2UZ1_=-+?9"E5=!%TZW81')C,?_D]Z:K( MY]]417QX6G_I+CD'+:A'\QP(F6OJ(K3-/OS&ED3NGSW_F^\!_*P]Y>&Q)OD< M@L43-(O5;*W9NC*05!-P*L+7Z_S;OWOLC=8U^]+.7\VVFFTUV^X1]"M['>_. MZ^X/L&"BT]-IF]@_^ZQ0%$'D\^_PU"^.9_Z14.)HK0,J?(9KCPCC+HX[\UGOR##DGZYRU:V1^/[ZO"XYS-=P7(Y#05?RQT3]Z*H#* M9J:GX=T-[7J_?GJJ+VS:9X7-3WA=$K4M(G_A 2DC;0-['K$"T)&^[5 1[J\_N!G13+ROTZEMPZ";M@+QQ;6 +.7F;&1H4B7D&R\*IVD6E$_^6WSZM"&^3HA/M?IS&G*4&; MT2T XB;J%V]PL0?P-[:U+FP7CBUG/DOS2 K=T0),>S MYU!V6= P_I,S)YP97U*RY'D9A'P.WR%6OD6 >]L4W^ 'GVV'Q@-Y+L$8@#=C M /<)]@]UO;C-3NA)3SX(-MF/&?NNSG@B_) XO WRS*=;+>E*RYDY4PM,U"6E M5J*-!*F5DQW!U0]WP]2F-L884) 1!I>%<%&J%>40[0!5)Q%FF'EOF7ZP@D $ MR4D( _C@Q>E&LFSN$?'BUD5'4K4AU87;QW9Z()Q-+PBQP74.ME*;9R\O(+A) M@".@ #AYBS?7[^0ZW7H?/>!]NKD0KG]WF2IX49-M+&GKOB, MKMXTX9@S%'RN%^++U=D-"XYGAG =PX>XTQR2+K8'I4#0J]0G$:4GLH ZM"- M05"DEY")BS*>1MOVX/LP6J1HF]JY8Y3-M9@#N@FQ,KRF(=])-$N2PK#G"X=" M<4P*E2Q@8<>>$" -PP%Z=E"[P:;!R98:!LCLD*7Z";\Q$'W&"[!7F#T+ E?! MIH&<"ZB&%_I_W$>+@-@[Z0 OF[X#^_DHE01_4:MX>7J!/@^[ 0/-"V" 'EZ@ MQ;GD(DGJ/6P-WNEF RS '7=A_ M[#$/P9OML4ZN/5;+!NF;KR90W[SD?@I ^0IB:8G@$9^DKI5$@XAP!(;X,"-D MZ(ME>E1'ZG$4B^:26K&KFX!4XB N]M:,=IH[(.4@$WC%VZR*, O=]^S=,=Q M$*]PA+D=F-QQF,MQ@H@M-#Z;[,8@FOP#&^6CTN'@72MO9M!(C']&((SG"TX0PG)-3]%M6_.L:OCC23H_H\\8(4S\':(7,K9T3' MKASOFYL:H(0G'/IQCJPN&;2LNKU6-<"[[ES!RTX'+)<- MN'-T_"MW(QZ4S?T;B$[-H_4.?0?5V)P_>K*>6K'K/F]>:I[]]AM] ;K,W T3VF>NG*>VC"<[6">Z@F>6F_G?1D\=2)K M]0)[ :[FSU[>L(\+XLX-\]W6N7.= ;$W>OO@*^V@=B_E+RY-%\7H8L/TLB)T M,<"F6&U-%U=)%QN&;Q6AB^'=XW@XUG1QE72QHW7WWEK>"+T1Y/^O,=F<-O)P M2;K)@K4[312WIHG!\;ITNVJC5:;JX3KHH'&-:IXL.T$6_*H?W1:MM%^B"VU*0 MKKUQ1^2WPO&G=7[KWCUVNNM-D.ID)FFZV)EB M?^_]L'_W.#QMB-RV_XQD>$0M;9: M&TF:+/8EB[U"(ENG"@Q']9B:?-)\L1O("KO6W*_^_G&(X?CNL;<^L%=3>6TH M05.YI/)!X:A*84$_JF[*J/:@GH6"OE//)=G1Y]33BV\SQ;KL.:HFM*4Y:B='':E:==0CEAI4%02ZJ,HZ];7$RIB:F9ZM/8]> MX!86N,:VEL>1HA??UO*<8*EI6\M]O7KGZI68S._ZEAJN=!%]$\])?1?8\^[, MX*IGWT1-0Y<$+MTW4?=-K"D(=>^<@_LFQJK(%QK?\C7IFG^J1K3)U$;;N>5@K MSMM1:UB0\[IP?[>NJ.Y0DTCQ]H<%2:17B8JG2:26)%))Q&U,K?&KBAAH$JD7 MB5025!I34*G>4D2[[G1_Q'JQ7B7QJ#$VW3EXO)VVOVM)(95$7,:CN\>>[J5Y MG112221@C)$ 32'722%51 +:<""P$[OU#@6OY?GS&YCM<0Y_T;]MUP)3[N&^U^POZL5R M'^8>;.9?(KS ?RRX&YS5PKS "_+=@2W\ S@!_+5Z57ZP_A$%(;H /GM^&DVY M=V+_[G&T[B3\J1[1/4TM>U/+6I)?)=0RN'L%:FJY=&I92TRKA%HPB)G3 MHDV3RX63RWHW^4K(981)Y^O&64W(Y:S6U\6JB5_#&??AY&G[+#IPYM/MQ@B/ MI#$2DE8\++\*E?XW'N;R*L:6UY,'B[.J#BO7T0NW:QY4>4)I4X2YU@%F32U' M5QOWH)LVT,UH/3-!2Y@+IYG"NN,>-(.QS-J2C"Y&VS6'J(9S0:\J('+$E1EJV'*]9339V14;F5?%OE6,HBS(M!K:& M!VLJLG%;H_N'ON'UUMKLKH6LJJ&JL9WC^-65;7$FJHNGJI. MD.#?P:A/HS,Z.-/Z3%17Y7B^=F?;?+Z]3+03/'_X?!J]LRO:F2X]V"1ZO^!$ M)1Z$*@>Z8;@\U&DM)S3A-CA@%&*RD4//C0WQ#5'$#D:>#Q^EH'89: M,9I)*T-3^P>W[O_%?2^7ECIW0#>C3KOS7M/3-=+3L651%S.H=1^HJZ2='798 MY;*H=QFR2.?);,^EEGKFS^]$'.&G_17.VRUW.(K"2>A),VB&/]>[)JHGFN-KD'C0SK*)9I"::.A+-FAI9'=6,T!-2:ZHY MK5]2NE$G7AAZ\R*1B+JGJ @2,"8/HAV1]TMF178[E!69T^+H M"D3# 9Z8GT,V<3C\OV6_/BK8_!;-@7I,\6]3X(T0]O@7^!G!U#;;TVF;MP86 MMR:]_G \&7<'YF3"NKV1:76Z_?_7[8$))M?%I^0NYLQ_L5T!FQ9E9PK 3WS< MDD3"ZD.21'O886GA!3;NY<'G#FSJE;]_LZUP!JNUD'Y33TGDM))'V 1P$86; M'UG971HS)D?:.P-;]O^,B0A9V*3_.XNS7A?LA=]/?,[^N&=3V.P#<][8,D!D MI\\(!TP#M LALU.C*J_-2.3J1=%.-&IVD\,1?H$QO242K$\'U@?+(#,PH"-27O@\N< M96 '")K/< 6XIDU5?*YEQY/T?N=!Y(3TD^0>V2@X-D#MQ-S[?<;AOG(<[PUK M$*WLH5GJT%[D&]/XX&;FX'YR<"\^N!',O,BQC F'[YEEV"X^]8_(%;?WFQW. MC!#>+BLA8\!'+HM@;6[12S (07_1385]/^B-<"M/X"Q6:DM!"-\B"@/Y"Q^V MM>'!NSL,US?1KMU_]]- MHQAT%K[W:ENPOIV:FSV/20H@X-C\%;X//0$-A[\R^!S^26P*.Q>[1'"4@S'\ MZ]ES7N$MT3QNE8*/O,MCJXTJPZFH#9'<232:/%NU9OP?L38)4"/QILS 9PP%-OS+?N'<_[ U&:,GG0-+X"08&5'0'Z%/V81!J6#4?WX?H&M0"0"YK!U/?F!._DAZ : MS\%@16UDLL3O K[M2%;$<7?,<",B?B"-*;S<\X%,!6&(V]^#922T<&4B7CQ& M2;VE82P8&NF1P_ 7\(S$UN]V\(?Q6;RY*;%D?,A"8A'R)ZD0XS% 'P6/A\@90-B@1H NC,+^1/*42\ MPF=2E-)1IP%!A@8#J,JV9VWB,B7C)K& )-UTFJM+3Z,P@N/!BJ2<@HAH@,"E MYUT.\B( EB&]B%1R6D*J@K*(1BJA;Z00SM@K&A+ELS92@F_"73XE;R"IH"D9C:9;JGV:./T2[X5% M%":2\HT[SOT?KO?F&A.0"A;:F6E1*:%+:$A>BR9>O#19HR1RXU4$RIAI4D#P M!:@)*0"HTP4=#VD3Z0LP9.+.4S>RXXFK01Z+; FX@B11I4Y';X&SF-Z+FS9U MU=F:!H ,(W9BY\3N? *$-W'LE\3F7*=7Z8=U^8H;-H$#?(:ZC/4*N@*>@Y$M M2.=?^![LFDU *"D+BW@D]1/U)5ICJ,[@&15E$Z/;[BL/9,<[8:3+*Q/I&^G\ MQ3:-$ 6XB()F;*0Y]U]@6Q+ZH H(#@H:$CS ^"[^SF0+O"R$?4+*-]BY]56M MSVNG?/5?F*MF]B$1:[4EJ1B13GPTJIH$/=I?PQ'6SO),2>/OT?-E^\_Q"[NM #Q;'X!>!/R@\% M:^!>10^@<,9DK :A0N0ABF0E,\"@]X7^$7N&8!O!0CG,IJG83S-G;;5#PTY= MT$H8)GI\("1T\%!SI!*@!V=D096YKS=\T]/:!WB6& MLFL*RF^)&8**6.Q.>.8O*"$T4/$D DUE$CDP'EO09!L(MSA=Q7-<(3)L+[R@+6?(O?(UEOR VT)$B/#JVB+/ M9>RC]F)BX@%YCJ, Y#_84?C4 I@/X_0NYU;0-/Z7K&+T6H;.$@P:_@BN/1VV6Z M* @:A@D8H7W:P,X.W#'BB"$W9R[ZS)?*?YL"-+F!_= .N,@3&+;^/V/)F:]\ MC+@[#/'!ONCG%)"1^\!_6J^H[%DI+,P8^KJ=!>8S!/@YVHFPL@)>((U# $_T M,L.VH>:,.0ZGY 5&H.+6<^0#6W]"%YN#GH)( M.C-E_#&37;,,L.9$D.LWH-.I;28>N\^V(Y.'FG4/E/^>Q&V1F^?,(N^X1TY( MTPB($$3BCDI*(A?.E#QH3 :&!:$ =%T>BF< ,A/TI:2]V5PZX0/,CQ$KD\\& M2WM W91Y1>92^)N=!)Y9WS*^@WB>/-<87,(,(HQ)-W!#*+E].TB<.#(P3PD\ MRGN-QTT6E3(V7N]>Q6C1Y_U*TK9I?$AM(HY6N1ZJB$0>) W5@T&T6*"S_L7G MZ40JD+^O?)F$3Y2W4LV?@9\DH6S84PI(+N![?562NKB.6!TN(Y)UJ76:QJ?D M8#$"U/X=+PC3;\D+X%F"(1@P#'P-]TR0\(^(S#&2H@3P#]$+B$3*(41D8+P' M_S_U'KQ,9"I%&G)J2?B%S_%;%80!OK-LMBE0DAPS':52&=Z8G)5. X=_1@&? M1@X"7H0^/!F_2&6(V^YJRJ/[XME)?$M%?6TWFY.?_15&M(" \V;H>8^EK?&-1Y(WBR@6M!5V/] MH'?F")[(M$662>4JHSV2TD56>"^57)(B6A%I[A\<$MPB\]]%X"0GHK MT;>V4LA,#B3Q=>)V:[:$ZTTVA9-OEE\WX:N?US_O=)NM3B?WJU:S7?+S[JA7 MZHE-FVK#%]UR2YU@4ZWF:#32F[I4]-5R4X"^\6#K4CO:/!8\7BPQ5%)WV]'#1L6 M]L4U?@- J2'1EP7&&\[[[)&H7TG4-:V.)]^>KP@U*:LM* MI#)@I5R19JD'SP:[&G!USTQ#%R9V2&O.$31UHK,+ ^E'Y0W^0C[+F@.W5DR< M#"*IK="[,&(42=EF>57B@&F/]6J,EP\7Y3G(^@BJGF]SVV,]]<[TSJK=V2V, M?)7Q_*J'O)8!T97V-KV@)J7M1GO4J=/)4S/UO-]AE0 M>J'F-^>CB9C-*@TJ#2H2H+J%IQRF09?5;OA=CU3K.KYVHJ9RAV^WAS3 M:;1*E]25+7D_A_6H*?<&*'?8NT+*+>/W.("*ZX?05K->Z*Q#B8:FIU,5 FI: M.GD#"X)DLSN4P*P]0;6:')JX*[F[[S[;\3G>?WM39[S?X1#>?+@?UCO3.[N.G=U"2K%N/JT; C]V M&[W!Y:9$:UJ[-%HKFPQ1'UHK%-,L2G?U0\[YTN_K$*/4]%$@[V2@&PUKNLBA MBQ+ERYHN;H4NVC<[S. 6ZC-T ^J#P#<>CG5C@7JBIMUHE:X1UL@YE;+1.T-[ M 8V6:FT#C993H:5]AA['&BT%T#+2/5)TZ^GZ4NAXJ#NUUA4U_CYW8$VRUX4G7[Z:H@.2P]E4.;O!HUMXZ:\E,Y-&I.YU8M M,=M9H^5T:-%NU?JAI=T0W8)K5;>?K@:./3V=K*:8N1H?1%G)I 0%W>NV*DB6J_S2M*1I:3,D#YJVJ6E*TU3N?;?G..HK MIJ<]NMN>H/N97D O<&T+$*?]'+*)PU4WO%33/LEX/6"\]PLOL#'=Z\'G#@OM M5_[^S;;"F>3?]%.B_=]#*WF$30(LP=W\R)SY+[8K=MS*:\AX!K=:'QNHCE8Z M!:;^.XOETX*]\/N)S]D?]VP*FWU@SAM;!@C?]!GA@&F %H#%L-DAD;?AZ-/I MT3R* @,6-SV1Y/< ]P_W\5>P'5:;O1@SGT__X^Y/MMF>3MN\-;"X->GUA^/) MN#LP)Q/6[8U,J]/M_[_VX.[Q.Y*YX4V-C_!&(*O@+S^SQSP$TW^.1&^TXH,= M G6;F:.O-V;LIQHS8D [X^0UOBXXPL-],;ZXIC?G1O8D\1D>_S+Q?W[,^9*X M?D5FF-B%>A'P!_7'>\L.%@Y;/M@N;8X>>B]I5'(Z4O.*,D$H$U\GA-YL"6*7 MOGCY9OEU$[[Z>?WS_J@Y'@USOVHUVR4_[XYZI9[8M*EVNSE M[O>5)%-=;I; MESK!W(!V_^(&!Q"G? ?Q5GAR@.Z%7YEZ5'?BT+WPC]8+7X,KH2[C-3 0;(8Y M8^X+KR2H?EWMLE=U,-TY^VIW=@OYL[K7LNY_^]CI76[MOJ:T2Z*T;JML+41] M**U0O.IR\\S?=5IEVO]4@1?=%/,T)]9-,0\L$M:%J/7$3+M=MFV_1LVIKI/N M0'>3T]WDZDRB[98N>JPK:DH+=HV:4PGV89DN Q6AY1:T=-UPJ3)_5DMKA?7$ M3&_/S%>-F:.+]?[H#"WL;T%?URU*JFI//CCQ0">M#Q;2!T^O#FJL[+9M1\VR MY=U:5]?-%^H;[+R2$G9AH S+>IXNH8!=T^VUTVV_M6>\I=9T6\:RNY9"5#FU MK-_LW6RE_.9D +4)^I3Z[NP6PCBZ4D;7+SP.AI<[2E%3VB51VJASIO"-CJWM#D2/ MFAU=*7.-<3U=*7-@7$N7RM04-=W>GMW>-6J.?I]T.LVV3KW3I3+U)=%N6]=M MUQ4UI6/R&C6GRG8O/=A I^#IIE: M4VA/U\O4$"W=;DNCI79HZ?9*3V4YL[(NX_.R(_M%)(PZV,W3K>.6G%XD./?N.A M\,5D:?R5>R\^6\QLT_C@<[8^YNCDI]DZ,NP;]S%'76:"&W8JVFBB4NO# MJ\(9A__A;!=T:KC;2U<,2C!_L\,9/1>P.3<6L#?/,F!I^FP!__*-)6=^PXA< M@%M@>/"Y_V8'N /+)H])4\^ NH5Q2[7KYC@:R\S9*R? \A:HZ)1.8[N$_B6:5O-L@D%UT4CIRY*(+?G.0[_Q35]S@+^ M\SN+B[]^RO'%GKB;BW[^S#UKSD:.E%YW '>KLSN-=LW+;$UA>S.L6^>.,=> M4\?E4$>K>8[2W/I0R,UH?!\CW^>NN33L^8*9X9&UO5MK4_Y__C3JM#OOZ^9' MU"@]X-YL[='Q1*-2HU)7R +(OV*FI];%ROG?SC4.2Z-FIP1IGV&BL$;+;NNE M;.CVS 6Q%V%TBGCE=-T<2MT MT2K=C^U::"-_L%F[LVVRV?'S\?4"52Y0FXJJ^M54[!@59JR-B]*%4KI02A=* MU1MNNE!*%TH=&YZWF;;?;?2[M4O;UY2K*;= P'N4.&NWAGA-: M:A],U:52-Q(RZ@_/$C.J@X=-$\?.;.K.63KL:N*X!.*XK?*H&TV3U851E_"\ M+HS2TGJ7@^B&"AOT35YVOD5S< LE49HNCIU\<2VT<3/ZG2Z#TF50&J7E,M\[ M-:J=T:@\J RJ?,YI[3WWM7;8ZS*H?XWAOPX+DW($$'UIHLC2=N M/4?^"SW^GYPY\.V7%'4_+X.0SX-FX3&*&KU[H#=3Q=4H@EN5 [..6_@&W[L) MQY\ "[#NL^=$^+I@? ]'-2Z\@&3?@\\=V.8K3R8T_CD[Z4Y>:ZWD M$38)\&6;'UFEH*,/RRM(+YWQBM&8^N\L+H=>L!=^/P%D_''/IK#9!^:\L66 M&E+ZC'# -$ +P&+8[&QCE>GT:&JDP 0DN<333Z $L-]_!5LA]5F+\;,Y]/_ MN/O3;KVB/8";BZY?;VI\A#<"6<&%Q1[S$'P!M_!GVP_"S"!8?1/KFUBC]\PW M\6?/AU>XAJE2&4(?=N@(_+G\A6Y.1V4X -;%RH(42ESD#6,!^K?-'%C+FTX# M'N*7\C&P.[Y% !(TNF)<^';P M1V'1>*YAX#28._2,#PO?=HRV:"[10&WM%7@VFM-T;K H0\ \T8!I+W!6-V*] M^T31AN'[P$"UR2?RF", M$0'K&5/;9:YI)YO!W8/Z"2RWLO\FBFT '*PI+?0 = LWL6GA%:M YP':[G8P M0T"'@>&]N:L ;1J_\RDGW/WFP3O;+9JVSA*?@<5#9CM;].UZD.!WA$CH>^X+ MG.;OS>>F8>%8=Q\09@%20';!?01+PXF2\P4&QP,GW3V+Z36)YNV0:\D(;;AS/8>!M?@8RA\#Y=4Z(V;7#3+[M- M WLF(,O KS[B4^XR9D)%(0&*7OX"-#]=O1_R[@0XNXLLL &(R!?%=YX";9"& M[?ZWP&#'+3"HT27P.98*R.'$B$6X[ZA'V,I\L0R1?Z#[.GM; M"ZO'!&OGA>_OZ!EU2JOXQSO_D6%?\LJ3ES7<'K_^6' WR+G['O\BXOQQ.(R2 M/4RT7!@T]]%X"6<;0,$ZTDNA!#ESQ=1)":K9$&$FF M>LHWRZ^;\-7/ZY^#[=H;M'._:C7+?MX=]4H]L6E3[59S-!KI3>E-W<"FQOVM M2^F&S'E2F 3=]YG/MW5D+I ">95PV=&H>I\>U06S_,_9R??=-^G6!07(]'R? M!PMT_V!\0O6S+=+%]F;:'Q.IK/4LU]VBM]$8^OHUN J#ZR-9()KIUJE(,YUF MNM,QW=G;V9^K+D$ Q M(*9!I".<<=U1ULX*SUGOTQOM.0JJZ8T&-RE[V)ZAF M=P@'UI2%E#4\L&I44Y8651DS1TLJ34_57GUM35":H*J\\0::H#1!50;)=K.O MZ>G0%IHRS:#*/CBUL(0#;QJ^,9]3SHI/A: '#2DY3K^(LM"_$,[L#/8=;W*\ MAA'E>W@51?F>5NVUXKZW;__B2\2]1CE=Q&4'&C,X&ZPG?N&Y\!"6@WO^4A:C6P:UHJ&GYBS =XO:=%$2@JT?1!%B!LD& M>_$YQY*'P'BSPQG5L'"+57VQ(M(;I/MT47FVN? MY[4.8A#ZV;^#&A+M\:H2]DO]D'PZ+8]FD+5=)/RCV-XW\B1W,D&@%<:[=78;:)I P MO@B[?]"+Q.& 4^P+NN#RT%-$JN4_EP@;2TB S=+I)F--]0$I0FJ0DCV=7.*RDHK M+\D6_IT'G/DXVXA2H5ZYXXG$F7>_D_W[:3_[=P42^^;77R CE6^BD$\UQZZ+ MJ*R<\0)Q-"KMB#@[CFX%-:W2EI=&S&\DZK=+\?C?++1OF[0;-; M+YE^6 >0J'Z7;9B04V/;D 7K:%UBL7&XO#JUMZY.KY M2.P+9F]S@(J<@=HP\ 'SLE&3 Z@ZJ MA;I\59>OZDJZDX)+4]Q:<&5:>'RR@ M)X(*7 45;!54P%B0'EYW*HVZAO-.CH1O/;DNC?@]2XTN$?&[[_I*<%PG 5OR MNB]]_IK3]BW.[M+$?1O$W2YKA9V"N/,3%'?D?)PC(2G7$9U,8+'5U\PT_8AC M/IIA\4EH>!,XL4A(:Z1&4,2_%]JK,?6]N6&R8"8GL?A_<)G9PLW(MT.;!TUC MXQX.S '8)MN_"LQV\J1J-RV:XLKK@@186B":8*8KY<:B\9W]X,D.\A>0ZO:G+24.\T*R\8\_'% T#9TO.S'?J519ZN+MT MRDV:BX"2'*PIOE]T\NR5V%7W;#T75F0RRE'*\JL.]Y\51@=U"-9T6E&[S<.2 MIC29:C*]W-95FDXUG58;_.PWR\;V;YQ.#VH=TVMW[NH;\>I06XQT('&X,Y X MC7P*^UAV8$9!(&,J,GH;8EA@_PA)>U2XV<,&&.8\@W#0#Y5Z2!)(#V,P"R^P M,?[U0'%)L.*2T N&75)/2W!W>-WBDF"E/H(;T1!]I>?V6,> M@G?RC1!D8]-J\VE[T.,CL]?E%AOTK?%HW!^W>H-VNTO-PL3BQZ7=_"8TW[A/ M61Z8;S)9&K]$ ?PD"(QG_E*TW=%1>^IL93RZA-H]=0NQR+(Q*@^7R\2F]).\ M:PF#_K9(G?DH6EI1Q<+P?6!\23)>C&?UA+' X+9%^3>&]XI9'+![H(]GSWF% M[Z-Y_/Q$02\0T*/D(P-5&M'("V]!Q\/&3($A!"3FO'@Y*ZD%#.9SM0'*5!)' M[L='-F5;+ES)](#DW8 @X))215D.E"^R#21-XW^Y <@ 45I#*E4!WCC%#_* M.1EV-?,Y]@F3&3VI'3]QZSGR7QK&)_@(WO6,@ETD<_TG9TXXRX)Z&65.Q#!=2NY( M'0=^ND@1.Q[H)6F$1:]:/67J4:&R'-":JK.K*V"=6E-]]/R%1[Y7!,O?7>8X MGHG$5&]YD&*V6#/-I=Y&FOTQ(PATB, PP:I@MNQ"A@OD">:-"9^G.B3*B$YB MD)T#SAO)HU%?B+7/"C'C;6:;,\,.,$8=H+)JJ6PQ[BQS!/O^LGPC<%R(ZOTRFMG\JBBU\EVEIB MPTHR)U%L2RZ=L3##S.;,"S#A,L27J[/#S>MS$[,9,0TWS+VIB^U!PM"@5ZE/ M1#+OSF1 B3TI7 "\T2)]UU*KQE3#37FB=/_/@&Y*3/9T"-TJ0SH+6-BQ9\K> MH0Y_ ?J G]KA,K6E1BSL1$M1V4O4>/&9NY+8B,!5L&F@+@*HIE3>^V@14!(R M)I<*H:MR7)GOXR#X1.%2IQ?H\S"+#]A+]GNL]Z6RF9^8$W@)4R5J!)Z*DK?I MDQ0O / L8"7JK^K8XK,,8.@+0,:+SR7P4D\C*LTE/H#IQ#.A1YFH;L743-SP MQGUBWV@.SX%.G[GJPAB73>,7;K(HX(4D!G$K#S'9VYB#&LL=A[GX& M1 '2+8@F_P!&P^U.'90:4L; Q:Q2A_%\+DHR-P+*G+# +D8!:<.J-B2 @BA1 M$C'AZ$0-55-YSBS(H'C&XF[ A43:(3IM[X)TVL1B6#5R@WH+H+2IE!('>09L M;(1E% UI[9*=)F7$U ,2?A.B6:G,P(TFNCQ^A.H)TX.++5B *D*V$DIURLR8 M<'PX63./A&K%P+';6A3,F 1+NA0=@(_4J!592'41@;!NF.>["-#5G75Q2U$O MP"]V M34OU $6WT1L4FJJA:4G34@%:ZAVFR,J\C@/4U16+ZQY__S"F5J)G&Z4APGD_ MOU.]D7XZ0)%=@= N"TD_?R'/[VOS5>6K_\)M7+VLDBDZJSCH005^-TDA99M(7RZ%:-HH2QME.\M?+FUHZ5$OZ5$[HRZG M(K<&5LR953/,+SVRX5)@K,,%,LZ[5G.XUD6N)/&48IJ*S9GKQ,I^4X8T=D[& M,WW-,S7"R@&3N2K 3FT:<]R\A^:CZ@@O^L5K3\U^PJU=7+A5H$57$VZ^@ZK>:H^AA=_0ZJLX9+9@T/ M]AU4I8GCZHGC77O4[&BIH0EC/9K5OX'4@@IK#0J-J[M(=4RUP3[$7#G.,+^R MH+\4WBN?"+04FR:?82%;(\B.V."L'@+ M9\8;"PS+MU^YB[-:7CTGFN-$I&3F#U/SE<08H2_-_VD:@1VJB7T4P\:N^'-N MH70POO[Z%$\?:- 4'YLY#@YNF08\I($P/HLG/KC\1$,9AAWW M?;98%I_LH,FA+#G\#^%:T0&.WK#=B--LJ S&<5"AP^]Q4L\N;&ED'8UW:3Y3 M/ _)P1%/I^V30L$'7E0-):!I+>MR6 MQN?1\/G9\^$G 'Y5$$E3S!PQV$6QF:/J).-A)( V+/_[\T^;4:/'87?T.&P] M#OO\0Y]V9_J)?1JJL:-58NJ:F'^LGES1XN3XM634(PYUO <-FR;]T2[$I.74 MM$0Y/^#AN M%]G881,/?[B(0C5'$27"E+V"Q$61*=]+L^#BA<5>U39F3 P,?;,=)S8 \(4@ M5Q (Z=WY?,Z0&'PU(E(KATKP85O[ZQ= -Q]ZV:(LBY34J7,26^*C&T"C 32 +R0D^PQJD%!% ME6]?"PF:=Q>?<0\7O$+A*BK?\"!]P\Y3OJ$RC'=H&&^/6]PR#\DR_H1 [QYB MT2;";'AKM!$N%6D&/_7J IS::BO@U".' U6#VG10"CA5 ::ZD9>P*,U!,64F5DBJ0*LM02)1*F'9# MC7ZWKX1)"=.N$)=?;&F^O-O5@DNDD$W5_0=QO\+-. )DT]=Q\S?M-&\U^WOJ M$E#I/%67@'+TZC:[I]!:1,G&5JU%3J,?T<%BF5:J::VFN4_-4:-=I2Z.BP(S M/3B]FJ+^E.C8M%IXJNADNZVL=P^HIOZMN0)73LGS<_)HH3P?*5M*0;[M MB"TJ4J$0/JL$RMV%%[)_C(A#W2V-9OOPO*8#4LHUE.8C98O1U/?.EI.!>U$0 MF*\@L>TMG,AC0963!L(.4>6ZRUE491ZT&6$/:6OO-@T%V+>SQ=IJ6FJQ*@C( MW='3>&'/T>.5*H4$J49V\"/;MVM0A851!@12V_7&\>)X;YW(2;KP2/$?199* MV:/FJ@\95K@32N(.2>(,HW5@(J:RCDQ-909UB'1VWK!QVCG+% MV7RKTOF4>"CQD!"9IZU ]H>4>4!&6PJ6^:*0HP+0*^,!6Z77X;:"6-]%NJM3 MT@TE;UMS\?A$4-B2K>:6\;XC$L$76Q)*^6UA@W2;/25Y2O(JT7F&DKPG;>.M M051;O4-J;KX>1'4CZ)P:8/XLM6/ U2I15D*JO"-7P-0!JIZBIDO(9 MVD 4#&-LEGP&9/[%8\WA, 9' 6=4!9*)8 27B"'ASZC"JOLATARQ>IC/(_@: MU'*4 :/ ]2PF E0\0XNM8MDE, CL7&LQI#=GH?_*G250Q*2)]%5)&@60H.0 MW"#W$4?MI"%54,:9W!8Q1K1+%!5<",@EHKX<1(Y0_)._BSWXRA\&X43H]+M9%/.)P(?L9OB0W;K@0W9TA0]Y MY*B':E";#DKA0RI\2(4/>3CT5=A^"A]2R5"U,J3P(14^9-6EE^4F7]O<(U&4 M:99MY%-V0571+E+)[?'+;=GD026W]>+@:*K[:WZ_@L4X @#/JJ$63KI674G(*M/]U,EUTJN:R?7*M*P M?P#.LN0]F/6O-PUE1I=:^WISRS!]#0Z1CE^>7[*?G33AWNJ+?505>*5"+]MC M,+L4%0XD#*$P\7:[][9*A[".3*J("DJ>J@N:'YD\*2WU"NNS_<*NBPE8$SUMG1"ZGA*.W$IR5.2MPO),TK7;I^0Y+T,BK-C'5)'^<.'XGRB)SYA+R53 MS6BV%>;5*X+.W*105@+$BE"%"H-IC* M$HH-2L"9U5P!+3!@$1>()S^NM>K(#YJ[HVN??<+RB*)#I%Z5Q%N-0#+E(:D. MWT;H%)^-.&4:11E\'J)D()J;:[LPYFD8.(D-,W;C67Z1@K1Z->UR^0SI4ZP] MIPB3)A#L1#6FQ)6A0S?,')/(P*"7! 1FU-QX;SA*S)]<56=P/Y,I]R.QF1+V MS_8 .YW.(9E#QP$ NI%)U%,FD3*)E$E4 ^I523PR;IZS@)1QHXR;&A@WKO\B MXX:E)-8F[F.*.9@24UH^43",'Q#A5AS_Y<"#<.L0Q@@$91X,-+QW;1ZM]B=> MP8CJFH=D1-TD\"#0=31S).$7UXL%7J?VUC":+0E3:-0'IK#;5C"%1PZ^IP:U MZ: 43*&"*50PA0=!7]HT-H28.QFB*#!"!4:HP @5&.&!U)8169=JR\JD6V\H M7A9UR#R$K S3ZNTZ?5T)T\D*4\M4PJ2$:3?4Z)H[[U"KA$D)4[V0(13 G;J_ MYO>KMO,*X.[%+:8MU4U 2<>Z7JQE^Z$8C5[ MI["W*&"[:H#MC@['2JP:8Q'TXS ZW1TY6XX&-N\XV0-^3(FN:(HMI[!J5'1D M_Z!\QVG);B?&-<28.T[V&*4[B"C6[&]?[N[7!U1LVJ "<7B*Q M[=(&_K& -[T*)-A\4:+>;%M*RJS2W9./4=(4[-P.H;R5/!T%F.$*95D7&E/Y MR]M6F<.6(Y,R!6ZH1G:,(U/@A@K:10CJ$3BDE%YZX2 ZY1P ME-0:+>,TTLQ5$<)VY\96F8/CPQ4/A6:HT SK1?E>Z>K!;86PYDMSK\!>NTWK M.!IA-/K-+6,M2AJ5&GR1Y.E*\I3D52)Y/06M61K@<#YAI(6MRYLJ/LVR<*1OQ MLT'(V:\S-H0IOF?> YM%N&2+E &R%-FP 06[3?.I0JOA\-5D3/#-X78@>OR_ MAT7%0P%N\CNKS5BT<B/%9(31(AFCU%*0$05HYP0."2S3;[_ZT\:12=:[0:C9&M(JR0" MCXA^-X3O-N9'W:&H@0@R(Z2Z:DC\13.0'^ MT1?,"WR$&PI!W22PFY%IF$DQW2,(.7$?5^%Y;6B1]HQ#@I': 1;G09@N(!0( MK:/,EKV:+1*E[1YTEM;OLV1\8"5]=&@,#4-(&O%VP28:@HRZ26EDFZ2WMI5QA@FUR^P#WL MV?"G=\=KI: $[LU.*4G%C[\/PO./V]HV;;WWC&W3R?E%CW0[<)Q,J+M0]T-4D.!)X'!/WA(&N/TBII[- MHC%X$,$#>?'R2; EWKNHGX<9L88>?W3EU_@,[F,<+R+!OT2\6']&T+G^/0?; M,AZ'03(:YVZF/;/AZJ;V=S>*88^U<2-OY,/51MRG%>%HTQ3?.Q]Y-D:!&\M@ M%?X;'B*F'"7VN'@%67ZDF(8\E""VL'=("P+OL*XSZM!]TR#P\#4L##'%%A=^ MU*")\>$0MAF\YV'LPFO (IF"E8PA= >?B)!-B)0+FD),?")^I'6-0,'<1QT! MFF- VUA.3N!:+-Y4>Q3AG]- 0 )[/,53+^ZW12Z.&6[II!?)7+/=J71;?:#Z MG]?36RA%)!I>@+_0#QR6Y#VH/2"3AJ;!F'L.?9O@*Z+ P]T&PTQX*\8IID+ (G@=&*D[52]4"6!J>EV9A M1[ -DN_AQS@"5/3C3+)!1D#](XQQ4X,M$X-DI&;@&P<-&@_LFA$+'1)M>AYM M$&+Z2Z,,.S1>]0O/ES<=//+)#=YH*[#4: M_;CNP(3D UB]J)3J2SNC4MKA:LW6-"R=*Y\P[(F6=ZG>VCY8TC:>"Y:\ZNY: M,E;R"<2%=,(E["5NK'UA-FZ";C'IKY:&PG=?^\('8<+"F69T!(QW8VZ[II-@ MT"&N3V&V(6RZ9X3L_IO9U,%5IP)I+8$M# Q^N"[DX-/?D]82M!@*6L"3'J=N M**QD?$^_ 133C-X919= :?DNJ,'\0:1SO0"NR9X :_2WMJYKLBQ;[O,$4B[& MM.E#C,+0WP*M/=28Z)6(N==WS5>K+W.QKB^%JM6*[YJ@"&$C"<$.7%Y+&(9P M0G@3"&"K5U@\#F[><&%.8&&9#.&K2%@.\U\_8\#B)@:6903FN8Q?H?U3.@!2 M#[UD=E.]E-N0;A3AF>1OG68_(R-Z-F+]?PMB$?P%.QS(,4^!*9M-9%KV:E() M2J8\>RZ05',%#])XD8P2\+:6Q1&)XP(1S8)*E79[D,04<4!U/06EC38ZN(43 M6-UQ+H^;*.^%7:#VCLQM:DFC$&D]$IM)$&+P.#-P-EH\KQH8+&F? ,#[U*%BN2YU@9FB9U/<(H3Q.#$*&0HI@PL,X^.1$EUX*D/ MWNC/FS%L-$*O"QB_)/081!@'82Q\09\T##Q!..N\^)WGB@@):?$+&"L%'_"U M="5YB"!'&,!#=8)>;Z>E.6PF-;U#,;^A&"CM W@E:'8_6)YG<:&R2.C *1C? M QX*ZEFZ(%_-%?YZM:#R(=N[R(=L&UV5#WFJ^9!U\I4O631NK(C<888:"W]Q MRHO6R) X! _ZXBFE.Q_V!%.KVS6+IM;:0&8C#R>S*>QECR[L&!C'_*W=S8TU MW!0HVCF8%3?'+' ]E$=Q43( ^]9E>&PMG.;Y9\)0EY\)^Q(^\Z?O8AR;0CK" M*XFX-F >[F4BWBJ"VK07PQ?^+_@7(Y-YH#2@XUP\\3_[(V'DA _=1[J!CLMR M7L-^2>3\Q&VBIF891$AKB9!&O_5"0AKM'1#RMU:K!.5PPG0B*#;ZI5G*Y!H\ M \#O80^3AQ;%(^ZB%02VS=SIW\)I2'Y>LG ?S@.(A&Z0C!D_X1=NN+^8_0,* MV*$2TKZ@55AO[7*9'UF12&0,;LAE1W:?GQT:X6\8RA*:$U>G/*7+I#).3^1 M=H8!&L9-2IF BY+,VHW2JXO'4SY5XI XT4I+SZOR4ZIL)8H1\T=*X%@X)(-/ MQ?$(G6V+4W"XTW]J#^]2 MPOD9W?1!/DNZ">WEGLIDN8FO86KWJF4\6&W7:? MO*R_=-F*\DWA7.ZG:K'W;/8+%BU^*R3]K[:; MJTF[B37R:DVO3J63?*7BNKJ5:$V$.6=*,AMZMJ$=S'6R90]H<+BB")&)M<:"%W Y\V_6PJB3=-?!S_$TD4:?! MO\&L$!MFM;!N#N3^2BT5H1NMFDOE)SX%273S,DHV"6!T_T]\4"7XV@&VSFKI M[3KI8L6: FM,LTZLJ72;/ S-=!-@%5SLAJ)^:,!]/G1C#0CB8SHZGFRIKM;E M.N*71<)2R.K[XDQ9P-=7Y8PRFYYEV%TPHG M]>W.?D%:JM9+AVPR?>*RVC&-=;+'%^*JG.!N_+9? NM.V4A[XTJ_)EQY%3VT MW4,/^ZJ3,ADO\S1H%D5.ZO@0G0K[F<7=BVR.\H M5P9 N0/_6IWV*\X4C "S=UQQQ?J MS%3L9"-BFKHZ;JHI:VH8UE+6T[-Z-6%*#4($ M=5<^F>LV9;/M_;;3W7*5-51;UI0NUCA>0^C0G3?*J]^5ZW;"&[.ECIEJR);M MW+9CMYSJ?KARX7FRB]9>JWB.>H%%K;;3R&"10@&7@7>3M[6H+$2VE=B>40K3]Q%R]VTYA/STA;C MSVZD>4!_/@\7+/N%.BMC0=AD?QY#PYT,DA!Q:*UK:NR9HM4BA'$B"T\+U %F ML1&21((?$N+=U0\MFD4QGT2$'Y-BP0FZ$9[@TK-FC;4C]**@ )Y+UACB? A< M$P+"R]A&"#*,L$TB 6Z2]UDF^#A\(# G"!<;!5-ZGP TC5,L4X)4F8GVJ-0' M((H"[ M @Y.<2D>+C\.72VS-4?PG\UMY/K4ZDU?K1*V3/:P3HU7> M=ZO5.JDB=Z5E%(_4!><^_CX(SS\N'4SOGZUFN0AABL&^ZG(,RQ.T$K NX3)@6-*IIRWQ'/2%-+7,2=MLG\"/S"M03] M$273:1#&&LCK0SQN:"'W^0/B]Q*,NHL@\0A%B[08A6P2-33NW[MAX.,3X+HQ M9UX\UH#<]Z[-X6N\,>1>8(O$$.!(,@1#)PG='" 7DT3L)(1WQ3 K.SBCRV%\ MF+,!U,3T$F;+?D_+"1P;R,V:+U-QDCQO86["-!"Y(^\IHP0(G*8_?0E ]Q6 MV4\J^TEE/ZGL)Y7]= KI/"K[264_U>"<:Q-S1&4_J>RGO8:L;KDLGD";W^&# M6.4XG7CVB5Z3[!,E9480PVX_99X(K.!#C-X9)>)H$?>Q+UOB1QR;P\%;,.+B!3!W&WYUXS09 M=[:BEUJ=2#7\-9.LY_=ZOHI MI?P@EHWI?C.:[147K"-@UDQP.C=2&$3$"Q;9?#,]''$:E)<)Y-8UOLP.?)_3 M5:+7W5Q7O<(S&K+E>SQF(E$][4P8C"*J8$DULL1@AYH7/E M/_S@P:=\WA!S[F4>OPA4?!^ .A;)]^\W6<>O._$G%W+6.Y*"*]T/V.U23IR$ M+UR:^"^:N+TP<0EUD$^\4$LAE$"F P+/"QY@\36HL>7#V+7'L"S@YPG=B943 ML%V.-:9%XR",152:D*FS&/6 1:"JW4)G4UD8XH(.%O4-0G/(=\)H'>Z+_J8^ M;;-T#3[4#B8#6FM2*AA^ M_*+<4@4D6F3Y$J*FXYX[$41S0SN9H =*=:'2^O#1]L";L-=YL9-28ZX=.B7+ MH^T2+[XNG<2<64$%_#!^!'9Q8DOEI:@<5AC^9Z;$">,LXL M;>">$Q9>DM%5=$*7MX(-&:!4\B&,#%X.IIG-IN@6H#'Y;_#RHOF:7OXXQ0]% MVW:;N_>H5; ,<":*;E>]$2@J5TX*?>]66/.R$^) M5)!!#(B$,$BLU]8B>)U'#>WEX%,"9HZ%("1YM>)15$ -(UB_K%7Q<'K9NMHR6V=.[+;T[?/-Q/[;$NO+BA!10 M.!,F DP:M+N/BNI+$#ZPT-&^!L$O_/TN-_UJTM/B!R)__%.$-T$AWW)J^ !; M# Q](D[Z#?WLGPT9*I@8,77/+H\2+Z9+O64.,^I+.F504E-6:M0N]938 M!*$L@A<9I,%0BUQX#PNU"6>87[JBDG"#I@O[GL>%-U=3*=-YAQ[XT=IRLX!B M,B\F\D;)9"HR>['*2[C?(M%W$"2BTDED!,]URBB\#\@V=J,X"+&M#3;SB.&Q MX5/YP(5D>E$WAR^B0CE,8-HTC8I[L6\(9%2]$^ 0M&N-2=J 7,*1'R$4R8ZAR6R![%F(0]FE&A6?IR.06@NI, LQQ^S[V #0;LNH+ MR#K3;(]C99TMQ\>FV$.!>5&#@#-Y[&)ME9:63F4IVYA5#X]_.K4:9^<'<;%X M+Z=MD83T9O@L2@8H(E1NG7CTH"DV M@K'CIG;AH3",QCD!M33_5-PJ:O *Z>A2T$4'!RS^>R(-W<6*QU]<3'K ).8G M0HD&/E7L%%8#E>G9(.DCI*T?T'?$A&P@T<)0<(^&X6HLEKU@D!(NM2@"WD0N MOD',7]3GA;+2 :LPD1P@;6EMHC=+F]]@PGO>(D. FT9/)ML[":7Q,RKYY*+: MDCBU*NG^#A/HUWR;IMTWM$$29X*2ECW&P7);C*>;SF1%;$^6X1N]*HJ!3;WR MNFP8PGQ=MM$2==DD\R >-BG;Q076P-W+0@?@>#!"Y*!Y]HI MPJT-(I2N?;%+R/*1 9_!PU;H0RI4#;P/ZVOUE9R4E)/$S^IU!?4;HCZ&15*/ M++3VNOS^KZM/9T9_!2_=Z(/BRZ[XDEDHL(SX([>I6E(H727^NR.SPR9L1%M? MD(18Z)[$LCM52)\,8/=V%,5W2'%A-Y"APNP_$C=*-PUI[(). 5/&E3TN@-*< M:@5#:<>*C2*_5B@MI7AVQI_E73?M)P*N!O/(QQ%5F>1AC5TP*+$=Q(R:0OBB MQTC6.63"PE]<\>=5^9,V2*%6DS8RBGKAR>X;9/B)GIF2&8O.U@H[2UPO&H4S9T,L%,;::@I]EP3G>N&![0*IFR&%G5VZ(3X?&DO$WK(A#.T)Q3']F5B!P-:/6A&!'[*KI ]%%H$1LET MZKEIY!T<)'*-W#D/%@:>X+%7$J;J- VTT=TS--#A-=F)ARLZ/L(KPB0];,"[ M'#>B#\":P<<%H9*$'4J"QT?2A2J1&K'3A\3L\?L MYO1M^'N1('2():WAGSX=\E"_MJ*LV]CK,A2'0VN-;&4W[TQJIP'V#\3C;!#( M@83)* ;RF38( ^;@D7(RQ=T'SVR])( /O5\S(?#3P)L5/XN20=9Y%B:'YZ>@ M=$!1": %FDR=^7FR\6=3-10/-UQV'3A,$:ZM'(IXA'.9@ZMVB)VS1@618'M M$@](LZ<.3[H 9U+/*LKOT+#VJ.6/#&4*EU1:PZ3D'"?$8.C\98H!NV, H5NA M;&-W87L\M^>G=BF:!Q3KS"%28FZ/?1CV:(8?ARP"NP<-8<6;5_5AALSU9.19 M^# -<$)<7_P$^@K8 L8GMG&GM!&QN7/D&YBT+C74C#GM^XEHH@Z;"=FS,!!E MO>W0>N-^UOMV"NY^R&.)S%1H#E^T[!3M=T9[R@64ZP2<=^N:$@U%0B,E"DID MAV*7?NKW3>98>N@9<7#U!)O8*.19/]J5^'+%BX4_#Z[2@-(]]L38BVD<1$3+ M95*:SR83UQ";Q#";5G>1G83KP#QX9"$?%&,TW.=#5Z0DS_.#W-YS@GB02:0% M7E'>)J8V#KAP_7EJ^TEG.'M!#-/48)N;8#+TXG<\G% "1,\/4^MY-VM9,WA M2%U7)"[*)%CMZO8N#Z9B?(,E\1A!6]QBLG!Q$>+E:<@\<[^*<)*BK _E %2U M !N*\-&4'%R\4G%WE\?H8@&M@?@DG8PH-/Z&:G>U%\3B" M9?VND3\+TRV$L[$D,L5P923:QR>$#ON\ -%>P!\Q*+RJ=B9M3?L!WZ%$9Y>B MXTZFP+_EK1M%!??T-'6-YQ"?N;0MW((5%:#$)T&QT*1!V_<9)G\D=/ ="/E M&"8L:4H541'JHS@P,0P0NR )*70:S:*83RC4'MC$X9,ZLW3IOBW C^J?BRO#WZTI#$KTH^390@;%M,)C#0NYA7"JI2,-+>I MD9X=XX\+-<<1AYQ]M@@N$?\NXAJV]!SXH]C!A/' MHVN$@.>8NBJ0I",>8[%:/$Y/%@66.CK?$X1:PF.H9PL4LUJ]U'HOEJTN(=3D M]8L%#!N!M-?01!VC"'S)J](ZO/RRITKR"K6NZ8WD5XH"FX5B1*J_>:I6CTM M/6$0%2KV9 9 LW#D0Y/F2/!B] @Q(*>(C$K)"_S>C;AX;?::AO8PYN)\&28I M1XWOP'2N0C2WL4"VU+EZ@$^QA\V05ZL3WBLI MQ1)$MYOL)65>PR]:74-5*V&4H*_,O;'(6T&#\ MG,:BFO6E6L7B5; P,G3NU,!SHR(XIC,/CDF&OL#53($UC0MEW*T;PBW&X;X( MPJKM1%40I,=.6%@T@6+C1K'4(;&"!MOI/CLBS"O]:7ST7H:2M.N MD^TO>.Y=/&'+O6L[1P-/=2^%[#'$8K,$5/)".R3PQ>\12WQU+R2*:CAI,.FI M'F,1YVDG"'#ZHQ336^N=_4,;NEYZ,(B/N?M\*=^!!_P8#,!_TWC?93 !FL[^ M'(%4C%SJ5X 3R[#,LR<;^N+9 8/OG;0M&RSM."#LY.77KXCZ$?+[LQ'7=J_S MIB2:?,?4VSW';@WU?K_T=>94BR9/^LUJ(B8[UE'0(0BQ M C[PTM]Q17N!R ^]H#YUUZ*"$;>B36)01:+L?H+TQ/=8L^_:&TPYJQ)):\8_ M/\I$V%N,Z^&%7>*;"8[#^4[W,XMNKREY)0FMJ/7.>@F+4 W>/)\=)@],Y]#VL)07O^S>=<$P\/S6+C1^4*%@F1=:W0624FJ M.;DRKDB5+TY9F2TVC#%W,&U\A+CWLDD@9;XB<>9E;XY)P1R3BAP!]BT0E83E M?\:@N3.3S+IN%,+SV*4OA'=ZLS01C4O)M*XS4P0'2E6"F)7K9H6$#QB9][Q M=/ECE)(+FU;NN:0);XY&<\38/&9'\$CFH44\)TA3^WOPP.]YV* [LZPX<38M MNFK*A\F-=>YVDF@\U$E[B*YY2#YS:C.KC=D]SU,MZ*BAD."1+LQA($*28%2Y M@1-AZ\<(^>UL=G90*[U]B::-G]H#>.(IFJV@PCX8?9UW*!4-4&6;QX+U)0ZI MI*%#IUH@P; ,4E5-.E2HI7'(Q68-V@?S+_QX'&EX,ZAK/H6=?OEKF(CBX -L[M[3Z=F >7F; MU5C[!-\(8ADI06@5I220C\ EC*8W=H1]I' 0\&M^ ,N,?G80S520::->S*0K MS"@_)%_Q,+= (&&U27*,> ">[72,?2K35BNRJV4Z/9DX$\]6OGWD!3#20D90 M#?:TTJIC,@DP-JS=A%0/?% Z0Q-Y$IBZD$X#^RBGY=*@!JB)K\]'0>S.5<)G MFPR51- ]LEYE/L5^W@IR B[R#"A'PG:GN).[?J:D"N-8V&!G+W"L^F4=JUY' MM_MMV^#PIS6P;39P#,,PN:-S77>ZO1HX5JTFI>5@>AJQX"9+7:NY[+%YB;!9 M&&);!G3],'?OGGF)3&+(CSU!Z/!,+PO\9 HD%R.Y<;MD]J2!HT4O_G+L\B$X M9=2Z$_38=\PHI')]1WZ7AY'D=XU4V6456)3J(S]T>(26)>4"I=&EA/:D@"S=;E36P')[DU8#4'HP8/40T/@67)-<69R_;>WOIW#5D M3@$203!'J#4@8&!+9\V12?0K'CG!+D5HU?FQ[+@GRJ.&0&AXXA\)J%(NZZK& M+"KZ#8R(C G58**2:,A&^S/-^]+UC9?-K"Q#GVE6KW*S^^MSLTL8 M4WWSC;45?/?]Z[\^?_OQ\UJ[_'Y[\_WVXL?5]V^;ZHS:S.++ M]]MK\///_GEX(Y>AHG^*C0/4_HTP)#ZOB1*]?(:DHO26U>TY5D_OX:&7U6?= M_I!;+9/9W5['86:UOMG-Q>T/[>JJJ7VG/.VK_/QT:_>UWW[&?>TL>*]=V^AW M.YV.TV.]ECTTV, <6+P_X#UF\:'3KX'W:C2UK]2A[2;OVU;OC//Y%"317FZ" M)24E4I#2#*2&]BV(P3 W5/+'VD2Y8#)QXTE6]8$;%@B).+Y1J4FOFII4D-/Z M$KI:\5Q27@>1451^Z^D]L_6T%K<>L^6TALZP8_3Z+:/GP(;#VW:OY9A]\#Q[ M=S?V;GN6D@0!SV75,W=WEVU5KVR:L!RMPZ'Y@R$5+D@$/. MT:P)+NU)Y6BN0+LMJU$[NE'V+$IW]/Z@I5NVU75: UL?,),;O-\;.CHW#*L. M9U%F4_OIAY1222OJCA(0@)N?_TCP*.].]"1,-1;G3[?7#$ M]4Y+[YD#P^E;!C<=L]7N#.J2=_J)#QFIE9]X=G''?1=VN%P4G]OW-R#&GF7J M6Y!YG+)RNW!*\@*1L$K&%P9=9NJ.8=N=;K_5ZPU[_8'9QO^XV;6';:,&[&\U MM6M,7+IC0RS#+V09USO*\"V("Y7X+^#I<[GDO06>MH9VSS'XH-6RS99NM_HZ MK.=^5[<&5L?S1+3?W8_G^H8^:!L@ M/Q=. *]UOGAL]$83"P/6\V/\?N@^, "7>T"(?GAFZA;]25;U;'@4(G4FB' PCM[1JS4&>\O>X>YVF\$1:7=G_U@7/'PF<:>FEESN4F@_*4_U"D1'^S'&=L,P M\10DDRHC9J'+M+\G, KM%A\A0*. 0*9NF,O5,D^29?\V%H:]+J(L-+H>=>"M M7-E7-U),WQ53POD0N\=%#6S@COEE N^ XJ].!GJ KXD+K=Z8PQ'1DJKPD,!- M[5(VCLOBOFMN$.4O#UKPX(OPR0H N;3BI% !=5619@7+,K\-GYX4P,RR][76-,E\I\+-6?1E-LNV(X: MB"CW8>XC($F<1H?2U$N*M,J2MXLH0A16F2G>* :8A.'^3&5/ ^R2(E#:U4T& M%0JLO4=?YAP+1B*.L7.76OL-^)AY0U%61UWJ?/Z /?HXC>PWP]+3$PM:,JN( M,I-362Q+$8G??V/^+^T:;G(;$DWI@?)@D>04\I\F881%Q_B>0F(J]2LT+!.G M10F+0N9PBJGW<JJ),5 M]$"GJ<<$*(M-!]T)E](-!!=@'G/5%86:PQ42@RMT452.1_F2.KIGKI>".(%0 MU2DB\.3 ,RGY&A&Z25-.Y@T86KW/!)'>FG#T:R] MO8]9)(L9U-B'"=:*S?,4WGFDGT"J\/2Y6'PU$IT3@*#^B/H@XX!"[G$6$<9E MX8:\5VHZ [@^&7C"CTH/VFSFR81MN,AFT6(A4!)1;W^J5QW#B+DGI7\R27P7 MJV?%6L^&V2B4ZZ7]'.1K&?4-*)! #%C"?14[M;I1E' YDB)-,)<]Q920+:<1 M03FB0FU1 U4H$"[P3G9-?>; D53 TZ>OA32-#, B/Z',-M_GG[11VG1OTZSI M5[]GTWAFB1*NNB2"@XZPS_@CE))0F^SPEK[_SMW/$:CNR=]S MX^>/8W?@QA\J'^#K9X1O(MASAPO#OFX-'*.GZ[;=ZK8[S!I8#NOJ3F<(XVE9 M-3A&P:\??I#Q\<-P+S;O;>]>GE=-.' M^5-&7";WZ W OBG5 7%8?)VOH*8N5E$SJJU^R_H[5U_?:S7:_^^2CSFF28J) 2V3*7]]8;W)=1)WFWYO31\V8 MUZ38?'Z)G,&T M7:!V:932,3J=AY;CHZ3D:295>SKB1/:U=:M)H!2BTZCN-I M]/[\G QS;C='P?WY16B/P52(SKDS8N&YPV)V;O0[K:[5.X?1&AVS9_; =]:- M5J_7/9=3,HVSWN.OYCB>@!S\-K4,=VW\D: M(N7>YZ4T1-.'@V^9VMQOGTE27_D0,';39FL-V>[L8AJZGM820WGWEQ4[!HKY ML2Q?2RU?M7QCJ[!\+R8B7"93%T4?0XQ+8L"%\!LP(F$7%F*Q>\O<"GV=)7GT M*])4*_*$5J3X$58D_#&[YUF ;##SV$/4I\3T]0OS;W35ZR]!6G2*"1^S0P1% M$$$0)1F2$&9'44)0XC3V:4-7IO-);=2K36=#+]C./[#?K:C\N1,'R=&6+F_! ML:4DBSW:U\?N\L+"51:V6KB&;A86+GN$%2FJ3]2"K=^"M=2"50M6M_(%^UDB MU:I56^-5VU*K5JU:O;72/IX[%CI@8_F_CG\9M]4R5LM8;Z]#M'F9-%/S;;N(X_&;\ Y65^B"*'4>K.KU+I2ZWHW7Q.K"],NPR"* MM*^R $^I]+IQ[;15>E>I]()*[RF5KE2ZWLO7!"C>'UFI[T^EOVO(HM/6W[T2 M^OL$XJI]I<"5 M?[J^*J8)/GJEP9Y?5FVVDK];Y2ZG,YH;K2ZDJKZX:>+XMK MAGUUM#N!+:ST=^T8=-H*O$B)7(-K)UE\API<9?4K!0ZKHI#6?\N!41'F&BI% M7FM&G;@B-U1\O*C(597'*2GR8GFBWH=5<08K(BM21*'W G_T&'.9UK*D0CFM M#.TK7'7V [O_7OG8M R;:]YXS&]0-TI9@ZT4](L985NG$ZAKDJ CI5?6ZT8.5@I2VN'%HTL3M]#*-D49<_J<&I:T;H MVJBR*:M1^^F[L7;QP$*GD+^HE/O+N'%ZBOT9@A2"*D)S7[.99G1/1W&K.K 3 M5]SFW,J A?&([>-?17G#4M.^!?Y95B#Z26)314JOOYQ9)ZO;GR+*R>MW52!X MXOK=FK=\IA$KI]MO>$AP!:B*[\:,4(>49;YS=IRL]EY'D)/7W*K:\Y0T]]J# MHT)CE5R%7O@^U@8MJ&JE@K>CZVGHWDTHH7),FH8JQU1Z%U9%:Y7>S3'][C#O MA(QBI7I?0-H35[TMI7J+JE>539Z2ZET^?V]9V?'[O3OECPB$B/BDBVKX7U/?SW5("=6K:<]K"?SV?7TQ?7!M43\[&K6 MTSDAA2H(XTTAC(T%0BH(8P5AO ;"6$'Y*BC?;$PT8^GO1][^9TXM$)Y]WEW_ZA2 M;P7^F0]_[N#_,TL9JM/A(! M@T@@!B@.0Q>I@T$CUQ>B@PIF3D[ U8XRU[JA8<-HD9[VO__RE[_\GX8V!D$; M8..Y8.*2X.4.O 9W#H)XK+UUWY'_#\^':<#;4!K?NO#I0Y!X> N\%DF,"HAMHT&7BN#9\Y;F1[0<2=9IUD8,/3U;]4(P3P[D4A0!*@)^PD M'A=P:S+(&&4<+ 8.KV(^T3JZ\9:]>]M^AQ'"6SY*_:.[LW\TM1\8@DP[#F(E M983W#9/0=Z.QQK0(NQE2OADPW@ZF,WP(7IR^+I*CP=LH,,GM) 1)D,/[_&B/ MF3^BETS64K,PI,=?GE."< M7.>O;Y[/4NB8YIO7SD0YH*23RL>RW_R2:N2YNUJW7OWWMXL?/V\_WY74'OM> M>#>%'1RW2E1Z;DB;<)2=_^7;;+;%RD- HV^U&G11FC@.CT)##[;IF4;FG2,, MPY!/@Y!> S91^,@+X/>0)S[<1,]C23P.0IC= M$Y9=]1*Q9K?]_O5?G[_]^'FM77Z_O?E^>_'CZONW@YO%VYS-[TI(]D$D?9GM MIM4IF]RUYE'-7NOI3*U-GV3UFJ:YFT>9_:;1:>\Q?TPP9?^22JS_!![D>^U; M<(^'P>%__H?1T3_T1+'*[J-%92_;D,Z[S<.IE!U_FY6@^B%,Z#PZU_Z'S1RN M7=O7+F@P?QNQVJT@/'.95+RDEZ>Q!OZ#ZVA(J0^KHIZ+^T[M.#!/_<:^R=_9 M1&S%9ETKLN7IE/]RL9X_Y!'%]BB$LBY#[.UUV,Q(C=$Z!C>Z<,T4+EJ^'!^5 MA?L63#221Q//K5Q)@,,((86="#\Y3##K7[^A(.DCP\8>7>> \ M0>=P4&_XT#L$@_AZ7GGY\?K[H?.#Y_>O?OXKV[WM\\/M\X5<<,YQ-RY MI!!PZ#G/B,\D>N MUSWR#D^[D^/!8=?[("[#]Z<#?WBBF+ZP,^;.X!PXPC3,SE[8>6?&^>*LUWM^ M?CYX/CP@=-H;]ON#WF]WMV/5M!.W#1#^8ZWURX0&2?O#GKP] 0PFS1D)GM:: MRPO".>'\P"7SGK2W+VQ)FDMFJ(0]PHP#[*[8>YQV^7(!63&-N-V3MZ6<8;=_ MV#T<9"5Y?$66%7/ M:Y"YS0&=0OX5S"%; !=6<<6G=XXC(4+S!:'MI3=T5Z5\2 NI0$L+QQ;T') E*.(,L.7(K!C$+_O"-3=#?)S+\O*#P0FB1- M- 'KO5S>%A(@$SE>V7N;&I2PD/U-2!%0!#!R49/M]Z!O:[\@01C](ZP/P,36 M>D$"@V_>>'FY+)DQ(:M4[8 M)0S3"/S45W\#IYO.T;N.HOK8R[?-<0D9].[Q)_5_OD_'Q'&3$L*<5RK3K7>B M0K+X8N*]4I]B#V)!+/X13D2>7*, +'[.)PA#;RP,4U-:1OP;LCP<'$NT5G0*KEB&DQ7B""E.(B9MSQSB.Y&D/<(E,/P^>$6,!?,]RF^+ MLK@FC)V)YN@)OF*G+I)CQ'ZX-?9K8O>1D$?H,PCD8G<\@Y"SG>&^SM6(\F$- ME&,13B1CCVBQ[T> "DMGD".A^ROAFY-A1/MH:[2=[]9E_F_F)H )M=!^1Y=_V^F+L1\I/M(1?" M'"6M15B/T10C7V0XS"]<59-$>#H2[G+%ZKPRIN5_Y$0[QD%8E[@ MW0@C\!1- GC!F,T\MHR'$8_3/!X)-Y7(4GY.Q+!%T-R+F1F]#*F8B)CTY9UK(D?4KY)4A*65B MQ&60QR5A][VC&'ZONLR*IV@@V+8(HH+:R V6NT" U:AB8&.$:9B'J:AXXF18 MM@BBR/A'\&*1Q[(T1N19 M3#6K^[\"*R,L1WE8)-.NY.)(MBIQ*<;1M91UBR ;R01!L'#%B#!.(4=4+=T^ M0RS$<)GBJX-6B9D1MF-MQ(G8*KS6&3LQ9S44M0FV*TC1D]#AR2*E96F,()SD M0VU='C-P8@XM\OCGD"$,&1O#J:IN M5_:Y1FCTNK;J3E@X"8\6^;VT#+[;HGK%XOK1D8Z0H;CN?)?\UZ9'GJ7.?@23 M8%? Q;R,L&EU$B-L$>$S,S)")A66RDOU;<1KPTU=TNLRKD8<=** M+1OK]VV$J*P&;XE3!59&L/022X6B?AMQ*R_+6R)7B9D1.ZTR8ZKTMQ$W<_G8 M$KO*#(WX:36=JE7I-N)8I:)LFS^KLS1BJ16'JI:JVXAEIH)L"9E.:41&JQAE M>+31^?G"IR4"&\A-,'S0JD=Z];2-:!3706W7PV5,C,CH]8L-)=4VXK->)+7$ MI9#8B(=6F,C56=L(0[YN:@G$!G(C%%K)02N^MA&,TO+;%>0 69Q2J<3,")16 MO!6]RU/M8@VB*RA']BIA5$L#8TQI%12KF(ITZBH5 M8H)$K?@BTA\0[4.L&."+.1$KC;^4JE]>Y/IOER-0)3G&<+$\N),+EZQD)Q:] MCX>-'3[DPL=_5U08I9EBXU2K-=FE$B5_'R*&A\JVV!O8&$'5RE0ECY5;B%+9 MP^"T;VUL98OFCL094=>*896>3Z]WZ!Q)CF(?+)O0NX+"2A=E4[!UK]]>DC%$ MM")=C1#)*I D^W;FD?*M"8G/5B\,N7#=I8PPRK5_Y+)XI6@K8S%S]-(V;@I( MC1AK)ZY+F\*1MMIVDLT5NES*-D&NUST:K(V!4'\O5MO+W3;]]0Z(I;5:HZ5]][5SA$FF,32TPF3-')$JLIXQ M6ILBJNR_JYTD:C$WQH)6=:R\S:_M::(*'FFG7U;)^")YE>5/T)O:KQ>-C(PX:97* M=9Q6+[]T(KYMARNS*P$@S&3%0^XF2N[?8)'>U!<]K2R>CBI,HX@.TC* =E\L4B,2Y> T1_ 4&HBLJ% MJ.X@=&K(,\:,5F#<'#.)>#4/D HX2H.HCET8/FV,E,UOVZE1@S9P,J*KE1;+ M7M_32KCRYTIJ3[:,C(Q@:47!@J,J;9]XY;V\OCH*([.(GV^V+9B68HQ0:V6_ M0JCSBZE8KOQ9=(JIA>%0? *I=A^NR,X(KU:ZVWBTJ>W]N=CC:707J\L Q5-F^8X@"C#S(66<1$EO5SG;1I8Q)K1B6GGZ M7I>=//!8B72>G/2QW)[/O<%L@ M;608,=;*7D489WNO=@QP[>U5_^P0^-A[86=@L4#"9'DE^HTQB717E\05&$1/ M?&6 2#Q_'X, LGM_3'S^+#+;!?8>I+T!NX/SB?RZ-I@P3H'+SSNMYQ*?00KVA:=&5.L(A0NJQG6#E<)00- 6HUQC[& M0WP94@6-;7!R>M!-0)+E:JN"1U1XD+HL6M*Y@8;#51;&/NZ@:FJ'S,2 M> *;Z,.<7PF'8Y&5B.\KU(2M0N((4E<0B@0BBY[L/N2R&WD(3T7"YQ1-0C%' MV^B='4NQZ.66'6 1*5#!CN'M+PG%S1L0@^^$RNWD$[C@;?4T3;#J)P@"/LL>?%DR057-O(K$3;!S%%+UTA[)5TQ( MKE' (Y&5#*U*W01++UQ7R!93KHE8R[+X$.O&=+FA=5,G-ZO!/1WQQ)!_[S^" MEXTFEM(T=K14FR73'=^&Q%_*F\= W<^ AUN2&;6C?!DHOC@Z/C_AAB M1*B<4["K$ [[P_?E%IFHFF)97]?QU&Q9&553+-.]?SBH@UE*U1#+3G3O'QX9 M+2NE:HAEI[J.QV;+2JD:8=G)05_7\<1DF8&J$98-/MP1S&>1EO+PT2T!>"V; M+PU66G!HA,6'_X. ;F%O9?HF6%NHH7$T-U$UP3)Y1B[=T#H6LF7M4O6S&\;" MDDI#!( 53:.&36MS?VDF9$WFQ*?*06_SOO= #R)W6R7ZBV!5E5?<:S':> M,J,KLN*)I]OZX"O!.W5#*;^W]L3%X9UIA+]KTD#W&2#Z4S@5H3X2DL2M7P&= M"U/CFMVM&)FG2H5RJZS9-,'V:RB&*Q!75^37,$:F>8K()V2\D$),(0%&P MO$)LCA@34P_YFC@A /D^J^H/:[8-)S+*.37, M^"_S14"6$+)?9^0:!6(=HFRPL]O Y*U-OACVAT?)BV?$A%G<%(E+SJ<-$Q,C M71/&KP?((*#N[ H^P8"H%RRJG41JBV;R(L5(X7)S:S!J@OWIX8![/]%2?1%F M(ZR;"79@C\?/9DNY9R&.I:V+:IV-R*):XD93;X M9(C>>CVCEN1J<^'%E$(8U[2>D&NL\ID)FX#9'1 +%#H.%XM@N5+48%HY31.L M&L,%H,F^A-7.I2P6*3S9VPE"<@C8/"/:$?=7"NV$:,=NN@,X](4O0MEQY&Q M.F9W?BIC_RTXZ@9[Z EY(0AV%4,;.7X+[GB (/C"Y!FA6Z&YK%"M\H2T8@NW M&#E_"^XISJ!;>J:,Z=L[Y<*7RE69X!2U;,*@DMU%7>&1QZ;F3=UV?4GH@@C! MT :*P$ %0 '-O;'8M,C R-# Y,S!?8V%L+GAM;.5=67,;.9)^GU_A M];XNVKB/CIG9\-'N=82G[; ].[-/#!P)BSL4J2F2/N;7;X*D;!V41)%95+G7 M#[)4*A$?,C\ F8E$XH__^>5T\N@3=//Q;/JGQ^(G_O@13/.LC* M,O_X/__\AS_\\=\8^_NS=Z\?O9CEY2E,%X^>=Q 74!Y]'B].'BU.X-'?9MT_ MQI_BH[>3N*BS[I2Q/Z_^[/GL[&LW_GBR>"2YU.>OG?^V^[EJ(VV S,!SS304 MSH+BDLD(*6K(R4C^'Q]_=KEF)9)@1>?"=%&!)2,4*QX?@PNB2KOZT,EX^H^? MVY<4Y_ (NS>=KW[\T^.3Q>+LYR=//G_^_-.7U$U^FG4?GTC.U9/SMQ]O7O]R M[?W/:O6V""$\6?WVVZOS\;87\6/%D[__Y?7[? *GD8VG\T607W4_O_K MNU>7FIS/)I]0H#X^/9M\>W;20<5GV QK#."HW0;OW_=HY=-6PU^W[V#+PO 3UC+]QS.9)8OO31IVIUUYW\YB0DFJZ>C MY9Q]C/%L]!LLUI_^>C:?CUSAP@F?F2C F180632\L.R-Y3Z7"B9>%FCKY!Q[ MN2)$C?.T8L7FTY\T23^!R6)^_F0E^Y7?R<8(Y/SO*W:%BH.+V3#U MO^8KRH&&T CTER]G;;9X!E.HX\4(M,M95LY\L95IHQ6++GD6K@[$(D^9U([(=BTF&")V/!\]E\,7\Z+1LL\Y&VRKM2-$M: =/9519J06J: MHKE,@I?"B=5_%0-%G][47V>STC[U/72?QAGF[V>3,O*VF!2X8PZ<;;:88U'Y MR!+:5]E4 SF:'GJW''"5X40*("/Y>UC-M[_B0.OB!"$]+:?CZ7B^ M:#/W)]CT>11MX<"C8<$8AX,: 7KG*ZLQ:"MJC-%98G+LANR>$^&/0Y0>%$-& MFG@/+@2GLV7%"\VTDH+%6 Q.-CI((90V'(B) MM@7&D(R!H?+J4.W1T6AQ MU%0E]B^LC4$D+1CN4JT+ !X9DWAC,$5U-Q210> MJ!EU*Z(AF1&#)1>=3GN=KF(2*@J3FK@1>*Q>H' ?[;T>+=5+3A$X59.SXM<-.O>UF M+?!J51*&XQ+@),>N22M8D."9@."-YZ6*2#UW7&A^2$LNM>+WE7(O:@8$ZYR/ M3.LV"_&("[/C@G&=@]19)>6I-S9N5#-I4%LHP0//@ED!JH7''(LV +-@R8E"UHY%G!$ MA: ,&$D]=9VW/20_E$K/>\GUBE;_^.2J0%[CST=,51E=B7CVE:R"[3Q0NLK5 M'A(EK&Q;_4100J<@&9<>B>"J8+[B(F:*]BDH&62EWC#LP8FZ%I'/HF0P/#$O MT!C7W,2V&&.W$C[E.6HM]%%W>0?H&-U']=L6C+T%3K],9&>%ES@GVAH"3F=H MPR73\DVL4! D3[SX_P?+!+66]Y+O<)8+?';6P0F^CK[Z<=(")DD7+ZE^9>S#N>'Z?-EAZWDKQ^Z.)W'O$(Q M+:N?-G-*^=_E?-'4O(M\13'>Z()6':!H=6K;TB4!0_M1UUJX",D=2;Z]='!( M.Y#'' M; _:#9!7M/M.6+KZ VF:_38KAVPGVZ7Z]B2DK832N;*!0[E$J%FPN MK$()"7% ?)-A)[Z,JP0ZP#'PU')TCOUFR2?Q_G)R\GL\W]!^0B_QO&T/7Q: M%]"]@SR)\_FXCM>'5-J(Q\ZM^Y%2]*$4P6*VT$2JT6PO^%WA7!O+E2!/PJ'O MQ:#BR@-D^Y'X09BI?:T+YZ(;!4@9G&SQ1W1==%&>)5R&F%0I5N.K<"F1N_,W MPNES1._"%IX"J!(TDP:0+;I*YB%S)B":#.C4\4 >LZ&TFQ\Z$YR&9_<9A]1: M)1MTET]]Z.R%$)&C:=?R6$.M+.J:6:A<)73SJ[>5F%BWG&%[Z#SP?FBRO\0? M-K#R+$[: =CW)P"+>1]AE,L-'"5H6K.P+FJG21>P!K^@"\8(3%F"O M% AG#9N^[K M>/KQO^-D"2/O8LX^9J;06\%U;WV"4S=HR2#<8"NUW[@3L"&Y@G2LH-<);4P" M74A 5&C#-OOVO,=91&6@.B9+RW8#&5GBHC"AA=/7>/*Y= [)^*;G#KF*R%CT>AS3>#)>()I1"$;*$A++TDN6\ASZO'0#?1Z3$A#Q?K&552IB@ MF.?),5W1U?79X7-X\+<)S3H%'1F M(-'\UKPTJB7-O%;*9JY42+VD_UT%,B0;F$#?APN;,$"XB-./XS2!#1Y8_/(E M3Y;M4H=O,XY-2E81-:N"HS]NN6+)1<ⅅ6XH)2W])44[\8U)/N5@!7DJJ!S MD[I6H&OQM5G,BW84]Y_+\=GF),/(>!#9M%T/E5LQ.,/164>/W0C;DDLDU^3E M?V[#,R3KE( 49*+O(T[2HM2+6?['R6R"N_7P7)LH N/$I2ZQ"9"IE'T-4-=L>NS$B.XEC$%3@6F#K4K8A Y;YE#)K MM20Y�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end XML 90 solv-20240930_htm.xml IDEA: XBRL DOCUMENT 0001964738 2024-01-01 2024-09-30 0001964738 2024-09-30 0001964738 us-gaap:ProductMember 2024-07-01 2024-09-30 0001964738 us-gaap:ProductMember 2023-07-01 2023-09-30 0001964738 us-gaap:ProductMember 2024-01-01 2024-09-30 0001964738 us-gaap:ProductMember 2023-01-01 2023-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2024-07-01 2024-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2023-07-01 2023-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2024-01-01 2024-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2023-01-01 2023-09-30 0001964738 2024-07-01 2024-09-30 0001964738 2023-07-01 2023-09-30 0001964738 2023-01-01 2023-09-30 0001964738 2023-12-31 0001964738 us-gaap:CommonStockMember 2024-06-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001964738 us-gaap:RetainedEarningsMember 2024-06-30 0001964738 solv:NetParentInvestmentMember 2024-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001964738 2024-06-30 0001964738 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001964738 solv:NetParentInvestmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001964738 us-gaap:CommonStockMember 2024-09-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001964738 us-gaap:RetainedEarningsMember 2024-09-30 0001964738 solv:NetParentInvestmentMember 2024-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001964738 us-gaap:CommonStockMember 2023-06-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001964738 us-gaap:RetainedEarningsMember 2023-06-30 0001964738 solv:NetParentInvestmentMember 2023-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001964738 2023-06-30 0001964738 solv:NetParentInvestmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001964738 us-gaap:CommonStockMember 2023-09-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001964738 us-gaap:RetainedEarningsMember 2023-09-30 0001964738 solv:NetParentInvestmentMember 2023-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001964738 2023-09-30 0001964738 us-gaap:CommonStockMember 2023-12-31 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001964738 us-gaap:RetainedEarningsMember 2023-12-31 0001964738 solv:NetParentInvestmentMember 2023-12-31 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001964738 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001964738 solv:NetParentInvestmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001964738 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001964738 us-gaap:CommonStockMember 2022-12-31 0001964738 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001964738 us-gaap:RetainedEarningsMember 2022-12-31 0001964738 solv:NetParentInvestmentMember 2022-12-31 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001964738 2022-12-31 0001964738 solv:NetParentInvestmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001964738 2024-04-01 0001964738 2024-04-01 2024-04-01 0001964738 solv:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001964738 solv:MedSurgSegmentMember 2023-12-31 0001964738 solv:DentalSolutionsSegmentMember 2023-12-31 0001964738 solv:HealthInformationSystemsSegmentMember 2023-12-31 0001964738 solv:PurificationAndFiltrationSegmentMember 2023-12-31 0001964738 solv:MedSurgSegmentMember 2024-01-01 2024-09-30 0001964738 solv:DentalSolutionsSegmentMember 2024-01-01 2024-09-30 0001964738 solv:HealthInformationSystemsSegmentMember 2024-01-01 2024-09-30 0001964738 solv:PurificationAndFiltrationSegmentMember 2024-01-01 2024-09-30 0001964738 solv:MedSurgSegmentMember 2024-09-30 0001964738 solv:DentalSolutionsSegmentMember 2024-09-30 0001964738 solv:HealthInformationSystemsSegmentMember 2024-09-30 0001964738 solv:PurificationAndFiltrationSegmentMember 2024-09-30 0001964738 us-gaap:CustomerRelatedIntangibleAssetsMember 2024-09-30 0001964738 us-gaap:CustomerRelatedIntangibleAssetsMember 2023-12-31 0001964738 us-gaap:IntellectualPropertyMember 2024-09-30 0001964738 us-gaap:IntellectualPropertyMember 2023-12-31 0001964738 us-gaap:TradeNamesMember 2024-09-30 0001964738 us-gaap:TradeNamesMember 2023-12-31 0001964738 us-gaap:BuildingAndBuildingImprovementsMember 2024-09-30 0001964738 us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0001964738 us-gaap:MachineryAndEquipmentMember 2024-09-30 0001964738 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001964738 us-gaap:ConstructionInProgressMember 2024-09-30 0001964738 us-gaap:ConstructionInProgressMember 2023-12-31 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-06-30 0001964738 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-06-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2024-09-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-09-30 0001964738 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-09-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001964738 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-09-30 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001964738 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-09-30 0001964738 solv:A18MonthSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 2024-02-16 0001964738 solv:A18MonthSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-09-30 0001964738 solv:A3YearSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 2024-02-16 0001964738 solv:A3YearSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-09-30 0001964738 solv:A5.450SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A5.450SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A5.450SeniorNotesDue2027Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:A5.400SeniorNotesDue2029Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A5.400SeniorNotesDue2029Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A5.400SeniorNotesDue2029Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:A5.450SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A5.450SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A5.450SeniorNotesDue2031Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:A5.600SeniorNotesDue2034Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A5.600SeniorNotesDue2034Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A5.600SeniorNotesDue2034Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:A5.900SeniorNotesDue2054Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A5.900SeniorNotesDue2054Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A5.900SeniorNotesDue2054Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:A6.000SeniorNotesDue2064Member us-gaap:SeniorNotesMember 2024-02-27 0001964738 solv:A6.000SeniorNotesDue2064Member us-gaap:SeniorNotesMember 2024-02-27 2024-02-27 0001964738 solv:A6.000SeniorNotesDue2064Member us-gaap:SeniorNotesMember 2024-09-30 0001964738 solv:OtherBorrowingsMember 2024-09-30 0001964738 us-gaap:SeniorNotesMember 2024-02-27 0001964738 us-gaap:RevolvingCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 2024-02-16 0001964738 us-gaap:RevolvingCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 0001964738 solv:A18MonthSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 0001964738 solv:A3YearSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-02-16 0001964738 us-gaap:RevolvingCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-09-30 0001964738 solv:TermLoanCreditFacilitiesMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-03-07 2024-03-07 0001964738 solv:A18MonthSeniorTermLoanCreditFacilityMember solv:CreditFacilitiesMember us-gaap:LineOfCreditMember 2024-08-01 2024-08-31 0001964738 us-gaap:CommercialPaperMember 2024-03-04 0001964738 us-gaap:CommercialPaperMember 2024-03-04 2024-03-04 0001964738 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-09-30 0001964738 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2024-09-30 0001964738 us-gaap:ForeignPlanMember 2024-03-31 0001964738 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001964738 country:US us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-09-30 0001964738 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001964738 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-09-30 0001964738 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001964738 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-07-01 2023-09-30 0001964738 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-09-30 0001964738 country:US us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-09-30 0001964738 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-09-30 0001964738 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-09-30 0001964738 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-01 2024-09-30 0001964738 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-09-30 0001964738 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-09-30 0001964738 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-07-01 2024-09-30 0001964738 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-07-01 2023-09-30 0001964738 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-09-30 0001964738 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-09-30 0001964738 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001964738 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001964738 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001964738 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001964738 us-gaap:DesignatedAsHedgingInstrumentMember 2024-09-30 0001964738 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001964738 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-09-30 0001964738 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001964738 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-09-30 0001964738 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001964738 us-gaap:NondesignatedMember 2024-09-30 0001964738 us-gaap:NondesignatedMember 2023-12-31 0001964738 solv:BairHuggerPatientWarmingSystemsLitigationMember solv:A3MMember 2024-09-30 0001964738 solv:A3MMember 2024-09-30 0001964738 solv:BairHuggerPatientWarmingSystemsLitigationMember stpr:MO solv:A3MMember 2024-09-30 0001964738 solv:BairHuggerPatientWarmingSystemsLitigationMember solv:A3MMember 2022-01-01 2022-12-31 0001964738 solv:BairHuggerPatientWarmingSystemsLitigationMember stpr:AL solv:A3MMember 2024-09-30 0001964738 solv:BairHuggerPatientWarmingSystemsLitigationMember solv:A3MMember 2019-01-01 2019-12-31 0001964738 solv:FederalFalseClaimsActQuiTamLitigationMember solv:A3MMember 2011-12-31 0001964738 solv:FederalFalseClaimsActQuiTamLitigationMember solv:A3MMember 2008-12-31 0001964738 solv:FederalFalseClaimsActQuiTamLitigationMember solv:A3MMember 2022-01-01 2022-01-31 0001964738 2024-03-31 0001964738 solv:A2024LongTermIncentivePlanMember us-gaap:SpinoffMember 2024-03-31 0001964738 solv:A2024LongTermIncentivePlanMember us-gaap:SpinoffMember 2024-01-01 2024-09-30 0001964738 us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001964738 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001964738 us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001964738 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001964738 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001964738 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001964738 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-09-30 0001964738 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001964738 solv:ResearchDevelopmentAndRelatedExpensesMemberMember 2024-07-01 2024-09-30 0001964738 solv:ResearchDevelopmentAndRelatedExpensesMemberMember 2023-07-01 2023-09-30 0001964738 solv:ResearchDevelopmentAndRelatedExpensesMemberMember 2024-01-01 2024-09-30 0001964738 solv:ResearchDevelopmentAndRelatedExpensesMemberMember 2023-01-01 2023-09-30 0001964738 us-gaap:ProductMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 us-gaap:ProductMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 us-gaap:ProductMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 solv:SalesOfSoftwareAndRentalsMember solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 solv:PriorToSpinOffMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 us-gaap:RelatedPartyMember 2024-04-01 2024-09-30 0001964738 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 srt:MinimumMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 srt:MaximumMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 solv:TransitionAgreementServicesMember us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001964738 solv:TransitionAgreementServicesMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 solv:MasterSupplyAgreementsMember us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001964738 solv:MasterSupplyAgreementsMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 us-gaap:ProductMember solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001964738 us-gaap:ProductMember solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 us-gaap:ProductMember solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 us-gaap:ProductMember solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001964738 solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001964738 solv:AfterSpinOffMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 us-gaap:RelatedPartyMember 2024-09-30 0001964738 us-gaap:RelatedPartyMember solv:NetParentInvestmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:RelatedPartyMember solv:NetParentInvestmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:RelatedPartyMember solv:NetParentInvestmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:RelatedPartyMember solv:NetParentInvestmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001964738 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001964738 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:MedSurgSegmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:MedSurgSegmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:MedSurgSegmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:MedSurgSegmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:DentalSolutionsSegmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:DentalSolutionsSegmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:DentalSolutionsSegmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:DentalSolutionsSegmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:HealthInformationSystemsSegmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:HealthInformationSystemsSegmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:HealthInformationSystemsSegmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:HealthInformationSystemsSegmentMember 2023-01-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:PurificationAndFiltrationSegmentMember 2024-07-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:PurificationAndFiltrationSegmentMember 2023-07-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:PurificationAndFiltrationSegmentMember 2024-01-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember solv:PurificationAndFiltrationSegmentMember 2023-01-01 2023-09-30 0001964738 solv:CorporateAndReconcilingItemsMember 2024-07-01 2024-09-30 0001964738 solv:CorporateAndReconcilingItemsMember 2023-07-01 2023-09-30 0001964738 solv:CorporateAndReconcilingItemsMember 2024-01-01 2024-09-30 0001964738 solv:CorporateAndReconcilingItemsMember 2023-01-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember 2024-07-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0001964738 us-gaap:OperatingSegmentsMember 2024-01-01 2024-09-30 0001964738 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 shares iso4217:USD iso4217:USD shares pure solv:operatingSegment solv:series solv:plan solv:country solv:lawsuit solv:classAction solv:case solv:quiTamAction solv:employee false 2024 Q3 0001964738 --12-31 P18M P3Y P3Y P5Y P7Y P10Y P30Y P40Y P18M 10-Q true 2024-09-30 false 001-41968 SOLVENTUM CORPORATION DE 92-2008841 3M Center, Building 275-6W 2510 Conway Avenue East Maplewood MN 55144 651 733-1110 Common Stock, Par Value $.01 Per Share SOLV NYSE Yes Yes Non-accelerated Filer false false false 172754070 1608000000 1593000000 4766000000 4750000000 474000000 481000000 1413000000 1411000000 2082000000 2074000000 6179000000 6161000000 793000000 748000000 2341000000 2262000000 124000000 117000000 364000000 364000000 1165000000 1209000000 3474000000 3535000000 701000000 525000000 1998000000 1681000000 189000000 180000000 576000000 568000000 1807000000 1570000000 5279000000 4875000000 275000000 504000000 900000000 1286000000 -107000000 0 -260000000 0 -1000000 -4000000 -48000000 -10000000 167000000 500000000 592000000 1276000000 45000000 40000000 144000000 202000000 122000000 460000000 448000000 1074000000 0.70 2.66 2.59 6.22 0.70 2.66 2.58 6.22 173400000 172700000 173100000 172700000 173900000 172700000 173400000 172700000 122000000 460000000 448000000 1074000000 179000000 -134000000 94000000 -44000000 -10000000 0 -20000000 0 -11000000 0 -10000000 0 178000000 -134000000 104000000 -44000000 300000000 326000000 552000000 1030000000 772000000 194000000 86000000 82000000 1105000000 1313000000 222000000 0 529000000 453000000 181000000 171000000 243000000 233000000 953000000 857000000 302000000 155000000 3354000000 2519000000 1599000000 1457000000 6592000000 6535000000 2651000000 2902000000 549000000 530000000 14745000000 13943000000 300000000 0 560000000 477000000 450000000 0 563000000 574000000 1031000000 677000000 2904000000 1728000000 7809000000 0 321000000 166000000 214000000 231000000 305000000 152000000 11553000000 2277000000 0.01 750000000 2000000 0 172754070 172754070 0 0 3744000000 0 211000000 0 0 12003000000 -765000000 -337000000 3192000000 11666000000 14745000000 13943000000 173000000 2000000 3719000000 89000000 0 -943000000 2867000000 122000000 0 122000000 179000000 179000000 -10000000 -10000000 -11000000 -11000000 178000000 178000000 0 0 27000000 27000000 2000000 2000000 173000000 2000000 3744000000 211000000 0 -765000000 3192000000 0 0 0 0 12136000000 -407000000 11729000000 460000000 460000000 -134000000 -134000000 0 -134000000 -134000000 473000000 473000000 0 0 0 0 12123000000 -541000000 11582000000 0 0 0 0 12003000000 -337000000 11666000000 211000000 237000000 448000000 94000000 94000000 -20000000 -20000000 -10000000 -10000000 104000000 104000000 8575000000 532000000 9107000000 83000000 0 83000000 2000000 2000000 173000000 2000000 3663000000 -3665000000 0 173000000 2000000 3744000000 211000000 0 -765000000 3192000000 0 0 0 0 12239000000 -497000000 11742000000 1074000000 1074000000 -44000000 -44000000 0 -44000000 -44000000 1190000000 1190000000 0 0 0 0 12123000000 -541000000 11582000000 448000000 1074000000 405000000 422000000 30000000 31000000 87000000 32000000 0 56000000 -93000000 -99000000 -14000000 24000000 -200000000 0 99000000 7000000 200000000 48000000 -393000000 0 167000000 -53000000 966000000 1368000000 253000000 202000000 0 60000000 -253000000 -142000000 200000000 0 8247000000 1248000000 8303000000 0 8000000 2000000 -136000000 -1246000000 1000000 1000000 578000000 -19000000 194000000 61000000 772000000 42000000 Significant Accounting Policies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Organization and Description of Business </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Solventum Corporation (“Solventum” or the “Company”) was a carve-out business of 3M Company (“3M”). On April 1, 2024 (the “Distribution Date”), 3M completed the previously announced spin-off of Solventum Corporation (the “Spin-Off”). The Spin-Off was completed through a distribution of approximately 80.1% of the Company’s outstanding common stock to holders of record of 3M’s common stock as of the close of business on March 18, 2024 (the “Distribution”), which resulted in the issuance of 172,709,505 shares of common stock. As a result of the Distribution, the Company became an independent public company. Solventum’s common stock is listed under the symbol “SOLV” on the New York Stock Exchange (“NYSE”).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Solventum is a leading global healthcare company with a broad portfolio of trusted solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. Solventum is organized into four operating business segments that are aligned with the end markets that we serve: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated and combined financial statements have been prepared in accordance with U.S. generally accepted accounting principles (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and present the historical results of operations, and comprehensive income for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, and the financial position as of September 30, 2024 and December 31, 2023. The interim condensed consolidated and combined financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of the Company’s consolidated and combined financial position, results of operations and cash flows for the periods presented. These adjustments consist of normal, recurring items. The results of operations for any interim periods are not necessarily indicative of results for the full year.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective April 1, 2024, the Company’s financial statements are presented on a consolidated basis, as the Spin-Off was completed on such date. The unaudited financial statements for all periods following the Spin-Off are referred to as the “Condensed Consolidated Financial Statements.” Prior to April 1, 2024, Solventum was a carve-out business of 3M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company's financial statements prior to April 1, 2024 were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of 3M, including the historical cost basis of assets and liabilities comprising the Company, as well as the historical revenues, direct costs, and allocations of indirect costs attributable to the operations of the Company, using the historical accounting policies applied by 3M. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The historical financial statements of the Company prior to April 1, 2024, are referred to as the “Condensed Combined Financial Statements”.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All intercompany transactions and balances within Solventum have been eliminated. These unaudited condensed consolidated and combined financial statements include certain transactions with 3M, which are disclosed as related party transactions in Note 14 “Related Parties”.<br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated and combined financial statements and related footnotes as of and for the three and nine months ended September 30, 2024 should be read in conjunction with the audited combined financial statements as of and for the year ended December 31, 2023 contained in Exhibit 99.1 to Amendment No. 2 to the Company’s Registration Statement on Form 10 as filed with the SEC on March 11, 2024, which became effective on March 13, 2024 (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information Statement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">New Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Relevant Description</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date for Solventum</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Adoption</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.</span></td></tr></table></div> 0.801 172709505 4 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated and combined financial statements have been prepared in accordance with U.S. generally accepted accounting principles (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and present the historical results of operations, and comprehensive income for the three and nine months ended September 30, 2024 and 2023, cash flows for the nine months ended September 30, 2024 and 2023, and the financial position as of September 30, 2024 and December 31, 2023. The interim condensed consolidated and combined financial statements are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of the Company’s consolidated and combined financial position, results of operations and cash flows for the periods presented. These adjustments consist of normal, recurring items. The results of operations for any interim periods are not necessarily indicative of results for the full year.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective April 1, 2024, the Company’s financial statements are presented on a consolidated basis, as the Spin-Off was completed on such date. The unaudited financial statements for all periods following the Spin-Off are referred to as the “Condensed Consolidated Financial Statements.” Prior to April 1, 2024, Solventum was a carve-out business of 3M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company's financial statements prior to April 1, 2024 were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of 3M, including the historical cost basis of assets and liabilities comprising the Company, as well as the historical revenues, direct costs, and allocations of indirect costs attributable to the operations of the Company, using the historical accounting policies applied by 3M. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The historical financial statements of the Company prior to April 1, 2024, are referred to as the “Condensed Combined Financial Statements”.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All intercompany transactions and balances within Solventum have been eliminated. These unaudited condensed consolidated and combined financial statements include certain transactions with 3M, which are disclosed as related party transactions in Note 14 “Related Parties”.<br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated and combined financial statements and related footnotes as of and for the three and nine months ended September 30, 2024 should be read in conjunction with the audited combined financial statements as of and for the year ended December 31, 2023 contained in Exhibit 99.1 to Amendment No. 2 to the Company’s Registration Statement on Form 10 as filed with the SEC on March 11, 2024, which became effective on March 13, 2024 (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Information Statement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">).</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">New Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Relevant Description</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date for Solventum</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Adoption</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.</span></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below provides summaries of applicable new accounting pronouncements issued, but not yet adopted by Solventum.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Relevant Description</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date for Solventum</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of Adoption</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in November 2023. Requires public entities to expand on segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses.</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company has assessed the impact that the updated standard will have on financial statement disclosures and will include expanded disclosures within the business segment footnote in the Company's 2024 Annual Report on Form 10-K.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Issued in December 2023. Requires disaggregated information about a Company's effective tax rate reconciliation as well as information on income taxes paid.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Company is currently assessing the impact that the updated standard will have on financial statement disclosures.</span></td></tr></table></div> Revenue Recognition<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $110 million and $500 million of the December 31, 2023 balance were recognized as revenue during the three and nine months ended September 30, 2024, respectively, while approximately $115 million and $475 million of the December 31, 2022 balance were recognized as revenue during the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Operating Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $148 million and $442 million for the three and nine months ended September 30, 2024, and $160 million and $458 million for the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Customer Concentration</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2024 or 2023. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2024 and one customer accounted for approximately 10% of accounts receivable at December 31, 2023.</span></div> Revenue Recognition<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unearned revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Approximately $110 million and $500 million of the December 31, 2023 balance were recognized as revenue during the three and nine months ended September 30, 2024, respectively, while approximately $115 million and $475 million of the December 31, 2022 balance were recognized as revenue during the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Operating Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of software and rental includes rental revenue from durable medical devices as part of operating lease arrangements (reported within the MedSurg segment), which was $148 million and $442 million for the three and nine months ended September 30, 2024, and $160 million and $458 million for the three and nine months ended September 30, 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Customer Concentration</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No customer accounted for more than 10% of the Company’s revenues for the three and nine months ended September 30, 2024 or 2023. Additionally, no customers accounted for more than 10% of accounts receivable as of September 30, 2024 and one customer accounted for approximately 10% of accounts receivable at December 31, 2023.</span></div> 110000000 500000000 115000000 475000000 148000000 442000000 160000000 458000000 0.10 Goodwill and Intangible Assets<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Goodwill</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There was no goodwill recorded from acquisitions during the nine months ended September 30, 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The goodwill balance by business segment follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Dental Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Health Information Systems</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,685</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">458</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">873</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,519</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,535</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Translation impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Balance as of September 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,731</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">461</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">874</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,526</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,592</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Acquired Intangible Assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Customer related intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Patents and other technology-based intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tradenames and other amortizable intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total gross carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,336 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — customer related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — patents and other technology-based</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — tradenames and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total accumulated amortization </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,459)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total finite-lived intangible assets — net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,877 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Indefinite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total intangible assets — net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,902 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2024, the Company made the decision to start phasing out the use of a tradename within its Dental Solutions business. This tradename, which was categorized as indefinite-lived as of December 31, 2023, has been reclassified to finite-lived and is being amortized over the expected phase-out period.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization expense was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">88 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">92 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">276 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected amortization expense for acquired amortizable intangible assets recorded as of September 30, 2024 is as follows:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.851%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Remainder of 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">After 2029</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">88 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">326 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">321 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">316 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">312 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">274 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,014 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 0 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The goodwill balance by business segment follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Dental Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Health Information Systems</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,685</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">458</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">873</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,519</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,535</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Translation impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Balance as of September 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,731</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">461</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">874</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,526</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,592</span></td></tr></table></div> 3685000000 458000000 873000000 1519000000 6535000000 46000000 3000000 1000000 7000000 57000000 3731000000 461000000 874000000 1526000000 6592000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:</span><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Customer related intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Patents and other technology-based intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tradenames and other amortizable intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total gross carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,336 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — customer related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — patents and other technology-based</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — tradenames and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total accumulated amortization </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,459)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total finite-lived intangible assets — net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,877 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Indefinite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total intangible assets — net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,902 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of acquired finite-lived intangible assets, in addition to the balance of non-amortizable intangible assets are as follows:</span><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Customer related intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,748 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Patents and other technology-based intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tradenames and other amortizable intangible assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">732 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total gross carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,381 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5,336 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — customer related</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — patents and other technology-based</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Accumulated amortization — tradenames and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total accumulated amortization </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2,459)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total finite-lived intangible assets — net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,877 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Indefinite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total intangible assets — net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,651 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,902 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 2748000000 2734000000 1901000000 1897000000 732000000 705000000 5381000000 5336000000 1188000000 1081000000 1185000000 1055000000 357000000 323000000 2730000000 2459000000 2651000000 2877000000 0 25000000 2651000000 2902000000 <div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization expense was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">88 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">92 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">276 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 88000000 92000000 261000000 276000000 <div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Expected amortization expense for acquired amortizable intangible assets recorded as of September 30, 2024 is as follows:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.851%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Remainder of 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">After 2029</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">88 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">326 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">321 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">316 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">312 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">274 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,014 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 88000000 326000000 321000000 316000000 312000000 274000000 1014000000 Other Current Liabilities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other current liabilities included in the condensed consolidated and combined balance sheets consist of the following:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other current liabilities included in the condensed consolidated and combined balance sheets consist of the following:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 251000000 209000000 202000000 106000000 166000000 206000000 91000000 0 321000000 156000000 1031000000 677000000 Property, Plant, and Equipment - Net<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment - at cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,338 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment - net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense consisted of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">37 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">45 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">121 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">124 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment - at cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,338 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment - net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense consisted of the following:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">37 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">45 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">121 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">124 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 952000000 937000000 2180000000 2081000000 465000000 320000000 3597000000 3338000000 1998000000 1881000000 1599000000 1457000000 37000000 45000000 121000000 124000000 Comprehensive Income Information<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes in Accumulated Other Comprehensive Income (Loss) by Component</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”), including the reclassifications out of AOCI by component:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cash Flow Hedging</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at June 30, 2024, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2024, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(253)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(502)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(10)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(765)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30, 2023</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at June 30, 2023, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2023, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(541)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cash Flow Hedging</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at December 31, 2023, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(337)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2024, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at December 31, 2022, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(497)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2023, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(541)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional details on the amounts reclassified from accumulated other comprehensive income (loss) into consolidated income include:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Cumulative translation adjustment: amounts were reclassified into other expense (income), net and were related to charges associated with the substantial liquidation of foreign operations completed as part of our separation from 3M.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Defined benefit pension plans adjustment: amounts were reclassified into other expense (income), net (see Note 9).</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The tax effects, if applicable, associated with these reclassifications were reflected in provision for income taxes.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below presents the changes in accumulated other comprehensive income (loss) (“AOCI”), including the reclassifications out of AOCI by component:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cash Flow Hedging</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at June 30, 2024, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2024, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(253)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(502)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(10)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(765)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30, 2023</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at June 30, 2023, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(414)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(134)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2023, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(541)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cash Flow Hedging</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at December 31, 2023, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(337)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2024, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Defined Benefit Pension</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at December 31, 2022, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(497)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amounts reclassified out</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(44)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Transfers from 3M, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Balance at September 30, 2023, net of tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(541)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> -432000000 -512000000 1000000 -943000000 179000000 0 -15000000 164000000 0 -13000000 0 -13000000 179000000 13000000 -15000000 177000000 0 3000000 -4000000 -1000000 179000000 10000000 -11000000 178000000 0 0 0 0 -253000000 -502000000 -10000000 -765000000 -414000000 7000000 -407000000 -134000000 0 -134000000 0 0 0 -134000000 0 -134000000 0 0 0 -134000000 0 -134000000 0 0 0 -548000000 7000000 -541000000 -347000000 10000000 0 -337000000 56000000 0 -13000000 43000000 -38000000 -26000000 0 -64000000 94000000 26000000 -13000000 107000000 0 6000000 -3000000 3000000 94000000 20000000 -10000000 104000000 0 -532000000 0 -532000000 -253000000 -502000000 -10000000 -765000000 -504000000 7000000 -497000000 -44000000 0 -44000000 0 0 0 -44000000 0 -44000000 0 0 0 -44000000 0 -44000000 0 0 0 -548000000 7000000 -541000000 Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s income tax provision through March 31, 2024 was prepared on a separate return basis. The income tax provision post Spin-Off is prepared based on a stand-alone basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rates for the three months ended September 30, 2024 and 2023 were 26.9% and 8.0%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rates for the nine months ended September 30, 2024 and 2023 were 24.3% and 15.8%, respectively. The prior period’s lower effective tax rate is primarily due to the tax benefit recognized as a result of the expiration of the statute of limitations on uncertain tax positions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2021, the Organisation for Economic Co-operation and Development (“OECD”) announced Pillar Two Model Rules which call for the taxation of large multinational corporations at a global minimum tax rate of 15%. Many non-U.S. tax jurisdictions, including Ireland, have either recently enacted legislation to adopt certain components of the Pillar Two Model Rules beginning in fiscal year 2024 or announced their plans to enact legislation in future years. The Company’s income tax provision for the nine months ended September 30, 2024, reflects currently enacted legislation and guidance related to the OECD model rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s income tax provision or benefit for the interim periods is determined based on an estimated annual effective tax rate, adjusted for discrete items. Because significant foreign earnings are generated by the Company’s subsidiaries organized in jurisdictions with lower statutory tax rates, the Company’s estimated annual effective tax rate may be materially impacted if earnings in these lower-tax jurisdictions fluctuate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized based on evaluation of all available positive and negative evidence. On the basis of this evaluation, the Company continues to maintain a valuation allowance to reduce its deferred tax assets to the amount realizable. As of September 30, 2024 and December 31, 2023, valuation allowances were $22 million and $56 million, respectively. The decrease is primarily due to separation-related adjustments in connection with the Spin-Off on April 1, 2024, which is reflected in the condensed consolidated and combined statements of changes in equity.</span></div> 0.269 0.080 0.243 0.158 22000000 56000000 Long-Term Debt and Short-Term Borrowings<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Carrying value includes the impact of debt issuance costs. Long-term debt and short-term borrowings as of September 30, 2024 consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.954%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency/ Fixed vs. Floating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">September 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-598">Eighteen</span> month senior term loan credit facility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Floating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-600">Three</span> year senior term loan credit facility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Floating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1 billion 5.45 percent <span style="-sec-ix-hidden:f-604">three</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5 billion 5.40 percent <span style="-sec-ix-hidden:f-608">five</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1 billion 5.45 percent <span style="-sec-ix-hidden:f-612">seven</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.65 billion 5.60 percent <span style="-sec-ix-hidden:f-616">ten</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.25 billion 5.90 percent <span style="-sec-ix-hidden:f-620">thirty</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2054</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 6.00 percent <span style="-sec-ix-hidden:f-624">forty</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2064</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (excluding current portion)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,809 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"></span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Senior Notes</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 27, 2024, the Company issued six series of senior notes with a combined aggregate principal amount of $6.9 billion: $1 billion aggregate principal amount of 5.45% senior notes due 2027, $1.5 billion aggregate principal amount of 5.40% senior notes due 2029, $1 billion aggregate principal amount of 5.45% senior notes due 2031, $1.65 billion aggregate principal amount of 5.60% senior notes due 2034, $1.25 aggregate principal amount of 5.90% senior notes due 2054, and $0.5 billion aggregate principal amount of 6.00% senior notes due 2064 (collectively, the “Senior Notes”). Interest payments on the Senior Notes are due semi-annually until maturity, with the first payment due in August 2024. The Company recorded $62 million of debt issuance costs related to the Senior Notes. Debt issuance costs are presented as a reduction of debt in the condensed consolidated and combined balance sheets and are amortized as a component of interest expense over the term of the related debt using the effective interest method.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the issuance of the senior notes, the Company entered into a registration rights agreement with the initial purchasers, pursuant to which the Company is obligated to use commercially reasonable efforts to file with the SEC and cause to become effective a registration statement with respect to an offer to exchange each series of Senior Notes for registered notes with terms that are substantially identical in all material respects to the notes of such series.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Senior Notes were offered as part of the financing for the Spin-Off. In connection with the consummation of the Spin-Off, Solventum made direct and indirect cash payments to 3M as partial consideration for 3M’s transfer of its health care business to Solventum. All of the net proceeds from the offering of the notes were paid to 3M, other than amounts retained in order to achieve the $600 million retained cash target.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Senior Notes are governed by an indenture and supplemental indenture between the Company and a trustee (collectively, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indenture</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). The Indenture contains certain customary affirmative and negative covenants, including restrictions on the Company’s ability to consolidate, merge, convey, transfer or lease substantially all of its assets. In addition, the Indenture contains other customary terms, including certain events of default, upon the occurrence of which, the Senior Notes may be declared immediately due and payable.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Credit Facilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 16, 2024, the Company entered into credit agreements providing for:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a five year senior unsecured revolving credit facility in an aggregate committed amount of $2.0 billion expiring in 2029 (the “5-year Revolving Credit Facility”); and</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">an eighteen month senior unsecured term loan credit facility in an aggregate principal amount of $500 million and a three year senior unsecured term credit loan facility in an aggregate principal amount of $1.0 billion (together, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Term Loan Credit Facilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and together with the 5-Year Revolving Credit Facility, the “Credit Facilities”). </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company intends to use the Credit Facilities for general corporate purposes. At September 30, 2024, there are no amounts outstanding under the 5-year Revolving Credit Facility. On March 7, 2024, the Company drew on the Term Loan Credit Facilities in the amount of $1.48 billion. These Term Loan Credit Facilities have a floating interest rate based on a Secured Overnight Financing Rate (“SOFR”) index.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2024, the Company repaid $200 million of the aggregate principal amount outstanding under the eighteen month senior unsecured term loan credit facility.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commercial Paper</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 4, 2024, the Company entered into a commercial paper program that allows it to issue up to $2.0 billion aggregate principal amount of short-term notes to finance short-term liabilities. Any such issuance will mature within 364 days from date of issue. There was no commercial paper outstanding as of September 30, 2024.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Future Maturities of Long-term Debt:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of long-term debt in the table below reflect the impact of repayment such that total maturities equal the contractual value of long-term debt net of amounts repaid as of September 30, 2024. The maturities of long-term debt for the periods subsequent to September 30, 2024 are as follows (in millions):</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.896%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Remainder of<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">After 2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total</span></td></tr><tr><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">300</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,980</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,500</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4,400</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">8,180</span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Financial Instruments Not Measured at Fair Value</span></div>The fair values of cash equivalents, accounts receivable, and accounts payable approximated carrying values because of the short-term nature of these instruments. At September 30, 2024, the estimated fair value of the Company’s long-term debt obligations, comprised of both Senior Notes and Term Loan Credit Facilities with current portions excluded, was $8.1 billion compared to a carrying value of $7.8 billion. The Company did not have any outstanding debt obligations at December 31, 2023. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts. Because there is no active market for trading outstanding term loans, the fair values of the Term Loan Credit Facilities are estimated to be equal to their respective carrying values. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Carrying value includes the impact of debt issuance costs. Long-term debt and short-term borrowings as of September 30, 2024 consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.954%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency/ Fixed vs. Floating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">September 30, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-598">Eighteen</span> month senior term loan credit facility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Floating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-600">Three</span> year senior term loan credit facility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Floating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1 billion 5.45 percent <span style="-sec-ix-hidden:f-604">three</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5 billion 5.40 percent <span style="-sec-ix-hidden:f-608">five</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1 billion 5.45 percent <span style="-sec-ix-hidden:f-612">seven</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.65 billion 5.60 percent <span style="-sec-ix-hidden:f-616">ten</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.25 billion 5.90 percent <span style="-sec-ix-hidden:f-620">thirty</span> year senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2054</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 million 6.00 percent <span style="-sec-ix-hidden:f-624">forty</span> year senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD Fixed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2064</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,109 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (excluding current portion)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,809 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"></span></div> 300000000 979000000 1000000000 0.0545 994000000 1500000000 0.054 1487000000 1000000000 0.0545 990000000 1650000000 0.056 1636000000 1250000000 0.059 1231000000 500000000 0.06 492000000 0 8109000000 300000000 7809000000 6 6900000000 1000000000 0.0545 1500000000 0.0540 1000000000 0.0545 1650000000 0.0560 1250000000 0.0590 500000000 0.0600 62000000 600000000 P5Y 2000000000.0 P5Y P18M 500000000 P3Y 1000000000.0 P5Y 0 P5Y 1480000000 200000000 P18M 2000000000.0 P364D 0 The maturities of long-term debt for the periods subsequent to September 30, 2024 are as follows (in millions):<div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.896%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Remainder of<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">After 2029</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Total</span></td></tr><tr><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">300</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,980</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">—</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,500</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4,400</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">8,180</span></td></tr></table></div> 0 300000000 0 1980000000 0 1500000000 4400000000 8180000000 8100000000 7800000000 Pension and Postretirement Benefit Plans<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Transfer of Solventum Sponsored Pension and Postretirement Benefit Plans</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Historically, certain employees of Solventum participated in U.S. and non-U.S. retirement plans sponsored by 3M. The primary U.S. defined-benefit pension plan was closed to new participants effective January 1, 2009. In December 2023, 3M committed to the future freeze of U.S. defined benefit pension benefits for non-union U.S. employees, effective December 31, 2028. During March 2024, in advance of the Spin-Off, all U.S. and most remaining 3M sponsored non-U.S. pension and postretirement plan obligations and assets were legally transferred to Solventum from 3M, except for certain assets held back within the 3M sponsored pension plans for regulatory purposes. Assets not yet delivered from 3M sponsored pension plans are already recognized within the Company's pension assets. These plans included the U.S. defined benefit pension plans as well as postretirement health care and life insurance benefits for U.S. employees who reach a retirement age while employed by the Company and were employed prior to January 1, 2016. Additionally, seven international plans covering employees in four countries were transferred to Solventum from 3M in March 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As these plans are sponsored by Solventum, they are accounted for as single employer plans. Therefore, the funded status is reflected in the condensed consolidated and combined balance sheets, and the net periodic benefit costs are included in the condensed consolidated and combined statements of income. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has made deposits for its defined benefit plans with independent trustees. In certain non-U.S. jurisdictions, trust funds and deposits with insurance companies are maintained to provide pension benefits to plan participants and their beneficiaries. There are no plan assets in the non-qualified plan due to its nature. For the U.S. postretirement health care benefit plan, the Company has set aside amounts at least equal to annual benefit payments with an independent trustee.</span></div><div style="margin-top:6pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Components of net periodic cost and other amounts recognized in other comprehensive (income) loss</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The service cost component of defined benefit net periodic benefit cost is recorded in costs of product; costs of software and rentals; selling, general and administrative; and research and development. Components of net periodic benefit cost and other supplemental information for the three and nine months ended September 30, 2024 and 2023 follow:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30,</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Qualified and Non-qualified Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total non-operating expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Qualified and Non-qualified Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total non-operating expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 7 4 Components of net periodic benefit cost and other supplemental information for the three and nine months ended September 30, 2024 and 2023 follow:<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three months ended September 30,</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Qualified and Non-qualified Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total non-operating expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Qualified and Non-qualified Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of prior service benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total non-operating expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total net periodic benefit cost (benefit)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 7000000 0 5000000 0 1000000 0 23000000 0 5000000 0 3000000 0 34000000 0 5000000 0 2000000 0 -1000000 0 0 0 -1000000 0 -14000000 0 0 0 -1000000 0 2000000 0 0 0 1000000 0 9000000 0 5000000 0 2000000 0 14000000 0 14000000 0 2000000 0 46000000 0 15000000 0 6000000 0 68000000 0 15000000 0 4000000 0 -2000000 0 0 0 -2000000 0 -28000000 0 0 0 -2000000 0 4000000 0 0 0 2000000 0 18000000 0 14000000 0 4000000 0 Derivatives<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to April 1, 2024, Solventum indirectly participated in 3M’s centrally managed hedging program, which utilizes a number of tools to manage currency risk including natural hedges such as pricing, productivity, hard currency, hard currency-indexed billings, and localizing source of supply. 3M also used financial hedges to mitigate currency risk. After Spin-Off, the Company established its own hedging program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cash Flow Hedges - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized in current earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash Flow Hedging - Foreign Currency Forward Contracts:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company enters into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as cash flow hedges. The settlement or extension of these derivatives will result in reclassifications (from accumulated other comprehensive income) to earnings in the period during which the hedged transactions affect earnings. Solventum may de-designate these cash flow hedge relationships in advance of the occurrence of the forecasted transaction. The portion of gains or losses on the derivative instrument previously included in accumulated other comprehensive income for de-designated hedges remains in accumulated other comprehensive income until the forecasted transaction occurs or becomes probable of not occurring. Changes in the value of derivative instruments after de-designation are recorded in earnings. The maximum length of time over which Solventum hedges its exposure to the variability in future cash flows of the forecasted transactions is 36 months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2024, the Company had a balance of $10 million associated with the after-tax net unrealized loss associated with cash flow hedging instruments recorded in accumulated other comprehensive income. Of the total after-tax net unrealized balance as of September 30, 2024, Solventum expects to reclassify to earnings approximately $7 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">after-tax net unrealized loss over the next 12 months based on exchange rates as of September 30, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of pretax gain (loss) recognized in other comprehensive income (loss) related to derivative instruments designated as cash flow hedges is provided in the following table. </span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Pretax Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Derivatives Not Designated as Hedging Instruments - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Derivatives not designated as hedging instruments include foreign currency contracts to offset, in part, the impacts of changes in value of various non-functional currency denominated items including certain intercompany financing balances. These derivative instruments are not designated in a hedging relationship; therefore, fair value gains and losses on these contracts are recorded in earnings. The Company does not hold or issue derivative financial instruments for trading purposes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Statement of Income Location and Impact of Cash Flow Derivative Instruments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There was an immaterial impact to income related to both derivative instruments designated in cash flow hedging relationships and those not designated as hedging instruments in the three and nine months ended September 30, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Location, Fair Value, and Gross Notional Amounts of Derivative Instruments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize the fair value of Solventum’s derivative instruments and their location in the condensed consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.266%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Gross Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%"> (Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Fair Value Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Fair Value Amount</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total derivatives designated as hedging instruments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">389 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Derivatives not designated as hedging instruments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total derivative instruments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s derivative assets and liabilities within the scope of ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, are required to be recorded at fair value. The Company’s derivatives that are recorded at fair value include foreign currency forward contracts. Solventum has determined that foreign currency forward contracts will be considered level 2 fair value measurements. Solventum determines fair value using observable inputs including foreign currency exchange rates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Credit Risk and Offsetting of Assets and Liabilities of Derivative Instruments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is exposed to credit loss in the event of nonperformance by counterparties in forward contracts. However, the Company’s risk is limited to the fair value of the instruments. The Company actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting major international banks and financial institutions as counterparties. Solventum enters into master netting arrangements with counterparties, which may allow each counterparty to net settle amounts owed between a Solventum entity and the counterparty as a result of multiple, separate derivative transactions. The Company does not anticipate nonperformance by any of these counterparties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Solventum has elected to present the fair value of derivative assets and liabilities within the Company’s condensed consolidated balance sheet on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. Solventum determined that the impact of the amount of eligible offsetting derivative assets and liabilities was not material if it had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties. For each counterparty, if netted, the Company would offset the asset and liability balances of all derivatives at the end of the reporting period based on the Solventum entity that is a party to the transactions. Derivatives not subject to master netting agreements are not eligible for net presentation. For the periods presented, Solventum has not received cash collateral from derivative counterparties.</span></div> P36M -10000000 -7000000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of pretax gain (loss) recognized in other comprehensive income (loss) related to derivative instruments designated as cash flow hedges is provided in the following table. </span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Pretax Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -15000000 0 -13000000 0 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize the fair value of Solventum’s derivative instruments and their location in the condensed consolidated balance sheet. Notional amounts below are presented at period end foreign exchange rates.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.266%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Gross Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Liabilities</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%"> (Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Fair Value Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Fair Value Amount</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total derivatives designated as hedging instruments </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">389 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">11 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Derivatives not designated as hedging instruments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total derivative instruments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 297000000 0 0 0 9000000 0 92000000 0 0 0 2000000 0 389000000 0 0 0 11000000 0 18000000 0 0 0 1000000 0 18000000 0 0 0 1000000 0 407000000 0 0 0 12000000 0 Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Legal Proceedings </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Solventum is involved in numerous claims and lawsuits, principally in the United States, and regulatory proceedings worldwide. These claims, lawsuits and proceedings relate to matters including, but not limited to, product liability (involving products that the Company now or formerly manufactured and sold, including products made by the Health Care Business Group at 3M), intellectual property, commercial, antitrust, federal healthcare program related laws and regulations, such as the False Claims Act and anti-kickback laws in the United States and other jurisdictions. Unless otherwise stated, Solventum is vigorously defending all such litigation and proceedings. From time to time, Solventum also receives subpoenas, investigative demands or requests for information from various government agencies in the United States and foreign countries. Solventum generally responds in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such requests can also lead to the assertion of claims or the commencement of administrative, civil, or criminal legal proceedings against Solventum and others, as well as to settlements. The outcomes of legal proceedings and regulatory matters are often difficult to predict. Any determination that the Company’s operations or activities are not, or were not, in compliance with applicable laws or regulations could result in the imposition of fines, civil or criminal penalties, and equitable remedies, including disgorgement, suspension or debarment or injunctive relief.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Process for Disclosure and Recording of Liabilities Related to Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many lawsuits and claims involve highly complex issues relating to causation, scientific evidence, and alleged actual damages, all of which are otherwise subject to substantial uncertainties. Assessments of lawsuits and claims can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. The categories of legal proceedings in which the Company is involved may include multiple lawsuits and claims, may be spread across multiple jurisdictions and courts that may handle the lawsuits and claims differently, may involve numerous and different types of plaintiffs, raising claims and legal theories based on specific allegations that may not apply to other matters, and may seek substantial compensatory and, in some cases, punitive, damages. These and other factors contribute to the complexity of these lawsuits and claims and make it difficult for the Company to predict outcomes and make reasonable estimates of any resulting losses. The Company's ability to predict outcomes and make reasonable estimates of potential losses is further influenced by the fact that a resolution of one or more matters within a category of legal proceedings may impact the resolution of other matters in that category in terms of timing, amount of liability, or both.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">When making determinations about recording liabilities related to legal proceedings, the Company complies with the requirements of ASC 450, Contingencies, and related guidance, and records liabilities in those instances where it can reasonably estimate the amount of the loss and when the loss is probable. Where the reasonable estimate of the probable loss is a range, the Company records as an accrual in its financial statements the most likely estimate of the loss, or the low end of the range if there is no one best estimate. The Company either discloses the amount of a possible loss or range of loss in excess of established accruals if estimable, or states that such an estimate cannot be made. The Company discloses significant legal proceedings even where liability is not probable or the amount of the liability is not estimable, or both, if the Company believes there is at least a reasonable possibility that a loss may be incurred. Based on experience and developments, the Company reexamines its estimates of probable liabilities and associated expenses and receivables each period, and whether a loss previously determined to not be reasonably estimable and/or not probable is now able to be reasonably estimated or has become probable. Where appropriate, the Company makes additions to or adjustments of its reasonably estimated losses and/or accruals. As a result, the current accruals and/or estimates of loss and the estimates of the potential impact on the Company’s consolidated financial position, results of operations and cash flows for the legal proceedings and claims pending against the Company will likely change over time. During the third quarter of 2024 and 2023, the Company recognized $3 million and no legal charges, respectively. During the first nine months of 2024 and 2023, the Company recognized $8 million and $1 million in legal charges, respectively. During the third quarter of 2024, the Company made a payment of $6 million related to a legal settlement, which reduced the accrued litigation balance. At September 30, 2024 and December 31, 2023, accrued litigation charges were $25 million and $23 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because litigation is subject to inherent uncertainties, and unfavorable rulings or developments could occur, the Company may ultimately incur charges substantially in excess of presently recorded liabilities, including with respect to matters for which no accruals are currently recorded because losses are not currently probable and reasonably estimable. Many of the matters described herein are at varying stages, seek an indeterminate amount of damages or seek damages in amounts that the Company believes are not indicative of the ultimate losses that may be incurred. It is not uncommon for claims to be resolved over many years. As a matter progresses, the Company may receive information, through plaintiff demands, through discovery, in the form of reports of purported experts, or in the context of settlement or mediation discussions that purport to quantify an amount of alleged damages, but with which the Company may not agree. Such information may or may not lead the Company to determine that it is able to make a reasonable estimate as to a probable loss or range of loss in connection with a matter. However, even when a loss or range of loss is not probable and reasonably estimable, developments in, or the ultimate resolution of, a matter could be material to the Company and could have a material adverse effect on the Company, its consolidated financial position, results of operations and cash flows. In addition, future adverse rulings or developments, or settlements in, one or more matters could result in future changes to determinations of probable and reasonably estimable losses in other matters.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal proceedings for which the Company has recorded an accrued liability in its financial statements, the Company also records receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those insured matters for which the Company has not recorded an accrued liability because the liability is not probable or the amount of the liability is not estimable, or both, but for which the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it concludes as recognizable for the expense incurred.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Product Liability Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following sections first describe the significant legal proceedings in which the Company is involved, and then describe the liabilities, if any, the Company has accrued relating to its significant legal proceedings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3M is a named defendant in over 7,500 lawsuits in the United States and one Canadian putative class action with a single named plaintiff, alleging that they underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections due to the use of the Bair Hugger patient warming system. Under the terms of the Separation and Distribution Agreement, dated as of March 31, 2024, by and between Solventum and 3M (the “Separation and Distribution Agreement”), Solventum has agreed to indemnify 3M for uninsured liabilities related to the Bair Hugger patient warming system, to manage the litigation, and pay for legal expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The plaintiffs seek damages and other relief based on theories of strict liability, negligence, breach of express and implied warranties, failure to warn, design and manufacturing defect, fraudulent and/or negligent misrepresentation/concealment, unjust enrichment, and violations of various state consumer fraud, deceptive or unlawful trade practices and/or false advertising acts. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The U.S. Judicial Panel on Multidistrict Litigation (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">JPML</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) consolidated all cases pending in federal courts to the U.S. District Court for the District of Minnesota to be managed in a multi-district litigation (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">MDL</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) proceeding. In July 2019, the court excluded several of the plaintiffs’ causation experts, and granted summary judgment for 3M in all cases pending at that time in the MDL. Plaintiffs appealed that decision to the U.S. Court of Appeals for the Eighth Circuit. Plaintiffs also appealed a 2018 jury verdict in favor of 3M in the first bellwether trial in the MDL and appealed the dismissal of another bellwether case. In August 2021, a panel of the appellate court reversed the district court’s exclusion of the plaintiffs’ causation experts and the grant of summary judgment for 3M. 3M sought further appellate en banc review by the full Eighth Circuit court. In November 2021, the Eighth Circuit court denied 3M’s petition for rehearing en banc. In May 2022, the U.S. Supreme Court declined 3M's February 2022 request to review the Eighth Circuit court's decision. Separately, in August 2021, the Eighth Circuit court affirmed the 2018 jury verdict in 3M’s favor in the only bellwether trial in the MDL.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2022, the MDL court ordered the parties to engage in any mediation sessions that a court-appointed mediator deems appropriate. Mediation sessions took place in May and August 2022 without success in resolving the litigation. In 2023, the MDL assigned a new mediator to facilitate discussions of the litigation and possible resolution. The MDL court denied plaintiffs’ April 2023 motion to disqualify the judge and magistrate judge overseeing the MDL. The parties, working with the new mediator, agreed on a bellwether process, selecting 34 cases. The MDL court transferred the non-Minnesota bellwether cases during April 2024. Bellwether cases are set for trial beginning in April 2025. Fifteen of the bellwether cases have now been voluntarily dismissed by plaintiffs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the federal MDL cases, there are eight state court cases relating to the Bair Hugger patient warming systems. Two are pending in Missouri state court and combine Bair Hugger product liability claims with medical malpractice claims. One of the Missouri cases was tried in 2022; the jury returned a verdict in 3M’s favor on all the claims. The trial court denied plaintiff’s motion for a new trial, and the verdict was affirmed on appeal in June 2024. The plaintiff has filed a request for further review by the Missouri Supreme Court. The other Missouri case is scheduled for trial in September 2025. There is one case in Etowah County, Alabama that combines Bair Hugger product liability claims with medical malpractice claims that has been settled in principle. A Texas case that 3M removed to federal court was remanded to state court in January 2024, a Pennsylvania case was remanded to state court in April 2024 with a trial date in April 2026, and two Montana cases were remanded to state court in June 2024. Finally, a putative class action has been filed in Ramsey County, Minnesota, seeking economic damages for the use of the Bair Hugger system in knee and hip replacement surgeries involving medically obese people in Minnesota from May 2017 to the present. Discovery is underway and the case is scheduled to be ready for trial in the fourth quarter of 2025.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3M had been named a defendant in 61 cases in Minnesota state court. In January 2018, the Minnesota state court excluded plaintiffs’ experts and granted 3M’s motion for summary judgment on general causation. The Minnesota Court of Appeals affirmed the state court orders in their entirety and the Minnesota Supreme Court denied plaintiffs’ petition for review and entered the final dismissal in 2019, effectively ending the Minnesota state court cases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, 3M was served with a putative class action filed in the Ontario Superior Court of Justice for all Canadian residents who underwent various joint arthroplasty, cardiovascular, and other surgeries and later developed surgical site infections that the representative plaintiff claims were due to the use of the Bair Hugger patient warming system. The representative plaintiff seeks relief (including punitive damages) under Canadian law based on theories similar to those asserted in the MDL. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For product liability litigation matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Process for Disclosure and Recording of Liabilities Related to Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">section and are not material to the Company’s results of operations or financial condition. In addition, the Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Federal False Claims Act/Qui Tam Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries, including Kinetic Concepts, Inc. and KCI USA, Inc. As previously disclosed in the SEC filings by the KCI entities, in 2009, Kinetic Concepts, Inc. received a subpoena from the U.S. Department of Health and Human Services Office of Inspector General. In 2011, following the completion of the government’s review and its decision declining to intervene in two qui tam actions described further below, the qui tam relator-plaintiffs’ pleadings were unsealed. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The government inquiry followed two qui tam actions filed in 2008 by two former employees against Kinetic Concepts, Inc. and KCI USA, Inc. (collectively, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">KCI Defendants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) under seal in the U.S. District Court for the Central District of California. One qui tam action (the Godecke case) was dismissed in January 2022. In the remaining action (the Hartpence case), the complaint contains allegations that the KCI Defendants violated the federal False Claims Act by submitting false or fraudulent claims to federal healthcare programs by billing for 3M V.A.C. Therapy in a manner that was not consistent with the Local Coverage Determinations issued by the Durable Medical Equipment Medicare Administrative Contractors and seeks monetary damages. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2019, the district court entered summary judgment in the KCI Defendants’ favor on all of the relator-plaintiff’s claims. The relator-plaintiff then filed an appeal in the U.S. Court of Appeals for the Ninth Circuit. Oral argument in the Hartpence case was held in July 2020. The appellate court issued an opinion in August 2022 reversing the decision of the district court and remanding the case for further proceedings. The district court held a status conference in January 2023 during which no case deadlines were set; the litigation remains in a pre-trial stage. The KCI Defendants filed a renewed motion for summary judgment in March 2023. In July 2023, the parties filed a joint status report notifying the court of the parties’ agreement to mediate the matter in November 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of a mediation held in November 2023, the relator-plaintiff and KCI reached an agreement in principle to settle the case and resolve all the remaining claims in this action, including the dismissal of the relator-plaintiff’s complaint with prejudice, subject to the agreement of the government and the parties’ negotiation and agreement of all remaining terms of the settlement. The KCI Defendants and relator-plaintiff have jointly requested that the court continue to hold in abeyance any hearing on the KCI Defendants’ pending Renewed Motion for Summary Judgment and any further proceedings in this case, to allow the parties to confer with counsel for the government and negotiate the remaining terms of the settlement agreement. The KCI Defendants and the relator-plaintiff submitted an updated status report to the court during January 2024 and further status reports in July and September 2024. Under the terms of the Separation and Distribution Agreement, Solventum has agreed to indemnify 3M for liabilities related to this matter, to manage the litigation, and pay for related legal expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the matters described in this section for which a liability has been recorded, the amount recorded is included in the disclosed amounts in the preceding “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Process for Disclosure and Recording of Liabilities Related to Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">section and are not material to the Company’s consolidated results of operations or financial condition. The Company is not able to estimate a possible loss or range of possible loss in excess of the recorded liability at this time.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Warranties/Guarantees</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has not issued any material financial guarantees of loans with third parties or other guarantee arrangements. Furthermore, the Company does not disclose information on its product warranties, as management considers the balance immaterial to its consolidated results of operations and financial condition.</span></div> 3000000 0 8000000 1000000 6000000 25000000 23000000 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company estimates insurance receivables based on an analysis of the terms of its numerous policies, including their exclusions, pertinent case law interpreting comparable policies, its experience with similar claims, and assessment of the nature of the claim and remaining coverage, and records an amount it has concluded is recognizable and expects to receive in light of the loss recovery and/or gain contingency models under ASC 450, ASC 610-30, and related guidance. For those insured legal proceedings for which the Company has recorded an accrued liability in its financial statements, the Company also records receivables for the amount of insurance that it concludes as recognizable from the Company’s insurance program. For those insured matters for which the Company has not recorded an accrued liability because the liability is not probable or the amount of the liability is not estimable, or both, but for which the Company has incurred an expense in defending itself, the Company records receivables for the amount of insurance that it concludes as recognizable for the expense incurred.</span></div> 7500 1 34 15 8 2 1 1 2 61 2 2 2 1 Earnings Per Share<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Earnings Per Share</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the completion of the Spin-Off, the Company had no common shares issued and outstanding. On April 1, 2024, there were 172,709,505 shares of Solventum common stock issued and outstanding as part of the Distribution. This share amount is utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off. For the three and nine months ended September 30, 2023, these shares are treated as issued and outstanding for purposes of calculating historical earnings per share. For periods prior to the Spin-Off, it is assumed that there are no dilutive equity instruments as there were no equity awards of Solventum outstanding prior to the Spin-Off.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The computations for basic and diluted earnings per share follow:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Amounts in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Weighted average common shares outstanding </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%"> basic </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">173.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">172.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">173.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">172.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dilution associated with stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Weighted average common shares outstanding – diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">0.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">0.70 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.66 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.58 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6.22 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 0 0 172709505 172709505 <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The computations for basic and diluted earnings per share follow:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Amounts in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:15pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Weighted average common shares outstanding </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">–</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%"> basic </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">173.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">172.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">173.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">172.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dilution associated with stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Weighted average common shares outstanding – diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">0.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">0.70 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.66 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2.58 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6.22 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 122000000 460000000 448000000 1074000000 173400000 172700000 173100000 172700000 500000 0 300000 0 173900000 172700000 173400000 172700000 0.70 2.66 2.59 6.22 0.70 2.66 2.58 6.22 Stock-Based Compensation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Spin-Off, certain eligible employees were awarded incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units (RSUs), performance share units (PSUs) and other stock awards under 3M's Amended and Restated 2016 Long-Term Incentive Plan (3M Company Plan). Stock-based compensation granted pursuant to the 3M Company Plan was based on 3M’s common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2024, 3M's Board of Directors approved the 2024 Long-Term Incentive Plan (Solventum 2024 Plan) providing for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, RSUs, PSUs, and other stock or cash-based awards to eligible employees and non-employee directors. Stock-based compensation granted pursuant to the 2024 Long-Term Incentive Plan is based on Solventum's stock. The maximum shares that can be issued under the Solventum 2024 Plan is 13,000,000 shares.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Spin-Off, all awards granted under the 3M Company Plan for Solventum employees were converted into equivalent awards under the Solventum 2024 Plan subsequent to the Spin-Off in April 2024. This stock award modification at Spin-Off resulted in expense of $20 million in the nine months ended September 30, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stock-Based Compensation Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, RSUs, and PSUs, are provided in the following table. Capitalized stock-based compensation amounts were not material.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:45.133%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Research, development and related expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">27 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">87 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">32 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Income tax benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock-based compensation expenses, net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">22 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">74 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">24 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 13000000 20000000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amounts recognized in the financial statements with respect to stock-based compensation programs, which include stock options, RSUs, and PSUs, are provided in the following table. Capitalized stock-based compensation amounts were not material.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:45.133%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Research, development and related expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">27 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">87 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">32 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Income tax benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock-based compensation expenses, net of tax</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">22 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">74 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">24 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 3000000 1000000 12000000 7000000 22000000 4000000 61000000 18000000 2000000 1000000 14000000 7000000 27000000 6000000 87000000 32000000 5000000 2000000 13000000 8000000 22000000 4000000 74000000 24000000 Related Parties<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Related Party Transactions Prior to Spin-Off</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Spin-Off, the Company participated in centralized 3M treasury programs. This arrangement was not reflective of the manner in which the Company would have financed its operations had it been a standalone business separate from 3M during the periods presented prior to April 1, 2024. All adjustments relating to certain transactions among the Company and 3M, which include the transfer of the balance of cash to and from 3M, transfer of the balance of cash held in centralized cash management arrangements to and from 3M, and pushdown of all costs of doing business that were paid on behalf of the Company by 3M, are excluded from the asset and liability balances in the condensed combined balance sheets and have instead been reported within Net parent investment as a component of equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate Allocations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The condensed combined statements of income for periods prior to April 1, 2024 include general corporate expenses of 3M for services provided by 3M for certain corporate and shared service functions that were provided on a centralized basis, including the use of shared assets. Expenses had been included on a direct usage basis where costs were specifically identifiable to Solventum or allocated based on the Company’s pro rata proportion of 3M's revenue. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management believes that the expense allocations were determined on a basis that was a reasonable reflection of the utilization of services provided for or the benefit received by the Company during each of the periods presented prior to April 1, 2024. The amounts that would have been incurred on a standalone basis could materially differ from the amounts allocated. Management does not believe, however, that it is practicable to estimate what these expenses would have been had the Company operated as an independent entity, including any expenses associated with obtaining any of these services from unaffiliated entities. There was no expense allocation activity after April 1, 2024. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3M expense allocations were recorded in the condensed combined statements of income within the following captions:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Costs of product</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Costs of software and rentals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">240 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">220 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">695 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Related Party Transactions After Spin-Off</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Separation and Distribution Agreement and Other Related Party Transactions with 3M</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Spin-Off on April 1, 2024, the Company entered into or adopted several agreements that provide a framework for Solventum's relationship with 3M after the separation and distribution. These include, but are not limited to, the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Separation and Distribution Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - The separation and distribution agreement contains key provisions related to the separation of Solventum from 3M, including the transfer of assets and assumptions of liabilities. In connection with this agreement, certain assets and liabilities included in the Company's condensed combined balance sheet as of March 31, 2024 were retained by 3M and certain assets and liabilities not included in the Company’s condensed combined balance sheet as of March 31, 2024 were transferred to Solventum as of the date of separation. Separation related adjustments resulted in a decrease to net assets and total equity of $1.1 billion and are reflected in the “Net transfers to 3M” line item of the condensed consolidated and combined statements of changes in equity. The impact on net assets primarily represent liabilities payable to 3M for services received prior to Spin-Off as well as cash and accounts receivable retained by 3M. </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Transition Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">- Transition services agreements include services that 3M will provide to Solventum and its affiliates, and Solventum and its affiliates will provide to 3M and its affiliates, on an interim, transitional basis.</span></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1) Transition services agreement. Includes various services, including, but not limited to, information technology support and access, logistics services, certain finance support functions, compliance reporting, human resources and toxicology laboratory support services. The transition services agreement has an overall term of two years.</span></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2) Transition distribution services agreement. Provides that 3M and its affiliates will retain inventories of and purchase certain Solventum products from Solventum and its subsidiaries and distribute those products to Solventum’s customers. The transition distribution services agreement has an overall term of two years, with shorter terms for individual countries. </span></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3) Transition contract manufacturing agreement. Solventum and 3M will manufacture certain products of the other party at specified manufacturing sites and will supply such products to the other party, in each case on a transitional basis to allow for the orderly exit of production at the supplier site and relocation. The transition contract manufacturing agreement has an overall term of three years, with the terms of individual services ranging from <span style="-sec-ix-hidden:f-909">eighteen</span> to thirty-six months.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three and nine months ended September 30, 2024, Solventum recognized operating expense of $144 million and $231 million, respectively, related to services received under the above transition agreements between the Company and 3M and its affiliates.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Tax Matters Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - The agreement governs the parties’ respective rights, responsibilities and obligations with respect to taxes (including responsibility for taxes, entitlement to refunds, allocation of tax attributes, preparation of tax returns, control of tax contests and other tax matters). In addition, the tax matters agreement imposes certain restrictions on Solventum and its subsidiaries (including restrictions on share issuances, business combinations, sales of assets and similar transactions) that are designed to preserve the tax-free status of the distribution and certain related transactions.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Employee Matters Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - The agreement allocates liabilities and responsibilities relating to employment matters, employee compensation and benefits plans and programs, and other related matters. The employee matters agreement provides that, unless otherwise specified, each party will be responsible for liabilities associated with current and former employees of such party and its subsidiaries. For the U.S. qualified and non-qualified defined benefit pension plans, Solventum established plans that mirror the corresponding 3M plans and assumed all obligations under 3M’s plans for the accrued benefits of current and former Solventum employees. The employee matters agreement also governs the terms of equity-based awards granted by 3M prior to separation. </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Real Estate License Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - Solventum or one of its affiliates, as licensee, has entered into certain real estate license agreements with 3M or one of its affiliates, as licensor, pursuant to which Solventum will be able to continue to use certain premises owned or leased by 3M for a limited period of time following the distribution date. Pursuant to the real estate license agreements, 3M will provide customary building services to the licensee consistent with the property’s use prior to the separation, including, without limitation, basic utilities, janitorial and trash removal services, maintenance services and employee amenities. The terms of the real estate license agreements are generally two years or less. </span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Master Supply Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - 3M and Solventum entered into master supply agreements in connection with the separation under which each agrees to supply the other with certain products. The term of the master supply agreements will initially be three years, which will extend automatically, with the length of the term extension subject to the parties' ability to identify a third-party supplier, and the ability for such third-party supplier to provide validated production samples. The Company recognized revenue and cost of sales associated with products sold to 3M of $17 million and $12 million, respectively, for the three months ended September 30, 2024. The Company recognized </span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">revenue and cost of sales associated with products sold to 3M of $27 million and $20 million, respectively, for the nine months ended September 30, 2024. Cost of sales related to purchases from 3M under the master supply agreements was $68 million for the three and nine months ended September 30, 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Related Party Transactions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had the following transactions with 3M and its affiliates, primarily in connection with the Transition Services Agreement, Transition Distribution Services Agreement, Transition Contract Manufacturing Agreements and Master Supply Agreements, reported on the Company’s condensed consolidated and combined financial statements:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Amounts in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net sales of product</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Cost of product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Current amounts due from and due to 3M under various agreements described above are recognized within the “Due from related parties” and “Due to related parties”, as applicable, in the condensed consolidated and combined financial statements. Non-current amounts due to 3M in connection with the transition distribution services agreement were approximately $72 million at September 30, 2024 and were recognized in “Other liabilities” in the consolidated balance sheet.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net Parent Investment</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net transfers to 3M are included within Net parent investment in the condensed consolidated and combined statements of changes in equity and within financing activities in the condensed consolidated and combined statements of cash flows and represent the net effect of transactions between the Company and 3M.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The reconciliation of net transfers to 3M between the condensed consolidated and combined changes in equity and the condensed consolidated and combined statements of cash flows are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net transfers to 3M on the condensed consolidated and combined changes in equity</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,575)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Multiemployer pension expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net balances transferred from 3M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net transfers to 3M on the condensed consolidated and combined statements of cash flows</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(487)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(8,247)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,248)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3M expense allocations were recorded in the condensed combined statements of income within the following captions:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Costs of product</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Costs of software and rentals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">551 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">240 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">220 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">695 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had the following transactions with 3M and its affiliates, primarily in connection with the Transition Services Agreement, Transition Distribution Services Agreement, Transition Contract Manufacturing Agreements and Master Supply Agreements, reported on the Company’s condensed consolidated and combined financial statements:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Amounts in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net sales of product</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Cost of product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">5 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The reconciliation of net transfers to 3M between the condensed consolidated and combined changes in equity and the condensed consolidated and combined statements of cash flows are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">(Millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net transfers to 3M on the condensed consolidated and combined changes in equity</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,575)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Stock compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Multiemployer pension expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net balances transferred from 3M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Net transfers to 3M on the condensed consolidated and combined statements of cash flows</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(487)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(8,247)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(1,248)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 25000000 15000000 60000000 0 0 0 186000000 177000000 551000000 29000000 28000000 84000000 240000000 220000000 695000000 1100000000 P2Y P2Y P3Y P36M 144000000 231000000 P2Y P3Y 17000000 12000000 27000000 20000000 68000000 68000000 17000000 0 27000000 0 171000000 0 201000000 0 63000000 0 135000000 0 2000000 0 5000000 0 72000000 0 473000000 8575000000 1190000000 0 6000000 4000000 32000000 0 8000000 5000000 26000000 0 0 -337000000 0 0 487000000 8247000000 1248000000 Business Segments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating segments include components of an enterprise where separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CODM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) for the purpose of assessing performance and allocating resources. The Company’s CODM is its Chief Executive Officer. The Company’s operating activities are managed through four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. There have been no changes to the composition of the segments or to financial information reported within each of the business segments. These segments have been identified based on the nature of the products sold and how the Company manages its operations. Transactions among reportable segments are recorded at cost. No operating segments have been aggregated to form reportable segments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Corporate and Unallocated includes amortization of acquired intangible assets, restructuring and related charges, benefits or costs related to capitalized manufacturing variances, Spin-Off and separation related costs and other net costs that the Company chose not to allocate directly to its business segments. Spin-Off and separation related costs include any costs incurred as part of our separation from 3M and costs to setup operations as a standalone company, including system implementations, manufacturing relocation, legal entity separation, certain equity awards granted as part of the Spin-Off, profit mark-ups on transition service arrangements with 3M and other one-time costs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Corporate and Unallocated also includes sales and cost of sales related to products supplied to 3M and other supply agreements related to legacy 3M business and assumed by the Company at Spin-Off. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. Business segment operating income is reconciled to total operating income and pre-tax income below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consistent accounting policies have been applied by all segments for all reporting periods. A description of our reportable segments has been provided in Note 1 to the audited combined financial statements within the Company’s Information Statement dated March 11, 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Business Segment Information</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Net Sales (Millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">MedSurg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,180 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,463 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,464 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dental Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,023 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Health Information Systems</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">971 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,082 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,074 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,179 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,161 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Operating Performance (Millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">MedSurg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">243 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">678 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dental Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Health Information Systems</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total business segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">583 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,345 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Corporate and Unallocated:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other corporate and unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(165)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(79)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total Company operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">275 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">504 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">900 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other expense/(income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">167 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">500 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">592 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,276 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 4 <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Net Sales (Millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">MedSurg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,180 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,463 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">3,464 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dental Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">313 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,023 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Health Information Systems</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">971 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,082 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">2,074 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,179 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">6,161 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">Operating Performance (Millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:119%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">MedSurg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">243 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">678 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Dental Solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Health Information Systems</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Purification and Filtration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total business segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">583 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,345 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Corporate and Unallocated:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other corporate and unallocated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Total Corporate and Unallocated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(165)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(79)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">(330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Total Company operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">275 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">504 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">900 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">Other expense/(income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">167 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">500 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">592 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">1,276 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1182000000 1180000000 3463000000 3464000000 313000000 331000000 979000000 1023000000 326000000 321000000 971000000 953000000 238000000 242000000 721000000 721000000 23000000 0 45000000 0 2082000000 2074000000 6179000000 6161000000 243000000 307000000 678000000 829000000 72000000 114000000 272000000 349000000 105000000 114000000 317000000 304000000 20000000 48000000 78000000 134000000 440000000 583000000 1345000000 1616000000 -88000000 -92000000 -261000000 -276000000 -77000000 13000000 -184000000 -54000000 -165000000 -79000000 -445000000 -330000000 275000000 504000000 900000000 1286000000 -107000000 0 -260000000 0 -1000000 -4000000 -48000000 -10000000 167000000 500000000 592000000 1276000000 false false false false